data_5mou_residue save_MolProbity _Software.Sf_category software _Software.Sf_framecode MolProbity _Software.Entry_ID ? _Software.ID 1 _Software.Name MolProbity _Software.Version 4.0 _Software.Details . save_ save_CYRANGE _Software.Sf_category software _Software.Sf_framecode CYRANGE _Software.Entry_ID ? _Software.ID 2 _Software.Name CYRANGE _Software.Version 2.0 _Software.Details . save_ save_Structure_validation_residue _Structure_validation_residue.Sf_category structure_validation _Structure_validation_residue.Sf_framecode Structure_validation_residue _Structure_validation_residue.Entry_ID ? _Structure_validation_residue.List_ID 1 _Structure_validation_residue.PDB_accession_code 5mou _Structure_validation_residue.Date_analyzed 2018-01-12 loop_ _Residue_analysis_software.Software_ID _Residue_analysis_software.Software_label _Residue_analysis_software.Method_ID _Residue_analysis_software.Method_label _Residue_analysis_software.Entry_ID _Residue_analysis_software.Structure_validation_oneline_list_ID 1 MolProbity . . ? 1 2 CYRANGE . . ? 1 stop_ loop_ _Residue_analysis.ID _Residue_analysis.PDB_model_num _Residue_analysis.Hydrogen_positions _Residue_analysis.MolProbity_flips _Residue_analysis.Cyrange_core_flag _Residue_analysis.Two_letter_chain_ID _Residue_analysis.PDB_strand_ID _Residue_analysis.PDB_residue_no _Residue_analysis.PDB_ins_code _Residue_analysis.PDB_residue_name _Residue_analysis.Assembly_ID _Residue_analysis.Entity_assembly_ID _Residue_analysis.Entity_ID _Residue_analysis.Comp_ID _Residue_analysis.Comp_index_ID _Residue_analysis.Clash_value _Residue_analysis.Clash_source_PDB_atom_name _Residue_analysis.Clash_destination_PDB_atom_name _Residue_analysis.Clash_destination_PDB_strand_ID _Residue_analysis.Clash_destination_PDB_residue_no _Residue_analysis.Clash_destination_PDB_ins_code _Residue_analysis.Clash_destination_PDB_residue_name _Residue_analysis.Cbeta_deviation_value _Residue_analysis.Rotamer_score _Residue_analysis.Rotamer_name _Residue_analysis.Ramachandran_phi _Residue_analysis.Ramachandran_psi _Residue_analysis.Ramachandran_score _Residue_analysis.Ramachandran_evaluation _Residue_analysis.Ramachandran_type _Residue_analysis.Bond_outlier_count _Residue_analysis.Worst_bond _Residue_analysis.Worst_bond_value _Residue_analysis.Worst_bond_sigma _Residue_analysis.Angle_outlier_count _Residue_analysis.Worst_angle _Residue_analysis.Worst_angle_value _Residue_analysis.Worst_angle_sigma _Residue_analysis.RNA_phosphate_perpendicular_outlier _Residue_analysis.RNA_suitness_score _Residue_analysis.RNA_suite_conformer _Residue_analysis.RNA_suite_triage _Residue_analysis.Max_b_factor _Residue_analysis.Tau_angle _Residue_analysis.Omega_dihedral _Residue_analysis.Disulfide_chi1 _Residue_analysis.Disulfide_chi2 _Residue_analysis.Disulfide_chi3 _Residue_analysis.Disulfide_ss_angle _Residue_analysis.Disulfide_ss _Residue_analysis.Disulfide_ss_angle_prime _Residue_analysis.Disulfide_chi2prime _Residue_analysis.Disulfide_chi1prime _Residue_analysis.Outlier_count_separate_geometry _Residue_analysis.Outlier_count _Residue_analysis.Entry_ID _Residue_analysis.Structure_validation_residue_list_ID . 001 nuclear orig core ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.231 0.115 0 CA-C-O 120.793 0.33 . . . . 0.0 111.095 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 2' ' ' ARG . . . . . 0.439 ' HD3' ' N ' ' A' ' 2' ' ' ARG . 0.0 OUTLIER -150.71 -177.28 5.89 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.898 -179.921 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 3' ' ' ASP . . . . . 0.415 ' CG ' HD13 ' A' ' 51' ' ' ILE . 9.5 m-20 -107.23 134.08 50.86 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.881 179.932 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -175.67 -174.66 0.7 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.165 -0.47 . . . . 0.0 111.138 179.999 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 5' ' ' TYR . . . . . 0.458 ' CE1' ' CZ3' ' A' ' 49' ' ' TRP . 2.0 m-85 -85.06 135.07 34.16 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.883 -179.835 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 6' ' ' ILE . . . . . 0.478 ' CG2' ' HB3' ' A' ' 48' ' ' CYS . 3.7 tt -75.93 134.08 29.85 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.111 -0.495 . . . . 0.0 111.185 179.868 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -85.78 152.01 23.37 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.211 -0.45 . . . . 0.0 111.096 179.873 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 8' ' ' LYS . . . . . 0.532 ' HB2' ' CZ ' ' A' ' 14' ' ' TYR . 0.0 OUTLIER -135.19 167.22 23.7 Favored Pre-proline 0 C--N 1.329 -0.306 0 CA-C-O 121.593 0.711 . . . . 0.0 110.864 179.963 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 9' ' ' PRO . . . . . 0.529 ' HA ' ' HA ' ' A' ' 10' ' ' HIS . 53.9 Cg_endo -69.73 105.93 1.57 Allowed 'Trans proline' 0 C--N 1.342 0.192 0 C-N-CA 122.703 2.269 . . . . 0.0 112.35 179.873 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 10' ' ' HIS . . . . . 0.529 ' HA ' ' HA ' ' A' ' 9' ' ' PRO . 11.3 m-70 -131.4 127.73 38.1 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.855 -0.067 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 11' ' ' ASN . . . . . 0.412 ' N ' ' O ' ' A' ' 8' ' ' LYS . 4.2 t30 61.36 26.62 16.39 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.889 -179.945 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 1.6 m -107.14 154.9 20.5 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.89 -179.998 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 13' ' ' VAL . . . . . 0.462 HG12 ' NE ' ' A' ' 60' ' ' ARG . 0.9 OUTLIER -84.83 154.44 3.57 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.169 179.923 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 14' ' ' TYR . . . . . 0.532 ' CZ ' ' HB2' ' A' ' 8' ' ' LYS . 9.5 m-85 -94.75 89.75 5.82 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.944 -179.912 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 3.3 pt-20 -64.65 125.41 24.65 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.89 -179.965 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 1.1 p -101.55 134.38 44.75 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.864 -179.901 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 17' ' ' TYR . . . . . 0.4 ' O ' ' HD3' ' A' ' 19' ' ' PRO . 4.8 m-30 -99.49 -28.18 13.37 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.929 -179.926 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -106.44 82.94 1.06 Allowed Pre-proline 0 C--N 1.329 -0.303 0 CA-C-O 121.616 0.722 . . . . 0.0 110.885 -179.987 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 19' ' ' PRO . . . . . 0.444 ' HA ' ' CB ' ' A' ' 38' ' ' CYS . 53.5 Cg_endo -69.76 -26.56 27.47 Favored 'Trans proline' 0 C--N 1.342 0.199 0 C-N-CA 122.632 2.221 . . . . 0.0 112.372 179.928 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 20' ' ' LYS . . . . . 0.466 ' HD3' ' N ' ' A' ' 20' ' ' LYS . 0.0 OUTLIER -94.18 24.54 4.31 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.849 179.943 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -136.28 -178.84 16.08 Favored Glycine 0 N--CA 1.452 -0.299 0 C-N-CA 120.763 -0.732 . . . . 0.0 112.497 179.923 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 2.0 p -94.2 28.76 2.38 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.871 0.367 . . . . 0.0 110.855 -179.737 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 0.9 OUTLIER -59.84 -66.67 0.48 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.909 -179.88 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 24' ' ' CYS . . . . . 0.484 ' SG ' ' N ' ' A' ' 49' ' ' TRP . 53.2 t -60.47 -38.3 83.78 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.89 179.986 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 25' ' ' ASN . . . . . 0.438 ' HA ' ' CA ' ' A' ' 36' ' ' GLY . 1.7 t30 -54.89 -57.05 13.19 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.903 -179.993 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -57.6 -51.37 69.78 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.863 179.95 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 2.2 tp -57.13 -38.8 74.01 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.908 -179.967 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 28' ' ' CYS . . . . . 0.407 ' SG ' ' O ' ' A' ' 49' ' ' TRP . 19.1 m -62.41 -50.6 70.87 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.899 179.905 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 1.1 p -62.78 -25.02 68.02 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.14 -179.97 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 6.8 tp10 -58.96 -22.75 60.7 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.938 179.992 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 1.9 m-80 -103.66 22.6 14.11 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.103 -0.498 . . . . 0.0 110.902 -179.949 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 84.15 18.83 62.03 Favored Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 120.765 -0.731 . . . . 0.0 112.515 -179.988 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 33' ' ' ALA . . . . . 0.477 ' CB ' HD11 ' A' ' 53' ' ' LEU . . . -85.4 152.37 23.29 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.733 0.301 . . . . 0.0 111.122 179.931 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . 0.459 ' CB ' ' HB2' ' A' ' 52' ' ' GLN . 4.3 tt0 -78.66 -33.07 47.38 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.233 -0.439 . . . . 0.0 110.886 -179.93 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 1.7 m -162.77 -177.2 5.39 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.844 -179.772 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 36' ' ' GLY . . . . . 0.438 ' CA ' ' HA ' ' A' ' 25' ' ' ASN . . . -174.92 157.54 24.7 Favored Glycine 0 N--CA 1.452 -0.284 0 C-N-CA 120.759 -0.734 . . . . 0.0 112.489 -179.984 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 37' ' ' TYR . . . . . 0.581 ' CE2' ' CD1' ' A' ' 49' ' ' TRP . 5.0 p90 -157.64 159.63 37.2 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.863 0.363 . . . . 0.0 110.918 -179.823 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 38' ' ' CYS . . . . . 0.444 ' CB ' ' HA ' ' A' ' 19' ' ' PRO . 21.3 t -74.88 119.47 19.1 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.913 179.999 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -98.49 126.03 43.91 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.913 -179.983 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 40' ' ' ILE . . . . . 0.518 ' CD1' ' N ' ' A' ' 40' ' ' ILE . 1.2 mp -95.97 -35.98 6.2 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.102 179.972 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 4.2 mm? -75.66 53.01 0.69 Allowed 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.934 179.922 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -105.72 138.91 14.53 Favored Glycine 0 N--CA 1.452 -0.296 0 C-N-CA 120.758 -0.734 . . . . 0.0 112.462 179.94 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -57.45 -27.6 62.6 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.83 0.348 . . . . 0.0 110.908 -179.962 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 0.6 OUTLIER -109.22 23.72 14.11 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.903 -179.959 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 93.37 -139.08 14.42 Favored Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.734 -0.745 . . . . 0.0 112.527 -179.978 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 46' ' ' ASN . . . . . 0.46 ' ND2' ' HA ' ' A' ' 40' ' ' ILE . 9.9 m120 -82.96 116.22 22.15 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.821 0.343 . . . . 0.0 110.894 -179.914 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -125.71 141.57 51.95 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.098 179.864 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 48' ' ' CYS . . . . . 0.478 ' HB3' ' CG2' ' A' ' 6' ' ' ILE . 19.5 t -65.47 114.92 5.2 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.883 -179.967 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 49' ' ' TRP . . . . . 0.581 ' CD1' ' CE2' ' A' ' 37' ' ' TYR . 61.7 t-105 -94.1 135.2 35.72 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.947 179.955 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 50' ' ' CYS . . . . . . . . . . . . . 42.1 m -122.1 142.04 50.78 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.851 -179.97 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 51' ' ' ILE . . . . . 0.415 HD13 ' CG ' ' A' ' 3' ' ' ASP . 14.4 mm -111.01 134.48 53.18 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.139 179.895 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 52' ' ' GLN . . . . . 0.459 ' HB2' ' CB ' ' A' ' 34' ' ' GLU . 3.2 mm-40 65.08 44.58 3.32 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.884 179.926 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 53' ' ' LEU . . . . . 0.477 HD11 ' CB ' ' A' ' 33' ' ' ALA . 14.5 tp -85.93 134.34 39.43 Favored Pre-proline 0 C--N 1.328 -0.35 0 CA-C-O 121.631 0.729 . . . . 0.0 110.945 179.955 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 54' ' ' PRO . . . . . 0.468 ' HD2' ' CD1' ' A' ' 53' ' ' LEU . 53.3 Cg_endo -69.74 145.42 57.22 Favored 'Trans proline' 0 C--N 1.342 0.184 0 C-N-CA 122.656 2.238 . . . . 0.0 112.323 179.898 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -62.58 -7.75 5.25 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.851 179.915 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 27.6 m120 -76.17 -25.31 55.11 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.913 -179.886 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 57' ' ' VAL . . . . . 0.467 ' CG1' ' HD2' ' A' ' 58' ' ' PRO . 10.7 t -92.17 136.24 26.06 Favored Pre-proline 0 C--N 1.33 -0.264 0 CA-C-O 121.634 0.73 . . . . 0.0 111.087 179.928 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 58' ' ' PRO . . . . . 0.467 ' HD2' ' CG1' ' A' ' 57' ' ' VAL . 53.9 Cg_endo -69.78 152.53 69.24 Favored 'Trans proline' 0 C--N 1.342 0.193 0 C-N-CA 122.644 2.229 . . . . 0.0 112.366 179.936 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 19.1 pt -125.3 166.3 21.29 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.169 179.91 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 60' ' ' ARG . . . . . 0.468 ' HD2' ' N ' ' A' ' 61' ' ' ILE . 6.7 tpt180 -65.95 116.17 6.81 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.891 179.935 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . 0.468 ' N ' ' HD2' ' A' ' 60' ' ' ARG . 1.0 OUTLIER -117.31 160.13 38.84 Favored Pre-proline 0 C--N 1.329 -0.31 0 CA-C-O 121.606 0.717 . . . . 0.0 111.096 -179.996 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.77 64.81 1.81 Allowed 'Trans proline' 0 C--N 1.342 0.2 0 C-N-CA 122.631 2.221 . . . . 0.0 112.384 179.853 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -136.03 -178.65 15.92 Favored Glycine 0 N--CA 1.451 -0.355 0 C-N-CA 120.719 -0.753 . . . . 0.0 112.474 -179.986 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 1.1 tppp? -85.22 140.29 30.99 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.817 0.341 . . . . 0.0 110.925 179.952 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 65' ' ' CYS . . . . . 0.497 ' SG ' ' N ' ' A' ' 66' ' ' HIS . 1.0 OUTLIER -94.55 160.88 14.44 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.872 179.963 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 66' ' ' HIS . . . . . 0.497 ' N ' ' SG ' ' A' ' 65' ' ' CYS . 7.3 p80 . . . . . 0 C--N 1.329 -0.298 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.824 -179.985 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.231 0.131 0 CA-C-O 120.77 0.319 . . . . 0.0 111.095 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 18.0 ptt180 -147.27 161.19 41.46 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.89 -179.965 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 3' ' ' ASP . . . . . 0.444 ' HB3' ' CZ2' ' A' ' 49' ' ' TRP . 2.9 m-20 -96.71 134.04 40.49 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.869 -179.988 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 4' ' ' ALA . . . . . 0.589 ' HA ' ' CZ3' ' A' ' 49' ' ' TRP . . . -174.83 -179.09 1.37 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.097 179.982 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 5' ' ' TYR . . . . . 0.403 ' CE2' ' HE3' ' A' ' 49' ' ' TRP . 16.0 m-85 -84.81 135.44 34.1 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.96 -179.857 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 5.5 tt -75.42 137.09 23.6 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.108 -0.496 . . . . 0.0 111.148 179.936 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -91.41 158.47 16.5 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.103 179.816 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 8' ' ' LYS . . . . . 0.525 ' HB2' ' CZ ' ' A' ' 14' ' ' TYR . 0.0 OUTLIER -134.72 166.26 30.51 Favored Pre-proline 0 C--N 1.328 -0.327 0 CA-C-O 121.632 0.729 . . . . 0.0 110.87 -179.988 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 9' ' ' PRO . . . . . 0.501 ' HA ' ' HA ' ' A' ' 10' ' ' HIS . 53.7 Cg_endo -69.79 106.97 1.76 Allowed 'Trans proline' 0 C--N 1.342 0.231 0 C-N-CA 122.666 2.244 . . . . 0.0 112.345 179.891 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 10' ' ' HIS . . . . . 0.501 ' HA ' ' HA ' ' A' ' 9' ' ' PRO . 7.7 m-70 -132.08 125.12 30.6 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.865 -0.069 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 2.3 t30 65.49 44.29 3.12 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.902 -179.896 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 1.6 m -128.81 155.47 45.13 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.873 -179.983 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 13' ' ' VAL . . . . . 0.421 ' CG1' ' NE ' ' A' ' 60' ' ' ARG . 2.7 m -86.5 153.53 3.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.115 179.958 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 14' ' ' TYR . . . . . 0.525 ' CZ ' ' HB2' ' A' ' 8' ' ' LYS . 9.1 m-85 -95.09 100.7 12.48 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.931 -179.942 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 4.9 tm-20 -64.54 137.1 57.66 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.099 -0.501 . . . . 0.0 110.85 -179.945 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 9.1 p -84.83 126.01 33.09 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.864 -179.942 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -100.63 -24.56 14.41 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.903 -179.88 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -134.54 85.15 37.99 Favored Pre-proline 0 C--N 1.329 -0.307 0 CA-C-O 121.555 0.693 . . . . 0.0 110.897 -179.989 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.76 -25.08 28.94 Favored 'Trans proline' 0 C--O 1.231 0.147 0 C-N-CA 122.689 2.259 . . . . 0.0 112.372 179.929 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -94.42 24.23 4.66 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.893 179.914 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -142.88 -174.61 15.33 Favored Glycine 0 N--CA 1.452 -0.279 0 C-N-CA 120.699 -0.763 . . . . 0.0 112.46 179.903 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 50.3 m -95.25 29.14 2.58 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.867 0.365 . . . . 0.0 110.871 -179.729 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 43.9 t80 -64.52 -71.61 0.17 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.921 -179.853 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 42.0 t -55.19 -39.9 70.12 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.824 -179.995 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 1.3 t30 -57.1 -55.57 32.96 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.895 179.998 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 4.5 m-20 -54.68 -53.33 56.34 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.895 179.94 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 2.1 tp -60.08 -36.38 77.25 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.918 -179.976 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 28' ' ' CYS . . . . . 0.458 ' CB ' ' HA3' ' A' ' 36' ' ' GLY . 1.3 m -64.73 -60.72 2.78 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.868 179.89 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 29' ' ' THR . . . . . 0.417 ' HA ' ' O ' ' A' ' 33' ' ' ALA . 1.1 p -62.75 -27.09 69.04 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.165 -0.47 . . . . 0.0 111.126 -179.971 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 9.5 tp10 -54.75 -19.83 7.16 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.253 -0.43 . . . . 0.0 110.861 -179.981 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 1.8 m-80 -101.81 21.99 13.66 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.154 -0.476 . . . . 0.0 110.914 -179.96 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 95.81 -12.66 67.14 Favored Glycine 0 N--CA 1.451 -0.302 0 C-N-CA 120.773 -0.727 . . . . 0.0 112.489 179.996 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 33' ' ' ALA . . . . . 0.534 ' CB ' ' CD1' ' A' ' 53' ' ' LEU . . . -62.17 155.27 24.89 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 120.742 0.306 . . . . 0.0 111.094 179.989 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . 0.484 ' HB2' ' CB ' ' A' ' 52' ' ' GLN . 2.7 tt0 -80.88 -31.46 35.27 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.9 -179.939 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 46.2 m -162.77 177.92 8.91 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.881 -179.771 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 36' ' ' GLY . . . . . 0.458 ' HA3' ' CB ' ' A' ' 28' ' ' CYS . . . -175.24 157.27 23.9 Favored Glycine 0 N--CA 1.452 -0.277 0 C-N-CA 120.8 -0.714 . . . . 0.0 112.501 -179.976 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 37' ' ' TYR . . . . . 0.545 ' CE2' HD13 ' A' ' 51' ' ' ILE . 0.6 OUTLIER -165.27 173.55 11.13 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.942 0.401 . . . . 0.0 110.904 -179.811 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 38' ' ' CYS . . . . . . . . . . . . . 41.9 t -74.72 120.28 20.05 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.858 -179.98 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 39' ' ' GLN . . . . . 0.478 ' OE1' ' CE3' ' A' ' 49' ' ' TRP . 3.8 tt0 -104.64 125.26 50.58 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.91 179.99 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 40' ' ' ILE . . . . . 0.495 ' CD1' ' N ' ' A' ' 40' ' ' ILE . 1.3 mp -95.44 -25.25 4.53 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.159 179.942 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -81.11 40.91 0.56 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.919 179.918 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -97.38 134.49 11.77 Favored Glycine 0 N--CA 1.452 -0.296 0 C-N-CA 120.752 -0.737 . . . . 0.0 112.474 179.907 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -54.14 -25.05 20.25 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.762 0.315 . . . . 0.0 110.861 -179.992 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 44' ' ' TYR . . . . . 0.488 ' CE1' ' CG ' ' A' ' 60' ' ' ARG . 0.6 OUTLIER -108.6 23.76 14.06 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.964 -179.964 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 93.42 -134.47 12.14 Favored Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.734 -0.746 . . . . 0.0 112.477 179.944 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 46' ' ' ASN . . . . . 0.48 ' ND2' ' HA ' ' A' ' 40' ' ' ILE . 27.8 m120 -91.51 118.82 30.92 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.844 0.354 . . . . 0.0 110.86 -179.884 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -137.33 148.52 46.37 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.099 179.842 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 48' ' ' CYS . . . . . 0.422 ' SG ' ' SG ' ' A' ' 28' ' ' CYS . 11.9 t -65.91 108.76 2.27 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.917 -179.976 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 49' ' ' TRP . . . . . 0.589 ' CZ3' ' HA ' ' A' ' 4' ' ' ALA . 36.3 t-105 -94.67 122.75 37.59 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.913 179.995 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 50' ' ' CYS . . . . . . . . . . . . . 4.9 m -107.79 135.13 49.72 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.844 -179.947 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 51' ' ' ILE . . . . . 0.545 HD13 ' CE2' ' A' ' 37' ' ' TYR . 4.2 mp -100.07 138.8 23.26 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.137 179.911 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 52' ' ' GLN . . . . . 0.484 ' CB ' ' HB2' ' A' ' 34' ' ' GLU . 5.7 mm-40 65.38 42.0 4.04 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.929 179.939 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 53' ' ' LEU . . . . . 0.534 ' CD1' ' CB ' ' A' ' 33' ' ' ALA . 12.7 tp -85.28 132.79 44.08 Favored Pre-proline 0 C--N 1.329 -0.32 0 CA-C-O 121.628 0.728 . . . . 0.0 110.941 -179.987 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 54' ' ' PRO . . . . . 0.438 ' HG2' ' CG2' ' A' ' 57' ' ' VAL . 53.5 Cg_endo -69.78 145.63 57.61 Favored 'Trans proline' 0 C--N 1.342 0.214 0 C-N-CA 122.694 2.263 . . . . 0.0 112.336 179.91 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 40.5 m-20 -62.89 -7.75 5.75 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.855 179.915 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 2.5 m120 -76.51 -25.64 54.4 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.908 -179.908 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 57' ' ' VAL . . . . . 0.466 ' CG1' ' HD2' ' A' ' 58' ' ' PRO . 12.1 t -92.01 136.23 26.3 Favored Pre-proline 0 C--N 1.33 -0.265 0 CA-C-O 121.642 0.734 . . . . 0.0 111.112 179.926 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 58' ' ' PRO . . . . . 0.466 ' HD2' ' CG1' ' A' ' 57' ' ' VAL . 53.6 Cg_endo -69.77 145.68 57.79 Favored 'Trans proline' 0 C--N 1.342 0.196 0 C-N-CA 122.691 2.261 . . . . 0.0 112.331 179.93 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 14.7 pt -124.23 173.8 9.51 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.111 179.914 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 60' ' ' ARG . . . . . 0.488 ' CG ' ' CE1' ' A' ' 44' ' ' TYR . 0.6 OUTLIER -69.04 118.8 12.4 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.879 179.965 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 1.3 pt -118.14 160.59 38.62 Favored Pre-proline 0 C--N 1.329 -0.307 0 CA-C-O 121.642 0.734 . . . . 0.0 111.082 -179.964 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.73 66.34 1.76 Allowed 'Trans proline' 0 C--N 1.342 0.191 0 C-N-CA 122.667 2.244 . . . . 0.0 112.314 179.897 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -141.61 179.41 19.72 Favored Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 120.761 -0.733 . . . . 0.0 112.517 179.934 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 6.0 mmmm -83.38 142.01 31.33 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.804 0.335 . . . . 0.0 110.898 -179.955 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 65' ' ' CYS . . . . . 0.585 ' O ' ' CD2' ' A' ' 66' ' ' HIS . 1.7 t -89.31 156.27 18.84 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.872 179.97 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 66' ' ' HIS . . . . . 0.585 ' CD2' ' O ' ' A' ' 65' ' ' CYS . 16.9 p80 . . . . . 0 C--N 1.329 -0.314 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.883 179.963 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 1' ' ' ALA . . . . . 0.411 ' HB2' ' C ' ' A' ' 53' ' ' LEU . . . . . . . . 0 C--O 1.231 0.124 0 CA-C-O 120.801 0.334 . . . . 0.0 111.079 . . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -135.37 162.28 33.05 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.865 -179.92 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 3' ' ' ASP . . . . . 0.499 ' OD2' ' CG2' ' A' ' 51' ' ' ILE . 1.8 m-20 -97.77 133.13 42.71 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.887 179.989 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 4' ' ' ALA . . . . . 0.597 ' HA ' ' CZ3' ' A' ' 49' ' ' TRP . . . -172.82 -177.95 1.76 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.103 179.937 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 5' ' ' TYR . . . . . 0.618 ' CE2' ' OE1' ' A' ' 39' ' ' GLN . 68.9 m-85 -84.36 136.66 33.79 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.24 -0.437 . . . . 0.0 110.904 -179.845 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 5.0 tt -74.93 134.7 28.87 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 116.12 -0.491 . . . . 0.0 111.097 179.929 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 7' ' ' ALA . . . . . 0.424 ' HB3' ' C ' ' A' ' 59' ' ' ILE . . . -93.48 156.73 16.58 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.085 179.815 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 8' ' ' LYS . . . . . 0.532 ' HB2' ' CZ ' ' A' ' 14' ' ' TYR . 0.0 OUTLIER -140.2 168.01 16.21 Favored Pre-proline 0 C--N 1.329 -0.297 0 CA-C-O 121.521 0.677 . . . . 0.0 110.886 179.991 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 9' ' ' PRO . . . . . 0.496 ' HA ' ' HA ' ' A' ' 10' ' ' HIS . 53.6 Cg_endo -69.74 107.95 1.97 Allowed 'Trans proline' 0 C--O 1.232 0.206 0 C-N-CA 122.665 2.243 . . . . 0.0 112.332 179.904 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 10' ' ' HIS . . . . . 0.496 ' HA ' ' HA ' ' A' ' 9' ' ' PRO . 5.2 m-70 -131.65 128.59 39.38 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.255 -0.429 . . . . 0.0 110.834 -0.065 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 2.4 t30 58.74 35.92 24.61 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.893 -179.889 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 1.5 m -119.38 152.29 37.05 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.878 179.981 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 13' ' ' VAL . . . . . 0.461 ' CG1' ' NE ' ' A' ' 60' ' ' ARG . 0.9 OUTLIER -84.55 156.04 3.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.143 -0.481 . . . . 0.0 111.169 179.903 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 14' ' ' TYR . . . . . 0.532 ' CZ ' ' HB2' ' A' ' 8' ' ' LYS . 9.3 m-85 -94.89 100.86 12.66 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.908 -179.889 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 38.1 tt0 -64.92 133.63 52.24 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.079 -0.509 . . . . 0.0 110.892 -179.996 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 1.0 OUTLIER -85.14 133.54 34.2 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.879 -179.949 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 9.3 t80 -121.54 24.89 9.64 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.902 -179.91 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 18' ' ' ASN . . . . . 0.45 ' CB ' ' HB2' ' A' ' 23' ' ' TYR . 9.8 t-20 -154.38 80.26 4.76 Favored Pre-proline 0 C--N 1.329 -0.293 0 CA-C-O 121.647 0.736 . . . . 0.0 110.882 179.959 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -69.76 -23.98 30.19 Favored 'Trans proline' 0 C--N 1.341 0.182 0 C-N-CA 122.702 2.268 . . . . 0.0 112.385 179.922 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 21.4 mtpp -94.52 -24.42 17.28 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.858 179.938 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -102.89 175.98 24.51 Favored Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.763 -0.732 . . . . 0.0 112.46 179.994 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 10.0 p -95.35 26.09 4.02 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.915 0.388 . . . . 0.0 110.874 -179.757 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 23' ' ' TYR . . . . . 0.45 ' HB2' ' CB ' ' A' ' 18' ' ' ASN . 34.4 t80 -44.59 -46.86 10.24 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.953 -179.881 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 53.9 t -65.67 -46.15 80.17 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.073 -0.512 . . . . 0.0 110.884 179.994 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -54.68 -51.78 64.45 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.859 -179.965 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -55.22 -52.1 64.45 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.84 179.945 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 1.8 tp -59.88 -35.55 75.06 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.88 -179.928 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 28' ' ' CYS . . . . . 0.4 ' O ' ' HB2' ' A' ' 33' ' ' ALA . 2.5 m -64.91 -53.2 50.2 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.887 179.919 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 1.1 p -62.63 -24.61 67.69 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.152 -0.476 . . . . 0.0 111.149 -179.981 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 5.6 mt-10 -59.45 -22.12 61.03 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.862 -179.982 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 3.6 m-80 -103.28 21.81 15.24 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.91 -179.968 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 83.34 18.83 63.6 Favored Glycine 0 N--CA 1.451 -0.332 0 C-N-CA 120.768 -0.729 . . . . 0.0 112.512 -179.999 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 33' ' ' ALA . . . . . 0.51 ' HB2' ' CD1' ' A' ' 53' ' ' LEU . . . -85.08 148.15 26.29 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.774 0.321 . . . . 0.0 111.099 179.954 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . 0.465 ' HB2' ' CB ' ' A' ' 52' ' ' GLN . 7.8 tt0 -74.7 -31.91 62.02 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.883 -179.943 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 53.9 m -162.1 177.13 9.99 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.813 -179.801 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -172.17 151.75 15.45 Favored Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.777 -0.725 . . . . 0.0 112.505 -179.983 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 37' ' ' TYR . . . . . 0.402 ' HE1' ' CD1' ' A' ' 49' ' ' TRP . 1.1 p90 -154.24 160.4 41.8 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 120.944 0.402 . . . . 0.0 110.897 -179.756 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 38' ' ' CYS . . . . . . . . . . . . . 6.1 t -77.23 119.2 20.57 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.856 179.986 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 39' ' ' GLN . . . . . 0.622 ' NE2' ' N ' ' A' ' 42' ' ' GLY . 0.7 OUTLIER -96.01 117.05 29.9 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.908 -179.986 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 40' ' ' ILE . . . . . 0.443 ' HA ' ' ND2' ' A' ' 46' ' ' ASN . 0.8 OUTLIER -96.58 -36.22 6.19 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.131 -0.486 . . . . 0.0 111.109 179.983 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 7.1 mt -84.52 55.88 3.59 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.911 179.895 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . 0.622 ' N ' ' NE2' ' A' ' 39' ' ' GLN . . . -105.27 -167.01 23.87 Favored Glycine 0 N--CA 1.451 -0.336 0 C-N-CA 120.759 -0.734 . . . . 0.0 112.438 179.939 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 43' ' ' LYS . . . . . 0.529 ' HD2' ' CE2' ' A' ' 44' ' ' TYR . 0.4 OUTLIER -101.52 -23.97 14.22 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.822 0.344 . . . . 0.0 110.968 179.982 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 44' ' ' TYR . . . . . 0.529 ' CE2' ' HD2' ' A' ' 43' ' ' LYS . 0.9 OUTLIER -113.21 23.41 13.33 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.938 -179.986 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 92.78 -130.52 10.36 Favored Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.708 -0.758 . . . . 0.0 112.469 179.942 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 46' ' ' ASN . . . . . 0.443 ' ND2' ' HA ' ' A' ' 40' ' ' ILE . 5.5 m120 -92.97 111.6 23.27 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.845 0.355 . . . . 0.0 110.855 -179.838 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 47' ' ' ALA . . . . . 0.441 ' HB1' ' CD2' ' A' ' 5' ' ' TYR . . . -129.11 137.76 51.42 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.174 -0.467 . . . . 0.0 111.082 179.898 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 8.5 t -67.88 108.26 2.94 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.889 -179.987 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 49' ' ' TRP . . . . . 0.597 ' CZ3' ' HA ' ' A' ' 4' ' ' ALA . 17.8 t-105 -94.76 116.86 29.25 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.948 179.967 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 50' ' ' CYS . . . . . . . . . . . . . 39.7 m -95.83 143.34 27.14 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.892 -179.982 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 51' ' ' ILE . . . . . 0.499 ' CG2' ' OD2' ' A' ' 3' ' ' ASP . 3.4 mp -108.96 135.75 46.89 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.113 179.918 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 52' ' ' GLN . . . . . 0.465 ' CB ' ' HB2' ' A' ' 34' ' ' GLU . 22.6 mm-40 63.71 43.99 5.3 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.916 179.963 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 53' ' ' LEU . . . . . 0.51 ' CD1' ' HB2' ' A' ' 33' ' ' ALA . 15.5 tp -85.38 137.43 36.77 Favored Pre-proline 0 C--N 1.329 -0.323 0 CA-C-O 121.666 0.746 . . . . 0.0 110.884 -179.992 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 54' ' ' PRO . . . . . 0.478 ' HD2' ' CD1' ' A' ' 53' ' ' LEU . 54.0 Cg_endo -69.78 147.78 63.46 Favored 'Trans proline' 0 C--N 1.342 0.221 0 C-N-CA 122.664 2.242 . . . . 0.0 112.398 179.841 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 3.8 m-20 -65.02 -5.96 7.54 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.851 179.974 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 7.8 m120 -78.14 -25.53 47.4 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.954 -179.978 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 57' ' ' VAL . . . . . 0.466 ' CG1' ' HD2' ' A' ' 58' ' ' PRO . 11.4 t -90.77 136.31 27.96 Favored Pre-proline 0 C--N 1.329 -0.288 0 CA-C-O 121.615 0.722 . . . . 0.0 111.132 179.895 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 58' ' ' PRO . . . . . 0.466 ' HD2' ' CG1' ' A' ' 57' ' ' VAL . 53.8 Cg_endo -69.78 135.77 31.25 Favored 'Trans proline' 0 C--N 1.341 0.161 0 C-N-CA 122.608 2.205 . . . . 0.0 112.353 179.945 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 59' ' ' ILE . . . . . 0.424 ' C ' ' HB3' ' A' ' 7' ' ' ALA . 3.9 pt -109.79 154.31 11.31 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.119 179.959 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 60' ' ' ARG . . . . . 0.461 ' NE ' ' CG1' ' A' ' 13' ' ' VAL . 8.0 tpt180 -65.34 132.67 49.62 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.86 179.933 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . 0.431 ' N ' ' HD2' ' A' ' 60' ' ' ARG . 1.3 pt -125.76 160.63 55.36 Favored Pre-proline 0 C--N 1.329 -0.306 0 CA-C-O 121.589 0.709 . . . . 0.0 111.125 179.969 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -69.73 65.08 1.79 Allowed 'Trans proline' 0 C--N 1.341 0.14 0 C-N-CA 122.715 2.276 . . . . 0.0 112.333 179.877 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -136.03 -173.67 13.07 Favored Glycine 0 N--CA 1.451 -0.308 0 C-N-CA 120.732 -0.746 . . . . 0.0 112.474 179.994 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 33.6 pttt -84.74 143.13 29.35 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.802 0.334 . . . . 0.0 110.878 -179.989 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 65' ' ' CYS . . . . . 0.506 ' SG ' ' N ' ' A' ' 66' ' ' HIS . 2.6 t -94.28 161.54 14.21 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.851 179.944 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 66' ' ' HIS . . . . . 0.506 ' N ' ' SG ' ' A' ' 65' ' ' CYS . 7.8 p80 . . . . . 0 C--N 1.329 -0.295 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.802 179.93 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.231 0.131 0 CA-C-O 120.811 0.339 . . . . 0.0 111.094 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 2' ' ' ARG . . . . . 0.515 ' NE ' ' OD2' ' A' ' 55' ' ' ASP . 30.3 ptt180 -153.24 164.35 38.24 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.866 -179.908 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 3' ' ' ASP . . . . . 0.532 ' HB3' ' CZ2' ' A' ' 49' ' ' TRP . 1.6 m-20 -100.26 139.69 35.57 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.902 179.943 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 4' ' ' ALA . . . . . 0.573 ' HA ' ' CZ3' ' A' ' 49' ' ' TRP . . . -174.88 177.64 1.97 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.149 179.961 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 5' ' ' TYR . . . . . 0.421 ' CE2' ' HE3' ' A' ' 49' ' ' TRP . 13.8 m-85 -84.63 132.03 34.53 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.918 -179.87 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 7.0 tt -72.04 136.03 26.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.124 -0.489 . . . . 0.0 111.135 179.9 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 7' ' ' ALA . . . . . 0.422 ' HB1' ' C ' ' A' ' 59' ' ' ILE . . . -101.51 152.65 20.52 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.189 -0.46 . . . . 0.0 111.102 179.828 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 8' ' ' LYS . . . . . 0.558 ' HD2' ' CE2' ' A' ' 14' ' ' TYR . 0.0 OUTLIER -118.0 172.32 4.23 Favored Pre-proline 0 C--N 1.328 -0.344 0 CA-C-O 121.606 0.717 . . . . 0.0 110.883 179.968 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 9' ' ' PRO . . . . . 0.533 ' HD2' ' CB ' ' A' ' 8' ' ' LYS . 53.9 Cg_endo -69.77 104.65 1.35 Allowed 'Trans proline' 0 C--O 1.231 0.163 0 C-N-CA 122.712 2.274 . . . . 0.0 112.327 179.86 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 10' ' ' HIS . . . . . 0.42 ' HA ' ' HA ' ' A' ' 9' ' ' PRO . 4.3 m-70 -131.91 120.14 22.12 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.89 -0.149 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 11' ' ' ASN . . . . . 0.552 ' N ' ' O ' ' A' ' 8' ' ' LYS . 41.5 t30 73.9 28.88 1.49 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.876 -179.903 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 12' ' ' CYS . . . . . 0.41 ' CB ' ' HG3' ' A' ' 8' ' ' LYS . 1.7 m -97.7 168.09 10.55 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.866 179.939 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 13' ' ' VAL . . . . . 0.476 HG13 ' NE ' ' A' ' 60' ' ' ARG . 0.9 OUTLIER -98.67 142.81 14.14 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.178 179.918 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 14' ' ' TYR . . . . . 0.558 ' CE2' ' HD2' ' A' ' 8' ' ' LYS . 11.2 m-85 -94.51 95.39 8.79 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.916 -179.886 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 4.1 pt-20 -65.01 135.41 55.59 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.878 -179.983 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -105.26 132.19 51.78 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.924 -179.943 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -104.85 -38.64 6.58 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.945 -179.881 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 12.0 t-20 -106.22 84.38 1.35 Allowed Pre-proline 0 C--N 1.329 -0.3 0 CA-C-O 121.605 0.717 . . . . 0.0 110.893 179.997 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.72 -27.39 26.7 Favored 'Trans proline' 0 C--N 1.341 0.164 0 C-N-CA 122.688 2.259 . . . . 0.0 112.322 179.93 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 19.1 mmtt -94.77 24.06 4.99 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.873 179.949 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -134.02 -174.59 13.57 Favored Glycine 0 N--CA 1.452 -0.276 0 C-N-CA 120.732 -0.747 . . . . 0.0 112.474 179.92 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 93.3 p -94.72 27.4 3.08 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.863 0.363 . . . . 0.0 110.797 -179.706 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 5.4 t80 -63.97 -68.2 0.37 Allowed 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.879 -179.852 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 24' ' ' CYS . . . . . 0.404 ' SG ' ' O ' ' A' ' 37' ' ' TYR . 47.3 t -64.89 -35.15 80.23 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.143 -0.481 . . . . 0.0 110.894 179.979 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 3.4 t30 -58.03 -62.41 1.84 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.869 -179.967 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 89.2 m-20 -54.7 -50.49 68.18 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.847 179.944 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 27' ' ' LEU . . . . . 0.428 ' O ' ' ND2' ' A' ' 31' ' ' ASN . 1.5 tp -59.4 -38.02 79.5 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.884 -179.981 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 28' ' ' CYS . . . . . 0.461 ' SG ' ' SG ' ' A' ' 48' ' ' CYS . 1.9 m -65.15 -55.63 17.55 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.89 179.937 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 1.1 p -64.07 -32.88 74.6 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.099 -179.918 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 32.6 mt-10 -55.66 -21.61 18.91 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.262 -0.427 . . . . 0.0 110.863 179.995 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 31' ' ' ASN . . . . . 0.428 ' ND2' ' O ' ' A' ' 27' ' ' LEU . 1.8 m-80 -104.1 22.47 14.62 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.876 -179.94 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . 0.518 ' O ' ' CD ' ' A' ' 54' ' ' PRO . . . 83.23 69.31 1.39 Allowed Glycine 0 N--CA 1.451 -0.359 0 C-N-CA 120.772 -0.728 . . . . 0.0 112.515 179.97 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 33' ' ' ALA . . . . . 0.489 ' CB ' ' CD1' ' A' ' 53' ' ' LEU . . . -150.11 158.26 43.97 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.779 0.323 . . . . 0.0 111.098 -179.98 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . 0.48 ' HB2' ' CB ' ' A' ' 52' ' ' GLN . 0.9 OUTLIER -73.85 -40.47 63.26 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.877 -179.902 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 66.2 m -163.57 -176.61 4.77 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.822 -179.785 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -175.19 158.48 26.07 Favored Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.72 -0.753 . . . . 0.0 112.461 -179.938 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 37' ' ' TYR . . . . . 0.483 ' C ' ' CD2' ' A' ' 37' ' ' TYR . 0.0 OUTLIER -162.45 171.87 16.43 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.955 0.407 . . . . 0.0 110.908 -179.823 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 38' ' ' CYS . . . . . . . . . . . . . 42.1 t -74.94 127.45 33.24 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.858 -179.976 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 39' ' ' GLN . . . . . 0.519 ' OE1' ' N ' ' A' ' 41' ' ' LEU . 0.0 OUTLIER -105.33 119.46 39.14 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.898 -179.95 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 40' ' ' ILE . . . . . 0.48 ' HA ' ' ND2' ' A' ' 46' ' ' ASN . 1.1 mm -88.41 -41.05 13.95 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 116.187 -0.461 . . . . 0.0 111.119 -179.989 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 41' ' ' LEU . . . . . 0.519 ' N ' ' OE1' ' A' ' 39' ' ' GLN . 3.4 mm? -75.32 47.88 0.4 Allowed 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.898 179.923 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -96.57 136.5 12.83 Favored Glycine 0 N--CA 1.451 -0.352 0 C-N-CA 120.762 -0.733 . . . . 0.0 112.519 179.89 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 33.4 mttm -53.93 -25.16 19.05 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 120.782 0.325 . . . . 0.0 110.874 -179.961 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 0.6 OUTLIER -112.28 24.01 13.03 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.889 -179.94 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 94.12 -134.57 12.11 Favored Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 120.722 -0.752 . . . . 0.0 112.51 179.997 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 46' ' ' ASN . . . . . 0.48 ' ND2' ' HA ' ' A' ' 40' ' ' ILE . 8.3 m120 -90.65 112.52 24.28 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-O 120.835 0.35 . . . . 0.0 110.907 -179.881 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -132.59 143.1 49.46 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.1 179.881 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 48' ' ' CYS . . . . . 0.461 ' SG ' ' SG ' ' A' ' 28' ' ' CYS . 51.3 t -65.03 107.49 1.53 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.231 -0.441 . . . . 0.0 110.855 -179.918 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 49' ' ' TRP . . . . . 0.573 ' CZ3' ' HA ' ' A' ' 4' ' ' ALA . 22.5 t-105 -94.9 119.57 33.67 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.929 179.997 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 50' ' ' CYS . . . . . . . . . . . . . 34.5 m -96.87 141.76 29.67 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.866 -179.961 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 51' ' ' ILE . . . . . 0.463 HD13 ' N ' ' A' ' 51' ' ' ILE . 4.0 mp -105.17 135.99 40.9 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.14 179.936 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 52' ' ' GLN . . . . . 0.48 ' CB ' ' HB2' ' A' ' 34' ' ' GLU . 4.3 mm-40 66.99 33.68 5.63 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.944 179.992 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 53' ' ' LEU . . . . . 0.489 ' CD1' ' CB ' ' A' ' 33' ' ' ALA . 12.5 tp -86.16 132.28 43.95 Favored Pre-proline 0 C--N 1.328 -0.334 0 CA-C-O 121.578 0.704 . . . . 0.0 110.966 -180.0 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 54' ' ' PRO . . . . . 0.518 ' CD ' ' O ' ' A' ' 32' ' ' GLY . 54.4 Cg_endo -69.65 150.8 69.38 Favored 'Trans proline' 0 C--O 1.231 0.156 0 C-N-CA 122.694 2.263 . . . . 0.0 112.367 179.861 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 55' ' ' ASP . . . . . 0.515 ' OD2' ' NE ' ' A' ' 2' ' ' ARG . 84.6 m-20 -65.42 -5.89 8.84 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.85 179.924 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 99.1 m-20 -74.71 -25.83 59.4 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.9 -179.971 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 57' ' ' VAL . . . . . 0.476 ' CG2' ' HG2' ' A' ' 54' ' ' PRO . 1.4 t -84.81 137.19 38.28 Favored Pre-proline 0 C--N 1.33 -0.275 0 CA-C-O 121.581 0.705 . . . . 0.0 111.156 179.895 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 58' ' ' PRO . . . . . 0.475 ' HD2' ' CG1' ' A' ' 57' ' ' VAL . 54.5 Cg_endo -69.71 126.55 13.47 Favored 'Trans proline' 0 C--O 1.231 0.152 0 C-N-CA 122.674 2.249 . . . . 0.0 112.348 179.905 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 59' ' ' ILE . . . . . 0.422 ' C ' ' HB1' ' A' ' 7' ' ' ALA . 4.8 pt -107.03 164.32 4.75 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.165 179.872 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 60' ' ' ARG . . . . . 0.476 ' NE ' HG13 ' A' ' 13' ' ' VAL . 20.4 tpt180 -75.17 119.59 19.52 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.868 179.982 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . 0.489 ' CG1' ' OD1' ' A' ' 11' ' ' ASN . 0.3 OUTLIER -122.51 160.84 46.64 Favored Pre-proline 0 C--N 1.329 -0.311 0 CA-C-O 121.632 0.729 . . . . 0.0 111.12 179.941 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.75 68.99 1.67 Allowed 'Trans proline' 0 C--N 1.342 0.194 0 C-N-CA 122.667 2.244 . . . . 0.0 112.372 179.904 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -144.22 -175.11 17.06 Favored Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.735 -0.745 . . . . 0.0 112.497 179.978 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 26.4 mtmt -84.98 134.88 34.22 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.787 0.327 . . . . 0.0 110.897 -179.976 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 65' ' ' CYS . . . . . 0.472 ' SG ' ' CD2' ' A' ' 66' ' ' HIS . 47.3 t -95.09 163.99 13.07 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.889 179.934 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 66' ' ' HIS . . . . . 0.472 ' CD2' ' SG ' ' A' ' 65' ' ' CYS . 0.6 OUTLIER . . . . . 0 C--N 1.329 -0.293 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.852 179.991 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.231 0.116 0 CA-C-O 120.83 0.347 . . . . 0.0 111.088 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 6.3 ptt85 -154.6 159.36 40.81 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.852 -179.94 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 4.7 m-20 -92.62 132.81 36.56 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.878 179.949 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 4' ' ' ALA . . . . . 0.575 ' HA ' ' CZ3' ' A' ' 49' ' ' TRP . . . -175.16 -178.7 1.22 Allowed 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.085 179.988 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 5' ' ' TYR . . . . . 0.419 ' CE1' ' HE3' ' A' ' 49' ' ' TRP . 32.9 m-85 -84.36 131.63 34.68 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.917 -179.862 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 3.7 tt -74.26 132.98 32.51 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-N 116.119 -0.491 . . . . 0.0 111.111 179.92 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 7' ' ' ALA . . . . . 0.42 ' HB2' ' C ' ' A' ' 59' ' ' ILE . . . -86.14 155.11 20.9 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.114 179.807 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 8' ' ' LYS . . . . . 0.53 ' HB2' ' CZ ' ' A' ' 14' ' ' TYR . 0.0 OUTLIER -133.54 167.19 24.17 Favored Pre-proline 0 C--N 1.329 -0.312 0 CA-C-O 121.566 0.698 . . . . 0.0 110.905 179.933 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 9' ' ' PRO . . . . . 0.489 ' HA ' ' HA ' ' A' ' 10' ' ' HIS . 53.7 Cg_endo -69.73 105.61 1.51 Allowed 'Trans proline' 0 C--O 1.231 0.154 0 C-N-CA 122.656 2.237 . . . . 0.0 112.363 179.902 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 10' ' ' HIS . . . . . 0.489 ' HA ' ' HA ' ' A' ' 9' ' ' PRO . 6.4 m-70 -131.35 128.94 40.72 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.92 -0.072 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 11' ' ' ASN . . . . . 0.486 ' OD1' ' CG1' ' A' ' 61' ' ' ILE . 3.6 t30 60.23 34.4 20.97 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.836 -179.916 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 12' ' ' CYS . . . . . 0.468 ' HB2' ' CD ' ' A' ' 8' ' ' LYS . 1.6 m -114.53 153.15 30.55 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.884 179.963 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 13' ' ' VAL . . . . . 0.469 HG13 ' NE ' ' A' ' 60' ' ' ARG . 0.9 OUTLIER -84.53 152.38 3.72 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.141 -0.481 . . . . 0.0 111.121 179.947 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 14' ' ' TYR . . . . . 0.53 ' CZ ' ' HB2' ' A' ' 8' ' ' LYS . 9.1 m-85 -94.8 89.56 5.73 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.123 -0.489 . . . . 0.0 110.902 -179.917 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 5.0 tp10 -64.93 136.47 56.86 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.812 -179.947 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 6.6 p -84.46 159.57 20.74 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.114 -0.493 . . . . 0.0 110.906 -179.974 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -96.72 -32.83 11.96 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.923 -179.894 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 18' ' ' ASN . . . . . 0.596 ' CG ' ' HD2' ' A' ' 19' ' ' PRO . 1.8 t-20 -154.41 146.86 17.52 Favored Pre-proline 0 C--N 1.329 -0.284 0 CA-C-O 121.624 0.726 . . . . 0.0 110.862 -179.969 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 19' ' ' PRO . . . . . 0.596 ' HD2' ' CG ' ' A' ' 18' ' ' ASN . 53.8 Cg_endo -69.75 -32.85 17.8 Favored 'Trans proline' 0 C--O 1.232 0.191 0 C-N-CA 122.738 2.292 . . . . 0.0 112.353 179.922 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 20.5 mmtt -94.55 24.56 4.5 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.871 179.892 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -114.63 132.37 10.39 Favored Glycine 0 N--CA 1.452 -0.267 0 C-N-CA 120.758 -0.734 . . . . 0.0 112.458 179.919 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 4.9 m -83.56 24.71 0.83 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.874 0.369 . . . . 0.0 110.838 -179.724 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 7.2 t80 -64.27 -43.15 95.72 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.933 -179.864 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 24' ' ' CYS . . . . . 0.405 ' SG ' ' O ' ' A' ' 37' ' ' TYR . 43.2 t -67.69 -42.75 81.58 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.899 179.971 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 25' ' ' ASN . . . . . 0.451 ' HA ' ' CA ' ' A' ' 36' ' ' GLY . 0.8 OUTLIER -55.1 -56.33 21.07 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.926 179.995 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 55.2 m-20 -55.3 -52.22 64.16 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.895 179.897 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 1.7 tp -58.24 -38.88 77.74 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.915 -179.962 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 11.0 m -62.12 -51.27 68.58 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.919 179.895 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 1.1 p -62.99 -24.75 68.06 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.129 -0.487 . . . . 0.0 111.172 -179.964 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 19.5 tp10 -59.2 -22.82 61.63 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.864 -179.966 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 1.8 m-80 -103.7 22.02 15.15 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.9 -179.956 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 83.29 19.96 61.46 Favored Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.755 -0.736 . . . . 0.0 112.456 -179.995 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 33' ' ' ALA . . . . . 0.482 ' CB ' HD11 ' A' ' 53' ' ' LEU . . . -85.16 147.7 26.48 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.776 0.322 . . . . 0.0 111.099 179.936 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . 0.473 ' HB2' ' CB ' ' A' ' 52' ' ' GLN . 5.8 tp10 -74.72 -31.37 61.82 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.911 -179.933 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 1.9 m -162.27 177.62 9.44 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.873 -179.829 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 36' ' ' GLY . . . . . 0.451 ' CA ' ' HA ' ' A' ' 25' ' ' ASN . . . -174.23 154.71 19.89 Favored Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 120.68 -0.772 . . . . 0.0 112.423 -179.924 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 37' ' ' TYR . . . . . 0.405 ' O ' ' SG ' ' A' ' 24' ' ' CYS . 48.8 p90 -165.35 166.37 18.68 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.964 0.411 . . . . 0.0 110.897 -179.819 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 38' ' ' CYS . . . . . . . . . . . . . 13.2 t -74.81 120.81 20.86 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.869 -179.985 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 39' ' ' GLN . . . . . 0.5 ' NE2' ' CD2' ' A' ' 49' ' ' TRP . 0.0 OUTLIER -104.06 127.29 51.62 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.899 -179.974 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 40' ' ' ILE . . . . . 0.476 ' N ' HD13 ' A' ' 40' ' ' ILE . 0.7 OUTLIER -95.53 -31.1 4.1 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.095 179.97 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 2.0 tt -77.28 47.08 0.54 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.934 179.919 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -101.77 138.87 14.13 Favored Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.711 -0.757 . . . . 0.0 112.485 179.881 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 1.8 mtmm -57.37 -24.65 56.57 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.768 0.318 . . . . 0.0 110.881 -179.944 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 1.1 m-85 -111.08 23.43 14.12 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.931 -179.946 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 93.22 -137.63 13.72 Favored Glycine 0 N--CA 1.451 -0.344 0 C-N-CA 120.719 -0.753 . . . . 0.0 112.498 179.992 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 46' ' ' ASN . . . . . 0.44 ' ND2' ' HA ' ' A' ' 40' ' ' ILE . 18.8 m120 -86.45 117.76 25.45 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.85 0.357 . . . . 0.0 110.863 -179.894 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -135.75 147.27 48.36 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.098 179.864 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 24.1 t -66.67 108.19 2.39 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.842 -179.957 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 49' ' ' TRP . . . . . 0.575 ' CZ3' ' HA ' ' A' ' 4' ' ' ALA . 53.6 t-105 -94.39 112.62 24.41 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.907 179.957 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 50' ' ' CYS . . . . . . . . . . . . . 34.8 m -95.12 142.41 27.6 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.913 179.969 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 3.8 mm -106.62 133.81 50.08 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.109 179.94 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 52' ' ' GLN . . . . . 0.473 ' CB ' ' HB2' ' A' ' 34' ' ' GLU . 3.4 mm-40 64.77 45.36 3.39 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.88 179.925 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 53' ' ' LEU . . . . . 0.482 HD11 ' CB ' ' A' ' 33' ' ' ALA . 14.6 tp -85.67 134.79 39.09 Favored Pre-proline 0 C--N 1.329 -0.307 0 CA-C-O 121.548 0.689 . . . . 0.0 110.942 -179.997 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 54' ' ' PRO . . . . . 0.466 ' HD2' ' CD1' ' A' ' 53' ' ' LEU . 53.9 Cg_endo -69.7 146.5 60.73 Favored 'Trans proline' 0 C--O 1.231 0.144 0 C-N-CA 122.668 2.245 . . . . 0.0 112.385 179.864 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 3.4 m-20 -65.18 -5.58 7.19 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.848 179.958 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 10.9 m120 -79.26 -26.39 42.4 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.921 -179.953 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 57' ' ' VAL . . . . . 0.462 ' CG1' ' HD2' ' A' ' 58' ' ' PRO . 21.3 t -88.85 136.7 30.48 Favored Pre-proline 0 C--N 1.33 -0.265 0 CA-C-O 121.571 0.701 . . . . 0.0 111.164 179.861 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 58' ' ' PRO . . . . . 0.462 ' HD2' ' CG1' ' A' ' 57' ' ' VAL . 53.6 Cg_endo -69.76 143.26 50.26 Favored 'Trans proline' 0 C--N 1.341 0.181 0 C-N-CA 122.71 2.273 . . . . 0.0 112.345 179.974 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 59' ' ' ILE . . . . . 0.455 ' O ' ' CD1' ' A' ' 61' ' ' ILE . 5.2 pt -117.03 168.9 7.95 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-N 116.255 -0.43 . . . . 0.0 111.156 179.895 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 60' ' ' ARG . . . . . 0.469 ' NE ' HG13 ' A' ' 13' ' ' VAL . 13.7 tpt180 -75.22 121.52 22.26 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.841 179.957 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . 0.486 ' CG1' ' OD1' ' A' ' 11' ' ' ASN . 0.0 OUTLIER -110.26 160.46 28.25 Favored Pre-proline 0 C--N 1.329 -0.299 0 CA-C-O 121.589 0.709 . . . . 0.0 111.157 179.952 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -69.76 64.89 1.8 Allowed 'Trans proline' 0 C--N 1.341 0.16 0 C-N-CA 122.693 2.262 . . . . 0.0 112.381 179.84 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -142.56 -174.15 14.85 Favored Glycine 0 N--CA 1.451 -0.344 0 C-N-CA 120.739 -0.743 . . . . 0.0 112.476 180.0 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -85.16 151.23 24.26 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 120.797 0.332 . . . . 0.0 110.956 179.968 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 65' ' ' CYS . . . . . 0.601 ' SG ' ' CD2' ' A' ' 66' ' ' HIS . 1.2 t -95.13 160.92 14.33 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.885 179.953 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 66' ' ' HIS . . . . . 0.601 ' CD2' ' SG ' ' A' ' 65' ' ' CYS . 1.0 OUTLIER . . . . . 0 C--N 1.329 -0.31 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.857 179.981 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 1' ' ' ALA . . . . . 0.51 ' N ' ' NE2' ' A' ' 52' ' ' GLN . . . . . . . . 0 C--O 1.231 0.123 0 CA-C-O 120.759 0.314 . . . . 0.0 111.09 . . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 2' ' ' ARG . . . . . 0.423 ' NH1' HG23 ' A' ' 59' ' ' ILE . 3.3 ptm180 -90.71 -175.52 4.42 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.85 -179.922 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -145.55 121.43 10.62 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.892 179.979 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 4' ' ' ALA . . . . . 0.577 ' HA ' ' CH2' ' A' ' 49' ' ' TRP . . . -173.89 -172.24 0.72 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.082 179.984 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 5' ' ' TYR . . . . . 0.535 ' CE1' ' HB2' ' A' ' 49' ' ' TRP . 66.9 m-85 -84.23 137.68 33.35 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.92 -179.883 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 6.9 tt -75.39 143.84 12.77 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.074 -0.512 . . . . 0.0 111.12 179.924 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -84.6 165.1 18.26 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.2 -0.454 . . . . 0.0 111.113 179.792 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 8' ' ' LYS . . . . . 0.56 ' HB2' ' CE2' ' A' ' 14' ' ' TYR . 0.1 OUTLIER -145.41 165.57 21.06 Favored Pre-proline 0 C--N 1.329 -0.318 0 CA-C-O 121.565 0.698 . . . . 0.0 110.903 -179.973 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 9' ' ' PRO . . . . . 0.474 ' HA ' ' HA ' ' A' ' 10' ' ' HIS . 53.7 Cg_endo -69.78 105.77 1.55 Allowed 'Trans proline' 0 C--N 1.341 0.175 0 C-N-CA 122.691 2.26 . . . . 0.0 112.34 179.909 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 10' ' ' HIS . . . . . 0.474 ' HA ' ' HA ' ' A' ' 9' ' ' PRO . 8.1 m-70 -132.61 122.5 24.81 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.887 -0.127 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 11' ' ' ASN . . . . . 0.466 ' N ' ' O ' ' A' ' 8' ' ' LYS . 3.2 t30 71.73 20.68 4.54 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.893 -179.902 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 12' ' ' CYS . . . . . 0.401 ' HB2' ' HG2' ' A' ' 8' ' ' LYS . 1.5 m -109.57 168.64 9.25 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.892 -179.999 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 13' ' ' VAL . . . . . 0.458 ' CG1' ' HG2' ' A' ' 60' ' ' ARG . 0.9 OUTLIER -90.8 156.08 3.04 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.135 179.939 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 14' ' ' TYR . . . . . 0.56 ' CE2' ' HB2' ' A' ' 8' ' ' LYS . 4.1 m-85 -94.26 87.0 5.09 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.929 -179.921 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 30.6 tt0 -64.59 120.67 12.81 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.853 -179.986 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 16' ' ' CYS . . . . . 1.147 ' SG ' ' SG ' ' A' ' 24' ' ' CYS . 0.7 OUTLIER -104.45 171.56 7.27 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.158 -0.473 . . . . 0.0 110.894 -179.963 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 17' ' ' TYR . . . . . 0.413 ' O ' ' HD3' ' A' ' 19' ' ' PRO . 67.4 t80 -125.7 -23.79 3.96 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.899 -179.833 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 10.4 t-20 -105.64 85.0 1.32 Allowed Pre-proline 0 C--N 1.329 -0.286 0 CA-C-O 121.626 0.726 . . . . 0.0 110.89 -179.997 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 19' ' ' PRO . . . . . 0.451 ' HA ' ' CB ' ' A' ' 38' ' ' CYS . 53.5 Cg_endo -69.88 -24.89 28.6 Favored 'Trans proline' 0 C--N 1.341 0.17 0 C-N-CA 122.636 2.224 . . . . 0.0 112.317 179.983 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 28.6 mmtm -94.4 -24.59 17.29 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.85 179.931 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -80.21 -174.7 47.78 Favored Glycine 0 N--CA 1.452 -0.287 0 C-N-CA 120.737 -0.744 . . . . 0.0 112.496 179.927 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 26.1 m -95.62 25.72 4.38 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.855 0.36 . . . . 0.0 110.814 -179.718 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 1.1 t80 -59.58 -66.88 0.44 Allowed 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.938 -179.894 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 24' ' ' CYS . . . . . 1.147 ' SG ' ' SG ' ' A' ' 16' ' ' CYS . 19.7 m -67.0 -37.39 84.12 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.141 -0.482 . . . . 0.0 110.913 179.953 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 2.5 t30 -57.34 -58.92 6.13 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.114 -0.493 . . . . 0.0 110.891 -179.968 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 12.4 m-20 -56.22 -53.34 58.3 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.9 179.9 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 1.8 tp -58.99 -35.5 73.32 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.956 -179.962 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 1.7 m -64.36 -58.83 5.37 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.879 179.874 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 29' ' ' THR . . . . . 0.406 ' HA ' ' O ' ' A' ' 33' ' ' ALA . 1.1 p -62.7 -28.39 69.91 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.124 -0.489 . . . . 0.0 111.143 -179.92 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 41.3 tt0 -55.17 -20.56 10.69 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.866 -179.999 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 2.0 m-80 -102.51 22.36 13.65 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.878 -179.94 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 95.35 -12.58 67.83 Favored Glycine 0 N--CA 1.452 -0.265 0 C-N-CA 120.766 -0.73 . . . . 0.0 112.497 179.977 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 33' ' ' ALA . . . . . 0.477 ' HB1' ' CD1' ' A' ' 53' ' ' LEU . . . -62.03 162.23 9.6 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.744 0.306 . . . . 0.0 111.131 179.959 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . 0.462 ' HB2' ' CB ' ' A' ' 52' ' ' GLN . 11.5 tp10 -90.33 -29.72 17.91 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.9 -179.91 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 15.6 m -162.41 179.62 7.68 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.838 -179.799 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -167.97 161.03 34.79 Favored Glycine 0 N--CA 1.452 -0.28 0 C-N-CA 120.721 -0.752 . . . . 0.0 112.47 -179.991 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 37' ' ' TYR . . . . . 0.619 ' CE2' ' CD1' ' A' ' 49' ' ' TRP . 3.3 p90 -162.44 151.86 15.71 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 120.953 0.406 . . . . 0.0 110.939 -179.828 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 38' ' ' CYS . . . . . 0.451 ' CB ' ' HA ' ' A' ' 19' ' ' PRO . 2.0 t -80.32 119.45 23.06 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.88 -179.969 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 39' ' ' GLN . . . . . 0.487 ' OE1' ' N ' ' A' ' 42' ' ' GLY . 1.4 tm0? -105.21 108.59 20.19 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.896 -179.943 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 40' ' ' ILE . . . . . 0.556 ' C ' ' CD1' ' A' ' 40' ' ' ILE . 0.1 OUTLIER -81.84 -35.79 13.76 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.153 179.983 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 41' ' ' LEU . . . . . 0.45 ' N ' HG13 ' A' ' 40' ' ' ILE . 3.4 mt -78.93 48.01 0.8 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.903 179.913 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . 0.487 ' N ' ' OE1' ' A' ' 39' ' ' GLN . . . -98.66 -179.71 32.01 Favored Glycine 0 N--CA 1.451 -0.303 0 C-N-CA 120.734 -0.746 . . . . 0.0 112.45 179.926 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 43' ' ' LYS . . . . . 0.539 ' HG2' ' CD1' ' A' ' 44' ' ' TYR . 0.3 OUTLIER -83.05 -26.83 30.76 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.787 0.327 . . . . 0.0 110.885 -179.983 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 44' ' ' TYR . . . . . 0.539 ' CD1' ' HG2' ' A' ' 43' ' ' LYS . 1.0 OUTLIER -114.31 24.45 11.92 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.907 -179.968 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 94.42 -133.96 11.81 Favored Glycine 0 N--CA 1.451 -0.342 0 C-N-CA 120.731 -0.747 . . . . 0.0 112.463 179.933 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 3.0 m120 -92.55 109.39 20.79 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 120.843 0.354 . . . . 0.0 110.893 -179.941 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 47' ' ' ALA . . . . . 0.455 ' HB1' ' CD1' ' A' ' 5' ' ' TYR . . . -125.61 140.39 52.77 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.08 179.855 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 3.1 m -66.25 111.27 3.38 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.904 -179.96 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 49' ' ' TRP . . . . . 0.619 ' CD1' ' CE2' ' A' ' 37' ' ' TYR . 45.0 t-105 -94.78 115.13 27.12 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.931 180.0 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 50' ' ' CYS . . . . . . . . . . . . . 33.4 m -97.66 142.72 29.1 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.899 179.994 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 51' ' ' ILE . . . . . 0.507 HD12 ' CD2' ' A' ' 37' ' ' TYR . 4.0 mp -110.97 137.62 42.65 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.14 179.895 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 52' ' ' GLN . . . . . 0.51 ' NE2' ' N ' ' A' ' 1' ' ' ALA . 36.2 mm-40 65.02 41.92 4.42 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.914 179.922 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 53' ' ' LEU . . . . . 0.477 ' CD1' ' HB1' ' A' ' 33' ' ' ALA . 15.7 tp -85.57 136.16 37.53 Favored Pre-proline 0 C--N 1.328 -0.327 0 CA-C-O 121.568 0.699 . . . . 0.0 110.969 179.961 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 54' ' ' PRO . . . . . 0.459 ' HG2' ' CG2' ' A' ' 57' ' ' VAL . 53.4 Cg_endo -69.8 147.68 63.12 Favored 'Trans proline' 0 C--N 1.341 0.174 0 C-N-CA 122.701 2.267 . . . . 0.0 112.299 179.93 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 74.3 m-20 -65.03 -5.3 6.01 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.858 179.899 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 5.1 m120 -79.64 -30.28 41.28 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.87 -179.899 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 57' ' ' VAL . . . . . 0.468 ' CG1' ' HD2' ' A' ' 58' ' ' PRO . 15.5 t -86.55 136.36 35.13 Favored Pre-proline 0 C--N 1.329 -0.307 0 CA-C-O 121.617 0.722 . . . . 0.0 111.134 179.928 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 58' ' ' PRO . . . . . 0.468 ' HD2' ' CG1' ' A' ' 57' ' ' VAL . 54.4 Cg_endo -69.75 141.77 46.15 Favored 'Trans proline' 0 C--O 1.231 0.167 0 C-N-CA 122.681 2.254 . . . . 0.0 112.391 179.939 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 59' ' ' ILE . . . . . 0.423 HG23 ' NH1' ' A' ' 2' ' ' ARG . 5.0 pt -118.61 157.65 20.07 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.104 179.967 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 60' ' ' ARG . . . . . 0.458 ' HG2' ' CG1' ' A' ' 13' ' ' VAL . 9.3 tpt180 -68.72 117.39 10.37 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.925 179.933 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . 0.447 ' N ' ' HD2' ' A' ' 60' ' ' ARG . 1.3 pp -123.21 160.66 49.01 Favored Pre-proline 0 C--N 1.329 -0.308 0 CA-C-O 121.669 0.747 . . . . 0.0 111.118 179.983 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.75 73.39 1.37 Allowed 'Trans proline' 0 C--N 1.342 0.194 0 C-N-CA 122.66 2.24 . . . . 0.0 112.362 179.901 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -135.2 -175.38 13.82 Favored Glycine 0 N--CA 1.451 -0.344 0 C-N-CA 120.705 -0.76 . . . . 0.0 112.479 179.985 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -84.88 115.35 22.72 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.855 0.359 . . . . 0.0 110.897 -179.97 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 65' ' ' CYS . . . . . 0.487 ' O ' ' CG ' ' A' ' 66' ' ' HIS . 8.4 t -94.46 159.66 15.0 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.894 179.977 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 66' ' ' HIS . . . . . 0.487 ' CG ' ' O ' ' A' ' 65' ' ' CYS . 28.8 p80 . . . . . 0 C--N 1.329 -0.318 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.87 179.949 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.232 0.155 0 CA-C-O 120.803 0.335 . . . . 0.0 111.07 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 16.1 ptt180 -152.55 171.43 18.14 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.871 -179.885 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 15.5 m-20 -99.63 130.49 45.87 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.868 179.961 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 4' ' ' ALA . . . . . 0.569 ' HA ' ' CZ3' ' A' ' 49' ' ' TRP . . . -174.94 -178.98 1.31 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.107 179.966 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 19.6 m-85 -84.6 135.33 34.24 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.896 -179.833 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 6' ' ' ILE . . . . . 0.448 HG12 ' CD1' ' A' ' 14' ' ' TYR . 3.1 tt -72.31 133.16 32.33 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.104 -0.498 . . . . 0.0 111.138 179.927 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 7' ' ' ALA . . . . . 0.477 ' HB1' ' CA ' ' A' ' 59' ' ' ILE . . . -92.46 143.09 26.71 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.209 -0.45 . . . . 0.0 111.102 179.815 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 8' ' ' LYS . . . . . 0.518 ' HB2' ' CZ ' ' A' ' 14' ' ' TYR . 0.0 OUTLIER -115.09 167.29 10.09 Favored Pre-proline 0 C--N 1.329 -0.316 0 CA-C-O 121.533 0.682 . . . . 0.0 110.907 179.98 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 9' ' ' PRO . . . . . 0.541 ' HA ' ' HA ' ' A' ' 10' ' ' HIS . 54.0 Cg_endo -69.74 103.89 1.23 Allowed 'Trans proline' 0 C--O 1.232 0.202 0 C-N-CA 122.641 2.227 . . . . 0.0 112.359 179.905 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 10' ' ' HIS . . . . . 0.541 ' HA ' ' HA ' ' A' ' 9' ' ' PRO . 2.9 m-70 -129.62 130.12 45.21 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.865 -0.053 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 11' ' ' ASN . . . . . 0.501 ' N ' ' O ' ' A' ' 8' ' ' LYS . 54.6 t-20 58.83 59.74 2.74 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.929 -179.914 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 12' ' ' CYS . . . . . 0.488 ' HB2' ' CD ' ' A' ' 8' ' ' LYS . 1.7 m -139.51 156.76 46.72 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.908 -179.982 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 13' ' ' VAL . . . . . 0.412 ' CG1' ' HE ' ' A' ' 60' ' ' ARG . 2.4 m -84.69 147.74 5.38 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.138 179.886 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 14' ' ' TYR . . . . . 0.518 ' CZ ' ' HB2' ' A' ' 8' ' ' LYS . 11.1 m-85 -94.67 101.01 12.84 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.909 -179.923 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 18.1 pt-20 -64.56 125.25 24.11 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.073 -0.512 . . . . 0.0 110.893 -180.0 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -101.99 135.35 43.71 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.86 -179.912 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 9.5 t80 -115.14 24.86 11.33 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.916 -179.902 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 18' ' ' ASN . . . . . 0.408 ' ND2' ' H ' ' A' ' 21' ' ' GLY . 0.2 OUTLIER -153.07 74.07 6.92 Favored Pre-proline 0 C--N 1.329 -0.309 0 CA-C-O 121.624 0.726 . . . . 0.0 110.849 -179.998 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.76 -19.89 35.54 Favored 'Trans proline' 0 C--O 1.232 0.18 0 C-N-CA 122.714 2.276 . . . . 0.0 112.317 179.903 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 56.8 mttm -94.16 -24.27 17.6 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.915 179.917 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 21' ' ' GLY . . . . . 0.408 ' H ' ' ND2' ' A' ' 18' ' ' ASN . . . -93.93 -176.99 39.51 Favored Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.702 -0.761 . . . . 0.0 112.468 179.925 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 52.6 p -95.49 25.83 4.25 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.906 0.384 . . . . 0.0 110.853 -179.721 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 23' ' ' TYR . . . . . 0.419 ' CD2' ' C ' ' A' ' 23' ' ' TYR . 1.1 t80 -55.0 -69.46 0.13 Allowed 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.91 -179.885 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 50.4 t -56.99 -36.61 70.56 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.103 -0.498 . . . . 0.0 110.905 179.966 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -57.87 -55.09 39.43 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.9 -179.946 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 47.7 m-20 -57.88 -52.71 64.35 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.174 -0.467 . . . . 0.0 110.794 179.958 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 1.7 tp -59.54 -37.4 78.3 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.965 -179.945 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 1.3 m -65.25 -54.53 27.97 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.874 179.884 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 29' ' ' THR . . . . . 0.421 ' HA ' ' O ' ' A' ' 33' ' ' ALA . 13.2 p -62.73 -29.15 70.46 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.139 -179.951 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 7.4 tp10 -54.69 -19.17 5.65 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.903 -179.981 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 31' ' ' ASN . . . . . 0.455 ' O ' ' CG2' ' A' ' 57' ' ' VAL . 2.3 m-80 -101.64 21.41 14.44 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.913 -179.946 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 95.5 -12.73 67.5 Favored Glycine 0 N--CA 1.452 -0.268 0 C-N-CA 120.682 -0.771 . . . . 0.0 112.463 -179.992 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 33' ' ' ALA . . . . . 0.498 ' HB3' ' CD1' ' A' ' 53' ' ' LEU . . . -61.75 153.91 27.1 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.729 0.3 . . . . 0.0 111.11 179.994 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . 0.416 ' CD ' ' CB ' ' A' ' 52' ' ' GLN . 67.0 mt-10 -85.6 -24.79 27.01 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.929 -179.959 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 12.4 m -161.99 177.88 9.37 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.841 -179.799 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -175.44 158.39 25.65 Favored Glycine 0 N--CA 1.452 -0.263 0 C-N-CA 120.722 -0.751 . . . . 0.0 112.448 -179.973 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 32.6 p90 -164.83 166.86 19.35 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.91 0.386 . . . . 0.0 110.904 -179.831 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 38' ' ' CYS . . . . . . . . . . . . . 4.1 t -75.33 124.3 26.87 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.11 -0.496 . . . . 0.0 110.857 179.996 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 2.4 tt0 -105.19 118.18 35.89 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.9 -179.978 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 40' ' ' ILE . . . . . 0.455 ' HA ' ' ND2' ' A' ' 46' ' ' ASN . 0.9 OUTLIER -88.3 -29.32 5.38 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.102 179.974 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 14.0 mt -82.58 38.91 0.58 Allowed 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.924 179.935 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -87.91 139.14 15.59 Favored Glycine 0 N--CA 1.45 -0.367 0 C-N-CA 120.762 -0.732 . . . . 0.0 112.479 179.92 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 39.1 mttp -53.79 -25.09 17.54 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.856 0.36 . . . . 0.0 110.904 -179.953 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 0.4 OUTLIER -113.85 24.41 12.11 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.945 179.992 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 94.3 -137.58 13.59 Favored Glycine 0 N--CA 1.452 -0.288 0 C-N-CA 120.736 -0.745 . . . . 0.0 112.445 179.962 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 46' ' ' ASN . . . . . 0.455 ' ND2' ' HA ' ' A' ' 40' ' ' ILE . 11.0 m120 -85.69 111.53 20.19 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.826 0.346 . . . . 0.0 110.907 -179.848 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -130.62 145.51 51.92 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.109 179.91 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 14.6 t -65.44 110.29 2.61 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.899 -179.985 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 49' ' ' TRP . . . . . 0.569 ' CZ3' ' HA ' ' A' ' 4' ' ' ALA . 41.6 t-105 -94.97 127.33 40.94 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.949 179.971 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 50' ' ' CYS . . . . . . . . . . . . . 29.9 m -108.41 141.02 40.88 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.841 -179.953 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 4.0 mm -108.06 130.99 59.64 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.126 179.917 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 52' ' ' GLN . . . . . 0.416 ' CB ' ' CD ' ' A' ' 34' ' ' GLU . 4.0 mm-40 67.72 43.08 1.87 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.921 179.955 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 53' ' ' LEU . . . . . 0.498 ' CD1' ' HB3' ' A' ' 33' ' ' ALA . 15.1 tp -85.6 135.53 38.19 Favored Pre-proline 0 C--N 1.328 -0.339 0 CA-C-O 121.582 0.706 . . . . 0.0 110.949 -179.955 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 54' ' ' PRO . . . . . 0.464 ' HG2' ' CG2' ' A' ' 57' ' ' VAL . 53.6 Cg_endo -69.81 145.68 57.6 Favored 'Trans proline' 0 C--N 1.341 0.179 0 C-N-CA 122.697 2.265 . . . . 0.0 112.31 179.914 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -61.4 -9.1 4.79 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.867 179.936 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 67.6 m-20 -74.85 -24.84 58.65 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.872 -179.867 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 57' ' ' VAL . . . . . 0.469 ' CG1' ' HD2' ' A' ' 58' ' ' PRO . 11.1 t -90.31 136.29 28.7 Favored Pre-proline 0 C--N 1.329 -0.305 0 CA-C-O 121.622 0.725 . . . . 0.0 111.12 179.883 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 58' ' ' PRO . . . . . 0.469 ' HD2' ' CG1' ' A' ' 57' ' ' VAL . 53.8 Cg_endo -69.77 146.59 60.57 Favored 'Trans proline' 0 C--O 1.232 0.181 0 C-N-CA 122.68 2.253 . . . . 0.0 112.37 179.924 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 59' ' ' ILE . . . . . 0.477 ' CA ' ' HB1' ' A' ' 7' ' ' ALA . 10.2 pt -123.89 159.98 28.37 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.116 179.964 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 60' ' ' ARG . . . . . 0.44 ' HD3' ' C ' ' A' ' 60' ' ' ARG . 2.9 tpp180 -64.66 111.19 2.64 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.885 179.924 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . 0.496 HG13 ' ND2' ' A' ' 11' ' ' ASN . 0.6 OUTLIER -110.48 161.74 23.39 Favored Pre-proline 0 C--N 1.329 -0.3 0 CA-C-O 121.625 0.726 . . . . 0.0 111.154 179.933 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -69.79 69.75 1.64 Allowed 'Trans proline' 0 C--N 1.342 0.199 0 C-N-CA 122.703 2.269 . . . . 0.0 112.342 179.851 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -144.95 -171.94 15.06 Favored Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.752 -0.737 . . . . 0.0 112.514 179.955 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 9.2 ptpt -85.47 131.23 34.41 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.836 0.35 . . . . 0.0 110.883 -179.964 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 65' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -91.06 140.58 29.7 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.872 179.953 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 66' ' ' HIS . . . . . 0.496 ' CG ' ' O ' ' A' ' 66' ' ' HIS . 26.9 p80 . . . . . 0 C--N 1.33 -0.279 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.824 179.95 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 1' ' ' ALA . . . . . 0.416 ' HB3' ' C ' ' A' ' 52' ' ' GLN . . . . . . . . 0 C--O 1.231 0.127 0 CA-C-O 120.8 0.333 . . . . 0.0 111.113 . . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 2' ' ' ARG . . . . . 0.441 ' NH1' ' O ' ' A' ' 53' ' ' LEU . 0.0 OUTLIER -136.8 157.04 47.67 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.894 -179.897 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 3.0 m-20 -92.34 133.9 35.42 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.898 179.976 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 4' ' ' ALA . . . . . 0.572 ' HA ' ' CZ3' ' A' ' 49' ' ' TRP . . . -173.94 -179.24 1.68 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.101 179.926 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 21.6 m-85 -84.99 136.41 33.6 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.948 -179.852 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 3.5 tt -75.34 135.63 26.75 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-N 116.115 -0.493 . . . . 0.0 111.176 179.901 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 7' ' ' ALA . . . . . 0.419 ' HB1' ' C ' ' A' ' 59' ' ' ILE . . . -85.56 150.98 24.28 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.096 179.849 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 8' ' ' LYS . . . . . 0.535 ' HB2' ' CZ ' ' A' ' 14' ' ' TYR . 0.0 OUTLIER -133.12 166.9 25.88 Favored Pre-proline 0 C--N 1.329 -0.285 0 CA-C-O 121.54 0.686 . . . . 0.0 110.903 179.994 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 9' ' ' PRO . . . . . 0.508 ' HA ' ' HA ' ' A' ' 10' ' ' HIS . 53.6 Cg_endo -69.79 105.53 1.51 Allowed 'Trans proline' 0 C--O 1.232 0.192 0 C-N-CA 122.646 2.231 . . . . 0.0 112.361 179.875 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 10' ' ' HIS . . . . . 0.508 ' HA ' ' HA ' ' A' ' 9' ' ' PRO . 4.1 m-70 -131.28 128.97 40.91 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.872 -0.061 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 11' ' ' ASN . . . . . 0.416 ' N ' ' O ' ' A' ' 8' ' ' LYS . 3.6 t30 59.14 44.52 15.78 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.865 -179.957 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 12' ' ' CYS . . . . . 0.459 ' HB2' ' CE ' ' A' ' 8' ' ' LYS . 1.4 m -129.93 157.56 41.96 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.873 179.978 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 13' ' ' VAL . . . . . 0.405 ' CG2' ' HB1' ' A' ' 47' ' ' ALA . 1.3 m -85.91 155.39 3.42 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.131 -0.486 . . . . 0.0 111.15 179.912 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 14' ' ' TYR . . . . . 0.535 ' CZ ' ' HB2' ' A' ' 8' ' ' LYS . 9.5 m-85 -94.45 94.87 8.49 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.939 -179.94 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 1.8 pm0 -64.6 133.98 53.38 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.869 -179.978 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 1.8 p -84.74 159.92 20.39 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.873 -179.96 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 8.4 t80 -95.47 -32.51 12.85 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.899 -179.865 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 18' ' ' ASN . . . . . 0.599 ' CG ' ' HD2' ' A' ' 19' ' ' PRO . 1.8 t-20 -154.7 147.0 17.46 Favored Pre-proline 0 C--N 1.329 -0.286 0 CA-C-O 121.604 0.716 . . . . 0.0 110.87 179.971 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 19' ' ' PRO . . . . . 0.599 ' HD2' ' CG ' ' A' ' 18' ' ' ASN . 54.1 Cg_endo -69.73 -31.45 20.62 Favored 'Trans proline' 0 C--O 1.231 0.166 0 C-N-CA 122.714 2.276 . . . . 0.0 112.348 179.918 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 2.0 mmmm -94.48 24.57 4.45 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.874 179.934 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -114.75 132.85 10.67 Favored Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.732 -0.747 . . . . 0.0 112.495 179.907 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 67.4 m -83.67 24.87 0.82 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.874 0.369 . . . . 0.0 110.819 -179.712 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 23' ' ' TYR . . . . . 0.42 ' O ' ' CD1' ' A' ' 23' ' ' TYR . 2.6 t80 -64.54 -41.24 96.48 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.134 -0.484 . . . . 0.0 110.916 -179.902 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 24' ' ' CYS . . . . . 0.409 ' SG ' ' O ' ' A' ' 37' ' ' TYR . 47.8 t -69.4 -43.12 74.09 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.866 -179.993 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 1.9 t30 -55.12 -56.39 20.44 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.855 -179.992 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 9.5 m-20 -56.13 -52.3 64.84 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.893 179.939 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 1.9 tp -58.29 -37.13 74.4 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.872 -179.967 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 10.9 m -63.65 -51.31 65.71 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.231 -0.441 . . . . 0.0 110.874 179.901 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 1.1 p -63.31 -24.54 67.9 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.145 -179.947 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 14.0 tp10 -59.68 -23.17 62.88 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.912 179.966 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 2.0 m-80 -103.93 22.3 14.82 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.88 -179.95 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 82.78 19.68 62.99 Favored Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.699 -0.762 . . . . 0.0 112.506 179.966 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 33' ' ' ALA . . . . . 0.485 ' HB3' ' CD1' ' A' ' 53' ' ' LEU . . . -84.92 149.31 25.74 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.775 0.321 . . . . 0.0 111.047 -179.988 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . 0.462 ' HB2' ' CB ' ' A' ' 52' ' ' GLN . 5.7 tp10 -74.84 -34.7 62.34 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.907 -179.947 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 2.4 m -161.77 178.15 9.24 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.868 -179.8 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -169.12 159.77 32.91 Favored Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.735 -0.745 . . . . 0.0 112.49 -179.982 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 37' ' ' TYR . . . . . 0.557 ' CD1' HD11 ' A' ' 51' ' ' ILE . 3.9 p90 -163.84 160.55 22.41 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 120.957 0.408 . . . . 0.0 110.875 -179.778 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 38' ' ' CYS . . . . . . . . . . . . . 2.4 t -74.43 113.02 11.18 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.853 179.974 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 39' ' ' GLN . . . . . 0.503 ' OE1' ' N ' ' A' ' 41' ' ' LEU . 0.0 OUTLIER -90.3 122.99 33.7 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.889 179.994 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 40' ' ' ILE . . . . . 0.422 ' HA ' ' ND2' ' A' ' 46' ' ' ASN . 2.5 mm -92.81 -51.42 11.34 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.138 179.94 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 41' ' ' LEU . . . . . 0.503 ' N ' ' OE1' ' A' ' 39' ' ' GLN . 0.1 OUTLIER -75.17 57.93 0.88 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.121 -0.491 . . . . 0.0 110.976 179.887 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -99.93 144.14 16.77 Favored Glycine 0 N--CA 1.451 -0.358 0 C-N-CA 120.747 -0.74 . . . . 0.0 112.465 179.954 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 55.8 tttp -53.91 -26.14 23.64 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.785 0.326 . . . . 0.0 110.92 179.997 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 0.9 OUTLIER -115.25 23.83 12.14 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.926 -179.988 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 93.65 -132.66 11.31 Favored Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.791 -0.719 . . . . 0.0 112.48 179.946 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 46' ' ' ASN . . . . . 0.422 ' ND2' ' HA ' ' A' ' 40' ' ' ILE . 0.9 OUTLIER -90.69 117.32 29.25 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.786 0.327 . . . . 0.0 110.922 -179.908 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 47' ' ' ALA . . . . . 0.405 ' HB1' ' CG2' ' A' ' 13' ' ' VAL . . . -140.72 146.16 37.41 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.086 179.91 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 48' ' ' CYS . . . . . 0.451 ' N ' ' O ' ' A' ' 14' ' ' TYR . 40.1 t -67.39 109.33 3.12 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.891 -179.957 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 49' ' ' TRP . . . . . 0.572 ' CZ3' ' HA ' ' A' ' 4' ' ' ALA . 36.9 t-105 -94.66 114.22 26.13 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.917 -179.997 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 50' ' ' CYS . . . . . . . . . . . . . 42.6 m -94.96 142.43 27.49 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.888 -179.962 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 51' ' ' ILE . . . . . 0.557 HD11 ' CD1' ' A' ' 37' ' ' TYR . 3.7 mp -105.92 133.85 49.15 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.187 -0.46 . . . . 0.0 111.143 179.953 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 52' ' ' GLN . . . . . 0.462 ' CB ' ' HB2' ' A' ' 34' ' ' GLU . 9.3 mm-40 64.49 45.42 3.68 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.906 179.952 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 53' ' ' LEU . . . . . 0.485 ' CD1' ' HB3' ' A' ' 33' ' ' ALA . 15.3 tp -85.37 134.0 41.31 Favored Pre-proline 0 C--N 1.329 -0.305 0 CA-C-O 121.592 0.711 . . . . 0.0 110.928 -179.999 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 54' ' ' PRO . . . . . 0.463 ' HD2' ' CD1' ' A' ' 53' ' ' LEU . 53.9 Cg_endo -69.74 147.14 62.33 Favored 'Trans proline' 0 C--O 1.231 0.165 0 C-N-CA 122.662 2.241 . . . . 0.0 112.377 179.87 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 2.4 m-20 -63.88 -6.44 5.97 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.842 179.947 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 9.0 m120 -77.92 -24.94 48.12 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.914 -179.94 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 57' ' ' VAL . . . . . 0.465 ' CG1' ' HD2' ' A' ' 58' ' ' PRO . 12.3 t -91.14 136.39 27.32 Favored Pre-proline 0 C--N 1.33 -0.251 0 CA-C-O 121.601 0.715 . . . . 0.0 111.115 179.922 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 58' ' ' PRO . . . . . 0.465 ' HD2' ' CG1' ' A' ' 57' ' ' VAL . 54.0 Cg_endo -69.76 136.4 32.89 Favored 'Trans proline' 0 C--O 1.231 0.17 0 C-N-CA 122.724 2.283 . . . . 0.0 112.351 179.953 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 59' ' ' ILE . . . . . 0.419 ' C ' ' HB1' ' A' ' 7' ' ' ALA . 13.9 pt -116.23 164.15 12.82 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.276 -0.42 . . . . 0.0 111.162 179.922 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 60' ' ' ARG . . . . . 0.444 ' C ' ' CD ' ' A' ' 60' ' ' ARG . 0.3 OUTLIER -65.62 106.42 1.46 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.848 179.983 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . 0.411 ' CD1' ' OD1' ' A' ' 11' ' ' ASN . 1.3 pt -94.87 160.64 30.7 Favored Pre-proline 0 C--N 1.329 -0.315 0 CA-C-O 121.606 0.717 . . . . 0.0 111.171 179.912 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -69.71 66.11 1.75 Allowed 'Trans proline' 0 C--N 1.341 0.159 0 C-N-CA 122.755 2.303 . . . . 0.0 112.352 179.866 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -144.78 -173.86 16.49 Favored Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 120.765 -0.731 . . . . 0.0 112.499 179.973 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 11.4 ttmm -85.1 147.17 26.78 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 120.786 0.327 . . . . 0.0 110.902 -179.944 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 65' ' ' CYS . . . . . 0.561 ' O ' ' CD2' ' A' ' 66' ' ' HIS . 0.8 OUTLIER -94.04 159.53 15.12 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.909 179.947 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 66' ' ' HIS . . . . . 0.561 ' CD2' ' O ' ' A' ' 65' ' ' CYS . 11.5 p80 . . . . . 0 C--N 1.329 -0.296 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.881 179.958 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 1' ' ' ALA . . . . . 0.414 ' HB2' ' C ' ' A' ' 53' ' ' LEU . . . . . . . . 0 C--O 1.231 0.12 0 CA-C-O 120.759 0.314 . . . . 0.0 111.099 . . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -152.99 150.08 28.85 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.229 -0.442 . . . . 0.0 110.897 -179.904 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 2.7 m-20 -89.02 132.36 34.78 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.859 179.967 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 4' ' ' ALA . . . . . 0.598 ' HA ' ' CZ3' ' A' ' 49' ' ' TRP . . . -174.93 -179.27 1.37 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.11 179.918 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 5' ' ' TYR . . . . . 0.41 ' CE2' ' HE3' ' A' ' 49' ' ' TRP . 12.5 m-85 -84.46 131.49 34.65 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.941 -179.861 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 4.9 tt -75.04 146.24 9.77 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.123 179.949 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -84.76 164.05 18.76 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.095 179.839 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 8' ' ' LYS . . . . . 0.534 ' HB2' ' CZ ' ' A' ' 14' ' ' TYR . 0.5 OUTLIER -145.18 168.88 10.93 Favored Pre-proline 0 C--N 1.329 -0.323 0 CA-C-O 121.633 0.73 . . . . 0.0 110.861 179.975 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 9' ' ' PRO . . . . . 0.49 ' N ' ' HG3' ' A' ' 8' ' ' LYS . 53.0 Cg_endo -69.8 104.94 1.4 Allowed 'Trans proline' 0 C--N 1.342 0.186 0 C-N-CA 122.682 2.255 . . . . 0.0 112.312 179.925 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 10' ' ' HIS . . . . . 0.471 ' HA ' ' HA ' ' A' ' 9' ' ' PRO . 5.5 m-70 -131.87 123.12 26.85 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.838 -0.071 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 11' ' ' ASN . . . . . 0.512 ' N ' ' O ' ' A' ' 8' ' ' LYS . 5.8 t30 69.59 21.42 6.69 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.899 -179.934 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 1.5 m -108.25 172.01 7.08 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.884 179.975 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 13' ' ' VAL . . . . . 0.47 ' CG2' ' HB3' ' A' ' 47' ' ' ALA . 0.9 OUTLIER -92.85 155.6 3.11 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.109 179.958 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 14' ' ' TYR . . . . . 0.534 ' CZ ' ' HB2' ' A' ' 8' ' ' LYS . 6.9 m-85 -93.82 95.7 9.29 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.878 -179.855 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 16.2 pt-20 -64.84 137.05 57.54 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.907 179.994 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 15.1 p -84.41 158.41 21.09 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.885 -179.923 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 24.2 t80 -95.57 -33.05 12.54 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.918 -179.866 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 18' ' ' ASN . . . . . 0.586 ' CG ' ' HD2' ' A' ' 19' ' ' PRO . 1.9 t-20 -155.15 147.0 17.15 Favored Pre-proline 0 C--N 1.328 -0.333 0 CA-C-O 121.637 0.732 . . . . 0.0 110.894 179.97 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 19' ' ' PRO . . . . . 0.586 ' HD2' ' CG ' ' A' ' 18' ' ' ASN . 53.4 Cg_endo -69.75 -33.96 15.56 Favored 'Trans proline' 0 C--N 1.342 0.188 0 C-N-CA 122.669 2.246 . . . . 0.0 112.343 179.935 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 3.7 mmmp? -94.61 24.56 4.53 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.87 179.907 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -115.83 135.59 12.3 Favored Glycine 0 N--CA 1.452 -0.281 0 C-N-CA 120.74 -0.743 . . . . 0.0 112.465 179.962 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 83.9 p -83.52 24.86 0.8 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.872 0.368 . . . . 0.0 110.835 -179.719 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 0.4 OUTLIER -60.67 -51.77 67.96 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.909 -179.874 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 24' ' ' CYS . . . . . 0.401 ' SG ' ' O ' ' A' ' 37' ' ' TYR . 42.7 t -62.23 -41.01 98.03 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.853 -179.978 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 25' ' ' ASN . . . . . 0.473 ' HA ' ' CA ' ' A' ' 36' ' ' GLY . 0.3 OUTLIER -54.41 -58.43 7.46 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.871 -179.966 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -54.92 -53.83 50.51 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.856 179.945 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 1.8 tp -56.75 -37.58 71.23 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.89 -179.922 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 28' ' ' CYS . . . . . 0.447 ' SG ' ' SG ' ' A' ' 48' ' ' CYS . 4.9 m -63.73 -51.96 62.62 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.897 179.89 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 1.1 p -62.43 -24.77 67.6 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.128 -0.487 . . . . 0.0 111.197 -179.993 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 5.2 tm-20 -58.81 -22.47 58.6 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.892 -180.0 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 1.8 m-80 -103.4 21.94 15.08 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.92 -179.956 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 83.46 19.23 62.55 Favored Glycine 0 N--CA 1.451 -0.366 0 C-N-CA 120.769 -0.729 . . . . 0.0 112.479 179.99 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 33' ' ' ALA . . . . . 0.498 ' HB1' ' CD1' ' A' ' 53' ' ' LEU . . . -85.24 148.65 25.97 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.801 0.334 . . . . 0.0 111.072 179.973 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . 0.47 ' HB2' ' CB ' ' A' ' 52' ' ' GLN . 5.7 tp10 -74.69 -31.27 61.84 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.837 -179.894 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 2.9 m -162.65 178.61 8.38 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.889 -179.774 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 36' ' ' GLY . . . . . 0.473 ' CA ' ' HA ' ' A' ' 25' ' ' ASN . . . -174.85 153.62 16.34 Favored Glycine 0 N--CA 1.451 -0.354 0 C-N-CA 120.72 -0.752 . . . . 0.0 112.465 -179.98 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 37' ' ' TYR . . . . . 0.401 ' O ' ' SG ' ' A' ' 24' ' ' CYS . 45.4 p90 -164.36 167.67 19.48 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.936 0.398 . . . . 0.0 110.876 -179.746 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 38' ' ' CYS . . . . . . . . . . . . . 27.0 t -75.11 120.15 20.24 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.845 179.993 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -105.5 130.28 53.6 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.95 179.99 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 40' ' ' ILE . . . . . 0.492 ' CD1' ' N ' ' A' ' 40' ' ' ILE . 1.3 mp -95.35 -33.76 5.0 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-N 116.25 -0.432 . . . . 0.0 111.149 179.966 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -75.56 48.96 0.47 Allowed 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.918 179.89 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -101.98 139.3 14.35 Favored Glycine 0 N--CA 1.452 -0.298 0 C-N-CA 120.783 -0.722 . . . . 0.0 112.493 179.88 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 38.7 tttp -54.12 -24.97 19.72 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.794 0.33 . . . . 0.0 110.862 -179.966 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 44' ' ' TYR . . . . . 0.429 ' CE1' ' CG ' ' A' ' 60' ' ' ARG . 0.5 OUTLIER -112.65 23.93 13.0 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.922 -179.929 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 93.8 -129.96 10.11 Favored Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 120.711 -0.757 . . . . 0.0 112.439 179.974 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 46' ' ' ASN . . . . . 0.48 ' ND2' ' HA ' ' A' ' 40' ' ' ILE . 28.3 m120 -93.19 119.09 31.99 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.872 0.368 . . . . 0.0 110.875 -179.873 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 47' ' ' ALA . . . . . 0.47 ' HB3' ' CG2' ' A' ' 13' ' ' VAL . . . -139.34 150.49 45.42 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.154 -0.476 . . . . 0.0 111.107 179.849 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 48' ' ' CYS . . . . . 0.447 ' SG ' ' SG ' ' A' ' 28' ' ' CYS . 41.5 t -65.99 109.55 2.59 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.851 -179.926 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 49' ' ' TRP . . . . . 0.598 ' CZ3' ' HA ' ' A' ' 4' ' ' ALA . 38.8 t-105 -95.21 115.17 27.07 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.9 -179.995 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 50' ' ' CYS . . . . . . . . . . . . . 39.9 m -95.79 142.47 28.02 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.834 -179.962 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 51' ' ' ILE . . . . . 0.405 ' O ' ' HB2' ' A' ' 52' ' ' GLN . 3.6 mm -107.52 133.16 53.12 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.145 179.871 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 52' ' ' GLN . . . . . 0.47 ' CB ' ' HB2' ' A' ' 34' ' ' GLU . 12.1 mm-40 64.95 42.8 4.1 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.922 179.958 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 53' ' ' LEU . . . . . 0.498 ' CD1' ' HB1' ' A' ' 33' ' ' ALA . 16.3 tp -85.5 136.77 36.98 Favored Pre-proline 0 C--N 1.329 -0.324 0 CA-C-O 121.611 0.72 . . . . 0.0 110.932 -179.996 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 54' ' ' PRO . . . . . 0.481 ' HD2' ' CD1' ' A' ' 53' ' ' LEU . 54.3 Cg_endo -69.74 146.07 59.23 Favored 'Trans proline' 0 C--N 1.342 0.194 0 C-N-CA 122.667 2.245 . . . . 0.0 112.394 179.823 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -65.23 -5.16 6.29 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.901 179.928 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 15.4 m-20 -78.35 -28.6 47.19 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.906 -179.947 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 57' ' ' VAL . . . . . 0.468 ' CG1' ' HD2' ' A' ' 58' ' ' PRO . 14.6 t -86.5 136.4 35.18 Favored Pre-proline 0 C--N 1.329 -0.294 0 CA-C-O 121.641 0.734 . . . . 0.0 111.121 179.917 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 58' ' ' PRO . . . . . 0.468 ' HD2' ' CG1' ' A' ' 57' ' ' VAL . 53.1 Cg_endo -69.77 145.36 56.88 Favored 'Trans proline' 0 C--N 1.342 0.19 0 C-N-CA 122.699 2.266 . . . . 0.0 112.322 179.966 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 41.7 pt -122.66 166.93 16.82 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.161 179.922 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 60' ' ' ARG . . . . . 0.461 ' HD2' ' N ' ' A' ' 61' ' ' ILE . 6.0 tpt180 -65.83 128.31 35.49 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.848 -179.998 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . 0.461 ' N ' ' HD2' ' A' ' 60' ' ' ARG . 1.8 pt -138.32 155.41 74.03 Favored Pre-proline 0 C--N 1.329 -0.313 0 CA-C-O 121.65 0.738 . . . . 0.0 111.161 179.941 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.76 75.11 1.24 Allowed 'Trans proline' 0 C--N 1.342 0.204 0 C-N-CA 122.673 2.249 . . . . 0.0 112.345 179.876 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -141.1 -177.44 16.34 Favored Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 120.751 -0.738 . . . . 0.0 112.466 179.987 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 7.6 mtpm? -75.18 111.41 10.4 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.811 0.338 . . . . 0.0 110.884 -179.989 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 65' ' ' CYS . . . . . 0.604 ' SG ' ' CD2' ' A' ' 66' ' ' HIS . 1.6 t -94.84 163.28 13.41 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.913 179.897 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 66' ' ' HIS . . . . . 0.604 ' CD2' ' SG ' ' A' ' 65' ' ' CYS . 0.8 OUTLIER . . . . . 0 C--N 1.33 -0.281 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.836 179.952 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.231 0.085 0 CA-C-O 120.798 0.332 . . . . 0.0 111.072 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 2' ' ' ARG . . . . . 0.455 ' CZ ' ' OD2' ' A' ' 55' ' ' ASP . 5.5 ptt-85 -149.65 177.52 9.69 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.912 -179.905 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 3' ' ' ASP . . . . . 0.522 ' HB3' ' CE2' ' A' ' 49' ' ' TRP . 4.0 m-20 -107.66 140.15 41.12 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.898 179.935 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 4' ' ' ALA . . . . . 0.571 ' HA ' ' CZ3' ' A' ' 49' ' ' TRP . . . -171.86 -176.85 1.81 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.094 -179.993 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 5' ' ' TYR . . . . . 0.438 ' OH ' ' NE2' ' A' ' 39' ' ' GLN . 29.0 m-85 -92.92 124.51 36.95 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.899 -179.834 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 6' ' ' ILE . . . . . 0.506 HG12 ' CD1' ' A' ' 14' ' ' TYR . 8.4 tt -75.24 135.38 27.33 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.128 -0.487 . . . . 0.0 111.141 179.899 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 7' ' ' ALA . . . . . 0.507 ' CB ' ' O ' ' A' ' 12' ' ' CYS . . . -135.2 140.88 45.66 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.124 179.775 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 8' ' ' LYS . . . . . 0.574 ' HB3' ' CE1' ' A' ' 14' ' ' TYR . 8.2 pttt -101.18 160.85 25.45 Favored Pre-proline 0 C--N 1.329 -0.322 0 CA-C-O 121.622 0.725 . . . . 0.0 110.861 179.958 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 9' ' ' PRO . . . . . 0.513 ' HA ' ' HA ' ' A' ' 10' ' ' HIS . 54.2 Cg_endo -69.74 144.65 54.79 Favored 'Trans proline' 0 C--N 1.342 0.198 0 C-N-CA 122.651 2.234 . . . . 0.0 112.388 179.883 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 10' ' ' HIS . . . . . 0.513 ' HA ' ' HA ' ' A' ' 9' ' ' PRO . 20.7 m170 -101.86 98.87 9.05 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.833 -0.008 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 11' ' ' ASN . . . . . 0.449 ' OD1' ' NH1' ' A' ' 60' ' ' ARG . 35.5 t-20 65.95 73.84 0.37 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.874 -179.931 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 12' ' ' CYS . . . . . 0.507 ' O ' ' CB ' ' A' ' 7' ' ' ALA . 10.0 m -141.19 145.21 35.37 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.928 179.943 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 13' ' ' VAL . . . . . 0.468 HG11 ' NE ' ' A' ' 60' ' ' ARG . 0.8 OUTLIER -84.06 155.32 3.67 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.153 179.943 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 14' ' ' TYR . . . . . 0.574 ' CE1' ' HB3' ' A' ' 8' ' ' LYS . 6.8 m-85 -103.83 88.6 3.08 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.939 -179.912 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -63.82 136.4 57.38 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.09 -0.505 . . . . 0.0 110.915 179.995 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 11.7 p -84.68 130.3 34.72 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.887 -179.948 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 65.1 t80 -101.03 -37.06 8.78 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.907 -179.902 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 13.3 t-20 -106.2 85.25 1.59 Allowed Pre-proline 0 C--N 1.328 -0.332 0 CA-C-O 121.604 0.716 . . . . 0.0 110.889 179.998 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.76 -27.7 26.17 Favored 'Trans proline' 0 C--N 1.342 0.198 0 C-N-CA 122.65 2.233 . . . . 0.0 112.344 179.935 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 9.7 mmtp -95.02 24.36 4.92 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.919 179.915 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -144.27 -179.91 21.08 Favored Glycine 0 N--CA 1.452 -0.28 0 C-N-CA 120.719 -0.753 . . . . 0.0 112.463 179.976 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 17.6 m -95.21 28.87 2.66 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.907 0.384 . . . . 0.0 110.848 -179.738 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 20.3 t80 -54.94 -58.93 5.61 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.905 -179.87 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 24' ' ' CYS . . . . . 0.459 ' SG ' ' C ' ' A' ' 37' ' ' TYR . 35.5 t -58.0 -32.87 68.33 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.89 -179.995 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 25' ' ' ASN . . . . . 0.422 ' CA ' ' O ' ' A' ' 36' ' ' GLY . 1.5 t30 -65.0 -56.38 13.44 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.928 179.961 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 17.7 m-20 -54.47 -47.91 72.42 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.868 179.938 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 27' ' ' LEU . . . . . 0.498 ' O ' ' ND2' ' A' ' 31' ' ' ASN . 1.4 tp -63.86 -38.81 92.46 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.972 179.989 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 28' ' ' CYS . . . . . 0.665 ' SG ' ' SG ' ' A' ' 48' ' ' CYS . 7.7 m -65.09 -57.45 8.58 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.894 179.892 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 1.3 p -63.93 -34.52 78.15 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.126 -0.488 . . . . 0.0 111.132 -179.944 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 48.1 tt0 -54.78 -22.14 13.31 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.882 -179.98 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 31' ' ' ASN . . . . . 0.498 ' ND2' ' O ' ' A' ' 27' ' ' LEU . 1.8 m-80 -104.81 23.11 14.0 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.868 -179.959 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . 0.531 ' O ' ' CD ' ' A' ' 54' ' ' PRO . . . 84.53 69.15 1.38 Allowed Glycine 0 N--CA 1.451 -0.36 0 C-N-CA 120.766 -0.731 . . . . 0.0 112.511 179.984 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 33' ' ' ALA . . . . . 0.443 ' CB ' ' CD1' ' A' ' 53' ' ' LEU . . . -150.15 153.65 36.69 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.778 0.323 . . . . 0.0 111.096 -179.998 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . 0.486 ' HB2' ' CB ' ' A' ' 52' ' ' GLN . 19.4 tp10 -74.08 -34.6 64.07 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.863 -179.937 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 22.1 m -163.48 -179.89 6.81 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.876 -179.771 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 36' ' ' GLY . . . . . 0.422 ' O ' ' CA ' ' A' ' 25' ' ' ASN . . . -176.18 139.23 4.48 Favored Glycine 0 N--CA 1.452 -0.288 0 C-N-CA 120.709 -0.758 . . . . 0.0 112.45 179.955 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 37' ' ' TYR . . . . . 0.576 ' CE1' HD13 ' A' ' 51' ' ' ILE . 1.2 p90 -144.91 164.64 30.48 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-O 120.913 0.387 . . . . 0.0 110.947 -179.799 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 38' ' ' CYS . . . . . . . . . . . . . 39.0 t -74.91 129.43 37.64 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.844 179.998 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 39' ' ' GLN . . . . . 0.438 ' NE2' ' OH ' ' A' ' 5' ' ' TYR . 16.4 tt0 -105.64 125.02 50.51 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.914 179.997 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 40' ' ' ILE . . . . . 0.497 ' HA ' ' ND2' ' A' ' 46' ' ' ASN . 0.7 OUTLIER -95.32 -24.87 4.63 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.154 179.934 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 2.7 mm? -82.22 35.34 0.44 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.923 179.935 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -92.58 131.76 10.94 Favored Glycine 0 N--CA 1.45 -0.37 0 C-N-CA 120.749 -0.739 . . . . 0.0 112.485 179.924 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -52.01 -24.69 7.01 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.756 0.312 . . . . 0.0 110.871 -179.967 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 0.7 OUTLIER -99.65 23.91 8.94 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.962 -179.957 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 93.81 -84.77 1.05 Allowed Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.725 -0.75 . . . . 0.0 112.498 -179.996 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 46' ' ' ASN . . . . . 0.497 ' ND2' ' HA ' ' A' ' 40' ' ' ILE . 2.5 m120 -144.12 130.49 19.85 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.86 0.362 . . . . 0.0 110.91 -179.916 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -145.95 146.54 31.08 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.105 179.847 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 48' ' ' CYS . . . . . 0.665 ' SG ' ' SG ' ' A' ' 28' ' ' CYS . 50.7 t -65.46 113.8 4.39 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.925 -179.952 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 49' ' ' TRP . . . . . 0.571 ' CZ3' ' HA ' ' A' ' 4' ' ' ALA . 49.6 t-105 -94.98 113.44 25.15 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.929 -179.982 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 50' ' ' CYS . . . . . . . . . . . . . 20.2 m -95.42 139.78 31.23 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.898 -179.994 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 51' ' ' ILE . . . . . 0.576 HD13 ' CE1' ' A' ' 37' ' ' TYR . 4.7 mp -107.25 138.74 31.73 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.095 179.945 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 52' ' ' GLN . . . . . 0.486 ' CB ' ' HB2' ' A' ' 34' ' ' GLU . 2.1 mm-40 67.38 30.77 6.78 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.897 179.955 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 53' ' ' LEU . . . . . 0.443 ' CD1' ' CB ' ' A' ' 33' ' ' ALA . 11.5 tp -85.93 132.88 42.56 Favored Pre-proline 0 C--N 1.328 -0.36 0 CA-C-O 121.616 0.722 . . . . 0.0 110.907 -179.999 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 54' ' ' PRO . . . . . 0.531 ' CD ' ' O ' ' A' ' 32' ' ' GLY . 53.7 Cg_endo -69.73 150.93 69.03 Favored 'Trans proline' 0 C--O 1.232 0.175 0 C-N-CA 122.712 2.275 . . . . 0.0 112.318 179.886 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 55' ' ' ASP . . . . . 0.455 ' OD2' ' CZ ' ' A' ' 2' ' ' ARG . 16.1 m-20 -65.11 -5.82 7.55 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.877 179.911 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 45.1 m-80 -74.93 -24.56 58.51 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.884 -179.908 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 57' ' ' VAL . . . . . 0.448 ' CG1' ' HD2' ' A' ' 58' ' ' PRO . 1.2 t -84.22 136.63 40.44 Favored Pre-proline 0 C--N 1.329 -0.287 0 CA-C-O 121.685 0.755 . . . . 0.0 111.119 179.936 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 58' ' ' PRO . . . . . 0.448 ' HD2' ' CG1' ' A' ' 57' ' ' VAL . 53.8 Cg_endo -69.79 130.26 18.99 Favored 'Trans proline' 0 C--N 1.342 0.186 0 C-N-CA 122.668 2.245 . . . . 0.0 112.324 179.971 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 59' ' ' ILE . . . . . 0.491 ' O ' ' CD1' ' A' ' 61' ' ' ILE . 27.4 pt -107.89 171.31 2.33 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.101 179.938 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 60' ' ' ARG . . . . . 0.468 ' NE ' HG11 ' A' ' 13' ' ' VAL . 5.6 tpt180 -75.76 113.53 13.33 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.871 179.936 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . 0.491 ' CD1' ' O ' ' A' ' 59' ' ' ILE . 0.0 OUTLIER -108.67 160.51 26.96 Favored Pre-proline 0 C--N 1.329 -0.304 0 CA-C-O 121.6 0.714 . . . . 0.0 111.124 179.986 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.77 64.17 1.8 Allowed 'Trans proline' 0 N--CA 1.465 -0.174 0 C-N-CA 122.692 2.262 . . . . 0.0 112.342 179.911 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -138.98 -179.49 17.42 Favored Glycine 0 N--CA 1.451 -0.351 0 C-N-CA 120.744 -0.741 . . . . 0.0 112.451 -179.989 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 25.9 ttmt -85.39 145.61 27.39 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-O 120.778 0.323 . . . . 0.0 110.871 -179.923 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 65' ' ' CYS . . . . . 0.566 ' SG ' ' CD2' ' A' ' 66' ' ' HIS . 7.9 t -93.85 148.37 22.2 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.885 179.957 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 66' ' ' HIS . . . . . 0.566 ' CD2' ' SG ' ' A' ' 65' ' ' CYS . 1.2 p-80 . . . . . 0 C--N 1.329 -0.313 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.871 -179.996 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.231 0.115 0 CA-C-O 120.793 0.33 . . . . 0.0 111.095 . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 2' ' ' ARG . . . . . 0.439 ' HD3' ' N ' ' A' ' 2' ' ' ARG . 0.0 OUTLIER -150.71 -177.28 5.89 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.898 -179.921 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 3' ' ' ASP . . . . . 0.415 ' CG ' HD13 ' A' ' 51' ' ' ILE . 9.5 m-20 -107.23 134.08 50.86 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.881 179.932 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -175.67 -174.66 0.7 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.165 -0.47 . . . . 0.0 111.138 179.999 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 5' ' ' TYR . . . . . 0.458 ' CE1' ' CZ3' ' A' ' 49' ' ' TRP . 2.0 m-85 -85.06 135.07 34.16 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.883 -179.835 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 6' ' ' ILE . . . . . 0.478 ' CG2' ' HB3' ' A' ' 48' ' ' CYS . 3.7 tt -75.93 134.08 29.85 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.111 -0.495 . . . . 0.0 111.185 179.868 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -85.78 152.01 23.37 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.211 -0.45 . . . . 0.0 111.096 179.873 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 8' ' ' LYS . . . . . 0.532 ' HB2' ' CZ ' ' A' ' 14' ' ' TYR . 0.0 OUTLIER -135.19 167.22 23.7 Favored Pre-proline 0 C--N 1.329 -0.306 0 CA-C-O 121.593 0.711 . . . . 0.0 110.864 179.963 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 9' ' ' PRO . . . . . 0.529 ' HA ' ' HA ' ' A' ' 10' ' ' HIS . 53.9 Cg_endo -69.73 105.93 1.57 Allowed 'Trans proline' 0 C--N 1.342 0.192 0 C-N-CA 122.703 2.269 . . . . 0.0 112.35 179.873 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 10' ' ' HIS . . . . . 0.529 ' HA ' ' HA ' ' A' ' 9' ' ' PRO . 11.3 m-70 -131.4 127.73 38.1 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.855 -0.067 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 11' ' ' ASN . . . . . 0.412 ' N ' ' O ' ' A' ' 8' ' ' LYS . 4.2 t30 61.36 26.62 16.39 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.889 -179.945 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 1.6 m -107.14 154.9 20.5 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.89 -179.998 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 13' ' ' VAL . . . . . 0.462 HG12 ' NE ' ' A' ' 60' ' ' ARG . 0.9 OUTLIER -84.83 154.44 3.57 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.169 179.923 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 14' ' ' TYR . . . . . 0.532 ' CZ ' ' HB2' ' A' ' 8' ' ' LYS . 9.5 m-85 -94.75 89.75 5.82 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.944 -179.912 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 3.3 pt-20 -64.65 125.41 24.65 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.89 -179.965 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 1.1 p -101.55 134.38 44.75 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.864 -179.901 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 17' ' ' TYR . . . . . 0.4 ' O ' ' HD3' ' A' ' 19' ' ' PRO . 4.8 m-30 -99.49 -28.18 13.37 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.929 -179.926 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -106.44 82.94 1.06 Allowed Pre-proline 0 C--N 1.329 -0.303 0 CA-C-O 121.616 0.722 . . . . 0.0 110.885 -179.987 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 19' ' ' PRO . . . . . 0.444 ' HA ' ' CB ' ' A' ' 38' ' ' CYS . 53.5 Cg_endo -69.76 -26.56 27.47 Favored 'Trans proline' 0 C--N 1.342 0.199 0 C-N-CA 122.632 2.221 . . . . 0.0 112.372 179.928 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 20' ' ' LYS . . . . . 0.466 ' HD3' ' N ' ' A' ' 20' ' ' LYS . 0.0 OUTLIER -94.18 24.54 4.31 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.849 179.943 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -136.28 -178.84 16.08 Favored Glycine 0 N--CA 1.452 -0.299 0 C-N-CA 120.763 -0.732 . . . . 0.0 112.497 179.923 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 2.0 p -94.2 28.76 2.38 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.871 0.367 . . . . 0.0 110.855 -179.737 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 0.9 OUTLIER -59.84 -66.67 0.48 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.909 -179.88 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 24' ' ' CYS . . . . . 0.484 ' SG ' ' N ' ' A' ' 49' ' ' TRP . 53.2 t -60.47 -38.3 83.78 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.89 179.986 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 25' ' ' ASN . . . . . 0.438 ' HA ' ' CA ' ' A' ' 36' ' ' GLY . 1.7 t30 -54.89 -57.05 13.19 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.903 -179.993 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -57.6 -51.37 69.78 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.863 179.95 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 2.2 tp -57.13 -38.8 74.01 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.908 -179.967 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 28' ' ' CYS . . . . . 0.407 ' SG ' ' O ' ' A' ' 49' ' ' TRP . 19.1 m -62.41 -50.6 70.87 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.899 179.905 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 1.1 p -62.78 -25.02 68.02 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.14 -179.97 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 6.8 tp10 -58.96 -22.75 60.7 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.938 179.992 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 1.9 m-80 -103.66 22.6 14.11 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.103 -0.498 . . . . 0.0 110.902 -179.949 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 84.15 18.83 62.03 Favored Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 120.765 -0.731 . . . . 0.0 112.515 -179.988 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 33' ' ' ALA . . . . . 0.477 ' CB ' HD11 ' A' ' 53' ' ' LEU . . . -85.4 152.37 23.29 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.733 0.301 . . . . 0.0 111.122 179.931 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . 0.459 ' CB ' ' HB2' ' A' ' 52' ' ' GLN . 4.3 tt0 -78.66 -33.07 47.38 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.233 -0.439 . . . . 0.0 110.886 -179.93 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 1.7 m -162.77 -177.2 5.39 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.844 -179.772 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . 0.438 ' CA ' ' HA ' ' A' ' 25' ' ' ASN . . . -174.92 157.54 24.7 Favored Glycine 0 N--CA 1.452 -0.284 0 C-N-CA 120.759 -0.734 . . . . 0.0 112.489 -179.984 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 37' ' ' TYR . . . . . 0.581 ' CE2' ' CD1' ' A' ' 49' ' ' TRP . 5.0 p90 -157.64 159.63 37.2 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.863 0.363 . . . . 0.0 110.918 -179.823 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 38' ' ' CYS . . . . . 0.444 ' CB ' ' HA ' ' A' ' 19' ' ' PRO . 21.3 t -74.88 119.47 19.1 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.913 179.999 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -98.49 126.03 43.91 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.913 -179.983 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 40' ' ' ILE . . . . . 0.518 ' CD1' ' N ' ' A' ' 40' ' ' ILE . 1.2 mp -95.97 -35.98 6.2 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.102 179.972 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 4.2 mm? -75.66 53.01 0.69 Allowed 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.934 179.922 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -105.72 138.91 14.53 Favored Glycine 0 N--CA 1.452 -0.296 0 C-N-CA 120.758 -0.734 . . . . 0.0 112.462 179.94 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -57.45 -27.6 62.6 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.83 0.348 . . . . 0.0 110.908 -179.962 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 0.6 OUTLIER -109.22 23.72 14.11 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.903 -179.959 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 93.37 -139.08 14.42 Favored Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.734 -0.745 . . . . 0.0 112.527 -179.978 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 46' ' ' ASN . . . . . 0.46 ' ND2' ' HA ' ' A' ' 40' ' ' ILE . 9.9 m120 -82.96 116.22 22.15 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.821 0.343 . . . . 0.0 110.894 -179.914 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -125.71 141.57 51.95 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.098 179.864 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 48' ' ' CYS . . . . . 0.478 ' HB3' ' CG2' ' A' ' 6' ' ' ILE . 19.5 t -65.47 114.92 5.2 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.883 -179.967 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 49' ' ' TRP . . . . . 0.581 ' CD1' ' CE2' ' A' ' 37' ' ' TYR . 61.7 t-105 -94.1 135.2 35.72 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.947 179.955 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 50' ' ' CYS . . . . . . . . . . . . . 42.1 m -122.1 142.04 50.78 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.851 -179.97 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 51' ' ' ILE . . . . . 0.415 HD13 ' CG ' ' A' ' 3' ' ' ASP . 14.4 mm -111.01 134.48 53.18 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.139 179.895 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 52' ' ' GLN . . . . . 0.459 ' HB2' ' CB ' ' A' ' 34' ' ' GLU . 3.2 mm-40 65.08 44.58 3.32 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.884 179.926 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 53' ' ' LEU . . . . . 0.477 HD11 ' CB ' ' A' ' 33' ' ' ALA . 14.5 tp -85.93 134.34 39.43 Favored Pre-proline 0 C--N 1.328 -0.35 0 CA-C-O 121.631 0.729 . . . . 0.0 110.945 179.955 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 54' ' ' PRO . . . . . 0.468 ' HD2' ' CD1' ' A' ' 53' ' ' LEU . 53.3 Cg_endo -69.74 145.42 57.22 Favored 'Trans proline' 0 C--N 1.342 0.184 0 C-N-CA 122.656 2.238 . . . . 0.0 112.323 179.898 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -62.58 -7.75 5.25 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.851 179.915 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 27.6 m120 -76.17 -25.31 55.11 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.913 -179.886 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 57' ' ' VAL . . . . . 0.467 ' CG1' ' HD2' ' A' ' 58' ' ' PRO . 10.7 t -92.17 136.24 26.06 Favored Pre-proline 0 C--N 1.33 -0.264 0 CA-C-O 121.634 0.73 . . . . 0.0 111.087 179.928 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 58' ' ' PRO . . . . . 0.467 ' HD2' ' CG1' ' A' ' 57' ' ' VAL . 53.9 Cg_endo -69.78 152.53 69.24 Favored 'Trans proline' 0 C--N 1.342 0.193 0 C-N-CA 122.644 2.229 . . . . 0.0 112.366 179.936 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 19.1 pt -125.3 166.3 21.29 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.169 179.91 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 60' ' ' ARG . . . . . 0.468 ' HD2' ' N ' ' A' ' 61' ' ' ILE . 6.7 tpt180 -65.95 116.17 6.81 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.891 179.935 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . 0.468 ' N ' ' HD2' ' A' ' 60' ' ' ARG . 1.0 OUTLIER -117.31 160.13 38.84 Favored Pre-proline 0 C--N 1.329 -0.31 0 CA-C-O 121.606 0.717 . . . . 0.0 111.096 -179.996 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.77 64.81 1.81 Allowed 'Trans proline' 0 C--N 1.342 0.2 0 C-N-CA 122.631 2.221 . . . . 0.0 112.384 179.853 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -136.03 -178.65 15.92 Favored Glycine 0 N--CA 1.451 -0.355 0 C-N-CA 120.719 -0.753 . . . . 0.0 112.474 -179.986 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 1.1 tppp? -85.22 140.29 30.99 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.817 0.341 . . . . 0.0 110.925 179.952 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 65' ' ' CYS . . . . . 0.497 ' SG ' ' N ' ' A' ' 66' ' ' HIS . 1.0 OUTLIER -94.55 160.88 14.44 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.872 179.963 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 66' ' ' HIS . . . . . 0.497 ' N ' ' SG ' ' A' ' 65' ' ' CYS . 7.3 p80 . . . . . 0 C--N 1.329 -0.298 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.824 -179.985 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.231 0.131 0 CA-C-O 120.77 0.319 . . . . 0.0 111.095 . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 18.0 ptt180 -147.27 161.19 41.46 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.89 -179.965 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 3' ' ' ASP . . . . . 0.444 ' HB3' ' CZ2' ' A' ' 49' ' ' TRP . 2.9 m-20 -96.71 134.04 40.49 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.869 -179.988 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 4' ' ' ALA . . . . . 0.589 ' HA ' ' CZ3' ' A' ' 49' ' ' TRP . . . -174.83 -179.09 1.37 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.097 179.982 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 5' ' ' TYR . . . . . 0.403 ' CE2' ' HE3' ' A' ' 49' ' ' TRP . 16.0 m-85 -84.81 135.44 34.1 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.96 -179.857 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 5.5 tt -75.42 137.09 23.6 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.108 -0.496 . . . . 0.0 111.148 179.936 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -91.41 158.47 16.5 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.103 179.816 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 8' ' ' LYS . . . . . 0.525 ' HB2' ' CZ ' ' A' ' 14' ' ' TYR . 0.0 OUTLIER -134.72 166.26 30.51 Favored Pre-proline 0 C--N 1.328 -0.327 0 CA-C-O 121.632 0.729 . . . . 0.0 110.87 -179.988 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 9' ' ' PRO . . . . . 0.501 ' HA ' ' HA ' ' A' ' 10' ' ' HIS . 53.7 Cg_endo -69.79 106.97 1.76 Allowed 'Trans proline' 0 C--N 1.342 0.231 0 C-N-CA 122.666 2.244 . . . . 0.0 112.345 179.891 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 10' ' ' HIS . . . . . 0.501 ' HA ' ' HA ' ' A' ' 9' ' ' PRO . 7.7 m-70 -132.08 125.12 30.6 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.865 -0.069 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 2.3 t30 65.49 44.29 3.12 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.902 -179.896 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 1.6 m -128.81 155.47 45.13 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.873 -179.983 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 13' ' ' VAL . . . . . 0.421 ' CG1' ' NE ' ' A' ' 60' ' ' ARG . 2.7 m -86.5 153.53 3.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.115 179.958 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 14' ' ' TYR . . . . . 0.525 ' CZ ' ' HB2' ' A' ' 8' ' ' LYS . 9.1 m-85 -95.09 100.7 12.48 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.931 -179.942 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 4.9 tm-20 -64.54 137.1 57.66 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.099 -0.501 . . . . 0.0 110.85 -179.945 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 9.1 p -84.83 126.01 33.09 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.864 -179.942 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -100.63 -24.56 14.41 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.903 -179.88 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -134.54 85.15 37.99 Favored Pre-proline 0 C--N 1.329 -0.307 0 CA-C-O 121.555 0.693 . . . . 0.0 110.897 -179.989 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.76 -25.08 28.94 Favored 'Trans proline' 0 C--O 1.231 0.147 0 C-N-CA 122.689 2.259 . . . . 0.0 112.372 179.929 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -94.42 24.23 4.66 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.893 179.914 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -142.88 -174.61 15.33 Favored Glycine 0 N--CA 1.452 -0.279 0 C-N-CA 120.699 -0.763 . . . . 0.0 112.46 179.903 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 50.3 m -95.25 29.14 2.58 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.867 0.365 . . . . 0.0 110.871 -179.729 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 43.9 t80 -64.52 -71.61 0.17 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.921 -179.853 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 42.0 t -55.19 -39.9 70.12 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.824 -179.995 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 1.3 t30 -57.1 -55.57 32.96 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.895 179.998 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 4.5 m-20 -54.68 -53.33 56.34 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.895 179.94 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 2.1 tp -60.08 -36.38 77.25 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.918 -179.976 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 28' ' ' CYS . . . . . 0.458 ' CB ' ' HA3' ' A' ' 36' ' ' GLY . 1.3 m -64.73 -60.72 2.78 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.868 179.89 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 29' ' ' THR . . . . . 0.417 ' HA ' ' O ' ' A' ' 33' ' ' ALA . 1.1 p -62.75 -27.09 69.04 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.165 -0.47 . . . . 0.0 111.126 -179.971 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 9.5 tp10 -54.75 -19.83 7.16 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.253 -0.43 . . . . 0.0 110.861 -179.981 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 1.8 m-80 -101.81 21.99 13.66 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.154 -0.476 . . . . 0.0 110.914 -179.96 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 95.81 -12.66 67.14 Favored Glycine 0 N--CA 1.451 -0.302 0 C-N-CA 120.773 -0.727 . . . . 0.0 112.489 179.996 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 33' ' ' ALA . . . . . 0.534 ' CB ' ' CD1' ' A' ' 53' ' ' LEU . . . -62.17 155.27 24.89 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 120.742 0.306 . . . . 0.0 111.094 179.989 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . 0.484 ' HB2' ' CB ' ' A' ' 52' ' ' GLN . 2.7 tt0 -80.88 -31.46 35.27 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.9 -179.939 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 46.2 m -162.77 177.92 8.91 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.881 -179.771 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . 0.458 ' HA3' ' CB ' ' A' ' 28' ' ' CYS . . . -175.24 157.27 23.9 Favored Glycine 0 N--CA 1.452 -0.277 0 C-N-CA 120.8 -0.714 . . . . 0.0 112.501 -179.976 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 37' ' ' TYR . . . . . 0.545 ' CE2' HD13 ' A' ' 51' ' ' ILE . 0.6 OUTLIER -165.27 173.55 11.13 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.942 0.401 . . . . 0.0 110.904 -179.811 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 38' ' ' CYS . . . . . . . . . . . . . 41.9 t -74.72 120.28 20.05 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.858 -179.98 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 39' ' ' GLN . . . . . 0.478 ' OE1' ' CE3' ' A' ' 49' ' ' TRP . 3.8 tt0 -104.64 125.26 50.58 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.91 179.99 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 40' ' ' ILE . . . . . 0.495 ' CD1' ' N ' ' A' ' 40' ' ' ILE . 1.3 mp -95.44 -25.25 4.53 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.159 179.942 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -81.11 40.91 0.56 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.919 179.918 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -97.38 134.49 11.77 Favored Glycine 0 N--CA 1.452 -0.296 0 C-N-CA 120.752 -0.737 . . . . 0.0 112.474 179.907 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -54.14 -25.05 20.25 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.762 0.315 . . . . 0.0 110.861 -179.992 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 44' ' ' TYR . . . . . 0.488 ' CE1' ' CG ' ' A' ' 60' ' ' ARG . 0.6 OUTLIER -108.6 23.76 14.06 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.964 -179.964 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 93.42 -134.47 12.14 Favored Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.734 -0.746 . . . . 0.0 112.477 179.944 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 46' ' ' ASN . . . . . 0.48 ' ND2' ' HA ' ' A' ' 40' ' ' ILE . 27.8 m120 -91.51 118.82 30.92 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.844 0.354 . . . . 0.0 110.86 -179.884 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -137.33 148.52 46.37 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.099 179.842 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 48' ' ' CYS . . . . . 0.422 ' SG ' ' SG ' ' A' ' 28' ' ' CYS . 11.9 t -65.91 108.76 2.27 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.917 -179.976 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 49' ' ' TRP . . . . . 0.589 ' CZ3' ' HA ' ' A' ' 4' ' ' ALA . 36.3 t-105 -94.67 122.75 37.59 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.913 179.995 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 50' ' ' CYS . . . . . . . . . . . . . 4.9 m -107.79 135.13 49.72 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.844 -179.947 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 51' ' ' ILE . . . . . 0.545 HD13 ' CE2' ' A' ' 37' ' ' TYR . 4.2 mp -100.07 138.8 23.26 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.137 179.911 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 52' ' ' GLN . . . . . 0.484 ' CB ' ' HB2' ' A' ' 34' ' ' GLU . 5.7 mm-40 65.38 42.0 4.04 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.929 179.939 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 53' ' ' LEU . . . . . 0.534 ' CD1' ' CB ' ' A' ' 33' ' ' ALA . 12.7 tp -85.28 132.79 44.08 Favored Pre-proline 0 C--N 1.329 -0.32 0 CA-C-O 121.628 0.728 . . . . 0.0 110.941 -179.987 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 54' ' ' PRO . . . . . 0.438 ' HG2' ' CG2' ' A' ' 57' ' ' VAL . 53.5 Cg_endo -69.78 145.63 57.61 Favored 'Trans proline' 0 C--N 1.342 0.214 0 C-N-CA 122.694 2.263 . . . . 0.0 112.336 179.91 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 40.5 m-20 -62.89 -7.75 5.75 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.855 179.915 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 2.5 m120 -76.51 -25.64 54.4 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.908 -179.908 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 57' ' ' VAL . . . . . 0.466 ' CG1' ' HD2' ' A' ' 58' ' ' PRO . 12.1 t -92.01 136.23 26.3 Favored Pre-proline 0 C--N 1.33 -0.265 0 CA-C-O 121.642 0.734 . . . . 0.0 111.112 179.926 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 58' ' ' PRO . . . . . 0.466 ' HD2' ' CG1' ' A' ' 57' ' ' VAL . 53.6 Cg_endo -69.77 145.68 57.79 Favored 'Trans proline' 0 C--N 1.342 0.196 0 C-N-CA 122.691 2.261 . . . . 0.0 112.331 179.93 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 14.7 pt -124.23 173.8 9.51 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.111 179.914 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 60' ' ' ARG . . . . . 0.488 ' CG ' ' CE1' ' A' ' 44' ' ' TYR . 0.6 OUTLIER -69.04 118.8 12.4 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.879 179.965 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 1.3 pt -118.14 160.59 38.62 Favored Pre-proline 0 C--N 1.329 -0.307 0 CA-C-O 121.642 0.734 . . . . 0.0 111.082 -179.964 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.73 66.34 1.76 Allowed 'Trans proline' 0 C--N 1.342 0.191 0 C-N-CA 122.667 2.244 . . . . 0.0 112.314 179.897 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -141.61 179.41 19.72 Favored Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 120.761 -0.733 . . . . 0.0 112.517 179.934 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 6.0 mmmm -83.38 142.01 31.33 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.804 0.335 . . . . 0.0 110.898 -179.955 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 65' ' ' CYS . . . . . 0.585 ' O ' ' CD2' ' A' ' 66' ' ' HIS . 1.7 t -89.31 156.27 18.84 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.872 179.97 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 66' ' ' HIS . . . . . 0.585 ' CD2' ' O ' ' A' ' 65' ' ' CYS . 16.9 p80 . . . . . 0 C--N 1.329 -0.314 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.883 179.963 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . 0.411 ' HB2' ' C ' ' A' ' 53' ' ' LEU . . . . . . . . 0 C--O 1.231 0.124 0 CA-C-O 120.801 0.334 . . . . 0.0 111.079 . . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -135.37 162.28 33.05 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.865 -179.92 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 3' ' ' ASP . . . . . 0.499 ' OD2' ' CG2' ' A' ' 51' ' ' ILE . 1.8 m-20 -97.77 133.13 42.71 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.887 179.989 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 4' ' ' ALA . . . . . 0.597 ' HA ' ' CZ3' ' A' ' 49' ' ' TRP . . . -172.82 -177.95 1.76 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.103 179.937 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 5' ' ' TYR . . . . . 0.618 ' CE2' ' OE1' ' A' ' 39' ' ' GLN . 68.9 m-85 -84.36 136.66 33.79 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.24 -0.437 . . . . 0.0 110.904 -179.845 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 5.0 tt -74.93 134.7 28.87 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 116.12 -0.491 . . . . 0.0 111.097 179.929 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 7' ' ' ALA . . . . . 0.424 ' HB3' ' C ' ' A' ' 59' ' ' ILE . . . -93.48 156.73 16.58 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.085 179.815 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 8' ' ' LYS . . . . . 0.532 ' HB2' ' CZ ' ' A' ' 14' ' ' TYR . 0.0 OUTLIER -140.2 168.01 16.21 Favored Pre-proline 0 C--N 1.329 -0.297 0 CA-C-O 121.521 0.677 . . . . 0.0 110.886 179.991 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 9' ' ' PRO . . . . . 0.496 ' HA ' ' HA ' ' A' ' 10' ' ' HIS . 53.6 Cg_endo -69.74 107.95 1.97 Allowed 'Trans proline' 0 C--O 1.232 0.206 0 C-N-CA 122.665 2.243 . . . . 0.0 112.332 179.904 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 10' ' ' HIS . . . . . 0.496 ' HA ' ' HA ' ' A' ' 9' ' ' PRO . 5.2 m-70 -131.65 128.59 39.38 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.255 -0.429 . . . . 0.0 110.834 -0.065 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 2.4 t30 58.74 35.92 24.61 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.893 -179.889 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 1.5 m -119.38 152.29 37.05 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.878 179.981 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 13' ' ' VAL . . . . . 0.461 ' CG1' ' NE ' ' A' ' 60' ' ' ARG . 0.9 OUTLIER -84.55 156.04 3.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.143 -0.481 . . . . 0.0 111.169 179.903 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 14' ' ' TYR . . . . . 0.532 ' CZ ' ' HB2' ' A' ' 8' ' ' LYS . 9.3 m-85 -94.89 100.86 12.66 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.908 -179.889 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 38.1 tt0 -64.92 133.63 52.24 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.079 -0.509 . . . . 0.0 110.892 -179.996 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 1.0 OUTLIER -85.14 133.54 34.2 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.879 -179.949 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 9.3 t80 -121.54 24.89 9.64 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.902 -179.91 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 18' ' ' ASN . . . . . 0.45 ' CB ' ' HB2' ' A' ' 23' ' ' TYR . 9.8 t-20 -154.38 80.26 4.76 Favored Pre-proline 0 C--N 1.329 -0.293 0 CA-C-O 121.647 0.736 . . . . 0.0 110.882 179.959 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -69.76 -23.98 30.19 Favored 'Trans proline' 0 C--N 1.341 0.182 0 C-N-CA 122.702 2.268 . . . . 0.0 112.385 179.922 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 21.4 mtpp -94.52 -24.42 17.28 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.858 179.938 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -102.89 175.98 24.51 Favored Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.763 -0.732 . . . . 0.0 112.46 179.994 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 10.0 p -95.35 26.09 4.02 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.915 0.388 . . . . 0.0 110.874 -179.757 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 23' ' ' TYR . . . . . 0.45 ' HB2' ' CB ' ' A' ' 18' ' ' ASN . 34.4 t80 -44.59 -46.86 10.24 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.953 -179.881 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 53.9 t -65.67 -46.15 80.17 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.073 -0.512 . . . . 0.0 110.884 179.994 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -54.68 -51.78 64.45 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.859 -179.965 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -55.22 -52.1 64.45 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.84 179.945 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 1.8 tp -59.88 -35.55 75.06 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.88 -179.928 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 28' ' ' CYS . . . . . 0.4 ' O ' ' HB2' ' A' ' 33' ' ' ALA . 2.5 m -64.91 -53.2 50.2 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.887 179.919 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 1.1 p -62.63 -24.61 67.69 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.152 -0.476 . . . . 0.0 111.149 -179.981 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 5.6 mt-10 -59.45 -22.12 61.03 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.862 -179.982 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 3.6 m-80 -103.28 21.81 15.24 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.91 -179.968 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 83.34 18.83 63.6 Favored Glycine 0 N--CA 1.451 -0.332 0 C-N-CA 120.768 -0.729 . . . . 0.0 112.512 -179.999 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 33' ' ' ALA . . . . . 0.51 ' HB2' ' CD1' ' A' ' 53' ' ' LEU . . . -85.08 148.15 26.29 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.774 0.321 . . . . 0.0 111.099 179.954 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . 0.465 ' HB2' ' CB ' ' A' ' 52' ' ' GLN . 7.8 tt0 -74.7 -31.91 62.02 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.883 -179.943 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 53.9 m -162.1 177.13 9.99 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.813 -179.801 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -172.17 151.75 15.45 Favored Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.777 -0.725 . . . . 0.0 112.505 -179.983 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 37' ' ' TYR . . . . . 0.402 ' HE1' ' CD1' ' A' ' 49' ' ' TRP . 1.1 p90 -154.24 160.4 41.8 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 120.944 0.402 . . . . 0.0 110.897 -179.756 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 38' ' ' CYS . . . . . . . . . . . . . 6.1 t -77.23 119.2 20.57 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.856 179.986 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 39' ' ' GLN . . . . . 0.622 ' NE2' ' N ' ' A' ' 42' ' ' GLY . 0.7 OUTLIER -96.01 117.05 29.9 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.908 -179.986 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 40' ' ' ILE . . . . . 0.443 ' HA ' ' ND2' ' A' ' 46' ' ' ASN . 0.8 OUTLIER -96.58 -36.22 6.19 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.131 -0.486 . . . . 0.0 111.109 179.983 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 7.1 mt -84.52 55.88 3.59 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.911 179.895 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . 0.622 ' N ' ' NE2' ' A' ' 39' ' ' GLN . . . -105.27 -167.01 23.87 Favored Glycine 0 N--CA 1.451 -0.336 0 C-N-CA 120.759 -0.734 . . . . 0.0 112.438 179.939 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 43' ' ' LYS . . . . . 0.529 ' HD2' ' CE2' ' A' ' 44' ' ' TYR . 0.4 OUTLIER -101.52 -23.97 14.22 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.822 0.344 . . . . 0.0 110.968 179.982 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 44' ' ' TYR . . . . . 0.529 ' CE2' ' HD2' ' A' ' 43' ' ' LYS . 0.9 OUTLIER -113.21 23.41 13.33 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.938 -179.986 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 92.78 -130.52 10.36 Favored Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.708 -0.758 . . . . 0.0 112.469 179.942 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 46' ' ' ASN . . . . . 0.443 ' ND2' ' HA ' ' A' ' 40' ' ' ILE . 5.5 m120 -92.97 111.6 23.27 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.845 0.355 . . . . 0.0 110.855 -179.838 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 47' ' ' ALA . . . . . 0.441 ' HB1' ' CD2' ' A' ' 5' ' ' TYR . . . -129.11 137.76 51.42 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.174 -0.467 . . . . 0.0 111.082 179.898 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 8.5 t -67.88 108.26 2.94 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.889 -179.987 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 49' ' ' TRP . . . . . 0.597 ' CZ3' ' HA ' ' A' ' 4' ' ' ALA . 17.8 t-105 -94.76 116.86 29.25 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.948 179.967 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 50' ' ' CYS . . . . . . . . . . . . . 39.7 m -95.83 143.34 27.14 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.892 -179.982 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 51' ' ' ILE . . . . . 0.499 ' CG2' ' OD2' ' A' ' 3' ' ' ASP . 3.4 mp -108.96 135.75 46.89 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.113 179.918 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 52' ' ' GLN . . . . . 0.465 ' CB ' ' HB2' ' A' ' 34' ' ' GLU . 22.6 mm-40 63.71 43.99 5.3 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.916 179.963 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 53' ' ' LEU . . . . . 0.51 ' CD1' ' HB2' ' A' ' 33' ' ' ALA . 15.5 tp -85.38 137.43 36.77 Favored Pre-proline 0 C--N 1.329 -0.323 0 CA-C-O 121.666 0.746 . . . . 0.0 110.884 -179.992 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 54' ' ' PRO . . . . . 0.478 ' HD2' ' CD1' ' A' ' 53' ' ' LEU . 54.0 Cg_endo -69.78 147.78 63.46 Favored 'Trans proline' 0 C--N 1.342 0.221 0 C-N-CA 122.664 2.242 . . . . 0.0 112.398 179.841 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 3.8 m-20 -65.02 -5.96 7.54 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.851 179.974 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 7.8 m120 -78.14 -25.53 47.4 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.954 -179.978 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 57' ' ' VAL . . . . . 0.466 ' CG1' ' HD2' ' A' ' 58' ' ' PRO . 11.4 t -90.77 136.31 27.96 Favored Pre-proline 0 C--N 1.329 -0.288 0 CA-C-O 121.615 0.722 . . . . 0.0 111.132 179.895 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 58' ' ' PRO . . . . . 0.466 ' HD2' ' CG1' ' A' ' 57' ' ' VAL . 53.8 Cg_endo -69.78 135.77 31.25 Favored 'Trans proline' 0 C--N 1.341 0.161 0 C-N-CA 122.608 2.205 . . . . 0.0 112.353 179.945 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 59' ' ' ILE . . . . . 0.424 ' C ' ' HB3' ' A' ' 7' ' ' ALA . 3.9 pt -109.79 154.31 11.31 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.119 179.959 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 60' ' ' ARG . . . . . 0.461 ' NE ' ' CG1' ' A' ' 13' ' ' VAL . 8.0 tpt180 -65.34 132.67 49.62 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.86 179.933 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . 0.431 ' N ' ' HD2' ' A' ' 60' ' ' ARG . 1.3 pt -125.76 160.63 55.36 Favored Pre-proline 0 C--N 1.329 -0.306 0 CA-C-O 121.589 0.709 . . . . 0.0 111.125 179.969 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -69.73 65.08 1.79 Allowed 'Trans proline' 0 C--N 1.341 0.14 0 C-N-CA 122.715 2.276 . . . . 0.0 112.333 179.877 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -136.03 -173.67 13.07 Favored Glycine 0 N--CA 1.451 -0.308 0 C-N-CA 120.732 -0.746 . . . . 0.0 112.474 179.994 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 33.6 pttt -84.74 143.13 29.35 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.802 0.334 . . . . 0.0 110.878 -179.989 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 65' ' ' CYS . . . . . 0.506 ' SG ' ' N ' ' A' ' 66' ' ' HIS . 2.6 t -94.28 161.54 14.21 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.851 179.944 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 66' ' ' HIS . . . . . 0.506 ' N ' ' SG ' ' A' ' 65' ' ' CYS . 7.8 p80 . . . . . 0 C--N 1.329 -0.295 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.802 179.93 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.231 0.131 0 CA-C-O 120.811 0.339 . . . . 0.0 111.094 . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 2' ' ' ARG . . . . . 0.515 ' NE ' ' OD2' ' A' ' 55' ' ' ASP . 30.3 ptt180 -153.24 164.35 38.24 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.866 -179.908 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 3' ' ' ASP . . . . . 0.532 ' HB3' ' CZ2' ' A' ' 49' ' ' TRP . 1.6 m-20 -100.26 139.69 35.57 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.902 179.943 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 4' ' ' ALA . . . . . 0.573 ' HA ' ' CZ3' ' A' ' 49' ' ' TRP . . . -174.88 177.64 1.97 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.149 179.961 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 5' ' ' TYR . . . . . 0.421 ' CE2' ' HE3' ' A' ' 49' ' ' TRP . 13.8 m-85 -84.63 132.03 34.53 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.918 -179.87 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 7.0 tt -72.04 136.03 26.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.124 -0.489 . . . . 0.0 111.135 179.9 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 7' ' ' ALA . . . . . 0.422 ' HB1' ' C ' ' A' ' 59' ' ' ILE . . . -101.51 152.65 20.52 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.189 -0.46 . . . . 0.0 111.102 179.828 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 8' ' ' LYS . . . . . 0.558 ' HD2' ' CE2' ' A' ' 14' ' ' TYR . 0.0 OUTLIER -118.0 172.32 4.23 Favored Pre-proline 0 C--N 1.328 -0.344 0 CA-C-O 121.606 0.717 . . . . 0.0 110.883 179.968 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 9' ' ' PRO . . . . . 0.533 ' HD2' ' CB ' ' A' ' 8' ' ' LYS . 53.9 Cg_endo -69.77 104.65 1.35 Allowed 'Trans proline' 0 C--O 1.231 0.163 0 C-N-CA 122.712 2.274 . . . . 0.0 112.327 179.86 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 10' ' ' HIS . . . . . 0.42 ' HA ' ' HA ' ' A' ' 9' ' ' PRO . 4.3 m-70 -131.91 120.14 22.12 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.89 -0.149 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 11' ' ' ASN . . . . . 0.552 ' N ' ' O ' ' A' ' 8' ' ' LYS . 41.5 t30 73.9 28.88 1.49 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.876 -179.903 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 12' ' ' CYS . . . . . 0.41 ' CB ' ' HG3' ' A' ' 8' ' ' LYS . 1.7 m -97.7 168.09 10.55 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.866 179.939 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 13' ' ' VAL . . . . . 0.476 HG13 ' NE ' ' A' ' 60' ' ' ARG . 0.9 OUTLIER -98.67 142.81 14.14 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.178 179.918 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 14' ' ' TYR . . . . . 0.558 ' CE2' ' HD2' ' A' ' 8' ' ' LYS . 11.2 m-85 -94.51 95.39 8.79 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.916 -179.886 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 4.1 pt-20 -65.01 135.41 55.59 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.878 -179.983 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -105.26 132.19 51.78 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.924 -179.943 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -104.85 -38.64 6.58 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.945 -179.881 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 12.0 t-20 -106.22 84.38 1.35 Allowed Pre-proline 0 C--N 1.329 -0.3 0 CA-C-O 121.605 0.717 . . . . 0.0 110.893 179.997 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.72 -27.39 26.7 Favored 'Trans proline' 0 C--N 1.341 0.164 0 C-N-CA 122.688 2.259 . . . . 0.0 112.322 179.93 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 19.1 mmtt -94.77 24.06 4.99 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.873 179.949 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -134.02 -174.59 13.57 Favored Glycine 0 N--CA 1.452 -0.276 0 C-N-CA 120.732 -0.747 . . . . 0.0 112.474 179.92 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 93.3 p -94.72 27.4 3.08 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.863 0.363 . . . . 0.0 110.797 -179.706 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 5.4 t80 -63.97 -68.2 0.37 Allowed 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.879 -179.852 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 24' ' ' CYS . . . . . 0.404 ' SG ' ' O ' ' A' ' 37' ' ' TYR . 47.3 t -64.89 -35.15 80.23 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.143 -0.481 . . . . 0.0 110.894 179.979 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 3.4 t30 -58.03 -62.41 1.84 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.869 -179.967 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 89.2 m-20 -54.7 -50.49 68.18 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.847 179.944 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 27' ' ' LEU . . . . . 0.428 ' O ' ' ND2' ' A' ' 31' ' ' ASN . 1.5 tp -59.4 -38.02 79.5 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.884 -179.981 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 28' ' ' CYS . . . . . 0.461 ' SG ' ' SG ' ' A' ' 48' ' ' CYS . 1.9 m -65.15 -55.63 17.55 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.89 179.937 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 1.1 p -64.07 -32.88 74.6 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.099 -179.918 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 32.6 mt-10 -55.66 -21.61 18.91 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.262 -0.427 . . . . 0.0 110.863 179.995 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 31' ' ' ASN . . . . . 0.428 ' ND2' ' O ' ' A' ' 27' ' ' LEU . 1.8 m-80 -104.1 22.47 14.62 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.876 -179.94 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . 0.518 ' O ' ' CD ' ' A' ' 54' ' ' PRO . . . 83.23 69.31 1.39 Allowed Glycine 0 N--CA 1.451 -0.359 0 C-N-CA 120.772 -0.728 . . . . 0.0 112.515 179.97 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 33' ' ' ALA . . . . . 0.489 ' CB ' ' CD1' ' A' ' 53' ' ' LEU . . . -150.11 158.26 43.97 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.779 0.323 . . . . 0.0 111.098 -179.98 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . 0.48 ' HB2' ' CB ' ' A' ' 52' ' ' GLN . 0.9 OUTLIER -73.85 -40.47 63.26 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.877 -179.902 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 66.2 m -163.57 -176.61 4.77 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.822 -179.785 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -175.19 158.48 26.07 Favored Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.72 -0.753 . . . . 0.0 112.461 -179.938 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 37' ' ' TYR . . . . . 0.483 ' C ' ' CD2' ' A' ' 37' ' ' TYR . 0.0 OUTLIER -162.45 171.87 16.43 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.955 0.407 . . . . 0.0 110.908 -179.823 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 38' ' ' CYS . . . . . . . . . . . . . 42.1 t -74.94 127.45 33.24 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.858 -179.976 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 39' ' ' GLN . . . . . 0.519 ' OE1' ' N ' ' A' ' 41' ' ' LEU . 0.0 OUTLIER -105.33 119.46 39.14 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.898 -179.95 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 40' ' ' ILE . . . . . 0.48 ' HA ' ' ND2' ' A' ' 46' ' ' ASN . 1.1 mm -88.41 -41.05 13.95 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 116.187 -0.461 . . . . 0.0 111.119 -179.989 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 41' ' ' LEU . . . . . 0.519 ' N ' ' OE1' ' A' ' 39' ' ' GLN . 3.4 mm? -75.32 47.88 0.4 Allowed 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.898 179.923 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -96.57 136.5 12.83 Favored Glycine 0 N--CA 1.451 -0.352 0 C-N-CA 120.762 -0.733 . . . . 0.0 112.519 179.89 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 33.4 mttm -53.93 -25.16 19.05 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 120.782 0.325 . . . . 0.0 110.874 -179.961 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 0.6 OUTLIER -112.28 24.01 13.03 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.889 -179.94 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 94.12 -134.57 12.11 Favored Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 120.722 -0.752 . . . . 0.0 112.51 179.997 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 46' ' ' ASN . . . . . 0.48 ' ND2' ' HA ' ' A' ' 40' ' ' ILE . 8.3 m120 -90.65 112.52 24.28 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-O 120.835 0.35 . . . . 0.0 110.907 -179.881 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -132.59 143.1 49.46 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.1 179.881 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 48' ' ' CYS . . . . . 0.461 ' SG ' ' SG ' ' A' ' 28' ' ' CYS . 51.3 t -65.03 107.49 1.53 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.231 -0.441 . . . . 0.0 110.855 -179.918 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 49' ' ' TRP . . . . . 0.573 ' CZ3' ' HA ' ' A' ' 4' ' ' ALA . 22.5 t-105 -94.9 119.57 33.67 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.929 179.997 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 50' ' ' CYS . . . . . . . . . . . . . 34.5 m -96.87 141.76 29.67 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.866 -179.961 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 51' ' ' ILE . . . . . 0.463 HD13 ' N ' ' A' ' 51' ' ' ILE . 4.0 mp -105.17 135.99 40.9 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.14 179.936 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 52' ' ' GLN . . . . . 0.48 ' CB ' ' HB2' ' A' ' 34' ' ' GLU . 4.3 mm-40 66.99 33.68 5.63 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.944 179.992 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 53' ' ' LEU . . . . . 0.489 ' CD1' ' CB ' ' A' ' 33' ' ' ALA . 12.5 tp -86.16 132.28 43.95 Favored Pre-proline 0 C--N 1.328 -0.334 0 CA-C-O 121.578 0.704 . . . . 0.0 110.966 -180.0 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 54' ' ' PRO . . . . . 0.518 ' CD ' ' O ' ' A' ' 32' ' ' GLY . 54.4 Cg_endo -69.65 150.8 69.38 Favored 'Trans proline' 0 C--O 1.231 0.156 0 C-N-CA 122.694 2.263 . . . . 0.0 112.367 179.861 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 55' ' ' ASP . . . . . 0.515 ' OD2' ' NE ' ' A' ' 2' ' ' ARG . 84.6 m-20 -65.42 -5.89 8.84 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.85 179.924 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 99.1 m-20 -74.71 -25.83 59.4 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.9 -179.971 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 57' ' ' VAL . . . . . 0.476 ' CG2' ' HG2' ' A' ' 54' ' ' PRO . 1.4 t -84.81 137.19 38.28 Favored Pre-proline 0 C--N 1.33 -0.275 0 CA-C-O 121.581 0.705 . . . . 0.0 111.156 179.895 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 58' ' ' PRO . . . . . 0.475 ' HD2' ' CG1' ' A' ' 57' ' ' VAL . 54.5 Cg_endo -69.71 126.55 13.47 Favored 'Trans proline' 0 C--O 1.231 0.152 0 C-N-CA 122.674 2.249 . . . . 0.0 112.348 179.905 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 59' ' ' ILE . . . . . 0.422 ' C ' ' HB1' ' A' ' 7' ' ' ALA . 4.8 pt -107.03 164.32 4.75 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.165 179.872 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 60' ' ' ARG . . . . . 0.476 ' NE ' HG13 ' A' ' 13' ' ' VAL . 20.4 tpt180 -75.17 119.59 19.52 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.868 179.982 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . 0.489 ' CG1' ' OD1' ' A' ' 11' ' ' ASN . 0.3 OUTLIER -122.51 160.84 46.64 Favored Pre-proline 0 C--N 1.329 -0.311 0 CA-C-O 121.632 0.729 . . . . 0.0 111.12 179.941 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.75 68.99 1.67 Allowed 'Trans proline' 0 C--N 1.342 0.194 0 C-N-CA 122.667 2.244 . . . . 0.0 112.372 179.904 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -144.22 -175.11 17.06 Favored Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.735 -0.745 . . . . 0.0 112.497 179.978 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 26.4 mtmt -84.98 134.88 34.22 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.787 0.327 . . . . 0.0 110.897 -179.976 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 65' ' ' CYS . . . . . 0.472 ' SG ' ' CD2' ' A' ' 66' ' ' HIS . 47.3 t -95.09 163.99 13.07 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.889 179.934 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 66' ' ' HIS . . . . . 0.472 ' CD2' ' SG ' ' A' ' 65' ' ' CYS . 0.6 OUTLIER . . . . . 0 C--N 1.329 -0.293 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.852 179.991 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.231 0.116 0 CA-C-O 120.83 0.347 . . . . 0.0 111.088 . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 6.3 ptt85 -154.6 159.36 40.81 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.852 -179.94 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 4.7 m-20 -92.62 132.81 36.56 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.878 179.949 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 4' ' ' ALA . . . . . 0.575 ' HA ' ' CZ3' ' A' ' 49' ' ' TRP . . . -175.16 -178.7 1.22 Allowed 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.085 179.988 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 5' ' ' TYR . . . . . 0.419 ' CE1' ' HE3' ' A' ' 49' ' ' TRP . 32.9 m-85 -84.36 131.63 34.68 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.917 -179.862 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 3.7 tt -74.26 132.98 32.51 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-N 116.119 -0.491 . . . . 0.0 111.111 179.92 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 7' ' ' ALA . . . . . 0.42 ' HB2' ' C ' ' A' ' 59' ' ' ILE . . . -86.14 155.11 20.9 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.114 179.807 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 8' ' ' LYS . . . . . 0.53 ' HB2' ' CZ ' ' A' ' 14' ' ' TYR . 0.0 OUTLIER -133.54 167.19 24.17 Favored Pre-proline 0 C--N 1.329 -0.312 0 CA-C-O 121.566 0.698 . . . . 0.0 110.905 179.933 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 9' ' ' PRO . . . . . 0.489 ' HA ' ' HA ' ' A' ' 10' ' ' HIS . 53.7 Cg_endo -69.73 105.61 1.51 Allowed 'Trans proline' 0 C--O 1.231 0.154 0 C-N-CA 122.656 2.237 . . . . 0.0 112.363 179.902 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 10' ' ' HIS . . . . . 0.489 ' HA ' ' HA ' ' A' ' 9' ' ' PRO . 6.4 m-70 -131.35 128.94 40.72 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.92 -0.072 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 11' ' ' ASN . . . . . 0.486 ' OD1' ' CG1' ' A' ' 61' ' ' ILE . 3.6 t30 60.23 34.4 20.97 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.836 -179.916 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 12' ' ' CYS . . . . . 0.468 ' HB2' ' CD ' ' A' ' 8' ' ' LYS . 1.6 m -114.53 153.15 30.55 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.884 179.963 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 13' ' ' VAL . . . . . 0.469 HG13 ' NE ' ' A' ' 60' ' ' ARG . 0.9 OUTLIER -84.53 152.38 3.72 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.141 -0.481 . . . . 0.0 111.121 179.947 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 14' ' ' TYR . . . . . 0.53 ' CZ ' ' HB2' ' A' ' 8' ' ' LYS . 9.1 m-85 -94.8 89.56 5.73 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.123 -0.489 . . . . 0.0 110.902 -179.917 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 5.0 tp10 -64.93 136.47 56.86 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.812 -179.947 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 6.6 p -84.46 159.57 20.74 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.114 -0.493 . . . . 0.0 110.906 -179.974 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -96.72 -32.83 11.96 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.923 -179.894 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 18' ' ' ASN . . . . . 0.596 ' CG ' ' HD2' ' A' ' 19' ' ' PRO . 1.8 t-20 -154.41 146.86 17.52 Favored Pre-proline 0 C--N 1.329 -0.284 0 CA-C-O 121.624 0.726 . . . . 0.0 110.862 -179.969 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 19' ' ' PRO . . . . . 0.596 ' HD2' ' CG ' ' A' ' 18' ' ' ASN . 53.8 Cg_endo -69.75 -32.85 17.8 Favored 'Trans proline' 0 C--O 1.232 0.191 0 C-N-CA 122.738 2.292 . . . . 0.0 112.353 179.922 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 20.5 mmtt -94.55 24.56 4.5 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.871 179.892 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -114.63 132.37 10.39 Favored Glycine 0 N--CA 1.452 -0.267 0 C-N-CA 120.758 -0.734 . . . . 0.0 112.458 179.919 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 4.9 m -83.56 24.71 0.83 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.874 0.369 . . . . 0.0 110.838 -179.724 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 7.2 t80 -64.27 -43.15 95.72 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.933 -179.864 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 24' ' ' CYS . . . . . 0.405 ' SG ' ' O ' ' A' ' 37' ' ' TYR . 43.2 t -67.69 -42.75 81.58 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.899 179.971 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 25' ' ' ASN . . . . . 0.451 ' HA ' ' CA ' ' A' ' 36' ' ' GLY . 0.8 OUTLIER -55.1 -56.33 21.07 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.926 179.995 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 55.2 m-20 -55.3 -52.22 64.16 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.895 179.897 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 1.7 tp -58.24 -38.88 77.74 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.915 -179.962 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 11.0 m -62.12 -51.27 68.58 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.919 179.895 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 1.1 p -62.99 -24.75 68.06 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.129 -0.487 . . . . 0.0 111.172 -179.964 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 19.5 tp10 -59.2 -22.82 61.63 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.864 -179.966 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 1.8 m-80 -103.7 22.02 15.15 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.9 -179.956 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 83.29 19.96 61.46 Favored Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.755 -0.736 . . . . 0.0 112.456 -179.995 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 33' ' ' ALA . . . . . 0.482 ' CB ' HD11 ' A' ' 53' ' ' LEU . . . -85.16 147.7 26.48 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.776 0.322 . . . . 0.0 111.099 179.936 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . 0.473 ' HB2' ' CB ' ' A' ' 52' ' ' GLN . 5.8 tp10 -74.72 -31.37 61.82 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.911 -179.933 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 1.9 m -162.27 177.62 9.44 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.873 -179.829 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . 0.451 ' CA ' ' HA ' ' A' ' 25' ' ' ASN . . . -174.23 154.71 19.89 Favored Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 120.68 -0.772 . . . . 0.0 112.423 -179.924 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 37' ' ' TYR . . . . . 0.405 ' O ' ' SG ' ' A' ' 24' ' ' CYS . 48.8 p90 -165.35 166.37 18.68 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.964 0.411 . . . . 0.0 110.897 -179.819 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 38' ' ' CYS . . . . . . . . . . . . . 13.2 t -74.81 120.81 20.86 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.869 -179.985 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 39' ' ' GLN . . . . . 0.5 ' NE2' ' CD2' ' A' ' 49' ' ' TRP . 0.0 OUTLIER -104.06 127.29 51.62 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.899 -179.974 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 40' ' ' ILE . . . . . 0.476 ' N ' HD13 ' A' ' 40' ' ' ILE . 0.7 OUTLIER -95.53 -31.1 4.1 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.095 179.97 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 2.0 tt -77.28 47.08 0.54 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.934 179.919 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -101.77 138.87 14.13 Favored Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.711 -0.757 . . . . 0.0 112.485 179.881 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 1.8 mtmm -57.37 -24.65 56.57 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.768 0.318 . . . . 0.0 110.881 -179.944 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 1.1 m-85 -111.08 23.43 14.12 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.931 -179.946 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 93.22 -137.63 13.72 Favored Glycine 0 N--CA 1.451 -0.344 0 C-N-CA 120.719 -0.753 . . . . 0.0 112.498 179.992 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 46' ' ' ASN . . . . . 0.44 ' ND2' ' HA ' ' A' ' 40' ' ' ILE . 18.8 m120 -86.45 117.76 25.45 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.85 0.357 . . . . 0.0 110.863 -179.894 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -135.75 147.27 48.36 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.098 179.864 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 24.1 t -66.67 108.19 2.39 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.842 -179.957 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 49' ' ' TRP . . . . . 0.575 ' CZ3' ' HA ' ' A' ' 4' ' ' ALA . 53.6 t-105 -94.39 112.62 24.41 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.907 179.957 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 50' ' ' CYS . . . . . . . . . . . . . 34.8 m -95.12 142.41 27.6 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.913 179.969 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 3.8 mm -106.62 133.81 50.08 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.109 179.94 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 52' ' ' GLN . . . . . 0.473 ' CB ' ' HB2' ' A' ' 34' ' ' GLU . 3.4 mm-40 64.77 45.36 3.39 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.88 179.925 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 53' ' ' LEU . . . . . 0.482 HD11 ' CB ' ' A' ' 33' ' ' ALA . 14.6 tp -85.67 134.79 39.09 Favored Pre-proline 0 C--N 1.329 -0.307 0 CA-C-O 121.548 0.689 . . . . 0.0 110.942 -179.997 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 54' ' ' PRO . . . . . 0.466 ' HD2' ' CD1' ' A' ' 53' ' ' LEU . 53.9 Cg_endo -69.7 146.5 60.73 Favored 'Trans proline' 0 C--O 1.231 0.144 0 C-N-CA 122.668 2.245 . . . . 0.0 112.385 179.864 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 3.4 m-20 -65.18 -5.58 7.19 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.848 179.958 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 10.9 m120 -79.26 -26.39 42.4 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.921 -179.953 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 57' ' ' VAL . . . . . 0.462 ' CG1' ' HD2' ' A' ' 58' ' ' PRO . 21.3 t -88.85 136.7 30.48 Favored Pre-proline 0 C--N 1.33 -0.265 0 CA-C-O 121.571 0.701 . . . . 0.0 111.164 179.861 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 58' ' ' PRO . . . . . 0.462 ' HD2' ' CG1' ' A' ' 57' ' ' VAL . 53.6 Cg_endo -69.76 143.26 50.26 Favored 'Trans proline' 0 C--N 1.341 0.181 0 C-N-CA 122.71 2.273 . . . . 0.0 112.345 179.974 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 59' ' ' ILE . . . . . 0.455 ' O ' ' CD1' ' A' ' 61' ' ' ILE . 5.2 pt -117.03 168.9 7.95 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-N 116.255 -0.43 . . . . 0.0 111.156 179.895 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 60' ' ' ARG . . . . . 0.469 ' NE ' HG13 ' A' ' 13' ' ' VAL . 13.7 tpt180 -75.22 121.52 22.26 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.841 179.957 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . 0.486 ' CG1' ' OD1' ' A' ' 11' ' ' ASN . 0.0 OUTLIER -110.26 160.46 28.25 Favored Pre-proline 0 C--N 1.329 -0.299 0 CA-C-O 121.589 0.709 . . . . 0.0 111.157 179.952 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -69.76 64.89 1.8 Allowed 'Trans proline' 0 C--N 1.341 0.16 0 C-N-CA 122.693 2.262 . . . . 0.0 112.381 179.84 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -142.56 -174.15 14.85 Favored Glycine 0 N--CA 1.451 -0.344 0 C-N-CA 120.739 -0.743 . . . . 0.0 112.476 180.0 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -85.16 151.23 24.26 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 120.797 0.332 . . . . 0.0 110.956 179.968 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 65' ' ' CYS . . . . . 0.601 ' SG ' ' CD2' ' A' ' 66' ' ' HIS . 1.2 t -95.13 160.92 14.33 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.885 179.953 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 66' ' ' HIS . . . . . 0.601 ' CD2' ' SG ' ' A' ' 65' ' ' CYS . 1.0 OUTLIER . . . . . 0 C--N 1.329 -0.31 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.857 179.981 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . 0.51 ' N ' ' NE2' ' A' ' 52' ' ' GLN . . . . . . . . 0 C--O 1.231 0.123 0 CA-C-O 120.759 0.314 . . . . 0.0 111.09 . . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 2' ' ' ARG . . . . . 0.423 ' NH1' HG23 ' A' ' 59' ' ' ILE . 3.3 ptm180 -90.71 -175.52 4.42 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.85 -179.922 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -145.55 121.43 10.62 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.892 179.979 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 4' ' ' ALA . . . . . 0.577 ' HA ' ' CH2' ' A' ' 49' ' ' TRP . . . -173.89 -172.24 0.72 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.082 179.984 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 5' ' ' TYR . . . . . 0.535 ' CE1' ' HB2' ' A' ' 49' ' ' TRP . 66.9 m-85 -84.23 137.68 33.35 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.92 -179.883 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 6.9 tt -75.39 143.84 12.77 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.074 -0.512 . . . . 0.0 111.12 179.924 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -84.6 165.1 18.26 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.2 -0.454 . . . . 0.0 111.113 179.792 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 8' ' ' LYS . . . . . 0.56 ' HB2' ' CE2' ' A' ' 14' ' ' TYR . 0.1 OUTLIER -145.41 165.57 21.06 Favored Pre-proline 0 C--N 1.329 -0.318 0 CA-C-O 121.565 0.698 . . . . 0.0 110.903 -179.973 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 9' ' ' PRO . . . . . 0.474 ' HA ' ' HA ' ' A' ' 10' ' ' HIS . 53.7 Cg_endo -69.78 105.77 1.55 Allowed 'Trans proline' 0 C--N 1.341 0.175 0 C-N-CA 122.691 2.26 . . . . 0.0 112.34 179.909 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 10' ' ' HIS . . . . . 0.474 ' HA ' ' HA ' ' A' ' 9' ' ' PRO . 8.1 m-70 -132.61 122.5 24.81 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.887 -0.127 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 11' ' ' ASN . . . . . 0.466 ' N ' ' O ' ' A' ' 8' ' ' LYS . 3.2 t30 71.73 20.68 4.54 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.893 -179.902 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 12' ' ' CYS . . . . . 0.401 ' HB2' ' HG2' ' A' ' 8' ' ' LYS . 1.5 m -109.57 168.64 9.25 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.892 -179.999 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 13' ' ' VAL . . . . . 0.458 ' CG1' ' HG2' ' A' ' 60' ' ' ARG . 0.9 OUTLIER -90.8 156.08 3.04 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.135 179.939 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 14' ' ' TYR . . . . . 0.56 ' CE2' ' HB2' ' A' ' 8' ' ' LYS . 4.1 m-85 -94.26 87.0 5.09 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.929 -179.921 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 30.6 tt0 -64.59 120.67 12.81 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.853 -179.986 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 16' ' ' CYS . . . . . 1.147 ' SG ' ' SG ' ' A' ' 24' ' ' CYS . 0.7 OUTLIER -104.45 171.56 7.27 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.158 -0.473 . . . . 0.0 110.894 -179.963 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 17' ' ' TYR . . . . . 0.413 ' O ' ' HD3' ' A' ' 19' ' ' PRO . 67.4 t80 -125.7 -23.79 3.96 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.899 -179.833 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 10.4 t-20 -105.64 85.0 1.32 Allowed Pre-proline 0 C--N 1.329 -0.286 0 CA-C-O 121.626 0.726 . . . . 0.0 110.89 -179.997 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 19' ' ' PRO . . . . . 0.451 ' HA ' ' CB ' ' A' ' 38' ' ' CYS . 53.5 Cg_endo -69.88 -24.89 28.6 Favored 'Trans proline' 0 C--N 1.341 0.17 0 C-N-CA 122.636 2.224 . . . . 0.0 112.317 179.983 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 28.6 mmtm -94.4 -24.59 17.29 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.85 179.931 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -80.21 -174.7 47.78 Favored Glycine 0 N--CA 1.452 -0.287 0 C-N-CA 120.737 -0.744 . . . . 0.0 112.496 179.927 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 26.1 m -95.62 25.72 4.38 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.855 0.36 . . . . 0.0 110.814 -179.718 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 1.1 t80 -59.58 -66.88 0.44 Allowed 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.938 -179.894 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 24' ' ' CYS . . . . . 1.147 ' SG ' ' SG ' ' A' ' 16' ' ' CYS . 19.7 m -67.0 -37.39 84.12 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.141 -0.482 . . . . 0.0 110.913 179.953 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 2.5 t30 -57.34 -58.92 6.13 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.114 -0.493 . . . . 0.0 110.891 -179.968 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 12.4 m-20 -56.22 -53.34 58.3 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.9 179.9 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 1.8 tp -58.99 -35.5 73.32 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.956 -179.962 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 1.7 m -64.36 -58.83 5.37 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.879 179.874 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 29' ' ' THR . . . . . 0.406 ' HA ' ' O ' ' A' ' 33' ' ' ALA . 1.1 p -62.7 -28.39 69.91 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.124 -0.489 . . . . 0.0 111.143 -179.92 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 41.3 tt0 -55.17 -20.56 10.69 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.866 -179.999 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 2.0 m-80 -102.51 22.36 13.65 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.878 -179.94 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 95.35 -12.58 67.83 Favored Glycine 0 N--CA 1.452 -0.265 0 C-N-CA 120.766 -0.73 . . . . 0.0 112.497 179.977 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 33' ' ' ALA . . . . . 0.477 ' HB1' ' CD1' ' A' ' 53' ' ' LEU . . . -62.03 162.23 9.6 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.744 0.306 . . . . 0.0 111.131 179.959 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . 0.462 ' HB2' ' CB ' ' A' ' 52' ' ' GLN . 11.5 tp10 -90.33 -29.72 17.91 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.9 -179.91 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 15.6 m -162.41 179.62 7.68 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.838 -179.799 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -167.97 161.03 34.79 Favored Glycine 0 N--CA 1.452 -0.28 0 C-N-CA 120.721 -0.752 . . . . 0.0 112.47 -179.991 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 37' ' ' TYR . . . . . 0.619 ' CE2' ' CD1' ' A' ' 49' ' ' TRP . 3.3 p90 -162.44 151.86 15.71 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 120.953 0.406 . . . . 0.0 110.939 -179.828 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 38' ' ' CYS . . . . . 0.451 ' CB ' ' HA ' ' A' ' 19' ' ' PRO . 2.0 t -80.32 119.45 23.06 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.88 -179.969 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 39' ' ' GLN . . . . . 0.487 ' OE1' ' N ' ' A' ' 42' ' ' GLY . 1.4 tm0? -105.21 108.59 20.19 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.896 -179.943 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 40' ' ' ILE . . . . . 0.556 ' C ' ' CD1' ' A' ' 40' ' ' ILE . 0.1 OUTLIER -81.84 -35.79 13.76 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.153 179.983 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 41' ' ' LEU . . . . . 0.45 ' N ' HG13 ' A' ' 40' ' ' ILE . 3.4 mt -78.93 48.01 0.8 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.903 179.913 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . 0.487 ' N ' ' OE1' ' A' ' 39' ' ' GLN . . . -98.66 -179.71 32.01 Favored Glycine 0 N--CA 1.451 -0.303 0 C-N-CA 120.734 -0.746 . . . . 0.0 112.45 179.926 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 43' ' ' LYS . . . . . 0.539 ' HG2' ' CD1' ' A' ' 44' ' ' TYR . 0.3 OUTLIER -83.05 -26.83 30.76 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.787 0.327 . . . . 0.0 110.885 -179.983 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 44' ' ' TYR . . . . . 0.539 ' CD1' ' HG2' ' A' ' 43' ' ' LYS . 1.0 OUTLIER -114.31 24.45 11.92 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.907 -179.968 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 94.42 -133.96 11.81 Favored Glycine 0 N--CA 1.451 -0.342 0 C-N-CA 120.731 -0.747 . . . . 0.0 112.463 179.933 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 3.0 m120 -92.55 109.39 20.79 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 120.843 0.354 . . . . 0.0 110.893 -179.941 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 47' ' ' ALA . . . . . 0.455 ' HB1' ' CD1' ' A' ' 5' ' ' TYR . . . -125.61 140.39 52.77 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.08 179.855 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 3.1 m -66.25 111.27 3.38 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.904 -179.96 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 49' ' ' TRP . . . . . 0.619 ' CD1' ' CE2' ' A' ' 37' ' ' TYR . 45.0 t-105 -94.78 115.13 27.12 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.931 180.0 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 50' ' ' CYS . . . . . . . . . . . . . 33.4 m -97.66 142.72 29.1 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.899 179.994 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 51' ' ' ILE . . . . . 0.507 HD12 ' CD2' ' A' ' 37' ' ' TYR . 4.0 mp -110.97 137.62 42.65 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.14 179.895 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 52' ' ' GLN . . . . . 0.51 ' NE2' ' N ' ' A' ' 1' ' ' ALA . 36.2 mm-40 65.02 41.92 4.42 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.914 179.922 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 53' ' ' LEU . . . . . 0.477 ' CD1' ' HB1' ' A' ' 33' ' ' ALA . 15.7 tp -85.57 136.16 37.53 Favored Pre-proline 0 C--N 1.328 -0.327 0 CA-C-O 121.568 0.699 . . . . 0.0 110.969 179.961 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 54' ' ' PRO . . . . . 0.459 ' HG2' ' CG2' ' A' ' 57' ' ' VAL . 53.4 Cg_endo -69.8 147.68 63.12 Favored 'Trans proline' 0 C--N 1.341 0.174 0 C-N-CA 122.701 2.267 . . . . 0.0 112.299 179.93 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 74.3 m-20 -65.03 -5.3 6.01 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.858 179.899 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 5.1 m120 -79.64 -30.28 41.28 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.87 -179.899 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 57' ' ' VAL . . . . . 0.468 ' CG1' ' HD2' ' A' ' 58' ' ' PRO . 15.5 t -86.55 136.36 35.13 Favored Pre-proline 0 C--N 1.329 -0.307 0 CA-C-O 121.617 0.722 . . . . 0.0 111.134 179.928 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 58' ' ' PRO . . . . . 0.468 ' HD2' ' CG1' ' A' ' 57' ' ' VAL . 54.4 Cg_endo -69.75 141.77 46.15 Favored 'Trans proline' 0 C--O 1.231 0.167 0 C-N-CA 122.681 2.254 . . . . 0.0 112.391 179.939 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 59' ' ' ILE . . . . . 0.423 HG23 ' NH1' ' A' ' 2' ' ' ARG . 5.0 pt -118.61 157.65 20.07 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.104 179.967 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 60' ' ' ARG . . . . . 0.458 ' HG2' ' CG1' ' A' ' 13' ' ' VAL . 9.3 tpt180 -68.72 117.39 10.37 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.925 179.933 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . 0.447 ' N ' ' HD2' ' A' ' 60' ' ' ARG . 1.3 pp -123.21 160.66 49.01 Favored Pre-proline 0 C--N 1.329 -0.308 0 CA-C-O 121.669 0.747 . . . . 0.0 111.118 179.983 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.75 73.39 1.37 Allowed 'Trans proline' 0 C--N 1.342 0.194 0 C-N-CA 122.66 2.24 . . . . 0.0 112.362 179.901 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -135.2 -175.38 13.82 Favored Glycine 0 N--CA 1.451 -0.344 0 C-N-CA 120.705 -0.76 . . . . 0.0 112.479 179.985 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -84.88 115.35 22.72 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.855 0.359 . . . . 0.0 110.897 -179.97 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 65' ' ' CYS . . . . . 0.487 ' O ' ' CG ' ' A' ' 66' ' ' HIS . 8.4 t -94.46 159.66 15.0 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.894 179.977 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 66' ' ' HIS . . . . . 0.487 ' CG ' ' O ' ' A' ' 65' ' ' CYS . 28.8 p80 . . . . . 0 C--N 1.329 -0.318 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.87 179.949 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.232 0.155 0 CA-C-O 120.803 0.335 . . . . 0.0 111.07 . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 16.1 ptt180 -152.55 171.43 18.14 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.871 -179.885 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 15.5 m-20 -99.63 130.49 45.87 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.868 179.961 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 4' ' ' ALA . . . . . 0.569 ' HA ' ' CZ3' ' A' ' 49' ' ' TRP . . . -174.94 -178.98 1.31 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.107 179.966 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 19.6 m-85 -84.6 135.33 34.24 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.896 -179.833 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 6' ' ' ILE . . . . . 0.448 HG12 ' CD1' ' A' ' 14' ' ' TYR . 3.1 tt -72.31 133.16 32.33 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.104 -0.498 . . . . 0.0 111.138 179.927 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 7' ' ' ALA . . . . . 0.477 ' HB1' ' CA ' ' A' ' 59' ' ' ILE . . . -92.46 143.09 26.71 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.209 -0.45 . . . . 0.0 111.102 179.815 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 8' ' ' LYS . . . . . 0.518 ' HB2' ' CZ ' ' A' ' 14' ' ' TYR . 0.0 OUTLIER -115.09 167.29 10.09 Favored Pre-proline 0 C--N 1.329 -0.316 0 CA-C-O 121.533 0.682 . . . . 0.0 110.907 179.98 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 9' ' ' PRO . . . . . 0.541 ' HA ' ' HA ' ' A' ' 10' ' ' HIS . 54.0 Cg_endo -69.74 103.89 1.23 Allowed 'Trans proline' 0 C--O 1.232 0.202 0 C-N-CA 122.641 2.227 . . . . 0.0 112.359 179.905 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 10' ' ' HIS . . . . . 0.541 ' HA ' ' HA ' ' A' ' 9' ' ' PRO . 2.9 m-70 -129.62 130.12 45.21 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.865 -0.053 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 11' ' ' ASN . . . . . 0.501 ' N ' ' O ' ' A' ' 8' ' ' LYS . 54.6 t-20 58.83 59.74 2.74 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.929 -179.914 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 12' ' ' CYS . . . . . 0.488 ' HB2' ' CD ' ' A' ' 8' ' ' LYS . 1.7 m -139.51 156.76 46.72 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.908 -179.982 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 13' ' ' VAL . . . . . 0.412 ' CG1' ' HE ' ' A' ' 60' ' ' ARG . 2.4 m -84.69 147.74 5.38 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.138 179.886 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 14' ' ' TYR . . . . . 0.518 ' CZ ' ' HB2' ' A' ' 8' ' ' LYS . 11.1 m-85 -94.67 101.01 12.84 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.909 -179.923 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 18.1 pt-20 -64.56 125.25 24.11 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.073 -0.512 . . . . 0.0 110.893 -180.0 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -101.99 135.35 43.71 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.86 -179.912 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 9.5 t80 -115.14 24.86 11.33 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.916 -179.902 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 18' ' ' ASN . . . . . 0.408 ' ND2' ' H ' ' A' ' 21' ' ' GLY . 0.2 OUTLIER -153.07 74.07 6.92 Favored Pre-proline 0 C--N 1.329 -0.309 0 CA-C-O 121.624 0.726 . . . . 0.0 110.849 -179.998 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.76 -19.89 35.54 Favored 'Trans proline' 0 C--O 1.232 0.18 0 C-N-CA 122.714 2.276 . . . . 0.0 112.317 179.903 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 56.8 mttm -94.16 -24.27 17.6 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.915 179.917 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 21' ' ' GLY . . . . . 0.408 ' H ' ' ND2' ' A' ' 18' ' ' ASN . . . -93.93 -176.99 39.51 Favored Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.702 -0.761 . . . . 0.0 112.468 179.925 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 52.6 p -95.49 25.83 4.25 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.906 0.384 . . . . 0.0 110.853 -179.721 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 23' ' ' TYR . . . . . 0.419 ' CD2' ' C ' ' A' ' 23' ' ' TYR . 1.1 t80 -55.0 -69.46 0.13 Allowed 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.91 -179.885 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 50.4 t -56.99 -36.61 70.56 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.103 -0.498 . . . . 0.0 110.905 179.966 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -57.87 -55.09 39.43 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.9 -179.946 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 47.7 m-20 -57.88 -52.71 64.35 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.174 -0.467 . . . . 0.0 110.794 179.958 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 1.7 tp -59.54 -37.4 78.3 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.965 -179.945 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 1.3 m -65.25 -54.53 27.97 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.874 179.884 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 29' ' ' THR . . . . . 0.421 ' HA ' ' O ' ' A' ' 33' ' ' ALA . 13.2 p -62.73 -29.15 70.46 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.139 -179.951 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 7.4 tp10 -54.69 -19.17 5.65 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.903 -179.981 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 31' ' ' ASN . . . . . 0.455 ' O ' ' CG2' ' A' ' 57' ' ' VAL . 2.3 m-80 -101.64 21.41 14.44 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.913 -179.946 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 95.5 -12.73 67.5 Favored Glycine 0 N--CA 1.452 -0.268 0 C-N-CA 120.682 -0.771 . . . . 0.0 112.463 -179.992 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 33' ' ' ALA . . . . . 0.498 ' HB3' ' CD1' ' A' ' 53' ' ' LEU . . . -61.75 153.91 27.1 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.729 0.3 . . . . 0.0 111.11 179.994 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . 0.416 ' CD ' ' CB ' ' A' ' 52' ' ' GLN . 67.0 mt-10 -85.6 -24.79 27.01 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.929 -179.959 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 12.4 m -161.99 177.88 9.37 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.841 -179.799 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -175.44 158.39 25.65 Favored Glycine 0 N--CA 1.452 -0.263 0 C-N-CA 120.722 -0.751 . . . . 0.0 112.448 -179.973 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 32.6 p90 -164.83 166.86 19.35 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.91 0.386 . . . . 0.0 110.904 -179.831 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 38' ' ' CYS . . . . . . . . . . . . . 4.1 t -75.33 124.3 26.87 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.11 -0.496 . . . . 0.0 110.857 179.996 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 2.4 tt0 -105.19 118.18 35.89 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.9 -179.978 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 40' ' ' ILE . . . . . 0.455 ' HA ' ' ND2' ' A' ' 46' ' ' ASN . 0.9 OUTLIER -88.3 -29.32 5.38 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.102 179.974 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 14.0 mt -82.58 38.91 0.58 Allowed 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.924 179.935 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -87.91 139.14 15.59 Favored Glycine 0 N--CA 1.45 -0.367 0 C-N-CA 120.762 -0.732 . . . . 0.0 112.479 179.92 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 39.1 mttp -53.79 -25.09 17.54 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.856 0.36 . . . . 0.0 110.904 -179.953 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 0.4 OUTLIER -113.85 24.41 12.11 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.945 179.992 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 94.3 -137.58 13.59 Favored Glycine 0 N--CA 1.452 -0.288 0 C-N-CA 120.736 -0.745 . . . . 0.0 112.445 179.962 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 46' ' ' ASN . . . . . 0.455 ' ND2' ' HA ' ' A' ' 40' ' ' ILE . 11.0 m120 -85.69 111.53 20.19 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.826 0.346 . . . . 0.0 110.907 -179.848 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -130.62 145.51 51.92 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.109 179.91 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 14.6 t -65.44 110.29 2.61 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.899 -179.985 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 49' ' ' TRP . . . . . 0.569 ' CZ3' ' HA ' ' A' ' 4' ' ' ALA . 41.6 t-105 -94.97 127.33 40.94 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.949 179.971 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 50' ' ' CYS . . . . . . . . . . . . . 29.9 m -108.41 141.02 40.88 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.841 -179.953 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 4.0 mm -108.06 130.99 59.64 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.126 179.917 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 52' ' ' GLN . . . . . 0.416 ' CB ' ' CD ' ' A' ' 34' ' ' GLU . 4.0 mm-40 67.72 43.08 1.87 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.921 179.955 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 53' ' ' LEU . . . . . 0.498 ' CD1' ' HB3' ' A' ' 33' ' ' ALA . 15.1 tp -85.6 135.53 38.19 Favored Pre-proline 0 C--N 1.328 -0.339 0 CA-C-O 121.582 0.706 . . . . 0.0 110.949 -179.955 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 54' ' ' PRO . . . . . 0.464 ' HG2' ' CG2' ' A' ' 57' ' ' VAL . 53.6 Cg_endo -69.81 145.68 57.6 Favored 'Trans proline' 0 C--N 1.341 0.179 0 C-N-CA 122.697 2.265 . . . . 0.0 112.31 179.914 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -61.4 -9.1 4.79 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.867 179.936 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 67.6 m-20 -74.85 -24.84 58.65 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.872 -179.867 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 57' ' ' VAL . . . . . 0.469 ' CG1' ' HD2' ' A' ' 58' ' ' PRO . 11.1 t -90.31 136.29 28.7 Favored Pre-proline 0 C--N 1.329 -0.305 0 CA-C-O 121.622 0.725 . . . . 0.0 111.12 179.883 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 58' ' ' PRO . . . . . 0.469 ' HD2' ' CG1' ' A' ' 57' ' ' VAL . 53.8 Cg_endo -69.77 146.59 60.57 Favored 'Trans proline' 0 C--O 1.232 0.181 0 C-N-CA 122.68 2.253 . . . . 0.0 112.37 179.924 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 59' ' ' ILE . . . . . 0.477 ' CA ' ' HB1' ' A' ' 7' ' ' ALA . 10.2 pt -123.89 159.98 28.37 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.116 179.964 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 60' ' ' ARG . . . . . 0.44 ' HD3' ' C ' ' A' ' 60' ' ' ARG . 2.9 tpp180 -64.66 111.19 2.64 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.885 179.924 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . 0.496 HG13 ' ND2' ' A' ' 11' ' ' ASN . 0.6 OUTLIER -110.48 161.74 23.39 Favored Pre-proline 0 C--N 1.329 -0.3 0 CA-C-O 121.625 0.726 . . . . 0.0 111.154 179.933 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -69.79 69.75 1.64 Allowed 'Trans proline' 0 C--N 1.342 0.199 0 C-N-CA 122.703 2.269 . . . . 0.0 112.342 179.851 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -144.95 -171.94 15.06 Favored Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.752 -0.737 . . . . 0.0 112.514 179.955 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 9.2 ptpt -85.47 131.23 34.41 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.836 0.35 . . . . 0.0 110.883 -179.964 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 65' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -91.06 140.58 29.7 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.872 179.953 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 66' ' ' HIS . . . . . 0.496 ' CG ' ' O ' ' A' ' 66' ' ' HIS . 26.9 p80 . . . . . 0 C--N 1.33 -0.279 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.824 179.95 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . 0.416 ' HB3' ' C ' ' A' ' 52' ' ' GLN . . . . . . . . 0 C--O 1.231 0.127 0 CA-C-O 120.8 0.333 . . . . 0.0 111.113 . . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 2' ' ' ARG . . . . . 0.441 ' NH1' ' O ' ' A' ' 53' ' ' LEU . 0.0 OUTLIER -136.8 157.04 47.67 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.894 -179.897 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 3.0 m-20 -92.34 133.9 35.42 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.898 179.976 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 4' ' ' ALA . . . . . 0.572 ' HA ' ' CZ3' ' A' ' 49' ' ' TRP . . . -173.94 -179.24 1.68 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.101 179.926 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 21.6 m-85 -84.99 136.41 33.6 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.948 -179.852 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 3.5 tt -75.34 135.63 26.75 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-N 116.115 -0.493 . . . . 0.0 111.176 179.901 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 7' ' ' ALA . . . . . 0.419 ' HB1' ' C ' ' A' ' 59' ' ' ILE . . . -85.56 150.98 24.28 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.096 179.849 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 8' ' ' LYS . . . . . 0.535 ' HB2' ' CZ ' ' A' ' 14' ' ' TYR . 0.0 OUTLIER -133.12 166.9 25.88 Favored Pre-proline 0 C--N 1.329 -0.285 0 CA-C-O 121.54 0.686 . . . . 0.0 110.903 179.994 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 9' ' ' PRO . . . . . 0.508 ' HA ' ' HA ' ' A' ' 10' ' ' HIS . 53.6 Cg_endo -69.79 105.53 1.51 Allowed 'Trans proline' 0 C--O 1.232 0.192 0 C-N-CA 122.646 2.231 . . . . 0.0 112.361 179.875 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 10' ' ' HIS . . . . . 0.508 ' HA ' ' HA ' ' A' ' 9' ' ' PRO . 4.1 m-70 -131.28 128.97 40.91 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.872 -0.061 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 11' ' ' ASN . . . . . 0.416 ' N ' ' O ' ' A' ' 8' ' ' LYS . 3.6 t30 59.14 44.52 15.78 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.865 -179.957 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 12' ' ' CYS . . . . . 0.459 ' HB2' ' CE ' ' A' ' 8' ' ' LYS . 1.4 m -129.93 157.56 41.96 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.873 179.978 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 13' ' ' VAL . . . . . 0.405 ' CG2' ' HB1' ' A' ' 47' ' ' ALA . 1.3 m -85.91 155.39 3.42 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.131 -0.486 . . . . 0.0 111.15 179.912 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 14' ' ' TYR . . . . . 0.535 ' CZ ' ' HB2' ' A' ' 8' ' ' LYS . 9.5 m-85 -94.45 94.87 8.49 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.939 -179.94 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 1.8 pm0 -64.6 133.98 53.38 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.869 -179.978 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 1.8 p -84.74 159.92 20.39 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.873 -179.96 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 8.4 t80 -95.47 -32.51 12.85 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.899 -179.865 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 18' ' ' ASN . . . . . 0.599 ' CG ' ' HD2' ' A' ' 19' ' ' PRO . 1.8 t-20 -154.7 147.0 17.46 Favored Pre-proline 0 C--N 1.329 -0.286 0 CA-C-O 121.604 0.716 . . . . 0.0 110.87 179.971 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 19' ' ' PRO . . . . . 0.599 ' HD2' ' CG ' ' A' ' 18' ' ' ASN . 54.1 Cg_endo -69.73 -31.45 20.62 Favored 'Trans proline' 0 C--O 1.231 0.166 0 C-N-CA 122.714 2.276 . . . . 0.0 112.348 179.918 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 2.0 mmmm -94.48 24.57 4.45 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.874 179.934 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -114.75 132.85 10.67 Favored Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.732 -0.747 . . . . 0.0 112.495 179.907 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 67.4 m -83.67 24.87 0.82 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.874 0.369 . . . . 0.0 110.819 -179.712 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 23' ' ' TYR . . . . . 0.42 ' O ' ' CD1' ' A' ' 23' ' ' TYR . 2.6 t80 -64.54 -41.24 96.48 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.134 -0.484 . . . . 0.0 110.916 -179.902 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 24' ' ' CYS . . . . . 0.409 ' SG ' ' O ' ' A' ' 37' ' ' TYR . 47.8 t -69.4 -43.12 74.09 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.866 -179.993 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 1.9 t30 -55.12 -56.39 20.44 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.855 -179.992 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 9.5 m-20 -56.13 -52.3 64.84 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.893 179.939 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 1.9 tp -58.29 -37.13 74.4 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.872 -179.967 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 10.9 m -63.65 -51.31 65.71 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.231 -0.441 . . . . 0.0 110.874 179.901 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 1.1 p -63.31 -24.54 67.9 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.145 -179.947 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 14.0 tp10 -59.68 -23.17 62.88 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.912 179.966 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 2.0 m-80 -103.93 22.3 14.82 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.88 -179.95 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 82.78 19.68 62.99 Favored Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.699 -0.762 . . . . 0.0 112.506 179.966 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 33' ' ' ALA . . . . . 0.485 ' HB3' ' CD1' ' A' ' 53' ' ' LEU . . . -84.92 149.31 25.74 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.775 0.321 . . . . 0.0 111.047 -179.988 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . 0.462 ' HB2' ' CB ' ' A' ' 52' ' ' GLN . 5.7 tp10 -74.84 -34.7 62.34 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.907 -179.947 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 2.4 m -161.77 178.15 9.24 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.868 -179.8 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -169.12 159.77 32.91 Favored Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.735 -0.745 . . . . 0.0 112.49 -179.982 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 37' ' ' TYR . . . . . 0.557 ' CD1' HD11 ' A' ' 51' ' ' ILE . 3.9 p90 -163.84 160.55 22.41 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 120.957 0.408 . . . . 0.0 110.875 -179.778 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 38' ' ' CYS . . . . . . . . . . . . . 2.4 t -74.43 113.02 11.18 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.853 179.974 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 39' ' ' GLN . . . . . 0.503 ' OE1' ' N ' ' A' ' 41' ' ' LEU . 0.0 OUTLIER -90.3 122.99 33.7 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.889 179.994 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 40' ' ' ILE . . . . . 0.422 ' HA ' ' ND2' ' A' ' 46' ' ' ASN . 2.5 mm -92.81 -51.42 11.34 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.138 179.94 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 41' ' ' LEU . . . . . 0.503 ' N ' ' OE1' ' A' ' 39' ' ' GLN . 0.1 OUTLIER -75.17 57.93 0.88 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.121 -0.491 . . . . 0.0 110.976 179.887 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -99.93 144.14 16.77 Favored Glycine 0 N--CA 1.451 -0.358 0 C-N-CA 120.747 -0.74 . . . . 0.0 112.465 179.954 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 55.8 tttp -53.91 -26.14 23.64 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.785 0.326 . . . . 0.0 110.92 179.997 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 0.9 OUTLIER -115.25 23.83 12.14 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.926 -179.988 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 93.65 -132.66 11.31 Favored Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.791 -0.719 . . . . 0.0 112.48 179.946 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 46' ' ' ASN . . . . . 0.422 ' ND2' ' HA ' ' A' ' 40' ' ' ILE . 0.9 OUTLIER -90.69 117.32 29.25 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.786 0.327 . . . . 0.0 110.922 -179.908 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 47' ' ' ALA . . . . . 0.405 ' HB1' ' CG2' ' A' ' 13' ' ' VAL . . . -140.72 146.16 37.41 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.086 179.91 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 48' ' ' CYS . . . . . 0.451 ' N ' ' O ' ' A' ' 14' ' ' TYR . 40.1 t -67.39 109.33 3.12 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.891 -179.957 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 49' ' ' TRP . . . . . 0.572 ' CZ3' ' HA ' ' A' ' 4' ' ' ALA . 36.9 t-105 -94.66 114.22 26.13 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.917 -179.997 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 50' ' ' CYS . . . . . . . . . . . . . 42.6 m -94.96 142.43 27.49 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.888 -179.962 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 51' ' ' ILE . . . . . 0.557 HD11 ' CD1' ' A' ' 37' ' ' TYR . 3.7 mp -105.92 133.85 49.15 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.187 -0.46 . . . . 0.0 111.143 179.953 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 52' ' ' GLN . . . . . 0.462 ' CB ' ' HB2' ' A' ' 34' ' ' GLU . 9.3 mm-40 64.49 45.42 3.68 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.906 179.952 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 53' ' ' LEU . . . . . 0.485 ' CD1' ' HB3' ' A' ' 33' ' ' ALA . 15.3 tp -85.37 134.0 41.31 Favored Pre-proline 0 C--N 1.329 -0.305 0 CA-C-O 121.592 0.711 . . . . 0.0 110.928 -179.999 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 54' ' ' PRO . . . . . 0.463 ' HD2' ' CD1' ' A' ' 53' ' ' LEU . 53.9 Cg_endo -69.74 147.14 62.33 Favored 'Trans proline' 0 C--O 1.231 0.165 0 C-N-CA 122.662 2.241 . . . . 0.0 112.377 179.87 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 2.4 m-20 -63.88 -6.44 5.97 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.842 179.947 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 9.0 m120 -77.92 -24.94 48.12 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.914 -179.94 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 57' ' ' VAL . . . . . 0.465 ' CG1' ' HD2' ' A' ' 58' ' ' PRO . 12.3 t -91.14 136.39 27.32 Favored Pre-proline 0 C--N 1.33 -0.251 0 CA-C-O 121.601 0.715 . . . . 0.0 111.115 179.922 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 58' ' ' PRO . . . . . 0.465 ' HD2' ' CG1' ' A' ' 57' ' ' VAL . 54.0 Cg_endo -69.76 136.4 32.89 Favored 'Trans proline' 0 C--O 1.231 0.17 0 C-N-CA 122.724 2.283 . . . . 0.0 112.351 179.953 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 59' ' ' ILE . . . . . 0.419 ' C ' ' HB1' ' A' ' 7' ' ' ALA . 13.9 pt -116.23 164.15 12.82 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.276 -0.42 . . . . 0.0 111.162 179.922 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 60' ' ' ARG . . . . . 0.444 ' C ' ' CD ' ' A' ' 60' ' ' ARG . 0.3 OUTLIER -65.62 106.42 1.46 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.848 179.983 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . 0.411 ' CD1' ' OD1' ' A' ' 11' ' ' ASN . 1.3 pt -94.87 160.64 30.7 Favored Pre-proline 0 C--N 1.329 -0.315 0 CA-C-O 121.606 0.717 . . . . 0.0 111.171 179.912 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -69.71 66.11 1.75 Allowed 'Trans proline' 0 C--N 1.341 0.159 0 C-N-CA 122.755 2.303 . . . . 0.0 112.352 179.866 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -144.78 -173.86 16.49 Favored Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 120.765 -0.731 . . . . 0.0 112.499 179.973 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 11.4 ttmm -85.1 147.17 26.78 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 120.786 0.327 . . . . 0.0 110.902 -179.944 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 65' ' ' CYS . . . . . 0.561 ' O ' ' CD2' ' A' ' 66' ' ' HIS . 0.8 OUTLIER -94.04 159.53 15.12 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.909 179.947 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 66' ' ' HIS . . . . . 0.561 ' CD2' ' O ' ' A' ' 65' ' ' CYS . 11.5 p80 . . . . . 0 C--N 1.329 -0.296 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.881 179.958 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . 0.414 ' HB2' ' C ' ' A' ' 53' ' ' LEU . . . . . . . . 0 C--O 1.231 0.12 0 CA-C-O 120.759 0.314 . . . . 0.0 111.099 . . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -152.99 150.08 28.85 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.229 -0.442 . . . . 0.0 110.897 -179.904 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 2.7 m-20 -89.02 132.36 34.78 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.859 179.967 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 4' ' ' ALA . . . . . 0.598 ' HA ' ' CZ3' ' A' ' 49' ' ' TRP . . . -174.93 -179.27 1.37 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.11 179.918 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 5' ' ' TYR . . . . . 0.41 ' CE2' ' HE3' ' A' ' 49' ' ' TRP . 12.5 m-85 -84.46 131.49 34.65 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.941 -179.861 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 4.9 tt -75.04 146.24 9.77 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.123 179.949 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -84.76 164.05 18.76 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.095 179.839 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 8' ' ' LYS . . . . . 0.534 ' HB2' ' CZ ' ' A' ' 14' ' ' TYR . 0.5 OUTLIER -145.18 168.88 10.93 Favored Pre-proline 0 C--N 1.329 -0.323 0 CA-C-O 121.633 0.73 . . . . 0.0 110.861 179.975 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 9' ' ' PRO . . . . . 0.49 ' N ' ' HG3' ' A' ' 8' ' ' LYS . 53.0 Cg_endo -69.8 104.94 1.4 Allowed 'Trans proline' 0 C--N 1.342 0.186 0 C-N-CA 122.682 2.255 . . . . 0.0 112.312 179.925 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 10' ' ' HIS . . . . . 0.471 ' HA ' ' HA ' ' A' ' 9' ' ' PRO . 5.5 m-70 -131.87 123.12 26.85 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.838 -0.071 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 11' ' ' ASN . . . . . 0.512 ' N ' ' O ' ' A' ' 8' ' ' LYS . 5.8 t30 69.59 21.42 6.69 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.899 -179.934 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 1.5 m -108.25 172.01 7.08 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.884 179.975 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 13' ' ' VAL . . . . . 0.47 ' CG2' ' HB3' ' A' ' 47' ' ' ALA . 0.9 OUTLIER -92.85 155.6 3.11 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.109 179.958 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 14' ' ' TYR . . . . . 0.534 ' CZ ' ' HB2' ' A' ' 8' ' ' LYS . 6.9 m-85 -93.82 95.7 9.29 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.878 -179.855 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 16.2 pt-20 -64.84 137.05 57.54 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.907 179.994 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 15.1 p -84.41 158.41 21.09 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.885 -179.923 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 24.2 t80 -95.57 -33.05 12.54 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.918 -179.866 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 18' ' ' ASN . . . . . 0.586 ' CG ' ' HD2' ' A' ' 19' ' ' PRO . 1.9 t-20 -155.15 147.0 17.15 Favored Pre-proline 0 C--N 1.328 -0.333 0 CA-C-O 121.637 0.732 . . . . 0.0 110.894 179.97 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 19' ' ' PRO . . . . . 0.586 ' HD2' ' CG ' ' A' ' 18' ' ' ASN . 53.4 Cg_endo -69.75 -33.96 15.56 Favored 'Trans proline' 0 C--N 1.342 0.188 0 C-N-CA 122.669 2.246 . . . . 0.0 112.343 179.935 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 3.7 mmmp? -94.61 24.56 4.53 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.87 179.907 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -115.83 135.59 12.3 Favored Glycine 0 N--CA 1.452 -0.281 0 C-N-CA 120.74 -0.743 . . . . 0.0 112.465 179.962 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 83.9 p -83.52 24.86 0.8 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.872 0.368 . . . . 0.0 110.835 -179.719 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 0.4 OUTLIER -60.67 -51.77 67.96 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.909 -179.874 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 24' ' ' CYS . . . . . 0.401 ' SG ' ' O ' ' A' ' 37' ' ' TYR . 42.7 t -62.23 -41.01 98.03 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.853 -179.978 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 25' ' ' ASN . . . . . 0.473 ' HA ' ' CA ' ' A' ' 36' ' ' GLY . 0.3 OUTLIER -54.41 -58.43 7.46 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.871 -179.966 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -54.92 -53.83 50.51 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.856 179.945 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 1.8 tp -56.75 -37.58 71.23 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.89 -179.922 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 28' ' ' CYS . . . . . 0.447 ' SG ' ' SG ' ' A' ' 48' ' ' CYS . 4.9 m -63.73 -51.96 62.62 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.897 179.89 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 1.1 p -62.43 -24.77 67.6 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.128 -0.487 . . . . 0.0 111.197 -179.993 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 5.2 tm-20 -58.81 -22.47 58.6 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.892 -180.0 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 1.8 m-80 -103.4 21.94 15.08 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.92 -179.956 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 83.46 19.23 62.55 Favored Glycine 0 N--CA 1.451 -0.366 0 C-N-CA 120.769 -0.729 . . . . 0.0 112.479 179.99 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 33' ' ' ALA . . . . . 0.498 ' HB1' ' CD1' ' A' ' 53' ' ' LEU . . . -85.24 148.65 25.97 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.801 0.334 . . . . 0.0 111.072 179.973 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . 0.47 ' HB2' ' CB ' ' A' ' 52' ' ' GLN . 5.7 tp10 -74.69 -31.27 61.84 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.837 -179.894 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 2.9 m -162.65 178.61 8.38 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.889 -179.774 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . 0.473 ' CA ' ' HA ' ' A' ' 25' ' ' ASN . . . -174.85 153.62 16.34 Favored Glycine 0 N--CA 1.451 -0.354 0 C-N-CA 120.72 -0.752 . . . . 0.0 112.465 -179.98 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 37' ' ' TYR . . . . . 0.401 ' O ' ' SG ' ' A' ' 24' ' ' CYS . 45.4 p90 -164.36 167.67 19.48 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.936 0.398 . . . . 0.0 110.876 -179.746 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 38' ' ' CYS . . . . . . . . . . . . . 27.0 t -75.11 120.15 20.24 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.845 179.993 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -105.5 130.28 53.6 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.95 179.99 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 40' ' ' ILE . . . . . 0.492 ' CD1' ' N ' ' A' ' 40' ' ' ILE . 1.3 mp -95.35 -33.76 5.0 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-N 116.25 -0.432 . . . . 0.0 111.149 179.966 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -75.56 48.96 0.47 Allowed 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.918 179.89 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -101.98 139.3 14.35 Favored Glycine 0 N--CA 1.452 -0.298 0 C-N-CA 120.783 -0.722 . . . . 0.0 112.493 179.88 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 38.7 tttp -54.12 -24.97 19.72 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.794 0.33 . . . . 0.0 110.862 -179.966 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 44' ' ' TYR . . . . . 0.429 ' CE1' ' CG ' ' A' ' 60' ' ' ARG . 0.5 OUTLIER -112.65 23.93 13.0 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.922 -179.929 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 93.8 -129.96 10.11 Favored Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 120.711 -0.757 . . . . 0.0 112.439 179.974 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 46' ' ' ASN . . . . . 0.48 ' ND2' ' HA ' ' A' ' 40' ' ' ILE . 28.3 m120 -93.19 119.09 31.99 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.872 0.368 . . . . 0.0 110.875 -179.873 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 47' ' ' ALA . . . . . 0.47 ' HB3' ' CG2' ' A' ' 13' ' ' VAL . . . -139.34 150.49 45.42 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.154 -0.476 . . . . 0.0 111.107 179.849 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 48' ' ' CYS . . . . . 0.447 ' SG ' ' SG ' ' A' ' 28' ' ' CYS . 41.5 t -65.99 109.55 2.59 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.851 -179.926 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 49' ' ' TRP . . . . . 0.598 ' CZ3' ' HA ' ' A' ' 4' ' ' ALA . 38.8 t-105 -95.21 115.17 27.07 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.9 -179.995 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 50' ' ' CYS . . . . . . . . . . . . . 39.9 m -95.79 142.47 28.02 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.834 -179.962 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 51' ' ' ILE . . . . . 0.405 ' O ' ' HB2' ' A' ' 52' ' ' GLN . 3.6 mm -107.52 133.16 53.12 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.145 179.871 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 52' ' ' GLN . . . . . 0.47 ' CB ' ' HB2' ' A' ' 34' ' ' GLU . 12.1 mm-40 64.95 42.8 4.1 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.922 179.958 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 53' ' ' LEU . . . . . 0.498 ' CD1' ' HB1' ' A' ' 33' ' ' ALA . 16.3 tp -85.5 136.77 36.98 Favored Pre-proline 0 C--N 1.329 -0.324 0 CA-C-O 121.611 0.72 . . . . 0.0 110.932 -179.996 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 54' ' ' PRO . . . . . 0.481 ' HD2' ' CD1' ' A' ' 53' ' ' LEU . 54.3 Cg_endo -69.74 146.07 59.23 Favored 'Trans proline' 0 C--N 1.342 0.194 0 C-N-CA 122.667 2.245 . . . . 0.0 112.394 179.823 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -65.23 -5.16 6.29 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.901 179.928 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 15.4 m-20 -78.35 -28.6 47.19 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.906 -179.947 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 57' ' ' VAL . . . . . 0.468 ' CG1' ' HD2' ' A' ' 58' ' ' PRO . 14.6 t -86.5 136.4 35.18 Favored Pre-proline 0 C--N 1.329 -0.294 0 CA-C-O 121.641 0.734 . . . . 0.0 111.121 179.917 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 58' ' ' PRO . . . . . 0.468 ' HD2' ' CG1' ' A' ' 57' ' ' VAL . 53.1 Cg_endo -69.77 145.36 56.88 Favored 'Trans proline' 0 C--N 1.342 0.19 0 C-N-CA 122.699 2.266 . . . . 0.0 112.322 179.966 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 41.7 pt -122.66 166.93 16.82 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.161 179.922 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 60' ' ' ARG . . . . . 0.461 ' HD2' ' N ' ' A' ' 61' ' ' ILE . 6.0 tpt180 -65.83 128.31 35.49 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.848 -179.998 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . 0.461 ' N ' ' HD2' ' A' ' 60' ' ' ARG . 1.8 pt -138.32 155.41 74.03 Favored Pre-proline 0 C--N 1.329 -0.313 0 CA-C-O 121.65 0.738 . . . . 0.0 111.161 179.941 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.76 75.11 1.24 Allowed 'Trans proline' 0 C--N 1.342 0.204 0 C-N-CA 122.673 2.249 . . . . 0.0 112.345 179.876 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -141.1 -177.44 16.34 Favored Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 120.751 -0.738 . . . . 0.0 112.466 179.987 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 7.6 mtpm? -75.18 111.41 10.4 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.811 0.338 . . . . 0.0 110.884 -179.989 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 65' ' ' CYS . . . . . 0.604 ' SG ' ' CD2' ' A' ' 66' ' ' HIS . 1.6 t -94.84 163.28 13.41 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.913 179.897 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 66' ' ' HIS . . . . . 0.604 ' CD2' ' SG ' ' A' ' 65' ' ' CYS . 0.8 OUTLIER . . . . . 0 C--N 1.33 -0.281 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.836 179.952 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.231 0.085 0 CA-C-O 120.798 0.332 . . . . 0.0 111.072 . . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 2' ' ' ARG . . . . . 0.455 ' CZ ' ' OD2' ' A' ' 55' ' ' ASP . 5.5 ptt-85 -149.65 177.52 9.69 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.912 -179.905 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 3' ' ' ASP . . . . . 0.522 ' HB3' ' CE2' ' A' ' 49' ' ' TRP . 4.0 m-20 -107.66 140.15 41.12 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.898 179.935 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 4' ' ' ALA . . . . . 0.571 ' HA ' ' CZ3' ' A' ' 49' ' ' TRP . . . -171.86 -176.85 1.81 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.094 -179.993 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 5' ' ' TYR . . . . . 0.438 ' OH ' ' NE2' ' A' ' 39' ' ' GLN . 29.0 m-85 -92.92 124.51 36.95 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.899 -179.834 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 6' ' ' ILE . . . . . 0.506 HG12 ' CD1' ' A' ' 14' ' ' TYR . 8.4 tt -75.24 135.38 27.33 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.128 -0.487 . . . . 0.0 111.141 179.899 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 7' ' ' ALA . . . . . 0.507 ' CB ' ' O ' ' A' ' 12' ' ' CYS . . . -135.2 140.88 45.66 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.124 179.775 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 8' ' ' LYS . . . . . 0.574 ' HB3' ' CE1' ' A' ' 14' ' ' TYR . 8.2 pttt -101.18 160.85 25.45 Favored Pre-proline 0 C--N 1.329 -0.322 0 CA-C-O 121.622 0.725 . . . . 0.0 110.861 179.958 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 9' ' ' PRO . . . . . 0.513 ' HA ' ' HA ' ' A' ' 10' ' ' HIS . 54.2 Cg_endo -69.74 144.65 54.79 Favored 'Trans proline' 0 C--N 1.342 0.198 0 C-N-CA 122.651 2.234 . . . . 0.0 112.388 179.883 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 10' ' ' HIS . . . . . 0.513 ' HA ' ' HA ' ' A' ' 9' ' ' PRO . 20.7 m170 -101.86 98.87 9.05 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.833 -0.008 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 11' ' ' ASN . . . . . 0.449 ' OD1' ' NH1' ' A' ' 60' ' ' ARG . 35.5 t-20 65.95 73.84 0.37 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.874 -179.931 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 12' ' ' CYS . . . . . 0.507 ' O ' ' CB ' ' A' ' 7' ' ' ALA . 10.0 m -141.19 145.21 35.37 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.928 179.943 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 13' ' ' VAL . . . . . 0.468 HG11 ' NE ' ' A' ' 60' ' ' ARG . 0.8 OUTLIER -84.06 155.32 3.67 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.153 179.943 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 14' ' ' TYR . . . . . 0.574 ' CE1' ' HB3' ' A' ' 8' ' ' LYS . 6.8 m-85 -103.83 88.6 3.08 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.939 -179.912 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -63.82 136.4 57.38 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.09 -0.505 . . . . 0.0 110.915 179.995 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 11.7 p -84.68 130.3 34.72 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.887 -179.948 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 65.1 t80 -101.03 -37.06 8.78 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.907 -179.902 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 13.3 t-20 -106.2 85.25 1.59 Allowed Pre-proline 0 C--N 1.328 -0.332 0 CA-C-O 121.604 0.716 . . . . 0.0 110.889 179.998 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.76 -27.7 26.17 Favored 'Trans proline' 0 C--N 1.342 0.198 0 C-N-CA 122.65 2.233 . . . . 0.0 112.344 179.935 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 9.7 mmtp -95.02 24.36 4.92 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.919 179.915 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -144.27 -179.91 21.08 Favored Glycine 0 N--CA 1.452 -0.28 0 C-N-CA 120.719 -0.753 . . . . 0.0 112.463 179.976 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 17.6 m -95.21 28.87 2.66 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.907 0.384 . . . . 0.0 110.848 -179.738 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 20.3 t80 -54.94 -58.93 5.61 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.905 -179.87 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 24' ' ' CYS . . . . . 0.459 ' SG ' ' C ' ' A' ' 37' ' ' TYR . 35.5 t -58.0 -32.87 68.33 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.89 -179.995 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 25' ' ' ASN . . . . . 0.422 ' CA ' ' O ' ' A' ' 36' ' ' GLY . 1.5 t30 -65.0 -56.38 13.44 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.928 179.961 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 17.7 m-20 -54.47 -47.91 72.42 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.868 179.938 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 27' ' ' LEU . . . . . 0.498 ' O ' ' ND2' ' A' ' 31' ' ' ASN . 1.4 tp -63.86 -38.81 92.46 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.972 179.989 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 28' ' ' CYS . . . . . 0.665 ' SG ' ' SG ' ' A' ' 48' ' ' CYS . 7.7 m -65.09 -57.45 8.58 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.894 179.892 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 1.3 p -63.93 -34.52 78.15 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.126 -0.488 . . . . 0.0 111.132 -179.944 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 48.1 tt0 -54.78 -22.14 13.31 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.882 -179.98 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 31' ' ' ASN . . . . . 0.498 ' ND2' ' O ' ' A' ' 27' ' ' LEU . 1.8 m-80 -104.81 23.11 14.0 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.868 -179.959 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . 0.531 ' O ' ' CD ' ' A' ' 54' ' ' PRO . . . 84.53 69.15 1.38 Allowed Glycine 0 N--CA 1.451 -0.36 0 C-N-CA 120.766 -0.731 . . . . 0.0 112.511 179.984 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 33' ' ' ALA . . . . . 0.443 ' CB ' ' CD1' ' A' ' 53' ' ' LEU . . . -150.15 153.65 36.69 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.778 0.323 . . . . 0.0 111.096 -179.998 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . 0.486 ' HB2' ' CB ' ' A' ' 52' ' ' GLN . 19.4 tp10 -74.08 -34.6 64.07 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.863 -179.937 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 22.1 m -163.48 -179.89 6.81 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.876 -179.771 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . 0.422 ' O ' ' CA ' ' A' ' 25' ' ' ASN . . . -176.18 139.23 4.48 Favored Glycine 0 N--CA 1.452 -0.288 0 C-N-CA 120.709 -0.758 . . . . 0.0 112.45 179.955 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 37' ' ' TYR . . . . . 0.576 ' CE1' HD13 ' A' ' 51' ' ' ILE . 1.2 p90 -144.91 164.64 30.48 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-O 120.913 0.387 . . . . 0.0 110.947 -179.799 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 38' ' ' CYS . . . . . . . . . . . . . 39.0 t -74.91 129.43 37.64 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.844 179.998 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 39' ' ' GLN . . . . . 0.438 ' NE2' ' OH ' ' A' ' 5' ' ' TYR . 16.4 tt0 -105.64 125.02 50.51 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.914 179.997 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 40' ' ' ILE . . . . . 0.497 ' HA ' ' ND2' ' A' ' 46' ' ' ASN . 0.7 OUTLIER -95.32 -24.87 4.63 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.154 179.934 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 2.7 mm? -82.22 35.34 0.44 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.923 179.935 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -92.58 131.76 10.94 Favored Glycine 0 N--CA 1.45 -0.37 0 C-N-CA 120.749 -0.739 . . . . 0.0 112.485 179.924 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -52.01 -24.69 7.01 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.756 0.312 . . . . 0.0 110.871 -179.967 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 0.7 OUTLIER -99.65 23.91 8.94 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.962 -179.957 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 93.81 -84.77 1.05 Allowed Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.725 -0.75 . . . . 0.0 112.498 -179.996 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 46' ' ' ASN . . . . . 0.497 ' ND2' ' HA ' ' A' ' 40' ' ' ILE . 2.5 m120 -144.12 130.49 19.85 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.86 0.362 . . . . 0.0 110.91 -179.916 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -145.95 146.54 31.08 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.105 179.847 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 48' ' ' CYS . . . . . 0.665 ' SG ' ' SG ' ' A' ' 28' ' ' CYS . 50.7 t -65.46 113.8 4.39 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.925 -179.952 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 49' ' ' TRP . . . . . 0.571 ' CZ3' ' HA ' ' A' ' 4' ' ' ALA . 49.6 t-105 -94.98 113.44 25.15 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.929 -179.982 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 50' ' ' CYS . . . . . . . . . . . . . 20.2 m -95.42 139.78 31.23 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.898 -179.994 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 51' ' ' ILE . . . . . 0.576 HD13 ' CE1' ' A' ' 37' ' ' TYR . 4.7 mp -107.25 138.74 31.73 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.095 179.945 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 52' ' ' GLN . . . . . 0.486 ' CB ' ' HB2' ' A' ' 34' ' ' GLU . 2.1 mm-40 67.38 30.77 6.78 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.897 179.955 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 53' ' ' LEU . . . . . 0.443 ' CD1' ' CB ' ' A' ' 33' ' ' ALA . 11.5 tp -85.93 132.88 42.56 Favored Pre-proline 0 C--N 1.328 -0.36 0 CA-C-O 121.616 0.722 . . . . 0.0 110.907 -179.999 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 54' ' ' PRO . . . . . 0.531 ' CD ' ' O ' ' A' ' 32' ' ' GLY . 53.7 Cg_endo -69.73 150.93 69.03 Favored 'Trans proline' 0 C--O 1.232 0.175 0 C-N-CA 122.712 2.275 . . . . 0.0 112.318 179.886 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 55' ' ' ASP . . . . . 0.455 ' OD2' ' CZ ' ' A' ' 2' ' ' ARG . 16.1 m-20 -65.11 -5.82 7.55 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.877 179.911 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 45.1 m-80 -74.93 -24.56 58.51 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.884 -179.908 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 57' ' ' VAL . . . . . 0.448 ' CG1' ' HD2' ' A' ' 58' ' ' PRO . 1.2 t -84.22 136.63 40.44 Favored Pre-proline 0 C--N 1.329 -0.287 0 CA-C-O 121.685 0.755 . . . . 0.0 111.119 179.936 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 58' ' ' PRO . . . . . 0.448 ' HD2' ' CG1' ' A' ' 57' ' ' VAL . 53.8 Cg_endo -69.79 130.26 18.99 Favored 'Trans proline' 0 C--N 1.342 0.186 0 C-N-CA 122.668 2.245 . . . . 0.0 112.324 179.971 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 59' ' ' ILE . . . . . 0.491 ' O ' ' CD1' ' A' ' 61' ' ' ILE . 27.4 pt -107.89 171.31 2.33 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.101 179.938 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 60' ' ' ARG . . . . . 0.468 ' NE ' HG11 ' A' ' 13' ' ' VAL . 5.6 tpt180 -75.76 113.53 13.33 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.871 179.936 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . 0.491 ' CD1' ' O ' ' A' ' 59' ' ' ILE . 0.0 OUTLIER -108.67 160.51 26.96 Favored Pre-proline 0 C--N 1.329 -0.304 0 CA-C-O 121.6 0.714 . . . . 0.0 111.124 179.986 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.77 64.17 1.8 Allowed 'Trans proline' 0 N--CA 1.465 -0.174 0 C-N-CA 122.692 2.262 . . . . 0.0 112.342 179.911 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -138.98 -179.49 17.42 Favored Glycine 0 N--CA 1.451 -0.351 0 C-N-CA 120.744 -0.741 . . . . 0.0 112.451 -179.989 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 25.9 ttmt -85.39 145.61 27.39 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-O 120.778 0.323 . . . . 0.0 110.871 -179.923 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 65' ' ' CYS . . . . . 0.566 ' SG ' ' CD2' ' A' ' 66' ' ' HIS . 7.9 t -93.85 148.37 22.2 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.885 179.957 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 66' ' ' HIS . . . . . 0.566 ' CD2' ' SG ' ' A' ' 65' ' ' CYS . 1.2 p-80 . . . . . 0 C--N 1.329 -0.313 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.871 -179.996 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 1' ' ' ALA . . . . . 0.449 ' HB1' ' O ' ' A' ' 53' ' ' LEU . . . . . . . . 0 C--O 1.231 0.115 0 CA-C-O 120.793 0.33 . . . . 0.0 111.095 . . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 2' ' ' ARG . . . . . 0.447 ' HD3' ' N ' ' A' ' 2' ' ' ARG . 0.0 OUTLIER -150.71 -177.28 5.89 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.898 -179.921 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 3' ' ' ASP . . . . . 0.552 ' CG ' HD13 ' A' ' 51' ' ' ILE . 9.5 m-20 -107.23 134.08 50.86 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.881 179.932 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -175.67 -174.66 0.7 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.165 -0.47 . . . . 0.0 111.138 179.999 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 5' ' ' TYR . . . . . 0.458 ' CE1' ' CZ3' ' A' ' 49' ' ' TRP . 2.0 m-85 -85.06 135.07 34.16 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.883 -179.835 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 6' ' ' ILE . . . . . 0.673 HG23 ' HD2' ' A' ' 14' ' ' TYR . 3.7 tt -75.93 134.08 29.85 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.111 -0.495 . . . . 0.0 111.185 179.868 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 7' ' ' ALA . . . . . 0.411 ' HB2' ' C ' ' A' ' 59' ' ' ILE . . . -85.78 152.01 23.37 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.211 -0.45 . . . . 0.0 111.096 179.873 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 8' ' ' LYS . . . . . 0.554 ' HB2' ' CZ ' ' A' ' 14' ' ' TYR . 0.0 OUTLIER -135.19 167.22 23.7 Favored Pre-proline 0 C--N 1.329 -0.306 0 CA-C-O 121.593 0.711 . . . . 0.0 110.864 179.963 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 9' ' ' PRO . . . . . 0.449 ' HA ' ' HA ' ' A' ' 10' ' ' HIS . 53.9 Cg_endo -69.73 105.93 1.57 Allowed 'Trans proline' 0 C--N 1.342 0.192 0 C-N-CA 122.703 2.269 . . . . 0.0 112.35 179.873 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 10' ' ' HIS . . . . . 0.449 ' HA ' ' HA ' ' A' ' 9' ' ' PRO . 11.3 m-70 -131.4 127.73 38.1 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.855 -0.067 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 11' ' ' ASN . . . . . 0.412 ' N ' ' O ' ' A' ' 8' ' ' LYS . 4.2 t30 61.36 26.62 16.39 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.889 -179.945 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 1.6 m -107.14 154.9 20.5 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.89 -179.998 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 13' ' ' VAL . . . . . 0.449 HG12 ' NE ' ' A' ' 60' ' ' ARG . 0.9 OUTLIER -84.83 154.44 3.57 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.169 179.923 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 14' ' ' TYR . . . . . 0.673 ' HD2' HG23 ' A' ' 6' ' ' ILE . 9.5 m-85 -94.75 89.75 5.82 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.944 -179.912 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 3.3 pt-20 -64.65 125.41 24.65 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.89 -179.965 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 1.1 p -101.55 134.38 44.75 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.864 -179.901 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 17' ' ' TYR . . . . . 0.436 ' O ' ' HD3' ' A' ' 19' ' ' PRO . 4.8 m-30 -99.49 -28.18 13.37 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.929 -179.926 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 9.2 t-20 -106.44 82.94 1.06 Allowed Pre-proline 0 C--N 1.329 -0.303 0 CA-C-O 121.616 0.722 . . . . 0.0 110.885 -179.987 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 19' ' ' PRO . . . . . 0.436 ' HD3' ' O ' ' A' ' 17' ' ' TYR . 53.5 Cg_endo -69.76 -26.56 27.47 Favored 'Trans proline' 0 C--N 1.342 0.199 0 C-N-CA 122.632 2.221 . . . . 0.0 112.372 179.928 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 20' ' ' LYS . . . . . 0.478 ' HD3' ' N ' ' A' ' 20' ' ' LYS . 0.0 OUTLIER -94.18 24.54 4.31 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.849 179.943 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -136.28 -178.84 16.08 Favored Glycine 0 N--CA 1.452 -0.299 0 C-N-CA 120.763 -0.732 . . . . 0.0 112.497 179.923 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 2.0 p -94.2 28.76 2.38 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.871 0.367 . . . . 0.0 110.855 -179.737 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 0.9 OUTLIER -59.84 -66.67 0.48 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.909 -179.88 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 24' ' ' CYS . . . . . 0.484 ' SG ' ' N ' ' A' ' 49' ' ' TRP . 53.2 t -60.47 -38.3 83.78 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.89 179.986 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 25' ' ' ASN . . . . . 0.846 ' O ' HG23 ' A' ' 29' ' ' THR . 1.7 t30 -54.89 -57.05 13.19 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.903 -179.993 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -57.6 -51.37 69.78 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.863 179.95 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 27' ' ' LEU . . . . . 0.662 ' O ' HD12 ' A' ' 27' ' ' LEU . 2.2 tp -57.13 -38.8 74.01 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.908 -179.967 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 28' ' ' CYS . . . . . 0.576 ' C ' ' HB3' ' A' ' 33' ' ' ALA . 19.1 m -62.41 -50.6 70.87 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.899 179.905 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 29' ' ' THR . . . . . 0.846 HG23 ' O ' ' A' ' 25' ' ' ASN . 1.1 p -62.78 -25.02 68.02 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.14 -179.97 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 6.8 tp10 -58.96 -22.75 60.7 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.938 179.992 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 31' ' ' ASN . . . . . 0.494 ' O ' HG21 ' A' ' 57' ' ' VAL . 6.4 m120 -103.66 22.6 14.11 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.103 -0.498 . . . . 0.0 110.902 -179.949 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 84.15 18.83 62.03 Favored Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 120.765 -0.731 . . . . 0.0 112.515 -179.988 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 33' ' ' ALA . . . . . 0.797 ' HB2' HD13 ' A' ' 53' ' ' LEU . . . -85.4 152.37 23.29 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.733 0.301 . . . . 0.0 111.122 179.931 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 34' ' ' GLU . . . . . 0.476 ' CB ' ' HB2' ' A' ' 52' ' ' GLN . 4.3 tt0 -78.66 -33.07 47.38 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.233 -0.439 . . . . 0.0 110.886 -179.93 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 1.7 m -162.77 -177.2 5.39 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.844 -179.772 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 36' ' ' GLY . . . . . 0.446 ' CA ' ' HA ' ' A' ' 25' ' ' ASN . . . -174.92 157.54 24.7 Favored Glycine 0 N--CA 1.452 -0.284 0 C-N-CA 120.759 -0.734 . . . . 0.0 112.489 -179.984 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 37' ' ' TYR . . . . . 0.581 ' CE2' ' CD1' ' A' ' 49' ' ' TRP . 5.0 p90 -157.64 159.63 37.2 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.863 0.363 . . . . 0.0 110.918 -179.823 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 38' ' ' CYS . . . . . 0.409 ' CB ' ' HA ' ' A' ' 19' ' ' PRO . 21.3 t -74.88 119.47 19.1 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.913 179.999 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 39' ' ' GLN . . . . . 0.408 ' OE1' ' HA2' ' A' ' 42' ' ' GLY . 0.0 OUTLIER -98.49 126.03 43.91 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.913 -179.983 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 40' ' ' ILE . . . . . 0.771 HD12 ' N ' ' A' ' 40' ' ' ILE . 1.2 mp -95.97 -35.98 6.2 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.102 179.972 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 4.2 mm? -75.66 53.01 0.69 Allowed 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.934 179.922 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 42' ' ' GLY . . . . . 0.408 ' HA2' ' OE1' ' A' ' 39' ' ' GLN . . . -105.72 138.91 14.53 Favored Glycine 0 N--CA 1.452 -0.296 0 C-N-CA 120.758 -0.734 . . . . 0.0 112.462 179.94 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -57.45 -27.6 62.6 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.83 0.348 . . . . 0.0 110.908 -179.962 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 0.6 OUTLIER -109.22 23.72 14.11 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.903 -179.959 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 93.37 -139.08 14.42 Favored Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.734 -0.745 . . . . 0.0 112.527 -179.978 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 39.2 m-20 -82.96 116.22 22.15 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.821 0.343 . . . . 0.0 110.894 -179.914 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -125.71 141.57 51.95 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.098 179.864 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 48' ' ' CYS . . . . . 0.475 ' HB3' ' CG2' ' A' ' 6' ' ' ILE . 19.5 t -65.47 114.92 5.2 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.883 -179.967 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 49' ' ' TRP . . . . . 0.581 ' CD1' ' CE2' ' A' ' 37' ' ' TYR . 61.7 t-105 -94.1 135.2 35.72 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.947 179.955 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 50' ' ' CYS . . . . . . . . . . . . . 42.1 m -122.1 142.04 50.78 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.851 -179.97 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 51' ' ' ILE . . . . . 0.552 HD13 ' CG ' ' A' ' 3' ' ' ASP . 14.4 mm -111.01 134.48 53.18 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.139 179.895 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 52' ' ' GLN . . . . . 0.476 ' HB2' ' CB ' ' A' ' 34' ' ' GLU . 3.2 mm-40 65.08 44.58 3.32 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.884 179.926 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 53' ' ' LEU . . . . . 0.797 HD13 ' HB2' ' A' ' 33' ' ' ALA . 14.5 tp -85.93 134.34 39.43 Favored Pre-proline 0 C--N 1.328 -0.35 0 CA-C-O 121.631 0.729 . . . . 0.0 110.945 179.955 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 54' ' ' PRO . . . . . 0.809 ' HG2' HG23 ' A' ' 57' ' ' VAL . 53.3 Cg_endo -69.74 145.42 57.22 Favored 'Trans proline' 0 C--N 1.342 0.184 0 C-N-CA 122.656 2.238 . . . . 0.0 112.323 179.898 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -62.58 -7.75 5.25 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.851 179.915 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 27.6 m120 -76.17 -25.31 55.11 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.913 -179.886 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 57' ' ' VAL . . . . . 0.809 HG23 ' HG2' ' A' ' 54' ' ' PRO . 10.7 t -92.17 136.24 26.06 Favored Pre-proline 0 C--N 1.33 -0.264 0 CA-C-O 121.634 0.73 . . . . 0.0 111.087 179.928 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 58' ' ' PRO . . . . . 0.466 ' HD2' ' CG1' ' A' ' 57' ' ' VAL . 53.9 Cg_endo -69.78 152.53 69.24 Favored 'Trans proline' 0 C--N 1.342 0.193 0 C-N-CA 122.644 2.229 . . . . 0.0 112.366 179.936 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 59' ' ' ILE . . . . . 0.411 ' C ' ' HB2' ' A' ' 7' ' ' ALA . 19.1 pt -125.3 166.3 21.29 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.169 179.91 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 60' ' ' ARG . . . . . 0.485 ' HD2' ' N ' ' A' ' 61' ' ' ILE . 6.7 tpt180 -65.95 116.17 6.81 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.891 179.935 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 61' ' ' ILE . . . . . 0.485 ' N ' ' HD2' ' A' ' 60' ' ' ARG . 1.0 OUTLIER -117.31 160.13 38.84 Favored Pre-proline 0 C--N 1.329 -0.31 0 CA-C-O 121.606 0.717 . . . . 0.0 111.096 -179.996 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.77 64.81 1.81 Allowed 'Trans proline' 0 C--N 1.342 0.2 0 C-N-CA 122.631 2.221 . . . . 0.0 112.384 179.853 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -136.03 -178.65 15.92 Favored Glycine 0 N--CA 1.451 -0.355 0 C-N-CA 120.719 -0.753 . . . . 0.0 112.474 -179.986 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 1.1 tppp? -85.22 140.29 30.99 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.817 0.341 . . . . 0.0 110.925 179.952 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 65' ' ' CYS . . . . . 0.497 ' SG ' ' N ' ' A' ' 66' ' ' HIS . 1.0 OUTLIER -94.55 160.88 14.44 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.872 179.963 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 66' ' ' HIS . . . . . 0.497 ' N ' ' SG ' ' A' ' 65' ' ' CYS . 7.3 p80 . . . . . 0 C--N 1.329 -0.298 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.824 -179.985 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 1' ' ' ALA . . . . . 0.489 ' HB1' ' O ' ' A' ' 53' ' ' LEU . . . . . . . . 0 C--O 1.231 0.131 0 CA-C-O 120.77 0.319 . . . . 0.0 111.095 . . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 18.0 ptt180 -147.27 161.19 41.46 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.89 -179.965 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 3' ' ' ASP . . . . . 0.685 ' OD2' HG23 ' A' ' 51' ' ' ILE . 2.9 m-20 -96.71 134.04 40.49 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.869 -179.988 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 4' ' ' ALA . . . . . 0.605 ' HA ' ' CZ3' ' A' ' 49' ' ' TRP . . . -174.83 -179.09 1.37 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.097 179.982 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 5' ' ' TYR . . . . . 0.412 ' CD2' ' HB3' ' A' ' 47' ' ' ALA . 16.0 m-85 -84.81 135.44 34.1 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.96 -179.857 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 6' ' ' ILE . . . . . 0.447 HG23 ' HD2' ' A' ' 14' ' ' TYR . 5.5 tt -75.42 137.09 23.6 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.108 -0.496 . . . . 0.0 111.148 179.936 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 7' ' ' ALA . . . . . 0.575 ' HB2' ' C ' ' A' ' 59' ' ' ILE . . . -91.41 158.47 16.5 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.103 179.816 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 8' ' ' LYS . . . . . 0.545 ' HB2' ' CZ ' ' A' ' 14' ' ' TYR . 0.0 OUTLIER -134.72 166.26 30.51 Favored Pre-proline 0 C--N 1.328 -0.327 0 CA-C-O 121.632 0.729 . . . . 0.0 110.87 -179.988 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 9' ' ' PRO . . . . . 0.477 ' HA ' ' HA ' ' A' ' 10' ' ' HIS . 53.7 Cg_endo -69.79 106.97 1.76 Allowed 'Trans proline' 0 C--N 1.342 0.231 0 C-N-CA 122.666 2.244 . . . . 0.0 112.345 179.891 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 10' ' ' HIS . . . . . 0.477 ' HA ' ' HA ' ' A' ' 9' ' ' PRO . 7.7 m-70 -132.08 125.12 30.6 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.865 -0.069 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 11' ' ' ASN . . . . . 0.442 ' OD1' HD11 ' A' ' 61' ' ' ILE . 2.3 t30 65.49 44.29 3.12 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.902 -179.896 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 1.6 m -128.81 155.47 45.13 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.873 -179.983 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 13' ' ' VAL . . . . . 0.421 ' CG1' ' NE ' ' A' ' 60' ' ' ARG . 2.7 m -86.5 153.53 3.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.115 179.958 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 14' ' ' TYR . . . . . 0.545 ' CZ ' ' HB2' ' A' ' 8' ' ' LYS . 9.1 m-85 -95.09 100.7 12.48 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.931 -179.942 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 4.9 tm-20 -64.54 137.1 57.66 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.099 -0.501 . . . . 0.0 110.85 -179.945 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 9.1 p -84.83 126.01 33.09 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.864 -179.942 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -100.63 -24.56 14.41 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.903 -179.88 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 10.5 t-20 -134.54 85.15 37.99 Favored Pre-proline 0 C--N 1.329 -0.307 0 CA-C-O 121.555 0.693 . . . . 0.0 110.897 -179.989 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.76 -25.08 28.94 Favored 'Trans proline' 0 C--O 1.231 0.147 0 C-N-CA 122.689 2.259 . . . . 0.0 112.372 179.929 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -94.42 24.23 4.66 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.893 179.914 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -142.88 -174.61 15.33 Favored Glycine 0 N--CA 1.452 -0.279 0 C-N-CA 120.699 -0.763 . . . . 0.0 112.46 179.903 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 50.3 m -95.25 29.14 2.58 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.867 0.365 . . . . 0.0 110.871 -179.729 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 43.9 t80 -64.52 -71.61 0.17 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.921 -179.853 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 42.0 t -55.19 -39.9 70.12 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.824 -179.995 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 25' ' ' ASN . . . . . 0.807 ' O ' HG23 ' A' ' 29' ' ' THR . 1.3 t30 -57.1 -55.57 32.96 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.895 179.998 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 4.5 m-20 -54.68 -53.33 56.34 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.895 179.94 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 27' ' ' LEU . . . . . 0.639 ' O ' HD12 ' A' ' 27' ' ' LEU . 2.1 tp -60.08 -36.38 77.25 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.918 -179.976 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 28' ' ' CYS . . . . . 0.47 ' CB ' ' HA3' ' A' ' 36' ' ' GLY . 1.3 m -64.73 -60.72 2.78 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.868 179.89 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 29' ' ' THR . . . . . 0.807 HG23 ' O ' ' A' ' 25' ' ' ASN . 1.1 p -62.75 -27.09 69.04 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.165 -0.47 . . . . 0.0 111.126 -179.971 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 9.5 tp10 -54.75 -19.83 7.16 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.253 -0.43 . . . . 0.0 110.861 -179.981 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 31' ' ' ASN . . . . . 0.572 ' O ' HG21 ' A' ' 57' ' ' VAL . 5.9 m120 -101.81 21.99 13.66 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.154 -0.476 . . . . 0.0 110.914 -179.96 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 95.81 -12.66 67.14 Favored Glycine 0 N--CA 1.451 -0.302 0 C-N-CA 120.773 -0.727 . . . . 0.0 112.489 179.996 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 33' ' ' ALA . . . . . 1.086 ' HB2' ' CD1' ' A' ' 53' ' ' LEU . . . -62.17 155.27 24.89 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 120.742 0.306 . . . . 0.0 111.094 179.989 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 34' ' ' GLU . . . . . 0.504 ' HB2' ' CB ' ' A' ' 52' ' ' GLN . 2.7 tt0 -80.88 -31.46 35.27 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.9 -179.939 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 35' ' ' SER . . . . . 0.417 ' HA ' HG22 ' A' ' 29' ' ' THR . 46.2 m -162.77 177.92 8.91 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.881 -179.771 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 36' ' ' GLY . . . . . 0.47 ' HA3' ' CB ' ' A' ' 28' ' ' CYS . . . -175.24 157.27 23.9 Favored Glycine 0 N--CA 1.452 -0.277 0 C-N-CA 120.8 -0.714 . . . . 0.0 112.501 -179.976 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 37' ' ' TYR . . . . . 0.491 ' CZ ' HD11 ' A' ' 51' ' ' ILE . 0.6 OUTLIER -165.27 173.55 11.13 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.942 0.401 . . . . 0.0 110.904 -179.811 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 38' ' ' CYS . . . . . . . . . . . . . 41.9 t -74.72 120.28 20.05 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.858 -179.98 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 39' ' ' GLN . . . . . 0.478 ' OE1' ' CE3' ' A' ' 49' ' ' TRP . 3.8 tt0 -104.64 125.26 50.58 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.91 179.99 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 40' ' ' ILE . . . . . 0.757 ' H ' HD12 ' A' ' 40' ' ' ILE . 1.3 mp -95.44 -25.25 4.53 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.159 179.942 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 41' ' ' LEU . . . . . 0.432 ' O ' HD23 ' A' ' 41' ' ' LEU . 1.0 OUTLIER -81.11 40.91 0.56 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.919 179.918 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -97.38 134.49 11.77 Favored Glycine 0 N--CA 1.452 -0.296 0 C-N-CA 120.752 -0.737 . . . . 0.0 112.474 179.907 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -54.14 -25.05 20.25 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.762 0.315 . . . . 0.0 110.861 -179.992 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 44' ' ' TYR . . . . . 0.488 ' CE1' ' CG ' ' A' ' 60' ' ' ARG . 0.6 OUTLIER -108.6 23.76 14.06 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.964 -179.964 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 93.42 -134.47 12.14 Favored Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.734 -0.746 . . . . 0.0 112.477 179.944 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 46' ' ' ASN . . . . . 0.41 ' HA ' ' O ' ' A' ' 39' ' ' GLN . 68.6 m-80 -91.51 118.82 30.92 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.844 0.354 . . . . 0.0 110.86 -179.884 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 47' ' ' ALA . . . . . 0.412 ' HB3' ' CD2' ' A' ' 5' ' ' TYR . . . -137.33 148.52 46.37 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.099 179.842 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 48' ' ' CYS . . . . . 0.422 ' SG ' ' SG ' ' A' ' 28' ' ' CYS . 11.9 t -65.91 108.76 2.27 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.917 -179.976 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 49' ' ' TRP . . . . . 0.605 ' CZ3' ' HA ' ' A' ' 4' ' ' ALA . 36.3 t-105 -94.67 122.75 37.59 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.913 179.995 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 50' ' ' CYS . . . . . . . . . . . . . 4.9 m -107.79 135.13 49.72 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.844 -179.947 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 51' ' ' ILE . . . . . 0.685 HG23 ' OD2' ' A' ' 3' ' ' ASP . 4.2 mp -100.07 138.8 23.26 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.137 179.911 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 52' ' ' GLN . . . . . 0.504 ' CB ' ' HB2' ' A' ' 34' ' ' GLU . 5.7 mm-40 65.38 42.0 4.04 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.929 179.939 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 53' ' ' LEU . . . . . 1.086 ' CD1' ' HB2' ' A' ' 33' ' ' ALA . 12.7 tp -85.28 132.79 44.08 Favored Pre-proline 0 C--N 1.329 -0.32 0 CA-C-O 121.628 0.728 . . . . 0.0 110.941 -179.987 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 54' ' ' PRO . . . . . 0.842 ' HG2' HG23 ' A' ' 57' ' ' VAL . 53.5 Cg_endo -69.78 145.63 57.61 Favored 'Trans proline' 0 C--N 1.342 0.214 0 C-N-CA 122.694 2.263 . . . . 0.0 112.336 179.91 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 40.5 m-20 -62.89 -7.75 5.75 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.855 179.915 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 2.5 m120 -76.51 -25.64 54.4 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.908 -179.908 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 57' ' ' VAL . . . . . 0.842 HG23 ' HG2' ' A' ' 54' ' ' PRO . 12.1 t -92.01 136.23 26.3 Favored Pre-proline 0 C--N 1.33 -0.265 0 CA-C-O 121.642 0.734 . . . . 0.0 111.112 179.926 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 58' ' ' PRO . . . . . 0.463 ' HD2' ' CG1' ' A' ' 57' ' ' VAL . 53.6 Cg_endo -69.77 145.68 57.79 Favored 'Trans proline' 0 C--N 1.342 0.196 0 C-N-CA 122.691 2.261 . . . . 0.0 112.331 179.93 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 59' ' ' ILE . . . . . 0.575 ' C ' ' HB2' ' A' ' 7' ' ' ALA . 14.7 pt -124.23 173.8 9.51 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.111 179.914 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 60' ' ' ARG . . . . . 0.488 ' CG ' ' CE1' ' A' ' 44' ' ' TYR . 0.6 OUTLIER -69.04 118.8 12.4 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.879 179.965 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 61' ' ' ILE . . . . . 0.442 HD11 ' OD1' ' A' ' 11' ' ' ASN . 1.3 pt -118.14 160.59 38.62 Favored Pre-proline 0 C--N 1.329 -0.307 0 CA-C-O 121.642 0.734 . . . . 0.0 111.082 -179.964 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.73 66.34 1.76 Allowed 'Trans proline' 0 C--N 1.342 0.191 0 C-N-CA 122.667 2.244 . . . . 0.0 112.314 179.897 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -141.61 179.41 19.72 Favored Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 120.761 -0.733 . . . . 0.0 112.517 179.934 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 6.0 mmmm -83.38 142.01 31.33 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.804 0.335 . . . . 0.0 110.898 -179.955 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 65' ' ' CYS . . . . . 0.419 ' SG ' ' N ' ' A' ' 66' ' ' HIS . 1.7 t -89.31 156.27 18.84 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.872 179.97 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 66' ' ' HIS . . . . . 0.507 ' CD2' ' O ' ' A' ' 66' ' ' HIS . 49.8 p-80 . . . . . 0 C--N 1.329 -0.314 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.883 179.963 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 1' ' ' ALA . . . . . 0.444 ' HB1' ' O ' ' A' ' 53' ' ' LEU . . . . . . . . 0 C--O 1.231 0.124 0 CA-C-O 120.801 0.334 . . . . 0.0 111.079 . . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -135.37 162.28 33.05 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.865 -179.92 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 3' ' ' ASP . . . . . 0.928 ' OD2' HG23 ' A' ' 51' ' ' ILE . 1.8 m-20 -97.77 133.13 42.71 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.887 179.989 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 4' ' ' ALA . . . . . 0.612 ' HA ' ' CZ3' ' A' ' 49' ' ' TRP . . . -172.82 -177.95 1.76 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.103 179.937 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 5' ' ' TYR . . . . . 0.768 ' CE2' ' NE2' ' A' ' 39' ' ' GLN . 68.9 m-85 -84.36 136.66 33.79 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.24 -0.437 . . . . 0.0 110.904 -179.845 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 6' ' ' ILE . . . . . 0.413 HG23 ' HB2' ' A' ' 14' ' ' TYR . 5.0 tt -74.93 134.7 28.87 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 116.12 -0.491 . . . . 0.0 111.097 179.929 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 7' ' ' ALA . . . . . 0.599 ' HB2' ' C ' ' A' ' 59' ' ' ILE . . . -93.48 156.73 16.58 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.085 179.815 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 8' ' ' LYS . . . . . 0.552 ' HB2' ' CZ ' ' A' ' 14' ' ' TYR . 0.0 OUTLIER -140.2 168.01 16.21 Favored Pre-proline 0 C--N 1.329 -0.297 0 CA-C-O 121.521 0.677 . . . . 0.0 110.886 179.991 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 9' ' ' PRO . . . . . 0.493 ' HA ' ' HA ' ' A' ' 10' ' ' HIS . 53.6 Cg_endo -69.74 107.95 1.97 Allowed 'Trans proline' 0 C--O 1.232 0.206 0 C-N-CA 122.665 2.243 . . . . 0.0 112.332 179.904 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 10' ' ' HIS . . . . . 0.493 ' HA ' ' HA ' ' A' ' 9' ' ' PRO . 5.2 m-70 -131.65 128.59 39.38 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.255 -0.429 . . . . 0.0 110.834 -0.065 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 2.4 t30 58.74 35.92 24.61 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.893 -179.889 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 1.5 m -119.38 152.29 37.05 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.878 179.981 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 13' ' ' VAL . . . . . 0.572 HG12 ' CD ' ' A' ' 60' ' ' ARG . 0.9 OUTLIER -84.55 156.04 3.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.143 -0.481 . . . . 0.0 111.169 179.903 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 14' ' ' TYR . . . . . 0.552 ' CZ ' ' HB2' ' A' ' 8' ' ' LYS . 9.3 m-85 -94.89 100.86 12.66 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.908 -179.889 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 38.1 tt0 -64.92 133.63 52.24 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.079 -0.509 . . . . 0.0 110.892 -179.996 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 1.0 OUTLIER -85.14 133.54 34.2 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.879 -179.949 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 9.3 t80 -121.54 24.89 9.64 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.902 -179.91 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 18' ' ' ASN . . . . . 0.472 ' CB ' ' HB2' ' A' ' 23' ' ' TYR . 9.8 t-20 -154.38 80.26 4.76 Favored Pre-proline 0 C--N 1.329 -0.293 0 CA-C-O 121.647 0.736 . . . . 0.0 110.882 179.959 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -69.76 -23.98 30.19 Favored 'Trans proline' 0 C--N 1.341 0.182 0 C-N-CA 122.702 2.268 . . . . 0.0 112.385 179.922 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 21.4 mtpp -94.52 -24.42 17.28 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.858 179.938 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -102.89 175.98 24.51 Favored Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.763 -0.732 . . . . 0.0 112.46 179.994 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 10.0 p -95.35 26.09 4.02 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.915 0.388 . . . . 0.0 110.874 -179.757 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 23' ' ' TYR . . . . . 0.472 ' HB2' ' CB ' ' A' ' 18' ' ' ASN . 34.4 t80 -44.59 -46.86 10.24 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.953 -179.881 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 53.9 t -65.67 -46.15 80.17 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.073 -0.512 . . . . 0.0 110.884 179.994 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 25' ' ' ASN . . . . . 0.841 ' O ' HG23 ' A' ' 29' ' ' THR . 0.2 OUTLIER -54.68 -51.78 64.45 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.859 -179.965 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -55.22 -52.1 64.45 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.84 179.945 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 27' ' ' LEU . . . . . 0.666 ' O ' HD12 ' A' ' 27' ' ' LEU . 1.8 tp -59.88 -35.55 75.06 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.88 -179.928 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 28' ' ' CYS . . . . . 0.5 ' C ' ' HB3' ' A' ' 33' ' ' ALA . 2.5 m -64.91 -53.2 50.2 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.887 179.919 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 29' ' ' THR . . . . . 0.841 HG23 ' O ' ' A' ' 25' ' ' ASN . 1.1 p -62.63 -24.61 67.69 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.152 -0.476 . . . . 0.0 111.149 -179.981 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 5.6 mt-10 -59.45 -22.12 61.03 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.862 -179.982 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 31' ' ' ASN . . . . . 0.632 ' O ' HG21 ' A' ' 57' ' ' VAL . 8.8 m120 -103.28 21.81 15.24 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.91 -179.968 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 83.34 18.83 63.6 Favored Glycine 0 N--CA 1.451 -0.332 0 C-N-CA 120.768 -0.729 . . . . 0.0 112.512 -179.999 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 33' ' ' ALA . . . . . 0.875 ' HB2' ' CD1' ' A' ' 53' ' ' LEU . . . -85.08 148.15 26.29 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.774 0.321 . . . . 0.0 111.099 179.954 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 34' ' ' GLU . . . . . 0.483 ' HB2' ' CB ' ' A' ' 52' ' ' GLN . 7.8 tt0 -74.7 -31.91 62.02 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.883 -179.943 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 53.9 m -162.1 177.13 9.99 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.813 -179.801 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -172.17 151.75 15.45 Favored Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.777 -0.725 . . . . 0.0 112.505 -179.983 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 37' ' ' TYR . . . . . 0.402 ' HE1' ' CD1' ' A' ' 49' ' ' TRP . 1.1 p90 -154.24 160.4 41.8 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 120.944 0.402 . . . . 0.0 110.897 -179.756 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 38' ' ' CYS . . . . . . . . . . . . . 6.1 t -77.23 119.2 20.57 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.856 179.986 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 39' ' ' GLN . . . . . 0.768 ' NE2' ' CE2' ' A' ' 5' ' ' TYR . 0.3 OUTLIER -96.01 117.05 29.9 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.908 -179.986 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 0.8 OUTLIER -96.58 -36.22 6.19 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.131 -0.486 . . . . 0.0 111.109 179.983 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 7.1 mt -84.52 55.88 3.59 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.911 179.895 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 42' ' ' GLY . . . . . 0.472 ' N ' ' OE1' ' A' ' 39' ' ' GLN . . . -105.27 -167.01 23.87 Favored Glycine 0 N--CA 1.451 -0.336 0 C-N-CA 120.759 -0.734 . . . . 0.0 112.438 179.939 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 43' ' ' LYS . . . . . 0.555 ' HD2' ' CE2' ' A' ' 44' ' ' TYR . 0.4 OUTLIER -101.52 -23.97 14.22 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.822 0.344 . . . . 0.0 110.968 179.982 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 44' ' ' TYR . . . . . 0.555 ' CE2' ' HD2' ' A' ' 43' ' ' LYS . 0.9 OUTLIER -113.21 23.41 13.33 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.938 -179.986 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 92.78 -130.52 10.36 Favored Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.708 -0.758 . . . . 0.0 112.469 179.942 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 46' ' ' ASN . . . . . 0.407 ' HA ' ' O ' ' A' ' 39' ' ' GLN . 25.8 m-20 -92.97 111.6 23.27 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.845 0.355 . . . . 0.0 110.855 -179.838 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 47' ' ' ALA . . . . . 0.409 ' O ' ' HB3' ' A' ' 39' ' ' GLN . . . -129.11 137.76 51.42 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.174 -0.467 . . . . 0.0 111.082 179.898 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 8.5 t -67.88 108.26 2.94 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.889 -179.987 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 49' ' ' TRP . . . . . 0.612 ' CZ3' ' HA ' ' A' ' 4' ' ' ALA . 17.8 t-105 -94.76 116.86 29.25 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.948 179.967 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 50' ' ' CYS . . . . . . . . . . . . . 39.7 m -95.83 143.34 27.14 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.892 -179.982 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 51' ' ' ILE . . . . . 0.928 HG23 ' OD2' ' A' ' 3' ' ' ASP . 3.4 mp -108.96 135.75 46.89 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.113 179.918 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 52' ' ' GLN . . . . . 0.483 ' CB ' ' HB2' ' A' ' 34' ' ' GLU . 6.4 mm100 63.71 43.99 5.3 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.916 179.963 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 53' ' ' LEU . . . . . 0.875 ' CD1' ' HB2' ' A' ' 33' ' ' ALA . 15.5 tp -85.38 137.43 36.77 Favored Pre-proline 0 C--N 1.329 -0.323 0 CA-C-O 121.666 0.746 . . . . 0.0 110.884 -179.992 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 54' ' ' PRO . . . . . 0.83 ' HG2' HG23 ' A' ' 57' ' ' VAL . 54.0 Cg_endo -69.78 147.78 63.46 Favored 'Trans proline' 0 C--N 1.342 0.221 0 C-N-CA 122.664 2.242 . . . . 0.0 112.398 179.841 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 3.8 m-20 -65.02 -5.96 7.54 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.851 179.974 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 7.8 m120 -78.14 -25.53 47.4 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.954 -179.978 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 57' ' ' VAL . . . . . 0.83 HG23 ' HG2' ' A' ' 54' ' ' PRO . 11.4 t -90.77 136.31 27.96 Favored Pre-proline 0 C--N 1.329 -0.288 0 CA-C-O 121.615 0.722 . . . . 0.0 111.132 179.895 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 58' ' ' PRO . . . . . 0.462 ' HD2' ' CG1' ' A' ' 57' ' ' VAL . 53.8 Cg_endo -69.78 135.77 31.25 Favored 'Trans proline' 0 C--N 1.341 0.161 0 C-N-CA 122.608 2.205 . . . . 0.0 112.353 179.945 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 59' ' ' ILE . . . . . 0.599 ' C ' ' HB2' ' A' ' 7' ' ' ALA . 3.9 pt -109.79 154.31 11.31 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.119 179.959 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 60' ' ' ARG . . . . . 0.572 ' CD ' HG12 ' A' ' 13' ' ' VAL . 8.0 tpt180 -65.34 132.67 49.62 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.86 179.933 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 61' ' ' ILE . . . . . 0.438 ' N ' ' HD2' ' A' ' 60' ' ' ARG . 1.3 pt -125.76 160.63 55.36 Favored Pre-proline 0 C--N 1.329 -0.306 0 CA-C-O 121.589 0.709 . . . . 0.0 111.125 179.969 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -69.73 65.08 1.79 Allowed 'Trans proline' 0 C--N 1.341 0.14 0 C-N-CA 122.715 2.276 . . . . 0.0 112.333 179.877 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -136.03 -173.67 13.07 Favored Glycine 0 N--CA 1.451 -0.308 0 C-N-CA 120.732 -0.746 . . . . 0.0 112.474 179.994 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 33.6 pttt -84.74 143.13 29.35 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.802 0.334 . . . . 0.0 110.878 -179.989 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 65' ' ' CYS . . . . . 0.506 ' SG ' ' N ' ' A' ' 66' ' ' HIS . 2.6 t -94.28 161.54 14.21 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.851 179.944 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 66' ' ' HIS . . . . . 0.506 ' N ' ' SG ' ' A' ' 65' ' ' CYS . 7.8 p80 . . . . . 0 C--N 1.329 -0.295 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.802 179.93 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.231 0.131 0 CA-C-O 120.811 0.339 . . . . 0.0 111.094 . . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 2' ' ' ARG . . . . . 0.515 ' NE ' ' OD2' ' A' ' 55' ' ' ASP . 30.3 ptt180 -153.24 164.35 38.24 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.866 -179.908 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 3' ' ' ASP . . . . . 0.581 ' OD1' HG23 ' A' ' 51' ' ' ILE . 1.6 m-20 -100.26 139.69 35.57 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.902 179.943 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 4' ' ' ALA . . . . . 0.588 ' HA ' ' CZ3' ' A' ' 49' ' ' TRP . . . -174.88 177.64 1.97 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.149 179.961 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 5' ' ' TYR . . . . . 0.419 ' CE2' ' HE3' ' A' ' 49' ' ' TRP . 13.8 m-85 -84.63 132.03 34.53 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.918 -179.87 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 6' ' ' ILE . . . . . 0.41 HG23 ' HB2' ' A' ' 14' ' ' TYR . 7.0 tt -72.04 136.03 26.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.124 -0.489 . . . . 0.0 111.135 179.9 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 7' ' ' ALA . . . . . 0.734 ' HB2' ' C ' ' A' ' 59' ' ' ILE . . . -101.51 152.65 20.52 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.189 -0.46 . . . . 0.0 111.102 179.828 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 8' ' ' LYS . . . . . 0.57 ' HD2' ' CE2' ' A' ' 14' ' ' TYR . 0.0 OUTLIER -118.0 172.32 4.23 Favored Pre-proline 0 C--N 1.328 -0.344 0 CA-C-O 121.606 0.717 . . . . 0.0 110.883 179.968 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 9' ' ' PRO . . . . . 0.547 ' HD2' ' CB ' ' A' ' 8' ' ' LYS . 53.9 Cg_endo -69.77 104.65 1.35 Allowed 'Trans proline' 0 C--O 1.231 0.163 0 C-N-CA 122.712 2.274 . . . . 0.0 112.327 179.86 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 10' ' ' HIS . . . . . 0.497 ' HA ' ' HA ' ' A' ' 9' ' ' PRO . 4.3 m-70 -131.91 120.14 22.12 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.89 -0.149 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 11' ' ' ASN . . . . . 0.552 ' N ' ' O ' ' A' ' 8' ' ' LYS . 41.5 t30 73.9 28.88 1.49 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.876 -179.903 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 12' ' ' CYS . . . . . 0.412 ' CB ' ' HG3' ' A' ' 8' ' ' LYS . 1.7 m -97.7 168.09 10.55 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.866 179.939 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 13' ' ' VAL . . . . . 0.78 HG12 ' HG2' ' A' ' 60' ' ' ARG . 0.9 OUTLIER -98.67 142.81 14.14 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.178 179.918 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 14' ' ' TYR . . . . . 0.57 ' CE2' ' HD2' ' A' ' 8' ' ' LYS . 11.2 m-85 -94.51 95.39 8.79 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.916 -179.886 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 4.1 pt-20 -65.01 135.41 55.59 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.878 -179.983 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -105.26 132.19 51.78 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.924 -179.943 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 17' ' ' TYR . . . . . 0.422 ' O ' ' HD3' ' A' ' 19' ' ' PRO . 0.2 OUTLIER -104.85 -38.64 6.58 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.945 -179.881 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 12.0 t-20 -106.22 84.38 1.35 Allowed Pre-proline 0 C--N 1.329 -0.3 0 CA-C-O 121.605 0.717 . . . . 0.0 110.893 179.997 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 19' ' ' PRO . . . . . 0.422 ' HD3' ' O ' ' A' ' 17' ' ' TYR . 53.7 Cg_endo -69.72 -27.39 26.7 Favored 'Trans proline' 0 C--N 1.341 0.164 0 C-N-CA 122.688 2.259 . . . . 0.0 112.322 179.93 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 19.1 mmtt -94.77 24.06 4.99 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.873 179.949 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -134.02 -174.59 13.57 Favored Glycine 0 N--CA 1.452 -0.276 0 C-N-CA 120.732 -0.747 . . . . 0.0 112.474 179.92 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 93.3 p -94.72 27.4 3.08 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.863 0.363 . . . . 0.0 110.797 -179.706 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 5.4 t80 -63.97 -68.2 0.37 Allowed 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.879 -179.852 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 24' ' ' CYS . . . . . 0.404 ' SG ' ' O ' ' A' ' 37' ' ' TYR . 47.3 t -64.89 -35.15 80.23 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.143 -0.481 . . . . 0.0 110.894 179.979 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 25' ' ' ASN . . . . . 0.83 ' O ' HG23 ' A' ' 29' ' ' THR . 3.4 t30 -58.03 -62.41 1.84 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.869 -179.967 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 89.2 m-20 -54.7 -50.49 68.18 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.847 179.944 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 27' ' ' LEU . . . . . 0.726 ' O ' HD12 ' A' ' 27' ' ' LEU . 1.5 tp -59.4 -38.02 79.5 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.884 -179.981 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 28' ' ' CYS . . . . . 0.461 ' SG ' ' SG ' ' A' ' 48' ' ' CYS . 1.9 m -65.15 -55.63 17.55 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.89 179.937 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 29' ' ' THR . . . . . 0.83 HG23 ' O ' ' A' ' 25' ' ' ASN . 1.1 p -64.07 -32.88 74.6 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.099 -179.918 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 32.6 mt-10 -55.66 -21.61 18.91 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.262 -0.427 . . . . 0.0 110.863 179.995 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 5.7 m120 -104.1 22.47 14.62 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.876 -179.94 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 32' ' ' GLY . . . . . 0.518 ' O ' ' CD ' ' A' ' 54' ' ' PRO . . . 83.23 69.31 1.39 Allowed Glycine 0 N--CA 1.451 -0.359 0 C-N-CA 120.772 -0.728 . . . . 0.0 112.515 179.97 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 33' ' ' ALA . . . . . 1.031 ' HB2' ' CD1' ' A' ' 53' ' ' LEU . . . -150.11 158.26 43.97 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.779 0.323 . . . . 0.0 111.098 -179.98 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 34' ' ' GLU . . . . . 0.5 ' HB2' ' CB ' ' A' ' 52' ' ' GLN . 0.9 OUTLIER -73.85 -40.47 63.26 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.877 -179.902 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 66.2 m -163.57 -176.61 4.77 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.822 -179.785 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -175.19 158.48 26.07 Favored Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.72 -0.753 . . . . 0.0 112.461 -179.938 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 37' ' ' TYR . . . . . 0.483 ' C ' ' CD2' ' A' ' 37' ' ' TYR . 0.0 OUTLIER -162.45 171.87 16.43 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.955 0.407 . . . . 0.0 110.908 -179.823 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 38' ' ' CYS . . . . . . . . . . . . . 42.1 t -74.94 127.45 33.24 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.858 -179.976 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 39' ' ' GLN . . . . . 0.519 ' OE1' ' N ' ' A' ' 41' ' ' LEU . 0.0 OUTLIER -105.33 119.46 39.14 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.898 -179.95 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 40' ' ' ILE . . . . . 0.53 ' N ' HD13 ' A' ' 40' ' ' ILE . 1.1 mm -88.41 -41.05 13.95 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 116.187 -0.461 . . . . 0.0 111.119 -179.989 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 41' ' ' LEU . . . . . 0.519 ' N ' ' OE1' ' A' ' 39' ' ' GLN . 3.4 mm? -75.32 47.88 0.4 Allowed 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.898 179.923 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -96.57 136.5 12.83 Favored Glycine 0 N--CA 1.451 -0.352 0 C-N-CA 120.762 -0.733 . . . . 0.0 112.519 179.89 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 33.4 mttm -53.93 -25.16 19.05 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 120.782 0.325 . . . . 0.0 110.874 -179.961 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 0.6 OUTLIER -112.28 24.01 13.03 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.889 -179.94 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 94.12 -134.57 12.11 Favored Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 120.722 -0.752 . . . . 0.0 112.51 179.997 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 27.6 m-80 -90.65 112.52 24.28 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-O 120.835 0.35 . . . . 0.0 110.907 -179.881 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -132.59 143.1 49.46 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.1 179.881 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 48' ' ' CYS . . . . . 0.461 ' SG ' ' SG ' ' A' ' 28' ' ' CYS . 51.3 t -65.03 107.49 1.53 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.231 -0.441 . . . . 0.0 110.855 -179.918 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 49' ' ' TRP . . . . . 0.588 ' CZ3' ' HA ' ' A' ' 4' ' ' ALA . 22.5 t-105 -94.9 119.57 33.67 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.929 179.997 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 50' ' ' CYS . . . . . 0.435 ' HB2' HD22 ' A' ' 53' ' ' LEU . 34.5 m -96.87 141.76 29.67 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.866 -179.961 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 51' ' ' ILE . . . . . 0.581 HG23 ' OD1' ' A' ' 3' ' ' ASP . 4.0 mp -105.17 135.99 40.9 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.14 179.936 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 52' ' ' GLN . . . . . 0.5 ' CB ' ' HB2' ' A' ' 34' ' ' GLU . 4.3 mm-40 66.99 33.68 5.63 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.944 179.992 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 53' ' ' LEU . . . . . 1.031 ' CD1' ' HB2' ' A' ' 33' ' ' ALA . 12.5 tp -86.16 132.28 43.95 Favored Pre-proline 0 C--N 1.328 -0.334 0 CA-C-O 121.578 0.704 . . . . 0.0 110.966 -180.0 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 54' ' ' PRO . . . . . 0.521 ' HG2' HG23 ' A' ' 57' ' ' VAL . 54.4 Cg_endo -69.65 150.8 69.38 Favored 'Trans proline' 0 C--O 1.231 0.156 0 C-N-CA 122.694 2.263 . . . . 0.0 112.367 179.861 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 55' ' ' ASP . . . . . 0.515 ' OD2' ' NE ' ' A' ' 2' ' ' ARG . 84.6 m-20 -65.42 -5.89 8.84 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.85 179.924 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 99.1 m-20 -74.71 -25.83 59.4 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.9 -179.971 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 57' ' ' VAL . . . . . 0.521 HG23 ' HG2' ' A' ' 54' ' ' PRO . 1.4 t -84.81 137.19 38.28 Favored Pre-proline 0 C--N 1.33 -0.275 0 CA-C-O 121.581 0.705 . . . . 0.0 111.156 179.895 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 58' ' ' PRO . . . . . 0.516 ' HD2' HG12 ' A' ' 57' ' ' VAL . 54.5 Cg_endo -69.71 126.55 13.47 Favored 'Trans proline' 0 C--O 1.231 0.152 0 C-N-CA 122.674 2.249 . . . . 0.0 112.348 179.905 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 59' ' ' ILE . . . . . 0.734 ' C ' ' HB2' ' A' ' 7' ' ' ALA . 4.8 pt -107.03 164.32 4.75 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.165 179.872 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 60' ' ' ARG . . . . . 0.78 ' HG2' HG12 ' A' ' 13' ' ' VAL . 20.4 tpt180 -75.17 119.59 19.52 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.868 179.982 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 61' ' ' ILE . . . . . 0.489 ' CG1' ' OD1' ' A' ' 11' ' ' ASN . 0.3 OUTLIER -122.51 160.84 46.64 Favored Pre-proline 0 C--N 1.329 -0.311 0 CA-C-O 121.632 0.729 . . . . 0.0 111.12 179.941 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.75 68.99 1.67 Allowed 'Trans proline' 0 C--N 1.342 0.194 0 C-N-CA 122.667 2.244 . . . . 0.0 112.372 179.904 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -144.22 -175.11 17.06 Favored Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.735 -0.745 . . . . 0.0 112.497 179.978 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 26.4 mtmt -84.98 134.88 34.22 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.787 0.327 . . . . 0.0 110.897 -179.976 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 65' ' ' CYS . . . . . 0.445 ' O ' ' C ' ' A' ' 66' ' ' HIS . 47.3 t -95.09 163.99 13.07 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.889 179.934 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 66' ' ' HIS . . . . . 0.483 ' CD2' ' O ' ' A' ' 9' ' ' PRO . 0.0 OUTLIER . . . . . 0 C--N 1.329 -0.293 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.852 179.991 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 1' ' ' ALA . . . . . 0.466 ' HB1' ' O ' ' A' ' 53' ' ' LEU . . . . . . . . 0 C--O 1.231 0.116 0 CA-C-O 120.83 0.347 . . . . 0.0 111.088 . . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 2' ' ' ARG . . . . . 0.589 HH22 HG21 ' A' ' 59' ' ' ILE . 6.3 ptt85 -154.6 159.36 40.81 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.852 -179.94 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 4.7 m-20 -92.62 132.81 36.56 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.878 179.949 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 4' ' ' ALA . . . . . 0.591 ' HA ' ' CZ3' ' A' ' 49' ' ' TRP . . . -175.16 -178.7 1.22 Allowed 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.085 179.988 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 5' ' ' TYR . . . . . 0.498 ' CD1' ' HB3' ' A' ' 47' ' ' ALA . 32.9 m-85 -84.36 131.63 34.68 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.917 -179.862 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 6' ' ' ILE . . . . . 0.534 HG23 ' HD1' ' A' ' 14' ' ' TYR . 3.7 tt -74.26 132.98 32.51 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-N 116.119 -0.491 . . . . 0.0 111.111 179.92 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 7' ' ' ALA . . . . . 0.788 ' HB2' ' C ' ' A' ' 59' ' ' ILE . . . -86.14 155.11 20.9 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.114 179.807 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 8' ' ' LYS . . . . . 0.551 ' HB2' ' CZ ' ' A' ' 14' ' ' TYR . 0.0 OUTLIER -133.54 167.19 24.17 Favored Pre-proline 0 C--N 1.329 -0.312 0 CA-C-O 121.566 0.698 . . . . 0.0 110.905 179.933 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 9' ' ' PRO . . . . . 0.484 ' HA ' ' HA ' ' A' ' 10' ' ' HIS . 53.7 Cg_endo -69.73 105.61 1.51 Allowed 'Trans proline' 0 C--O 1.231 0.154 0 C-N-CA 122.656 2.237 . . . . 0.0 112.363 179.902 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 10' ' ' HIS . . . . . 0.484 ' HA ' ' HA ' ' A' ' 9' ' ' PRO . 6.4 m-70 -131.35 128.94 40.72 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.92 -0.072 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 11' ' ' ASN . . . . . 0.486 ' OD1' ' CG1' ' A' ' 61' ' ' ILE . 3.6 t30 60.23 34.4 20.97 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.836 -179.916 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 12' ' ' CYS . . . . . 0.478 ' HB2' ' CD ' ' A' ' 8' ' ' LYS . 1.6 m -114.53 153.15 30.55 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.884 179.963 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 13' ' ' VAL . . . . . 0.553 HG12 ' CD ' ' A' ' 60' ' ' ARG . 0.9 OUTLIER -84.53 152.38 3.72 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.141 -0.481 . . . . 0.0 111.121 179.947 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 14' ' ' TYR . . . . . 0.551 ' CZ ' ' HB2' ' A' ' 8' ' ' LYS . 9.1 m-85 -94.8 89.56 5.73 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.123 -0.489 . . . . 0.0 110.902 -179.917 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 5.0 tp10 -64.93 136.47 56.86 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.812 -179.947 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 6.6 p -84.46 159.57 20.74 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.114 -0.493 . . . . 0.0 110.906 -179.974 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -96.72 -32.83 11.96 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.923 -179.894 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 18' ' ' ASN . . . . . 0.603 ' CG ' ' HD2' ' A' ' 19' ' ' PRO . 1.8 t-20 -154.41 146.86 17.52 Favored Pre-proline 0 C--N 1.329 -0.284 0 CA-C-O 121.624 0.726 . . . . 0.0 110.862 -179.969 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 19' ' ' PRO . . . . . 0.603 ' HD2' ' CG ' ' A' ' 18' ' ' ASN . 53.8 Cg_endo -69.75 -32.85 17.8 Favored 'Trans proline' 0 C--O 1.232 0.191 0 C-N-CA 122.738 2.292 . . . . 0.0 112.353 179.922 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 20.5 mmtt -94.55 24.56 4.5 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.871 179.892 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -114.63 132.37 10.39 Favored Glycine 0 N--CA 1.452 -0.267 0 C-N-CA 120.758 -0.734 . . . . 0.0 112.458 179.919 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 4.9 m -83.56 24.71 0.83 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.874 0.369 . . . . 0.0 110.838 -179.724 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 7.2 t80 -64.27 -43.15 95.72 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.933 -179.864 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 24' ' ' CYS . . . . . 0.405 ' SG ' ' O ' ' A' ' 37' ' ' TYR . 43.2 t -67.69 -42.75 81.58 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.899 179.971 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 25' ' ' ASN . . . . . 0.869 ' O ' HG23 ' A' ' 29' ' ' THR . 0.8 OUTLIER -55.1 -56.33 21.07 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.926 179.995 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 55.2 m-20 -55.3 -52.22 64.16 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.895 179.897 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 27' ' ' LEU . . . . . 0.705 ' O ' HD12 ' A' ' 27' ' ' LEU . 1.7 tp -58.24 -38.88 77.74 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.915 -179.962 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 28' ' ' CYS . . . . . 0.565 ' C ' ' HB3' ' A' ' 33' ' ' ALA . 11.0 m -62.12 -51.27 68.58 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.919 179.895 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 29' ' ' THR . . . . . 0.869 HG23 ' O ' ' A' ' 25' ' ' ASN . 1.1 p -62.99 -24.75 68.06 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.129 -0.487 . . . . 0.0 111.172 -179.964 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 19.5 tp10 -59.2 -22.82 61.63 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.864 -179.966 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 31' ' ' ASN . . . . . 0.625 ' O ' HG21 ' A' ' 57' ' ' VAL . 6.1 m120 -103.7 22.02 15.15 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.9 -179.956 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 83.29 19.96 61.46 Favored Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.755 -0.736 . . . . 0.0 112.456 -179.995 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 33' ' ' ALA . . . . . 0.779 ' HB2' HD13 ' A' ' 53' ' ' LEU . . . -85.16 147.7 26.48 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.776 0.322 . . . . 0.0 111.099 179.936 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 34' ' ' GLU . . . . . 0.493 ' HB2' ' CB ' ' A' ' 52' ' ' GLN . 5.8 tp10 -74.72 -31.37 61.82 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.911 -179.933 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 1.9 m -162.27 177.62 9.44 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.873 -179.829 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 36' ' ' GLY . . . . . 0.458 ' CA ' ' HA ' ' A' ' 25' ' ' ASN . . . -174.23 154.71 19.89 Favored Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 120.68 -0.772 . . . . 0.0 112.423 -179.924 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 37' ' ' TYR . . . . . 0.405 ' O ' ' SG ' ' A' ' 24' ' ' CYS . 48.8 p90 -165.35 166.37 18.68 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.964 0.411 . . . . 0.0 110.897 -179.819 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 38' ' ' CYS . . . . . . . . . . . . . 13.2 t -74.81 120.81 20.86 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.869 -179.985 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 39' ' ' GLN . . . . . 0.5 ' NE2' ' CD2' ' A' ' 49' ' ' TRP . 0.0 OUTLIER -104.06 127.29 51.62 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.899 -179.974 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 40' ' ' ILE . . . . . 0.511 ' N ' HD13 ' A' ' 40' ' ' ILE . 0.7 OUTLIER -95.53 -31.1 4.1 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.095 179.97 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 2.0 tt -77.28 47.08 0.54 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.934 179.919 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -101.77 138.87 14.13 Favored Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.711 -0.757 . . . . 0.0 112.485 179.881 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 1.8 mtmm -57.37 -24.65 56.57 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.768 0.318 . . . . 0.0 110.881 -179.944 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 1.1 m-85 -111.08 23.43 14.12 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.931 -179.946 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 93.22 -137.63 13.72 Favored Glycine 0 N--CA 1.451 -0.344 0 C-N-CA 120.719 -0.753 . . . . 0.0 112.498 179.992 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 46' ' ' ASN . . . . . 0.438 ' OD1' HG23 ' A' ' 40' ' ' ILE . 57.3 m-80 -86.45 117.76 25.45 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.85 0.357 . . . . 0.0 110.863 -179.894 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 47' ' ' ALA . . . . . 0.498 ' HB3' ' CD1' ' A' ' 5' ' ' TYR . . . -135.75 147.27 48.36 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.098 179.864 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 24.1 t -66.67 108.19 2.39 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.842 -179.957 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 49' ' ' TRP . . . . . 0.591 ' CZ3' ' HA ' ' A' ' 4' ' ' ALA . 53.6 t-105 -94.39 112.62 24.41 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.907 179.957 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 50' ' ' CYS . . . . . . . . . . . . . 34.8 m -95.12 142.41 27.6 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.913 179.969 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 51' ' ' ILE . . . . . 0.406 ' O ' ' HB2' ' A' ' 52' ' ' GLN . 3.8 mm -106.62 133.81 50.08 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.109 179.94 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 52' ' ' GLN . . . . . 0.493 ' CB ' ' HB2' ' A' ' 34' ' ' GLU . 3.4 mm-40 64.77 45.36 3.39 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.88 179.925 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 53' ' ' LEU . . . . . 0.779 HD13 ' HB2' ' A' ' 33' ' ' ALA . 14.6 tp -85.67 134.79 39.09 Favored Pre-proline 0 C--N 1.329 -0.307 0 CA-C-O 121.548 0.689 . . . . 0.0 110.942 -179.997 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 54' ' ' PRO . . . . . 0.847 ' HG2' HG23 ' A' ' 57' ' ' VAL . 53.9 Cg_endo -69.7 146.5 60.73 Favored 'Trans proline' 0 C--O 1.231 0.144 0 C-N-CA 122.668 2.245 . . . . 0.0 112.385 179.864 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 3.4 m-20 -65.18 -5.58 7.19 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.848 179.958 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 10.9 m120 -79.26 -26.39 42.4 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.921 -179.953 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 57' ' ' VAL . . . . . 0.847 HG23 ' HG2' ' A' ' 54' ' ' PRO . 21.3 t -88.85 136.7 30.48 Favored Pre-proline 0 C--N 1.33 -0.265 0 CA-C-O 121.571 0.701 . . . . 0.0 111.164 179.861 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 58' ' ' PRO . . . . . 0.471 ' HD2' HG13 ' A' ' 57' ' ' VAL . 53.6 Cg_endo -69.76 143.26 50.26 Favored 'Trans proline' 0 C--N 1.341 0.181 0 C-N-CA 122.71 2.273 . . . . 0.0 112.345 179.974 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 59' ' ' ILE . . . . . 0.788 ' C ' ' HB2' ' A' ' 7' ' ' ALA . 5.2 pt -117.03 168.9 7.95 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-N 116.255 -0.43 . . . . 0.0 111.156 179.895 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 60' ' ' ARG . . . . . 0.553 ' CD ' HG12 ' A' ' 13' ' ' VAL . 13.7 tpt180 -75.22 121.52 22.26 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.841 179.957 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 61' ' ' ILE . . . . . 0.653 HD13 ' N ' ' A' ' 61' ' ' ILE . 0.0 OUTLIER -110.26 160.46 28.25 Favored Pre-proline 0 C--N 1.329 -0.299 0 CA-C-O 121.589 0.709 . . . . 0.0 111.157 179.952 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -69.76 64.89 1.8 Allowed 'Trans proline' 0 C--N 1.341 0.16 0 C-N-CA 122.693 2.262 . . . . 0.0 112.381 179.84 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -142.56 -174.15 14.85 Favored Glycine 0 N--CA 1.451 -0.344 0 C-N-CA 120.739 -0.743 . . . . 0.0 112.476 180.0 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -85.16 151.23 24.26 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 120.797 0.332 . . . . 0.0 110.956 179.968 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 65' ' ' CYS . . . . . 0.601 ' SG ' ' CD2' ' A' ' 66' ' ' HIS . 1.2 t -95.13 160.92 14.33 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.885 179.953 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 66' ' ' HIS . . . . . 0.601 ' CD2' ' SG ' ' A' ' 65' ' ' CYS . 1.0 OUTLIER . . . . . 0 C--N 1.329 -0.31 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.857 179.981 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 1' ' ' ALA . . . . . 0.812 ' HB3' ' C ' ' A' ' 52' ' ' GLN . . . . . . . . 0 C--O 1.231 0.123 0 CA-C-O 120.759 0.314 . . . . 0.0 111.09 . . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 2' ' ' ARG . . . . . 0.528 ' NH1' HD13 ' A' ' 59' ' ' ILE . 3.3 ptm180 -90.71 -175.52 4.42 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.85 -179.922 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -145.55 121.43 10.62 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.892 179.979 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 4' ' ' ALA . . . . . 0.588 ' HA ' ' CZ3' ' A' ' 49' ' ' TRP . . . -173.89 -172.24 0.72 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.082 179.984 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 5' ' ' TYR . . . . . 0.546 ' CE1' ' HB2' ' A' ' 49' ' ' TRP . 66.9 m-85 -84.23 137.68 33.35 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.92 -179.883 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 6' ' ' ILE . . . . . 0.449 HG23 ' HD1' ' A' ' 14' ' ' TYR . 6.9 tt -75.39 143.84 12.77 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.074 -0.512 . . . . 0.0 111.12 179.924 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -84.6 165.1 18.26 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.2 -0.454 . . . . 0.0 111.113 179.792 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 8' ' ' LYS . . . . . 0.578 ' HB2' ' CE2' ' A' ' 14' ' ' TYR . 0.1 OUTLIER -145.41 165.57 21.06 Favored Pre-proline 0 C--N 1.329 -0.318 0 CA-C-O 121.565 0.698 . . . . 0.0 110.903 -179.973 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 9' ' ' PRO . . . . . 0.483 ' HA ' ' HA ' ' A' ' 10' ' ' HIS . 53.7 Cg_endo -69.78 105.77 1.55 Allowed 'Trans proline' 0 C--N 1.341 0.175 0 C-N-CA 122.691 2.26 . . . . 0.0 112.34 179.909 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 10' ' ' HIS . . . . . 0.483 ' HA ' ' HA ' ' A' ' 9' ' ' PRO . 8.1 m-70 -132.61 122.5 24.81 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.887 -0.127 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 11' ' ' ASN . . . . . 0.479 ' OD1' HD11 ' A' ' 61' ' ' ILE . 3.2 t30 71.73 20.68 4.54 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.893 -179.902 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 12' ' ' CYS . . . . . 0.448 ' HB2' ' HG2' ' A' ' 8' ' ' LYS . 1.5 m -109.57 168.64 9.25 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.892 -179.999 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 13' ' ' VAL . . . . . 0.767 HG12 ' HG2' ' A' ' 60' ' ' ARG . 0.9 OUTLIER -90.8 156.08 3.04 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.135 179.939 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 14' ' ' TYR . . . . . 0.578 ' CE2' ' HB2' ' A' ' 8' ' ' LYS . 4.1 m-85 -94.26 87.0 5.09 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.929 -179.921 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 30.6 tt0 -64.59 120.67 12.81 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.853 -179.986 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 16' ' ' CYS . . . . . 1.147 ' SG ' ' SG ' ' A' ' 24' ' ' CYS . 0.7 OUTLIER -104.45 171.56 7.27 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.158 -0.473 . . . . 0.0 110.894 -179.963 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 17' ' ' TYR . . . . . 0.446 ' O ' ' HD3' ' A' ' 19' ' ' PRO . 67.4 t80 -125.7 -23.79 3.96 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.899 -179.833 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 10.4 t-20 -105.64 85.0 1.32 Allowed Pre-proline 0 C--N 1.329 -0.286 0 CA-C-O 121.626 0.726 . . . . 0.0 110.89 -179.997 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 19' ' ' PRO . . . . . 0.446 ' HD3' ' O ' ' A' ' 17' ' ' TYR . 53.5 Cg_endo -69.88 -24.89 28.6 Favored 'Trans proline' 0 C--N 1.341 0.17 0 C-N-CA 122.636 2.224 . . . . 0.0 112.317 179.983 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 28.6 mmtm -94.4 -24.59 17.29 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.85 179.931 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -80.21 -174.7 47.78 Favored Glycine 0 N--CA 1.452 -0.287 0 C-N-CA 120.737 -0.744 . . . . 0.0 112.496 179.927 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 26.1 m -95.62 25.72 4.38 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.855 0.36 . . . . 0.0 110.814 -179.718 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 1.1 t80 -59.58 -66.88 0.44 Allowed 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.938 -179.894 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 24' ' ' CYS . . . . . 1.147 ' SG ' ' SG ' ' A' ' 16' ' ' CYS . 19.7 m -67.0 -37.39 84.12 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.141 -0.482 . . . . 0.0 110.913 179.953 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 25' ' ' ASN . . . . . 0.783 ' O ' HG23 ' A' ' 29' ' ' THR . 2.5 t30 -57.34 -58.92 6.13 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.114 -0.493 . . . . 0.0 110.891 -179.968 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 12.4 m-20 -56.22 -53.34 58.3 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.9 179.9 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 27' ' ' LEU . . . . . 0.66 ' O ' HD12 ' A' ' 27' ' ' LEU . 1.8 tp -58.99 -35.5 73.32 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.956 -179.962 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 28' ' ' CYS . . . . . 0.471 ' O ' ' HB3' ' A' ' 33' ' ' ALA . 1.7 m -64.36 -58.83 5.37 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.879 179.874 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 29' ' ' THR . . . . . 0.783 HG23 ' O ' ' A' ' 25' ' ' ASN . 1.1 p -62.7 -28.39 69.91 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.124 -0.489 . . . . 0.0 111.143 -179.92 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 41.3 tt0 -55.17 -20.56 10.69 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.866 -179.999 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 31' ' ' ASN . . . . . 0.671 ' O ' HG21 ' A' ' 57' ' ' VAL . 6.6 m120 -102.51 22.36 13.65 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.878 -179.94 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 95.35 -12.58 67.83 Favored Glycine 0 N--CA 1.452 -0.265 0 C-N-CA 120.766 -0.73 . . . . 0.0 112.497 179.977 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 33' ' ' ALA . . . . . 0.941 ' HB2' HD13 ' A' ' 53' ' ' LEU . . . -62.03 162.23 9.6 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.744 0.306 . . . . 0.0 111.131 179.959 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 34' ' ' GLU . . . . . 0.482 ' HB2' ' CB ' ' A' ' 52' ' ' GLN . 11.5 tp10 -90.33 -29.72 17.91 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.9 -179.91 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 15.6 m -162.41 179.62 7.68 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.838 -179.799 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -167.97 161.03 34.79 Favored Glycine 0 N--CA 1.452 -0.28 0 C-N-CA 120.721 -0.752 . . . . 0.0 112.47 -179.991 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 37' ' ' TYR . . . . . 0.619 ' CE2' ' CD1' ' A' ' 49' ' ' TRP . 3.3 p90 -162.44 151.86 15.71 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 120.953 0.406 . . . . 0.0 110.939 -179.828 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 38' ' ' CYS . . . . . 0.4 ' CB ' ' HA ' ' A' ' 19' ' ' PRO . 2.0 t -80.32 119.45 23.06 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.88 -179.969 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 39' ' ' GLN . . . . . 0.487 ' OE1' ' N ' ' A' ' 42' ' ' GLY . 1.4 tm0? -105.21 108.59 20.19 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.896 -179.943 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 40' ' ' ILE . . . . . 0.984 ' O ' HD12 ' A' ' 40' ' ' ILE . 0.1 OUTLIER -81.84 -35.79 13.76 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.153 179.983 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 41' ' ' LEU . . . . . 0.439 ' N ' HG13 ' A' ' 40' ' ' ILE . 3.4 mt -78.93 48.01 0.8 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.903 179.913 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 42' ' ' GLY . . . . . 0.487 ' N ' ' OE1' ' A' ' 39' ' ' GLN . . . -98.66 -179.71 32.01 Favored Glycine 0 N--CA 1.451 -0.303 0 C-N-CA 120.734 -0.746 . . . . 0.0 112.45 179.926 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 43' ' ' LYS . . . . . 0.56 ' HG2' ' CD1' ' A' ' 44' ' ' TYR . 0.3 OUTLIER -83.05 -26.83 30.76 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.787 0.327 . . . . 0.0 110.885 -179.983 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 44' ' ' TYR . . . . . 0.56 ' CD1' ' HG2' ' A' ' 43' ' ' LYS . 1.0 OUTLIER -114.31 24.45 11.92 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.907 -179.968 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 94.42 -133.96 11.81 Favored Glycine 0 N--CA 1.451 -0.342 0 C-N-CA 120.731 -0.747 . . . . 0.0 112.463 179.933 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 3.0 m120 -92.55 109.39 20.79 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 120.843 0.354 . . . . 0.0 110.893 -179.941 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -125.61 140.39 52.77 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.08 179.855 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 3.1 m -66.25 111.27 3.38 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.904 -179.96 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 49' ' ' TRP . . . . . 0.619 ' CD1' ' CE2' ' A' ' 37' ' ' TYR . 45.0 t-105 -94.78 115.13 27.12 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.931 180.0 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 50' ' ' CYS . . . . . . . . . . . . . 33.4 m -97.66 142.72 29.1 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.899 179.994 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 51' ' ' ILE . . . . . 0.495 HD11 ' CD2' ' A' ' 37' ' ' TYR . 4.0 mp -110.97 137.62 42.65 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.14 179.895 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 52' ' ' GLN . . . . . 0.812 ' C ' ' HB3' ' A' ' 1' ' ' ALA . 11.1 mm100 65.02 41.92 4.42 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.914 179.922 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 53' ' ' LEU . . . . . 0.941 HD13 ' HB2' ' A' ' 33' ' ' ALA . 15.7 tp -85.57 136.16 37.53 Favored Pre-proline 0 C--N 1.328 -0.327 0 CA-C-O 121.568 0.699 . . . . 0.0 110.969 179.961 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 54' ' ' PRO . . . . . 0.875 ' HG2' HG23 ' A' ' 57' ' ' VAL . 53.4 Cg_endo -69.8 147.68 63.12 Favored 'Trans proline' 0 C--N 1.341 0.174 0 C-N-CA 122.701 2.267 . . . . 0.0 112.299 179.93 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 74.3 m-20 -65.03 -5.3 6.01 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.858 179.899 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 17.7 m-20 -79.64 -30.28 41.28 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.87 -179.899 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 57' ' ' VAL . . . . . 0.875 HG23 ' HG2' ' A' ' 54' ' ' PRO . 15.5 t -86.55 136.36 35.13 Favored Pre-proline 0 C--N 1.329 -0.307 0 CA-C-O 121.617 0.722 . . . . 0.0 111.134 179.928 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 58' ' ' PRO . . . . . 0.465 ' HD2' ' CG1' ' A' ' 57' ' ' VAL . 54.4 Cg_endo -69.75 141.77 46.15 Favored 'Trans proline' 0 C--O 1.231 0.167 0 C-N-CA 122.681 2.254 . . . . 0.0 112.391 179.939 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 59' ' ' ILE . . . . . 0.528 HD13 ' NH1' ' A' ' 2' ' ' ARG . 5.0 pt -118.61 157.65 20.07 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.104 179.967 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 60' ' ' ARG . . . . . 0.767 ' HG2' HG12 ' A' ' 13' ' ' VAL . 9.3 tpt180 -68.72 117.39 10.37 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.925 179.933 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 61' ' ' ILE . . . . . 0.479 HD11 ' OD1' ' A' ' 11' ' ' ASN . 1.3 pp -123.21 160.66 49.01 Favored Pre-proline 0 C--N 1.329 -0.308 0 CA-C-O 121.669 0.747 . . . . 0.0 111.118 179.983 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.75 73.39 1.37 Allowed 'Trans proline' 0 C--N 1.342 0.194 0 C-N-CA 122.66 2.24 . . . . 0.0 112.362 179.901 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -135.2 -175.38 13.82 Favored Glycine 0 N--CA 1.451 -0.344 0 C-N-CA 120.705 -0.76 . . . . 0.0 112.479 179.985 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -84.88 115.35 22.72 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.855 0.359 . . . . 0.0 110.897 -179.97 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 65' ' ' CYS . . . . . 0.487 ' O ' ' CG ' ' A' ' 66' ' ' HIS . 8.4 t -94.46 159.66 15.0 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.894 179.977 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 66' ' ' HIS . . . . . 0.487 ' CG ' ' O ' ' A' ' 65' ' ' CYS . 43.3 p-80 . . . . . 0 C--N 1.329 -0.318 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.87 179.949 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.232 0.155 0 CA-C-O 120.803 0.335 . . . . 0.0 111.07 . . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 16.1 ptt180 -152.55 171.43 18.14 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.871 -179.885 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 15.5 m-20 -99.63 130.49 45.87 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.868 179.961 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 4' ' ' ALA . . . . . 0.585 ' HA ' ' CZ3' ' A' ' 49' ' ' TRP . . . -174.94 -178.98 1.31 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.107 179.966 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 19.6 m-85 -84.6 135.33 34.24 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.896 -179.833 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 6' ' ' ILE . . . . . 0.456 HG12 ' CD1' ' A' ' 14' ' ' TYR . 3.1 tt -72.31 133.16 32.33 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.104 -0.498 . . . . 0.0 111.138 179.927 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 7' ' ' ALA . . . . . 0.855 ' HB2' ' C ' ' A' ' 59' ' ' ILE . . . -92.46 143.09 26.71 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.209 -0.45 . . . . 0.0 111.102 179.815 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 8' ' ' LYS . . . . . 0.538 ' HB2' ' CZ ' ' A' ' 14' ' ' TYR . 0.0 OUTLIER -115.09 167.29 10.09 Favored Pre-proline 0 C--N 1.329 -0.316 0 CA-C-O 121.533 0.682 . . . . 0.0 110.907 179.98 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 9' ' ' PRO . . . . . 0.487 ' HA ' ' HA ' ' A' ' 10' ' ' HIS . 54.0 Cg_endo -69.74 103.89 1.23 Allowed 'Trans proline' 0 C--O 1.232 0.202 0 C-N-CA 122.641 2.227 . . . . 0.0 112.359 179.905 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 10' ' ' HIS . . . . . 0.487 ' HA ' ' HA ' ' A' ' 9' ' ' PRO . 4.3 m80 -129.62 130.12 45.21 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.865 -0.053 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 11' ' ' ASN . . . . . 0.501 ' N ' ' O ' ' A' ' 8' ' ' LYS . 54.6 t-20 58.83 59.74 2.74 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.929 -179.914 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 12' ' ' CYS . . . . . 0.493 ' HB2' ' CD ' ' A' ' 8' ' ' LYS . 1.7 m -139.51 156.76 46.72 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.908 -179.982 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 13' ' ' VAL . . . . . 0.432 ' CG1' ' HE ' ' A' ' 60' ' ' ARG . 2.4 m -84.69 147.74 5.38 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.138 179.886 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 14' ' ' TYR . . . . . 0.538 ' CZ ' ' HB2' ' A' ' 8' ' ' LYS . 11.1 m-85 -94.67 101.01 12.84 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.909 -179.923 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 18.1 pt-20 -64.56 125.25 24.11 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.073 -0.512 . . . . 0.0 110.893 -180.0 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -101.99 135.35 43.71 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.86 -179.912 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 9.5 t80 -115.14 24.86 11.33 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.916 -179.902 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 10.8 t-20 -153.07 74.07 6.92 Favored Pre-proline 0 C--N 1.329 -0.309 0 CA-C-O 121.624 0.726 . . . . 0.0 110.849 -179.998 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.76 -19.89 35.54 Favored 'Trans proline' 0 C--O 1.232 0.18 0 C-N-CA 122.714 2.276 . . . . 0.0 112.317 179.903 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 56.8 mttm -94.16 -24.27 17.6 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.915 179.917 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -93.93 -176.99 39.51 Favored Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.702 -0.761 . . . . 0.0 112.468 179.925 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 52.6 p -95.49 25.83 4.25 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.906 0.384 . . . . 0.0 110.853 -179.721 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 23' ' ' TYR . . . . . 0.419 ' CD2' ' C ' ' A' ' 23' ' ' TYR . 1.1 t80 -55.0 -69.46 0.13 Allowed 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.91 -179.885 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 50.4 t -56.99 -36.61 70.56 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.103 -0.498 . . . . 0.0 110.905 179.966 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -57.87 -55.09 39.43 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.9 -179.946 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 47.7 m-20 -57.88 -52.71 64.35 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.174 -0.467 . . . . 0.0 110.794 179.958 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 27' ' ' LEU . . . . . 0.683 ' O ' HD12 ' A' ' 27' ' ' LEU . 1.7 tp -59.54 -37.4 78.3 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.965 -179.945 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 1.3 m -65.25 -54.53 27.97 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.874 179.884 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 29' ' ' THR . . . . . 0.617 HG22 ' O ' ' A' ' 33' ' ' ALA . 13.2 p -62.73 -29.15 70.46 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.139 -179.951 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 7.4 tp10 -54.69 -19.17 5.65 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.903 -179.981 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 31' ' ' ASN . . . . . 0.675 ' O ' HG21 ' A' ' 57' ' ' VAL . 2.3 m-80 -101.64 21.41 14.44 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.913 -179.946 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 95.5 -12.73 67.5 Favored Glycine 0 N--CA 1.452 -0.268 0 C-N-CA 120.682 -0.771 . . . . 0.0 112.463 -179.992 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 33' ' ' ALA . . . . . 0.91 ' HB2' HD13 ' A' ' 53' ' ' LEU . . . -61.75 153.91 27.1 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.729 0.3 . . . . 0.0 111.11 179.994 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 34' ' ' GLU . . . . . 0.514 ' OE1' ' NE2' ' A' ' 52' ' ' GLN . 67.0 mt-10 -85.6 -24.79 27.01 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.929 -179.959 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 12.4 m -161.99 177.88 9.37 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.841 -179.799 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -175.44 158.39 25.65 Favored Glycine 0 N--CA 1.452 -0.263 0 C-N-CA 120.722 -0.751 . . . . 0.0 112.448 -179.973 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 32.6 p90 -164.83 166.86 19.35 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.91 0.386 . . . . 0.0 110.904 -179.831 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 38' ' ' CYS . . . . . . . . . . . . . 4.1 t -75.33 124.3 26.87 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.11 -0.496 . . . . 0.0 110.857 179.996 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 2.4 tt0 -105.19 118.18 35.89 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.9 -179.978 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 0.9 OUTLIER -88.3 -29.32 5.38 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.102 179.974 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 14.0 mt -82.58 38.91 0.58 Allowed 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.924 179.935 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -87.91 139.14 15.59 Favored Glycine 0 N--CA 1.45 -0.367 0 C-N-CA 120.762 -0.732 . . . . 0.0 112.479 179.92 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 39.1 mttp -53.79 -25.09 17.54 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.856 0.36 . . . . 0.0 110.904 -179.953 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 0.4 OUTLIER -113.85 24.41 12.11 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.945 179.992 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 94.3 -137.58 13.59 Favored Glycine 0 N--CA 1.452 -0.288 0 C-N-CA 120.736 -0.745 . . . . 0.0 112.445 179.962 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 37.5 m-80 -85.69 111.53 20.19 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.826 0.346 . . . . 0.0 110.907 -179.848 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -130.62 145.51 51.92 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.109 179.91 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 14.6 t -65.44 110.29 2.61 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.899 -179.985 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 49' ' ' TRP . . . . . 0.585 ' CZ3' ' HA ' ' A' ' 4' ' ' ALA . 41.6 t-105 -94.97 127.33 40.94 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.949 179.971 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 50' ' ' CYS . . . . . . . . . . . . . 29.9 m -108.41 141.02 40.88 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.841 -179.953 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 51' ' ' ILE . . . . . 0.665 HG22 ' HG2' ' A' ' 52' ' ' GLN . 4.0 mm -108.06 130.99 59.64 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.126 179.917 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 52' ' ' GLN . . . . . 0.665 ' HG2' HG22 ' A' ' 51' ' ' ILE . 6.9 mm100 67.72 43.08 1.87 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.921 179.955 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 53' ' ' LEU . . . . . 0.91 HD13 ' HB2' ' A' ' 33' ' ' ALA . 15.1 tp -85.6 135.53 38.19 Favored Pre-proline 0 C--N 1.328 -0.339 0 CA-C-O 121.582 0.706 . . . . 0.0 110.949 -179.955 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 54' ' ' PRO . . . . . 0.802 ' HG2' HG23 ' A' ' 57' ' ' VAL . 53.6 Cg_endo -69.81 145.68 57.6 Favored 'Trans proline' 0 C--N 1.341 0.179 0 C-N-CA 122.697 2.265 . . . . 0.0 112.31 179.914 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -61.4 -9.1 4.79 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.867 179.936 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 67.6 m-20 -74.85 -24.84 58.65 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.872 -179.867 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 57' ' ' VAL . . . . . 0.802 HG23 ' HG2' ' A' ' 54' ' ' PRO . 11.1 t -90.31 136.29 28.7 Favored Pre-proline 0 C--N 1.329 -0.305 0 CA-C-O 121.622 0.725 . . . . 0.0 111.12 179.883 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 58' ' ' PRO . . . . . 0.467 ' HD2' ' CG1' ' A' ' 57' ' ' VAL . 53.8 Cg_endo -69.77 146.59 60.57 Favored 'Trans proline' 0 C--O 1.232 0.181 0 C-N-CA 122.68 2.253 . . . . 0.0 112.37 179.924 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 59' ' ' ILE . . . . . 0.855 ' C ' ' HB2' ' A' ' 7' ' ' ALA . 10.2 pt -123.89 159.98 28.37 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.116 179.964 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 60' ' ' ARG . . . . . 0.446 ' HD3' ' C ' ' A' ' 60' ' ' ARG . 2.9 tpp180 -64.66 111.19 2.64 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.885 179.924 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 61' ' ' ILE . . . . . 0.483 HG13 ' ND2' ' A' ' 11' ' ' ASN . 0.6 OUTLIER -110.48 161.74 23.39 Favored Pre-proline 0 C--N 1.329 -0.3 0 CA-C-O 121.625 0.726 . . . . 0.0 111.154 179.933 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -69.79 69.75 1.64 Allowed 'Trans proline' 0 C--N 1.342 0.199 0 C-N-CA 122.703 2.269 . . . . 0.0 112.342 179.851 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -144.95 -171.94 15.06 Favored Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.752 -0.737 . . . . 0.0 112.514 179.955 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 9.2 ptpt -85.47 131.23 34.41 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.836 0.35 . . . . 0.0 110.883 -179.964 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 65' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -91.06 140.58 29.7 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.872 179.953 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 66' ' ' HIS . . . . . 0.496 ' CG ' ' O ' ' A' ' 66' ' ' HIS . 26.9 p80 . . . . . 0 C--N 1.33 -0.279 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.824 179.95 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 1' ' ' ALA . . . . . 0.619 ' HB1' ' O ' ' A' ' 53' ' ' LEU . . . . . . . . 0 C--O 1.231 0.127 0 CA-C-O 120.8 0.333 . . . . 0.0 111.113 . . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 2' ' ' ARG . . . . . 0.441 ' NH1' ' O ' ' A' ' 53' ' ' LEU . 0.0 OUTLIER -136.8 157.04 47.67 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.894 -179.897 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 3' ' ' ASP . . . . . 0.724 ' OD2' HG23 ' A' ' 51' ' ' ILE . 3.0 m-20 -92.34 133.9 35.42 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.898 179.976 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 4' ' ' ALA . . . . . 0.588 ' HA ' ' CZ3' ' A' ' 49' ' ' TRP . . . -173.94 -179.24 1.68 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.101 179.926 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 5' ' ' TYR . . . . . 0.438 ' CD1' ' HB3' ' A' ' 47' ' ' ALA . 21.6 m-85 -84.99 136.41 33.6 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.948 -179.852 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 6' ' ' ILE . . . . . 0.592 HG23 ' HD2' ' A' ' 14' ' ' TYR . 3.5 tt -75.34 135.63 26.75 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-N 116.115 -0.493 . . . . 0.0 111.176 179.901 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 7' ' ' ALA . . . . . 0.513 ' HB2' ' C ' ' A' ' 59' ' ' ILE . . . -85.56 150.98 24.28 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.096 179.849 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 8' ' ' LYS . . . . . 0.554 ' HB2' ' CZ ' ' A' ' 14' ' ' TYR . 0.0 OUTLIER -133.12 166.9 25.88 Favored Pre-proline 0 C--N 1.329 -0.285 0 CA-C-O 121.54 0.686 . . . . 0.0 110.903 179.994 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 9' ' ' PRO . . . . . 0.426 ' HA ' ' HA ' ' A' ' 10' ' ' HIS . 53.6 Cg_endo -69.79 105.53 1.51 Allowed 'Trans proline' 0 C--O 1.232 0.192 0 C-N-CA 122.646 2.231 . . . . 0.0 112.361 179.875 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 10' ' ' HIS . . . . . 0.426 ' HA ' ' HA ' ' A' ' 9' ' ' PRO . 4.1 m-70 -131.28 128.97 40.91 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.872 -0.061 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 11' ' ' ASN . . . . . 0.615 ' OD1' HD11 ' A' ' 61' ' ' ILE . 3.6 t30 59.14 44.52 15.78 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.865 -179.957 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 12' ' ' CYS . . . . . 0.468 ' HB2' ' CE ' ' A' ' 8' ' ' LYS . 1.4 m -129.93 157.56 41.96 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.873 179.978 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 13' ' ' VAL . . . . . 0.532 ' HB ' ' HB1' ' A' ' 47' ' ' ALA . 1.3 m -85.91 155.39 3.42 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.131 -0.486 . . . . 0.0 111.15 179.912 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 14' ' ' TYR . . . . . 0.592 ' HD2' HG23 ' A' ' 6' ' ' ILE . 9.5 m-85 -94.45 94.87 8.49 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.939 -179.94 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 1.8 pm0 -64.6 133.98 53.38 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.869 -179.978 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 1.8 p -84.74 159.92 20.39 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.873 -179.96 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 8.4 t80 -95.47 -32.51 12.85 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.899 -179.865 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 18' ' ' ASN . . . . . 0.605 ' CG ' ' HD2' ' A' ' 19' ' ' PRO . 1.8 t-20 -154.7 147.0 17.46 Favored Pre-proline 0 C--N 1.329 -0.286 0 CA-C-O 121.604 0.716 . . . . 0.0 110.87 179.971 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 19' ' ' PRO . . . . . 0.605 ' HD2' ' CG ' ' A' ' 18' ' ' ASN . 54.1 Cg_endo -69.73 -31.45 20.62 Favored 'Trans proline' 0 C--O 1.231 0.166 0 C-N-CA 122.714 2.276 . . . . 0.0 112.348 179.918 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 2.0 mmmm -94.48 24.57 4.45 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.874 179.934 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -114.75 132.85 10.67 Favored Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.732 -0.747 . . . . 0.0 112.495 179.907 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 67.4 m -83.67 24.87 0.82 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.874 0.369 . . . . 0.0 110.819 -179.712 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 23' ' ' TYR . . . . . 0.42 ' O ' ' CD1' ' A' ' 23' ' ' TYR . 2.6 t80 -64.54 -41.24 96.48 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.134 -0.484 . . . . 0.0 110.916 -179.902 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 24' ' ' CYS . . . . . 0.409 ' SG ' ' O ' ' A' ' 37' ' ' TYR . 47.8 t -69.4 -43.12 74.09 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.866 -179.993 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 25' ' ' ASN . . . . . 0.858 ' O ' HG23 ' A' ' 29' ' ' THR . 1.9 t30 -55.12 -56.39 20.44 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.855 -179.992 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 9.5 m-20 -56.13 -52.3 64.84 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.893 179.939 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 27' ' ' LEU . . . . . 0.663 ' O ' HD12 ' A' ' 27' ' ' LEU . 1.9 tp -58.29 -37.13 74.4 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.872 -179.967 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 28' ' ' CYS . . . . . 0.587 ' C ' ' HB3' ' A' ' 33' ' ' ALA . 10.9 m -63.65 -51.31 65.71 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.231 -0.441 . . . . 0.0 110.874 179.901 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 29' ' ' THR . . . . . 0.858 HG23 ' O ' ' A' ' 25' ' ' ASN . 1.1 p -63.31 -24.54 67.9 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.145 -179.947 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 14.0 tp10 -59.68 -23.17 62.88 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.912 179.966 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 31' ' ' ASN . . . . . 0.581 ' O ' HG21 ' A' ' 57' ' ' VAL . 6.8 m120 -103.93 22.3 14.82 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.88 -179.95 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 82.78 19.68 62.99 Favored Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.699 -0.762 . . . . 0.0 112.506 179.966 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 33' ' ' ALA . . . . . 0.77 ' HB2' HD13 ' A' ' 53' ' ' LEU . . . -84.92 149.31 25.74 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.775 0.321 . . . . 0.0 111.047 -179.988 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 34' ' ' GLU . . . . . 0.481 ' HB2' ' CB ' ' A' ' 52' ' ' GLN . 5.7 tp10 -74.84 -34.7 62.34 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.907 -179.947 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 2.4 m -161.77 178.15 9.24 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.868 -179.8 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -169.12 159.77 32.91 Favored Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.735 -0.745 . . . . 0.0 112.49 -179.982 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 37' ' ' TYR . . . . . 0.635 ' CE1' HD11 ' A' ' 51' ' ' ILE . 3.9 p90 -163.84 160.55 22.41 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 120.957 0.408 . . . . 0.0 110.875 -179.778 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 38' ' ' CYS . . . . . . . . . . . . . 2.4 t -74.43 113.02 11.18 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.853 179.974 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 39' ' ' GLN . . . . . 0.503 ' OE1' ' N ' ' A' ' 41' ' ' LEU . 0.0 OUTLIER -90.3 122.99 33.7 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.889 179.994 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 40' ' ' ILE . . . . . 0.509 HD13 ' OD1' ' A' ' 46' ' ' ASN . 2.5 mm -92.81 -51.42 11.34 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.138 179.94 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 41' ' ' LEU . . . . . 0.539 HD23 ' H ' ' A' ' 41' ' ' LEU . 0.1 OUTLIER -75.17 57.93 0.88 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.121 -0.491 . . . . 0.0 110.976 179.887 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -99.93 144.14 16.77 Favored Glycine 0 N--CA 1.451 -0.358 0 C-N-CA 120.747 -0.74 . . . . 0.0 112.465 179.954 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 55.8 tttp -53.91 -26.14 23.64 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.785 0.326 . . . . 0.0 110.92 179.997 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 0.9 OUTLIER -115.25 23.83 12.14 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.926 -179.988 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 93.65 -132.66 11.31 Favored Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.791 -0.719 . . . . 0.0 112.48 179.946 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 46' ' ' ASN . . . . . 0.509 ' OD1' HD13 ' A' ' 40' ' ' ILE . 0.9 OUTLIER -90.69 117.32 29.25 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.786 0.327 . . . . 0.0 110.922 -179.908 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 47' ' ' ALA . . . . . 0.532 ' HB1' ' HB ' ' A' ' 13' ' ' VAL . . . -140.72 146.16 37.41 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.086 179.91 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 48' ' ' CYS . . . . . 0.451 ' N ' ' O ' ' A' ' 14' ' ' TYR . 40.1 t -67.39 109.33 3.12 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.891 -179.957 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 49' ' ' TRP . . . . . 0.588 ' CZ3' ' HA ' ' A' ' 4' ' ' ALA . 36.9 t-105 -94.66 114.22 26.13 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.917 -179.997 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 50' ' ' CYS . . . . . . . . . . . . . 42.6 m -94.96 142.43 27.49 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.888 -179.962 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 51' ' ' ILE . . . . . 0.724 HG23 ' OD2' ' A' ' 3' ' ' ASP . 3.7 mp -105.92 133.85 49.15 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.187 -0.46 . . . . 0.0 111.143 179.953 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 52' ' ' GLN . . . . . 0.481 ' CB ' ' HB2' ' A' ' 34' ' ' GLU . 9.3 mm-40 64.49 45.42 3.68 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.906 179.952 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 53' ' ' LEU . . . . . 0.77 HD13 ' HB2' ' A' ' 33' ' ' ALA . 15.3 tp -85.37 134.0 41.31 Favored Pre-proline 0 C--N 1.329 -0.305 0 CA-C-O 121.592 0.711 . . . . 0.0 110.928 -179.999 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 54' ' ' PRO . . . . . 0.841 ' HG2' HG23 ' A' ' 57' ' ' VAL . 53.9 Cg_endo -69.74 147.14 62.33 Favored 'Trans proline' 0 C--O 1.231 0.165 0 C-N-CA 122.662 2.241 . . . . 0.0 112.377 179.87 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 2.4 m-20 -63.88 -6.44 5.97 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.842 179.947 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 9.0 m120 -77.92 -24.94 48.12 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.914 -179.94 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 57' ' ' VAL . . . . . 0.841 HG23 ' HG2' ' A' ' 54' ' ' PRO . 12.3 t -91.14 136.39 27.32 Favored Pre-proline 0 C--N 1.33 -0.251 0 CA-C-O 121.601 0.715 . . . . 0.0 111.115 179.922 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 58' ' ' PRO . . . . . 0.46 ' HD2' ' CG1' ' A' ' 57' ' ' VAL . 54.0 Cg_endo -69.76 136.4 32.89 Favored 'Trans proline' 0 C--O 1.231 0.17 0 C-N-CA 122.724 2.283 . . . . 0.0 112.351 179.953 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 59' ' ' ILE . . . . . 0.513 ' C ' ' HB2' ' A' ' 7' ' ' ALA . 13.9 pt -116.23 164.15 12.82 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.276 -0.42 . . . . 0.0 111.162 179.922 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 60' ' ' ARG . . . . . 0.444 ' C ' ' CD ' ' A' ' 60' ' ' ARG . 0.3 OUTLIER -65.62 106.42 1.46 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.848 179.983 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 61' ' ' ILE . . . . . 0.615 HD11 ' OD1' ' A' ' 11' ' ' ASN . 1.3 pt -94.87 160.64 30.7 Favored Pre-proline 0 C--N 1.329 -0.315 0 CA-C-O 121.606 0.717 . . . . 0.0 111.171 179.912 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -69.71 66.11 1.75 Allowed 'Trans proline' 0 C--N 1.341 0.159 0 C-N-CA 122.755 2.303 . . . . 0.0 112.352 179.866 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -144.78 -173.86 16.49 Favored Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 120.765 -0.731 . . . . 0.0 112.499 179.973 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 11.4 ttmm -85.1 147.17 26.78 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 120.786 0.327 . . . . 0.0 110.902 -179.944 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 65' ' ' CYS . . . . . 0.484 ' SG ' ' N ' ' A' ' 66' ' ' HIS . 0.8 OUTLIER -94.04 159.53 15.12 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.909 179.947 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 66' ' ' HIS . . . . . 0.484 ' N ' ' SG ' ' A' ' 65' ' ' CYS . 42.0 p-80 . . . . . 0 C--N 1.329 -0.296 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.881 179.958 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 1' ' ' ALA . . . . . 0.564 ' HB1' ' O ' ' A' ' 53' ' ' LEU . . . . . . . . 0 C--O 1.231 0.12 0 CA-C-O 120.759 0.314 . . . . 0.0 111.099 . . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -152.99 150.08 28.85 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.229 -0.442 . . . . 0.0 110.897 -179.904 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 2.7 m-20 -89.02 132.36 34.78 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.859 179.967 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 4' ' ' ALA . . . . . 0.613 ' HA ' ' CZ3' ' A' ' 49' ' ' TRP . . . -174.93 -179.27 1.37 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.11 179.918 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 5' ' ' TYR . . . . . 0.405 ' CE2' ' HE3' ' A' ' 49' ' ' TRP . 12.5 m-85 -84.46 131.49 34.65 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.941 -179.861 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 6' ' ' ILE . . . . . 0.558 HG23 ' HD2' ' A' ' 14' ' ' TYR . 4.9 tt -75.04 146.24 9.77 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.123 179.949 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -84.76 164.05 18.76 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.095 179.839 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 8' ' ' LYS . . . . . 0.549 ' HB2' ' CZ ' ' A' ' 14' ' ' TYR . 0.5 OUTLIER -145.18 168.88 10.93 Favored Pre-proline 0 C--N 1.329 -0.323 0 CA-C-O 121.633 0.73 . . . . 0.0 110.861 179.975 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 9' ' ' PRO . . . . . 0.51 ' HA ' ' HA ' ' A' ' 10' ' ' HIS . 53.0 Cg_endo -69.8 104.94 1.4 Allowed 'Trans proline' 0 C--N 1.342 0.186 0 C-N-CA 122.682 2.255 . . . . 0.0 112.312 179.925 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 10' ' ' HIS . . . . . 0.51 ' HA ' ' HA ' ' A' ' 9' ' ' PRO . 5.5 m-70 -131.87 123.12 26.85 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.838 -0.071 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 11' ' ' ASN . . . . . 0.512 ' N ' ' O ' ' A' ' 8' ' ' LYS . 5.8 t30 69.59 21.42 6.69 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.899 -179.934 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 12' ' ' CYS . . . . . 0.414 ' HB2' ' HG2' ' A' ' 8' ' ' LYS . 1.5 m -108.25 172.01 7.08 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.884 179.975 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 13' ' ' VAL . . . . . 0.576 HG12 ' HG2' ' A' ' 60' ' ' ARG . 0.9 OUTLIER -92.85 155.6 3.11 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.109 179.958 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 14' ' ' TYR . . . . . 0.558 ' HD2' HG23 ' A' ' 6' ' ' ILE . 6.9 m-85 -93.82 95.7 9.29 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.878 -179.855 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 16.2 pt-20 -64.84 137.05 57.54 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.907 179.994 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 15.1 p -84.41 158.41 21.09 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.885 -179.923 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 24.2 t80 -95.57 -33.05 12.54 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.918 -179.866 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 18' ' ' ASN . . . . . 0.599 ' CG ' ' HD2' ' A' ' 19' ' ' PRO . 1.9 t-20 -155.15 147.0 17.15 Favored Pre-proline 0 C--N 1.328 -0.333 0 CA-C-O 121.637 0.732 . . . . 0.0 110.894 179.97 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 19' ' ' PRO . . . . . 0.599 ' HD2' ' CG ' ' A' ' 18' ' ' ASN . 53.4 Cg_endo -69.75 -33.96 15.56 Favored 'Trans proline' 0 C--N 1.342 0.188 0 C-N-CA 122.669 2.246 . . . . 0.0 112.343 179.935 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 3.7 mmmp? -94.61 24.56 4.53 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.87 179.907 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -115.83 135.59 12.3 Favored Glycine 0 N--CA 1.452 -0.281 0 C-N-CA 120.74 -0.743 . . . . 0.0 112.465 179.962 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 83.9 p -83.52 24.86 0.8 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.872 0.368 . . . . 0.0 110.835 -179.719 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 0.4 OUTLIER -60.67 -51.77 67.96 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.909 -179.874 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 24' ' ' CYS . . . . . 0.401 ' SG ' ' O ' ' A' ' 37' ' ' TYR . 42.7 t -62.23 -41.01 98.03 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.853 -179.978 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 25' ' ' ASN . . . . . 0.852 ' O ' HG23 ' A' ' 29' ' ' THR . 0.3 OUTLIER -54.41 -58.43 7.46 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.871 -179.966 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -54.92 -53.83 50.51 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.856 179.945 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 27' ' ' LEU . . . . . 0.699 ' O ' HD12 ' A' ' 27' ' ' LEU . 1.8 tp -56.75 -37.58 71.23 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.89 -179.922 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 28' ' ' CYS . . . . . 0.512 ' C ' ' HB3' ' A' ' 33' ' ' ALA . 4.9 m -63.73 -51.96 62.62 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.897 179.89 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 29' ' ' THR . . . . . 0.852 HG23 ' O ' ' A' ' 25' ' ' ASN . 1.1 p -62.43 -24.77 67.6 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.128 -0.487 . . . . 0.0 111.197 -179.993 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 5.2 tm-20 -58.81 -22.47 58.6 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.892 -180.0 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 31' ' ' ASN . . . . . 0.564 ' O ' HG21 ' A' ' 57' ' ' VAL . 1.8 m-80 -103.4 21.94 15.08 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.92 -179.956 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 83.46 19.23 62.55 Favored Glycine 0 N--CA 1.451 -0.366 0 C-N-CA 120.769 -0.729 . . . . 0.0 112.479 179.99 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 33' ' ' ALA . . . . . 0.831 ' HB2' ' CD1' ' A' ' 53' ' ' LEU . . . -85.24 148.65 25.97 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.801 0.334 . . . . 0.0 111.072 179.973 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 34' ' ' GLU . . . . . 0.489 ' HB2' ' CB ' ' A' ' 52' ' ' GLN . 5.7 tp10 -74.69 -31.27 61.84 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.837 -179.894 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 2.9 m -162.65 178.61 8.38 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.889 -179.774 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 36' ' ' GLY . . . . . 0.48 ' CA ' ' HA ' ' A' ' 25' ' ' ASN . . . -174.85 153.62 16.34 Favored Glycine 0 N--CA 1.451 -0.354 0 C-N-CA 120.72 -0.752 . . . . 0.0 112.465 -179.98 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 37' ' ' TYR . . . . . 0.401 ' O ' ' SG ' ' A' ' 24' ' ' CYS . 45.4 p90 -164.36 167.67 19.48 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.936 0.398 . . . . 0.0 110.876 -179.746 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 38' ' ' CYS . . . . . . . . . . . . . 27.0 t -75.11 120.15 20.24 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.845 179.993 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 39' ' ' GLN . . . . . 0.403 ' O ' ' HA ' ' A' ' 46' ' ' ASN . 0.6 OUTLIER -105.5 130.28 53.6 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.95 179.99 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 40' ' ' ILE . . . . . 0.753 ' H ' HD12 ' A' ' 40' ' ' ILE . 1.3 mp -95.35 -33.76 5.0 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-N 116.25 -0.432 . . . . 0.0 111.149 179.966 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 41' ' ' LEU . . . . . 0.457 HD22 ' HA ' ' A' ' 41' ' ' LEU . 0.4 OUTLIER -75.56 48.96 0.47 Allowed 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.918 179.89 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -101.98 139.3 14.35 Favored Glycine 0 N--CA 1.452 -0.298 0 C-N-CA 120.783 -0.722 . . . . 0.0 112.493 179.88 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 38.7 tttp -54.12 -24.97 19.72 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.794 0.33 . . . . 0.0 110.862 -179.966 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 44' ' ' TYR . . . . . 0.44 ' CE1' ' HG3' ' A' ' 60' ' ' ARG . 0.5 OUTLIER -112.65 23.93 13.0 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.922 -179.929 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 93.8 -129.96 10.11 Favored Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 120.711 -0.757 . . . . 0.0 112.439 179.974 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 46' ' ' ASN . . . . . 0.403 ' HA ' ' O ' ' A' ' 39' ' ' GLN . 68.6 m-80 -93.19 119.09 31.99 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.872 0.368 . . . . 0.0 110.875 -179.873 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -139.34 150.49 45.42 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.154 -0.476 . . . . 0.0 111.107 179.849 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 48' ' ' CYS . . . . . 0.447 ' SG ' ' SG ' ' A' ' 28' ' ' CYS . 41.5 t -65.99 109.55 2.59 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.851 -179.926 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 49' ' ' TRP . . . . . 0.613 ' CZ3' ' HA ' ' A' ' 4' ' ' ALA . 38.8 t-105 -95.21 115.17 27.07 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.9 -179.995 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 50' ' ' CYS . . . . . . . . . . . . . 39.9 m -95.79 142.47 28.02 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.834 -179.962 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 51' ' ' ILE . . . . . 0.412 ' O ' ' HB2' ' A' ' 52' ' ' GLN . 3.6 mm -107.52 133.16 53.12 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.145 179.871 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 52' ' ' GLN . . . . . 0.489 ' CB ' ' HB2' ' A' ' 34' ' ' GLU . 12.1 mm-40 64.95 42.8 4.1 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.922 179.958 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 53' ' ' LEU . . . . . 0.831 ' CD1' ' HB2' ' A' ' 33' ' ' ALA . 16.3 tp -85.5 136.77 36.98 Favored Pre-proline 0 C--N 1.329 -0.324 0 CA-C-O 121.611 0.72 . . . . 0.0 110.932 -179.996 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 54' ' ' PRO . . . . . 0.847 ' HG2' HG23 ' A' ' 57' ' ' VAL . 54.3 Cg_endo -69.74 146.07 59.23 Favored 'Trans proline' 0 C--N 1.342 0.194 0 C-N-CA 122.667 2.245 . . . . 0.0 112.394 179.823 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -65.23 -5.16 6.29 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.901 179.928 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 15.4 m-20 -78.35 -28.6 47.19 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.906 -179.947 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 57' ' ' VAL . . . . . 0.847 HG23 ' HG2' ' A' ' 54' ' ' PRO . 14.6 t -86.5 136.4 35.18 Favored Pre-proline 0 C--N 1.329 -0.294 0 CA-C-O 121.641 0.734 . . . . 0.0 111.121 179.917 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 58' ' ' PRO . . . . . 0.464 ' HD2' ' CG1' ' A' ' 57' ' ' VAL . 53.1 Cg_endo -69.77 145.36 56.88 Favored 'Trans proline' 0 C--N 1.342 0.19 0 C-N-CA 122.699 2.266 . . . . 0.0 112.322 179.966 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 41.7 pt -122.66 166.93 16.82 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.161 179.922 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 60' ' ' ARG . . . . . 0.576 ' HG2' HG12 ' A' ' 13' ' ' VAL . 6.0 tpt180 -65.83 128.31 35.49 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.848 -179.998 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 61' ' ' ILE . . . . . 0.474 ' N ' ' HD2' ' A' ' 60' ' ' ARG . 1.8 pt -138.32 155.41 74.03 Favored Pre-proline 0 C--N 1.329 -0.313 0 CA-C-O 121.65 0.738 . . . . 0.0 111.161 179.941 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.76 75.11 1.24 Allowed 'Trans proline' 0 C--N 1.342 0.204 0 C-N-CA 122.673 2.249 . . . . 0.0 112.345 179.876 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -141.1 -177.44 16.34 Favored Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 120.751 -0.738 . . . . 0.0 112.466 179.987 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 7.6 mtpm? -75.18 111.41 10.4 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.811 0.338 . . . . 0.0 110.884 -179.989 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 65' ' ' CYS . . . . . 0.604 ' SG ' ' CD2' ' A' ' 66' ' ' HIS . 1.6 t -94.84 163.28 13.41 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.913 179.897 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 66' ' ' HIS . . . . . 0.604 ' CD2' ' SG ' ' A' ' 65' ' ' CYS . 0.8 OUTLIER . . . . . 0 C--N 1.33 -0.281 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.836 179.952 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.231 0.085 0 CA-C-O 120.798 0.332 . . . . 0.0 111.072 . . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 2' ' ' ARG . . . . . 0.455 ' CZ ' ' OD2' ' A' ' 55' ' ' ASP . 5.5 ptt-85 -149.65 177.52 9.69 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.912 -179.905 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 3' ' ' ASP . . . . . 0.582 ' OD2' HG23 ' A' ' 51' ' ' ILE . 4.0 m-20 -107.66 140.15 41.12 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.898 179.935 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 4' ' ' ALA . . . . . 0.587 ' HA ' ' CZ3' ' A' ' 49' ' ' TRP . . . -171.86 -176.85 1.81 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.094 -179.993 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 5' ' ' TYR . . . . . 0.438 ' OH ' ' NE2' ' A' ' 39' ' ' GLN . 29.0 m-85 -92.92 124.51 36.95 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.899 -179.834 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 6' ' ' ILE . . . . . 0.514 HG12 ' CD1' ' A' ' 14' ' ' TYR . 8.4 tt -75.24 135.38 27.33 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.128 -0.487 . . . . 0.0 111.141 179.899 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 7' ' ' ALA . . . . . 0.681 ' HB1' ' O ' ' A' ' 12' ' ' CYS . . . -135.2 140.88 45.66 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.124 179.775 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 8' ' ' LYS . . . . . 0.592 ' HB3' ' CE1' ' A' ' 14' ' ' TYR . 8.2 pttt -101.18 160.85 25.45 Favored Pre-proline 0 C--N 1.329 -0.322 0 CA-C-O 121.622 0.725 . . . . 0.0 110.861 179.958 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 9' ' ' PRO . . . . . 0.508 ' HA ' ' HA ' ' A' ' 10' ' ' HIS . 54.2 Cg_endo -69.74 144.65 54.79 Favored 'Trans proline' 0 C--N 1.342 0.198 0 C-N-CA 122.651 2.234 . . . . 0.0 112.388 179.883 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 10' ' ' HIS . . . . . 0.508 ' HA ' ' HA ' ' A' ' 9' ' ' PRO . 2.4 m-70 -101.86 98.87 9.05 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.833 -0.008 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 11' ' ' ASN . . . . . 0.449 ' OD1' ' NH1' ' A' ' 60' ' ' ARG . 35.5 t-20 65.95 73.84 0.37 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.874 -179.931 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 12' ' ' CYS . . . . . 0.681 ' O ' ' HB1' ' A' ' 7' ' ' ALA . 10.0 m -141.19 145.21 35.37 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.928 179.943 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 13' ' ' VAL . . . . . 0.582 HG12 ' NE ' ' A' ' 60' ' ' ARG . 0.8 OUTLIER -84.06 155.32 3.67 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.153 179.943 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 14' ' ' TYR . . . . . 0.592 ' CE1' ' HB3' ' A' ' 8' ' ' LYS . 6.8 m-85 -103.83 88.6 3.08 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.939 -179.912 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -63.82 136.4 57.38 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.09 -0.505 . . . . 0.0 110.915 179.995 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 11.7 p -84.68 130.3 34.72 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.887 -179.948 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 17' ' ' TYR . . . . . 0.426 ' O ' ' HD3' ' A' ' 19' ' ' PRO . 65.1 t80 -101.03 -37.06 8.78 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.907 -179.902 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 13.3 t-20 -106.2 85.25 1.59 Allowed Pre-proline 0 C--N 1.328 -0.332 0 CA-C-O 121.604 0.716 . . . . 0.0 110.889 179.998 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 19' ' ' PRO . . . . . 0.426 ' HD3' ' O ' ' A' ' 17' ' ' TYR . 53.9 Cg_endo -69.76 -27.7 26.17 Favored 'Trans proline' 0 C--N 1.342 0.198 0 C-N-CA 122.65 2.233 . . . . 0.0 112.344 179.935 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 9.7 mmtp -95.02 24.36 4.92 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.919 179.915 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -144.27 -179.91 21.08 Favored Glycine 0 N--CA 1.452 -0.28 0 C-N-CA 120.719 -0.753 . . . . 0.0 112.463 179.976 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 17.6 m -95.21 28.87 2.66 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.907 0.384 . . . . 0.0 110.848 -179.738 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 20.3 t80 -54.94 -58.93 5.61 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.905 -179.87 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 24' ' ' CYS . . . . . 0.459 ' SG ' ' C ' ' A' ' 37' ' ' TYR . 35.5 t -58.0 -32.87 68.33 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.89 -179.995 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 25' ' ' ASN . . . . . 0.845 ' O ' HG23 ' A' ' 29' ' ' THR . 1.5 t30 -65.0 -56.38 13.44 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.928 179.961 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 17.7 m-20 -54.47 -47.91 72.42 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.868 179.938 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 27' ' ' LEU . . . . . 0.74 ' O ' HD12 ' A' ' 27' ' ' LEU . 1.4 tp -63.86 -38.81 92.46 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.972 179.989 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 28' ' ' CYS . . . . . 0.665 ' SG ' ' SG ' ' A' ' 48' ' ' CYS . 7.7 m -65.09 -57.45 8.58 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.894 179.892 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 29' ' ' THR . . . . . 0.845 HG23 ' O ' ' A' ' 25' ' ' ASN . 1.3 p -63.93 -34.52 78.15 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.126 -0.488 . . . . 0.0 111.132 -179.944 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 48.1 tt0 -54.78 -22.14 13.31 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.882 -179.98 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 5.7 m120 -104.81 23.11 14.0 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.868 -179.959 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 32' ' ' GLY . . . . . 0.531 ' O ' ' CD ' ' A' ' 54' ' ' PRO . . . 84.53 69.15 1.38 Allowed Glycine 0 N--CA 1.451 -0.36 0 C-N-CA 120.766 -0.731 . . . . 0.0 112.511 179.984 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 33' ' ' ALA . . . . . 0.978 ' HB2' ' CD1' ' A' ' 53' ' ' LEU . . . -150.15 153.65 36.69 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.778 0.323 . . . . 0.0 111.096 -179.998 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 34' ' ' GLU . . . . . 0.506 ' HB2' ' CB ' ' A' ' 52' ' ' GLN . 19.4 tp10 -74.08 -34.6 64.07 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.863 -179.937 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 22.1 m -163.48 -179.89 6.81 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.876 -179.771 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 36' ' ' GLY . . . . . 0.422 ' O ' ' CA ' ' A' ' 25' ' ' ASN . . . -176.18 139.23 4.48 Favored Glycine 0 N--CA 1.452 -0.288 0 C-N-CA 120.709 -0.758 . . . . 0.0 112.45 179.955 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 37' ' ' TYR . . . . . 0.575 ' CE1' HD11 ' A' ' 51' ' ' ILE . 1.2 p90 -144.91 164.64 30.48 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-O 120.913 0.387 . . . . 0.0 110.947 -179.799 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 38' ' ' CYS . . . . . . . . . . . . . 39.0 t -74.91 129.43 37.64 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.844 179.998 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 39' ' ' GLN . . . . . 0.438 ' NE2' ' OH ' ' A' ' 5' ' ' TYR . 16.4 tt0 -105.64 125.02 50.51 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.914 179.997 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 40' ' ' ILE . . . . . 0.509 ' HA ' ' ND2' ' A' ' 46' ' ' ASN . 0.7 OUTLIER -95.32 -24.87 4.63 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.154 179.934 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 41' ' ' LEU . . . . . 0.531 ' N ' HD22 ' A' ' 41' ' ' LEU . 2.7 mm? -82.22 35.34 0.44 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.923 179.935 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -92.58 131.76 10.94 Favored Glycine 0 N--CA 1.45 -0.37 0 C-N-CA 120.749 -0.739 . . . . 0.0 112.485 179.924 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -52.01 -24.69 7.01 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.756 0.312 . . . . 0.0 110.871 -179.967 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 0.7 OUTLIER -99.65 23.91 8.94 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.962 -179.957 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 93.81 -84.77 1.05 Allowed Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.725 -0.75 . . . . 0.0 112.498 -179.996 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 46' ' ' ASN . . . . . 0.509 ' ND2' ' HA ' ' A' ' 40' ' ' ILE . 2.5 m120 -144.12 130.49 19.85 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.86 0.362 . . . . 0.0 110.91 -179.916 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -145.95 146.54 31.08 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.105 179.847 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 48' ' ' CYS . . . . . 0.665 ' SG ' ' SG ' ' A' ' 28' ' ' CYS . 50.7 t -65.46 113.8 4.39 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.925 -179.952 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 49' ' ' TRP . . . . . 0.587 ' CZ3' ' HA ' ' A' ' 4' ' ' ALA . 49.6 t-105 -94.98 113.44 25.15 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.929 -179.982 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 50' ' ' CYS . . . . . . . . . . . . . 20.2 m -95.42 139.78 31.23 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.898 -179.994 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 51' ' ' ILE . . . . . 0.582 HG23 ' OD2' ' A' ' 3' ' ' ASP . 4.7 mp -107.25 138.74 31.73 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.095 179.945 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 52' ' ' GLN . . . . . 0.506 ' CB ' ' HB2' ' A' ' 34' ' ' GLU . 2.1 mm-40 67.38 30.77 6.78 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.897 179.955 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 53' ' ' LEU . . . . . 0.978 ' CD1' ' HB2' ' A' ' 33' ' ' ALA . 11.5 tp -85.93 132.88 42.56 Favored Pre-proline 0 C--N 1.328 -0.36 0 CA-C-O 121.616 0.722 . . . . 0.0 110.907 -179.999 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 54' ' ' PRO . . . . . 0.531 ' CD ' ' O ' ' A' ' 32' ' ' GLY . 53.7 Cg_endo -69.73 150.93 69.03 Favored 'Trans proline' 0 C--O 1.232 0.175 0 C-N-CA 122.712 2.275 . . . . 0.0 112.318 179.886 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 55' ' ' ASP . . . . . 0.455 ' OD2' ' CZ ' ' A' ' 2' ' ' ARG . 16.1 m-20 -65.11 -5.82 7.55 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.877 179.911 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 45.1 m-80 -74.93 -24.56 58.51 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.884 -179.908 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 57' ' ' VAL . . . . . 0.491 HG12 ' HD2' ' A' ' 58' ' ' PRO . 1.2 t -84.22 136.63 40.44 Favored Pre-proline 0 C--N 1.329 -0.287 0 CA-C-O 121.685 0.755 . . . . 0.0 111.119 179.936 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 58' ' ' PRO . . . . . 0.491 ' HD2' HG12 ' A' ' 57' ' ' VAL . 53.8 Cg_endo -69.79 130.26 18.99 Favored 'Trans proline' 0 C--N 1.342 0.186 0 C-N-CA 122.668 2.245 . . . . 0.0 112.324 179.971 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 59' ' ' ILE . . . . . 0.842 ' O ' HD13 ' A' ' 61' ' ' ILE . 27.4 pt -107.89 171.31 2.33 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.101 179.938 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 60' ' ' ARG . . . . . 0.582 ' NE ' HG12 ' A' ' 13' ' ' VAL . 5.6 tpt180 -75.76 113.53 13.33 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.871 179.936 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 61' ' ' ILE . . . . . 0.842 HD13 ' O ' ' A' ' 59' ' ' ILE . 0.0 OUTLIER -108.67 160.51 26.96 Favored Pre-proline 0 C--N 1.329 -0.304 0 CA-C-O 121.6 0.714 . . . . 0.0 111.124 179.986 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.77 64.17 1.8 Allowed 'Trans proline' 0 N--CA 1.465 -0.174 0 C-N-CA 122.692 2.262 . . . . 0.0 112.342 179.911 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -138.98 -179.49 17.42 Favored Glycine 0 N--CA 1.451 -0.351 0 C-N-CA 120.744 -0.741 . . . . 0.0 112.451 -179.989 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 25.9 ttmt -85.39 145.61 27.39 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-O 120.778 0.323 . . . . 0.0 110.871 -179.923 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 65' ' ' CYS . . . . . 0.449 ' O ' ' C ' ' A' ' 66' ' ' HIS . 7.9 t -93.85 148.37 22.2 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.885 179.957 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 66' ' ' HIS . . . . . 0.449 ' C ' ' O ' ' A' ' 65' ' ' CYS . 0.1 OUTLIER . . . . . 0 C--N 1.329 -0.313 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.871 -179.996 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 1' ' ' ALA . . . . . 0.449 ' HB1' ' O ' ' A' ' 53' ' ' LEU . . . . . . . . 0 C--O 1.231 0.115 0 CA-C-O 120.793 0.33 . . . . 0.0 111.095 . . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 2' ' ' ARG . . . . . 0.447 ' HD3' ' N ' ' A' ' 2' ' ' ARG . 0.0 OUTLIER -150.71 -177.28 5.89 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.898 -179.921 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 3' ' ' ASP . . . . . 0.552 ' CG ' HD13 ' A' ' 51' ' ' ILE . 9.5 m-20 -107.23 134.08 50.86 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.881 179.932 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -175.67 -174.66 0.7 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.165 -0.47 . . . . 0.0 111.138 179.999 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 5' ' ' TYR . . . . . 0.458 ' CE1' ' CZ3' ' A' ' 49' ' ' TRP . 2.0 m-85 -85.06 135.07 34.16 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.883 -179.835 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 6' ' ' ILE . . . . . 0.673 HG23 ' HD2' ' A' ' 14' ' ' TYR . 3.7 tt -75.93 134.08 29.85 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.111 -0.495 . . . . 0.0 111.185 179.868 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 7' ' ' ALA . . . . . 0.411 ' HB2' ' C ' ' A' ' 59' ' ' ILE . . . -85.78 152.01 23.37 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.211 -0.45 . . . . 0.0 111.096 179.873 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 8' ' ' LYS . . . . . 0.554 ' HB2' ' CZ ' ' A' ' 14' ' ' TYR . 0.0 OUTLIER -135.19 167.22 23.7 Favored Pre-proline 0 C--N 1.329 -0.306 0 CA-C-O 121.593 0.711 . . . . 0.0 110.864 179.963 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 9' ' ' PRO . . . . . 0.449 ' HA ' ' HA ' ' A' ' 10' ' ' HIS . 53.9 Cg_endo -69.73 105.93 1.57 Allowed 'Trans proline' 0 C--N 1.342 0.192 0 C-N-CA 122.703 2.269 . . . . 0.0 112.35 179.873 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 10' ' ' HIS . . . . . 0.449 ' HA ' ' HA ' ' A' ' 9' ' ' PRO . 11.3 m-70 -131.4 127.73 38.1 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.855 -0.067 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 11' ' ' ASN . . . . . 0.412 ' N ' ' O ' ' A' ' 8' ' ' LYS . 4.2 t30 61.36 26.62 16.39 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.889 -179.945 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 1.6 m -107.14 154.9 20.5 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.89 -179.998 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 13' ' ' VAL . . . . . 0.449 HG12 ' NE ' ' A' ' 60' ' ' ARG . 0.9 OUTLIER -84.83 154.44 3.57 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.169 179.923 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 14' ' ' TYR . . . . . 0.673 ' HD2' HG23 ' A' ' 6' ' ' ILE . 9.5 m-85 -94.75 89.75 5.82 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.944 -179.912 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 3.3 pt-20 -64.65 125.41 24.65 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.89 -179.965 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 1.1 p -101.55 134.38 44.75 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.864 -179.901 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 17' ' ' TYR . . . . . 0.436 ' O ' ' HD3' ' A' ' 19' ' ' PRO . 4.8 m-30 -99.49 -28.18 13.37 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.929 -179.926 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 9.2 t-20 -106.44 82.94 1.06 Allowed Pre-proline 0 C--N 1.329 -0.303 0 CA-C-O 121.616 0.722 . . . . 0.0 110.885 -179.987 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 19' ' ' PRO . . . . . 0.436 ' HD3' ' O ' ' A' ' 17' ' ' TYR . 53.5 Cg_endo -69.76 -26.56 27.47 Favored 'Trans proline' 0 C--N 1.342 0.199 0 C-N-CA 122.632 2.221 . . . . 0.0 112.372 179.928 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 20' ' ' LYS . . . . . 0.478 ' HD3' ' N ' ' A' ' 20' ' ' LYS . 0.0 OUTLIER -94.18 24.54 4.31 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.849 179.943 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -136.28 -178.84 16.08 Favored Glycine 0 N--CA 1.452 -0.299 0 C-N-CA 120.763 -0.732 . . . . 0.0 112.497 179.923 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 2.0 p -94.2 28.76 2.38 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.871 0.367 . . . . 0.0 110.855 -179.737 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 0.9 OUTLIER -59.84 -66.67 0.48 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.909 -179.88 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 24' ' ' CYS . . . . . 0.484 ' SG ' ' N ' ' A' ' 49' ' ' TRP . 53.2 t -60.47 -38.3 83.78 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.89 179.986 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 25' ' ' ASN . . . . . 0.846 ' O ' HG23 ' A' ' 29' ' ' THR . 1.7 t30 -54.89 -57.05 13.19 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.903 -179.993 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -57.6 -51.37 69.78 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.863 179.95 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 27' ' ' LEU . . . . . 0.662 ' O ' HD12 ' A' ' 27' ' ' LEU . 2.2 tp -57.13 -38.8 74.01 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.908 -179.967 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 28' ' ' CYS . . . . . 0.576 ' C ' ' HB3' ' A' ' 33' ' ' ALA . 19.1 m -62.41 -50.6 70.87 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.899 179.905 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 29' ' ' THR . . . . . 0.846 HG23 ' O ' ' A' ' 25' ' ' ASN . 1.1 p -62.78 -25.02 68.02 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.14 -179.97 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 6.8 tp10 -58.96 -22.75 60.7 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.938 179.992 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 31' ' ' ASN . . . . . 0.494 ' O ' HG21 ' A' ' 57' ' ' VAL . 6.4 m120 -103.66 22.6 14.11 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.103 -0.498 . . . . 0.0 110.902 -179.949 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 84.15 18.83 62.03 Favored Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 120.765 -0.731 . . . . 0.0 112.515 -179.988 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 33' ' ' ALA . . . . . 0.797 ' HB2' HD13 ' A' ' 53' ' ' LEU . . . -85.4 152.37 23.29 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.733 0.301 . . . . 0.0 111.122 179.931 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 34' ' ' GLU . . . . . 0.476 ' CB ' ' HB2' ' A' ' 52' ' ' GLN . 4.3 tt0 -78.66 -33.07 47.38 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.233 -0.439 . . . . 0.0 110.886 -179.93 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 1.7 m -162.77 -177.2 5.39 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.844 -179.772 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 36' ' ' GLY . . . . . 0.446 ' CA ' ' HA ' ' A' ' 25' ' ' ASN . . . -174.92 157.54 24.7 Favored Glycine 0 N--CA 1.452 -0.284 0 C-N-CA 120.759 -0.734 . . . . 0.0 112.489 -179.984 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 37' ' ' TYR . . . . . 0.581 ' CE2' ' CD1' ' A' ' 49' ' ' TRP . 5.0 p90 -157.64 159.63 37.2 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.863 0.363 . . . . 0.0 110.918 -179.823 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 38' ' ' CYS . . . . . 0.409 ' CB ' ' HA ' ' A' ' 19' ' ' PRO . 21.3 t -74.88 119.47 19.1 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.913 179.999 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 39' ' ' GLN . . . . . 0.408 ' OE1' ' HA2' ' A' ' 42' ' ' GLY . 0.0 OUTLIER -98.49 126.03 43.91 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.913 -179.983 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 40' ' ' ILE . . . . . 0.771 HD12 ' N ' ' A' ' 40' ' ' ILE . 1.2 mp -95.97 -35.98 6.2 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.102 179.972 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 4.2 mm? -75.66 53.01 0.69 Allowed 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.934 179.922 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 42' ' ' GLY . . . . . 0.408 ' HA2' ' OE1' ' A' ' 39' ' ' GLN . . . -105.72 138.91 14.53 Favored Glycine 0 N--CA 1.452 -0.296 0 C-N-CA 120.758 -0.734 . . . . 0.0 112.462 179.94 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -57.45 -27.6 62.6 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.83 0.348 . . . . 0.0 110.908 -179.962 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 0.6 OUTLIER -109.22 23.72 14.11 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.903 -179.959 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 93.37 -139.08 14.42 Favored Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.734 -0.745 . . . . 0.0 112.527 -179.978 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 39.2 m-20 -82.96 116.22 22.15 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.821 0.343 . . . . 0.0 110.894 -179.914 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -125.71 141.57 51.95 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.098 179.864 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 48' ' ' CYS . . . . . 0.475 ' HB3' ' CG2' ' A' ' 6' ' ' ILE . 19.5 t -65.47 114.92 5.2 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.883 -179.967 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 49' ' ' TRP . . . . . 0.581 ' CD1' ' CE2' ' A' ' 37' ' ' TYR . 61.7 t-105 -94.1 135.2 35.72 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.947 179.955 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 50' ' ' CYS . . . . . . . . . . . . . 42.1 m -122.1 142.04 50.78 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.851 -179.97 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 51' ' ' ILE . . . . . 0.552 HD13 ' CG ' ' A' ' 3' ' ' ASP . 14.4 mm -111.01 134.48 53.18 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.139 179.895 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 52' ' ' GLN . . . . . 0.476 ' HB2' ' CB ' ' A' ' 34' ' ' GLU . 3.2 mm-40 65.08 44.58 3.32 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.884 179.926 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 53' ' ' LEU . . . . . 0.797 HD13 ' HB2' ' A' ' 33' ' ' ALA . 14.5 tp -85.93 134.34 39.43 Favored Pre-proline 0 C--N 1.328 -0.35 0 CA-C-O 121.631 0.729 . . . . 0.0 110.945 179.955 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 54' ' ' PRO . . . . . 0.809 ' HG2' HG23 ' A' ' 57' ' ' VAL . 53.3 Cg_endo -69.74 145.42 57.22 Favored 'Trans proline' 0 C--N 1.342 0.184 0 C-N-CA 122.656 2.238 . . . . 0.0 112.323 179.898 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -62.58 -7.75 5.25 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.851 179.915 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 27.6 m120 -76.17 -25.31 55.11 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.913 -179.886 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 57' ' ' VAL . . . . . 0.809 HG23 ' HG2' ' A' ' 54' ' ' PRO . 10.7 t -92.17 136.24 26.06 Favored Pre-proline 0 C--N 1.33 -0.264 0 CA-C-O 121.634 0.73 . . . . 0.0 111.087 179.928 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 58' ' ' PRO . . . . . 0.466 ' HD2' ' CG1' ' A' ' 57' ' ' VAL . 53.9 Cg_endo -69.78 152.53 69.24 Favored 'Trans proline' 0 C--N 1.342 0.193 0 C-N-CA 122.644 2.229 . . . . 0.0 112.366 179.936 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 59' ' ' ILE . . . . . 0.411 ' C ' ' HB2' ' A' ' 7' ' ' ALA . 19.1 pt -125.3 166.3 21.29 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.169 179.91 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 60' ' ' ARG . . . . . 0.485 ' HD2' ' N ' ' A' ' 61' ' ' ILE . 6.7 tpt180 -65.95 116.17 6.81 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.891 179.935 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 61' ' ' ILE . . . . . 0.485 ' N ' ' HD2' ' A' ' 60' ' ' ARG . 1.0 OUTLIER -117.31 160.13 38.84 Favored Pre-proline 0 C--N 1.329 -0.31 0 CA-C-O 121.606 0.717 . . . . 0.0 111.096 -179.996 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.77 64.81 1.81 Allowed 'Trans proline' 0 C--N 1.342 0.2 0 C-N-CA 122.631 2.221 . . . . 0.0 112.384 179.853 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -136.03 -178.65 15.92 Favored Glycine 0 N--CA 1.451 -0.355 0 C-N-CA 120.719 -0.753 . . . . 0.0 112.474 -179.986 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 1.1 tppp? -85.22 140.29 30.99 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.817 0.341 . . . . 0.0 110.925 179.952 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 65' ' ' CYS . . . . . 0.497 ' SG ' ' N ' ' A' ' 66' ' ' HIS . 1.0 OUTLIER -94.55 160.88 14.44 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.872 179.963 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 66' ' ' HIS . . . . . 0.497 ' N ' ' SG ' ' A' ' 65' ' ' CYS . 7.3 p80 . . . . . 0 C--N 1.329 -0.298 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.824 -179.985 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 1' ' ' ALA . . . . . 0.489 ' HB1' ' O ' ' A' ' 53' ' ' LEU . . . . . . . . 0 C--O 1.231 0.131 0 CA-C-O 120.77 0.319 . . . . 0.0 111.095 . . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 18.0 ptt180 -147.27 161.19 41.46 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.89 -179.965 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 3' ' ' ASP . . . . . 0.685 ' OD2' HG23 ' A' ' 51' ' ' ILE . 2.9 m-20 -96.71 134.04 40.49 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.869 -179.988 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 4' ' ' ALA . . . . . 0.605 ' HA ' ' CZ3' ' A' ' 49' ' ' TRP . . . -174.83 -179.09 1.37 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.097 179.982 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 5' ' ' TYR . . . . . 0.412 ' CD2' ' HB3' ' A' ' 47' ' ' ALA . 16.0 m-85 -84.81 135.44 34.1 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.96 -179.857 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 6' ' ' ILE . . . . . 0.447 HG23 ' HD2' ' A' ' 14' ' ' TYR . 5.5 tt -75.42 137.09 23.6 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.108 -0.496 . . . . 0.0 111.148 179.936 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 7' ' ' ALA . . . . . 0.575 ' HB2' ' C ' ' A' ' 59' ' ' ILE . . . -91.41 158.47 16.5 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.103 179.816 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 8' ' ' LYS . . . . . 0.545 ' HB2' ' CZ ' ' A' ' 14' ' ' TYR . 0.0 OUTLIER -134.72 166.26 30.51 Favored Pre-proline 0 C--N 1.328 -0.327 0 CA-C-O 121.632 0.729 . . . . 0.0 110.87 -179.988 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 9' ' ' PRO . . . . . 0.477 ' HA ' ' HA ' ' A' ' 10' ' ' HIS . 53.7 Cg_endo -69.79 106.97 1.76 Allowed 'Trans proline' 0 C--N 1.342 0.231 0 C-N-CA 122.666 2.244 . . . . 0.0 112.345 179.891 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 10' ' ' HIS . . . . . 0.477 ' HA ' ' HA ' ' A' ' 9' ' ' PRO . 7.7 m-70 -132.08 125.12 30.6 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.865 -0.069 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 11' ' ' ASN . . . . . 0.442 ' OD1' HD11 ' A' ' 61' ' ' ILE . 2.3 t30 65.49 44.29 3.12 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.902 -179.896 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 1.6 m -128.81 155.47 45.13 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.873 -179.983 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 13' ' ' VAL . . . . . 0.421 ' CG1' ' NE ' ' A' ' 60' ' ' ARG . 2.7 m -86.5 153.53 3.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.115 179.958 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 14' ' ' TYR . . . . . 0.545 ' CZ ' ' HB2' ' A' ' 8' ' ' LYS . 9.1 m-85 -95.09 100.7 12.48 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.931 -179.942 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 4.9 tm-20 -64.54 137.1 57.66 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.099 -0.501 . . . . 0.0 110.85 -179.945 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 9.1 p -84.83 126.01 33.09 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.864 -179.942 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -100.63 -24.56 14.41 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.903 -179.88 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 10.5 t-20 -134.54 85.15 37.99 Favored Pre-proline 0 C--N 1.329 -0.307 0 CA-C-O 121.555 0.693 . . . . 0.0 110.897 -179.989 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.76 -25.08 28.94 Favored 'Trans proline' 0 C--O 1.231 0.147 0 C-N-CA 122.689 2.259 . . . . 0.0 112.372 179.929 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -94.42 24.23 4.66 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.893 179.914 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -142.88 -174.61 15.33 Favored Glycine 0 N--CA 1.452 -0.279 0 C-N-CA 120.699 -0.763 . . . . 0.0 112.46 179.903 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 50.3 m -95.25 29.14 2.58 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.867 0.365 . . . . 0.0 110.871 -179.729 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 43.9 t80 -64.52 -71.61 0.17 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.921 -179.853 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 42.0 t -55.19 -39.9 70.12 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.824 -179.995 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 25' ' ' ASN . . . . . 0.807 ' O ' HG23 ' A' ' 29' ' ' THR . 1.3 t30 -57.1 -55.57 32.96 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.895 179.998 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 4.5 m-20 -54.68 -53.33 56.34 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.895 179.94 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 27' ' ' LEU . . . . . 0.639 ' O ' HD12 ' A' ' 27' ' ' LEU . 2.1 tp -60.08 -36.38 77.25 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.918 -179.976 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 28' ' ' CYS . . . . . 0.47 ' CB ' ' HA3' ' A' ' 36' ' ' GLY . 1.3 m -64.73 -60.72 2.78 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.868 179.89 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 29' ' ' THR . . . . . 0.807 HG23 ' O ' ' A' ' 25' ' ' ASN . 1.1 p -62.75 -27.09 69.04 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.165 -0.47 . . . . 0.0 111.126 -179.971 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 9.5 tp10 -54.75 -19.83 7.16 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.253 -0.43 . . . . 0.0 110.861 -179.981 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 31' ' ' ASN . . . . . 0.572 ' O ' HG21 ' A' ' 57' ' ' VAL . 5.9 m120 -101.81 21.99 13.66 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.154 -0.476 . . . . 0.0 110.914 -179.96 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 95.81 -12.66 67.14 Favored Glycine 0 N--CA 1.451 -0.302 0 C-N-CA 120.773 -0.727 . . . . 0.0 112.489 179.996 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 33' ' ' ALA . . . . . 1.086 ' HB2' ' CD1' ' A' ' 53' ' ' LEU . . . -62.17 155.27 24.89 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 120.742 0.306 . . . . 0.0 111.094 179.989 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 34' ' ' GLU . . . . . 0.504 ' HB2' ' CB ' ' A' ' 52' ' ' GLN . 2.7 tt0 -80.88 -31.46 35.27 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.9 -179.939 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 35' ' ' SER . . . . . 0.417 ' HA ' HG22 ' A' ' 29' ' ' THR . 46.2 m -162.77 177.92 8.91 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.881 -179.771 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 36' ' ' GLY . . . . . 0.47 ' HA3' ' CB ' ' A' ' 28' ' ' CYS . . . -175.24 157.27 23.9 Favored Glycine 0 N--CA 1.452 -0.277 0 C-N-CA 120.8 -0.714 . . . . 0.0 112.501 -179.976 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 37' ' ' TYR . . . . . 0.491 ' CZ ' HD11 ' A' ' 51' ' ' ILE . 0.6 OUTLIER -165.27 173.55 11.13 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.942 0.401 . . . . 0.0 110.904 -179.811 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 38' ' ' CYS . . . . . . . . . . . . . 41.9 t -74.72 120.28 20.05 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.858 -179.98 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 39' ' ' GLN . . . . . 0.478 ' OE1' ' CE3' ' A' ' 49' ' ' TRP . 3.8 tt0 -104.64 125.26 50.58 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.91 179.99 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 40' ' ' ILE . . . . . 0.757 ' H ' HD12 ' A' ' 40' ' ' ILE . 1.3 mp -95.44 -25.25 4.53 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.159 179.942 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 41' ' ' LEU . . . . . 0.432 ' O ' HD23 ' A' ' 41' ' ' LEU . 1.0 OUTLIER -81.11 40.91 0.56 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.919 179.918 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -97.38 134.49 11.77 Favored Glycine 0 N--CA 1.452 -0.296 0 C-N-CA 120.752 -0.737 . . . . 0.0 112.474 179.907 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -54.14 -25.05 20.25 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.762 0.315 . . . . 0.0 110.861 -179.992 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 44' ' ' TYR . . . . . 0.488 ' CE1' ' CG ' ' A' ' 60' ' ' ARG . 0.6 OUTLIER -108.6 23.76 14.06 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.964 -179.964 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 93.42 -134.47 12.14 Favored Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.734 -0.746 . . . . 0.0 112.477 179.944 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 46' ' ' ASN . . . . . 0.41 ' HA ' ' O ' ' A' ' 39' ' ' GLN . 68.6 m-80 -91.51 118.82 30.92 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.844 0.354 . . . . 0.0 110.86 -179.884 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 47' ' ' ALA . . . . . 0.412 ' HB3' ' CD2' ' A' ' 5' ' ' TYR . . . -137.33 148.52 46.37 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.099 179.842 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 48' ' ' CYS . . . . . 0.422 ' SG ' ' SG ' ' A' ' 28' ' ' CYS . 11.9 t -65.91 108.76 2.27 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.917 -179.976 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 49' ' ' TRP . . . . . 0.605 ' CZ3' ' HA ' ' A' ' 4' ' ' ALA . 36.3 t-105 -94.67 122.75 37.59 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.913 179.995 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 50' ' ' CYS . . . . . . . . . . . . . 4.9 m -107.79 135.13 49.72 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.844 -179.947 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 51' ' ' ILE . . . . . 0.685 HG23 ' OD2' ' A' ' 3' ' ' ASP . 4.2 mp -100.07 138.8 23.26 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.137 179.911 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 52' ' ' GLN . . . . . 0.504 ' CB ' ' HB2' ' A' ' 34' ' ' GLU . 5.7 mm-40 65.38 42.0 4.04 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.929 179.939 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 53' ' ' LEU . . . . . 1.086 ' CD1' ' HB2' ' A' ' 33' ' ' ALA . 12.7 tp -85.28 132.79 44.08 Favored Pre-proline 0 C--N 1.329 -0.32 0 CA-C-O 121.628 0.728 . . . . 0.0 110.941 -179.987 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 54' ' ' PRO . . . . . 0.842 ' HG2' HG23 ' A' ' 57' ' ' VAL . 53.5 Cg_endo -69.78 145.63 57.61 Favored 'Trans proline' 0 C--N 1.342 0.214 0 C-N-CA 122.694 2.263 . . . . 0.0 112.336 179.91 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 40.5 m-20 -62.89 -7.75 5.75 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.855 179.915 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 2.5 m120 -76.51 -25.64 54.4 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.908 -179.908 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 57' ' ' VAL . . . . . 0.842 HG23 ' HG2' ' A' ' 54' ' ' PRO . 12.1 t -92.01 136.23 26.3 Favored Pre-proline 0 C--N 1.33 -0.265 0 CA-C-O 121.642 0.734 . . . . 0.0 111.112 179.926 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 58' ' ' PRO . . . . . 0.463 ' HD2' ' CG1' ' A' ' 57' ' ' VAL . 53.6 Cg_endo -69.77 145.68 57.79 Favored 'Trans proline' 0 C--N 1.342 0.196 0 C-N-CA 122.691 2.261 . . . . 0.0 112.331 179.93 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 59' ' ' ILE . . . . . 0.575 ' C ' ' HB2' ' A' ' 7' ' ' ALA . 14.7 pt -124.23 173.8 9.51 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.111 179.914 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 60' ' ' ARG . . . . . 0.488 ' CG ' ' CE1' ' A' ' 44' ' ' TYR . 0.6 OUTLIER -69.04 118.8 12.4 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.879 179.965 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 61' ' ' ILE . . . . . 0.442 HD11 ' OD1' ' A' ' 11' ' ' ASN . 1.3 pt -118.14 160.59 38.62 Favored Pre-proline 0 C--N 1.329 -0.307 0 CA-C-O 121.642 0.734 . . . . 0.0 111.082 -179.964 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.73 66.34 1.76 Allowed 'Trans proline' 0 C--N 1.342 0.191 0 C-N-CA 122.667 2.244 . . . . 0.0 112.314 179.897 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -141.61 179.41 19.72 Favored Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 120.761 -0.733 . . . . 0.0 112.517 179.934 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 6.0 mmmm -83.38 142.01 31.33 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.804 0.335 . . . . 0.0 110.898 -179.955 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 65' ' ' CYS . . . . . 0.419 ' SG ' ' N ' ' A' ' 66' ' ' HIS . 1.7 t -89.31 156.27 18.84 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.872 179.97 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 66' ' ' HIS . . . . . 0.507 ' CD2' ' O ' ' A' ' 66' ' ' HIS . 49.8 p-80 . . . . . 0 C--N 1.329 -0.314 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.883 179.963 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 1' ' ' ALA . . . . . 0.444 ' HB1' ' O ' ' A' ' 53' ' ' LEU . . . . . . . . 0 C--O 1.231 0.124 0 CA-C-O 120.801 0.334 . . . . 0.0 111.079 . . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -135.37 162.28 33.05 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.865 -179.92 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 3' ' ' ASP . . . . . 0.928 ' OD2' HG23 ' A' ' 51' ' ' ILE . 1.8 m-20 -97.77 133.13 42.71 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.887 179.989 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 4' ' ' ALA . . . . . 0.612 ' HA ' ' CZ3' ' A' ' 49' ' ' TRP . . . -172.82 -177.95 1.76 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.103 179.937 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 5' ' ' TYR . . . . . 0.768 ' CE2' ' NE2' ' A' ' 39' ' ' GLN . 68.9 m-85 -84.36 136.66 33.79 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.24 -0.437 . . . . 0.0 110.904 -179.845 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 6' ' ' ILE . . . . . 0.413 HG23 ' HB2' ' A' ' 14' ' ' TYR . 5.0 tt -74.93 134.7 28.87 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 116.12 -0.491 . . . . 0.0 111.097 179.929 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 7' ' ' ALA . . . . . 0.599 ' HB2' ' C ' ' A' ' 59' ' ' ILE . . . -93.48 156.73 16.58 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.085 179.815 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 8' ' ' LYS . . . . . 0.552 ' HB2' ' CZ ' ' A' ' 14' ' ' TYR . 0.0 OUTLIER -140.2 168.01 16.21 Favored Pre-proline 0 C--N 1.329 -0.297 0 CA-C-O 121.521 0.677 . . . . 0.0 110.886 179.991 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 9' ' ' PRO . . . . . 0.493 ' HA ' ' HA ' ' A' ' 10' ' ' HIS . 53.6 Cg_endo -69.74 107.95 1.97 Allowed 'Trans proline' 0 C--O 1.232 0.206 0 C-N-CA 122.665 2.243 . . . . 0.0 112.332 179.904 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 10' ' ' HIS . . . . . 0.493 ' HA ' ' HA ' ' A' ' 9' ' ' PRO . 5.2 m-70 -131.65 128.59 39.38 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.255 -0.429 . . . . 0.0 110.834 -0.065 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 2.4 t30 58.74 35.92 24.61 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.893 -179.889 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 1.5 m -119.38 152.29 37.05 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.878 179.981 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 13' ' ' VAL . . . . . 0.572 HG12 ' CD ' ' A' ' 60' ' ' ARG . 0.9 OUTLIER -84.55 156.04 3.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.143 -0.481 . . . . 0.0 111.169 179.903 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 14' ' ' TYR . . . . . 0.552 ' CZ ' ' HB2' ' A' ' 8' ' ' LYS . 9.3 m-85 -94.89 100.86 12.66 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.908 -179.889 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 38.1 tt0 -64.92 133.63 52.24 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.079 -0.509 . . . . 0.0 110.892 -179.996 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 1.0 OUTLIER -85.14 133.54 34.2 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.879 -179.949 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 9.3 t80 -121.54 24.89 9.64 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.902 -179.91 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 18' ' ' ASN . . . . . 0.472 ' CB ' ' HB2' ' A' ' 23' ' ' TYR . 9.8 t-20 -154.38 80.26 4.76 Favored Pre-proline 0 C--N 1.329 -0.293 0 CA-C-O 121.647 0.736 . . . . 0.0 110.882 179.959 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -69.76 -23.98 30.19 Favored 'Trans proline' 0 C--N 1.341 0.182 0 C-N-CA 122.702 2.268 . . . . 0.0 112.385 179.922 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 21.4 mtpp -94.52 -24.42 17.28 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.858 179.938 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -102.89 175.98 24.51 Favored Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.763 -0.732 . . . . 0.0 112.46 179.994 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 10.0 p -95.35 26.09 4.02 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.915 0.388 . . . . 0.0 110.874 -179.757 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 23' ' ' TYR . . . . . 0.472 ' HB2' ' CB ' ' A' ' 18' ' ' ASN . 34.4 t80 -44.59 -46.86 10.24 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.953 -179.881 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 53.9 t -65.67 -46.15 80.17 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.073 -0.512 . . . . 0.0 110.884 179.994 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 25' ' ' ASN . . . . . 0.841 ' O ' HG23 ' A' ' 29' ' ' THR . 0.2 OUTLIER -54.68 -51.78 64.45 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.859 -179.965 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -55.22 -52.1 64.45 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.84 179.945 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 27' ' ' LEU . . . . . 0.666 ' O ' HD12 ' A' ' 27' ' ' LEU . 1.8 tp -59.88 -35.55 75.06 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.88 -179.928 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 28' ' ' CYS . . . . . 0.5 ' C ' ' HB3' ' A' ' 33' ' ' ALA . 2.5 m -64.91 -53.2 50.2 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.887 179.919 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 29' ' ' THR . . . . . 0.841 HG23 ' O ' ' A' ' 25' ' ' ASN . 1.1 p -62.63 -24.61 67.69 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.152 -0.476 . . . . 0.0 111.149 -179.981 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 5.6 mt-10 -59.45 -22.12 61.03 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.862 -179.982 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 31' ' ' ASN . . . . . 0.632 ' O ' HG21 ' A' ' 57' ' ' VAL . 8.8 m120 -103.28 21.81 15.24 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.91 -179.968 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 83.34 18.83 63.6 Favored Glycine 0 N--CA 1.451 -0.332 0 C-N-CA 120.768 -0.729 . . . . 0.0 112.512 -179.999 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 33' ' ' ALA . . . . . 0.875 ' HB2' ' CD1' ' A' ' 53' ' ' LEU . . . -85.08 148.15 26.29 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.774 0.321 . . . . 0.0 111.099 179.954 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 34' ' ' GLU . . . . . 0.483 ' HB2' ' CB ' ' A' ' 52' ' ' GLN . 7.8 tt0 -74.7 -31.91 62.02 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.883 -179.943 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 53.9 m -162.1 177.13 9.99 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.813 -179.801 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -172.17 151.75 15.45 Favored Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.777 -0.725 . . . . 0.0 112.505 -179.983 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 37' ' ' TYR . . . . . 0.402 ' HE1' ' CD1' ' A' ' 49' ' ' TRP . 1.1 p90 -154.24 160.4 41.8 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 120.944 0.402 . . . . 0.0 110.897 -179.756 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 38' ' ' CYS . . . . . . . . . . . . . 6.1 t -77.23 119.2 20.57 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.856 179.986 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 39' ' ' GLN . . . . . 0.768 ' NE2' ' CE2' ' A' ' 5' ' ' TYR . 0.3 OUTLIER -96.01 117.05 29.9 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.908 -179.986 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 0.8 OUTLIER -96.58 -36.22 6.19 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.131 -0.486 . . . . 0.0 111.109 179.983 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 7.1 mt -84.52 55.88 3.59 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.911 179.895 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 42' ' ' GLY . . . . . 0.472 ' N ' ' OE1' ' A' ' 39' ' ' GLN . . . -105.27 -167.01 23.87 Favored Glycine 0 N--CA 1.451 -0.336 0 C-N-CA 120.759 -0.734 . . . . 0.0 112.438 179.939 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 43' ' ' LYS . . . . . 0.555 ' HD2' ' CE2' ' A' ' 44' ' ' TYR . 0.4 OUTLIER -101.52 -23.97 14.22 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.822 0.344 . . . . 0.0 110.968 179.982 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 44' ' ' TYR . . . . . 0.555 ' CE2' ' HD2' ' A' ' 43' ' ' LYS . 0.9 OUTLIER -113.21 23.41 13.33 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.938 -179.986 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 92.78 -130.52 10.36 Favored Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.708 -0.758 . . . . 0.0 112.469 179.942 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 46' ' ' ASN . . . . . 0.407 ' HA ' ' O ' ' A' ' 39' ' ' GLN . 25.8 m-20 -92.97 111.6 23.27 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.845 0.355 . . . . 0.0 110.855 -179.838 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 47' ' ' ALA . . . . . 0.409 ' O ' ' HB3' ' A' ' 39' ' ' GLN . . . -129.11 137.76 51.42 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.174 -0.467 . . . . 0.0 111.082 179.898 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 8.5 t -67.88 108.26 2.94 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.889 -179.987 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 49' ' ' TRP . . . . . 0.612 ' CZ3' ' HA ' ' A' ' 4' ' ' ALA . 17.8 t-105 -94.76 116.86 29.25 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.948 179.967 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 50' ' ' CYS . . . . . . . . . . . . . 39.7 m -95.83 143.34 27.14 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.892 -179.982 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 51' ' ' ILE . . . . . 0.928 HG23 ' OD2' ' A' ' 3' ' ' ASP . 3.4 mp -108.96 135.75 46.89 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.113 179.918 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 52' ' ' GLN . . . . . 0.483 ' CB ' ' HB2' ' A' ' 34' ' ' GLU . 6.4 mm100 63.71 43.99 5.3 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.916 179.963 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 53' ' ' LEU . . . . . 0.875 ' CD1' ' HB2' ' A' ' 33' ' ' ALA . 15.5 tp -85.38 137.43 36.77 Favored Pre-proline 0 C--N 1.329 -0.323 0 CA-C-O 121.666 0.746 . . . . 0.0 110.884 -179.992 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 54' ' ' PRO . . . . . 0.83 ' HG2' HG23 ' A' ' 57' ' ' VAL . 54.0 Cg_endo -69.78 147.78 63.46 Favored 'Trans proline' 0 C--N 1.342 0.221 0 C-N-CA 122.664 2.242 . . . . 0.0 112.398 179.841 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 3.8 m-20 -65.02 -5.96 7.54 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.851 179.974 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 7.8 m120 -78.14 -25.53 47.4 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.954 -179.978 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 57' ' ' VAL . . . . . 0.83 HG23 ' HG2' ' A' ' 54' ' ' PRO . 11.4 t -90.77 136.31 27.96 Favored Pre-proline 0 C--N 1.329 -0.288 0 CA-C-O 121.615 0.722 . . . . 0.0 111.132 179.895 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 58' ' ' PRO . . . . . 0.462 ' HD2' ' CG1' ' A' ' 57' ' ' VAL . 53.8 Cg_endo -69.78 135.77 31.25 Favored 'Trans proline' 0 C--N 1.341 0.161 0 C-N-CA 122.608 2.205 . . . . 0.0 112.353 179.945 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 59' ' ' ILE . . . . . 0.599 ' C ' ' HB2' ' A' ' 7' ' ' ALA . 3.9 pt -109.79 154.31 11.31 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.119 179.959 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 60' ' ' ARG . . . . . 0.572 ' CD ' HG12 ' A' ' 13' ' ' VAL . 8.0 tpt180 -65.34 132.67 49.62 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.86 179.933 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 61' ' ' ILE . . . . . 0.438 ' N ' ' HD2' ' A' ' 60' ' ' ARG . 1.3 pt -125.76 160.63 55.36 Favored Pre-proline 0 C--N 1.329 -0.306 0 CA-C-O 121.589 0.709 . . . . 0.0 111.125 179.969 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -69.73 65.08 1.79 Allowed 'Trans proline' 0 C--N 1.341 0.14 0 C-N-CA 122.715 2.276 . . . . 0.0 112.333 179.877 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -136.03 -173.67 13.07 Favored Glycine 0 N--CA 1.451 -0.308 0 C-N-CA 120.732 -0.746 . . . . 0.0 112.474 179.994 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 33.6 pttt -84.74 143.13 29.35 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.802 0.334 . . . . 0.0 110.878 -179.989 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 65' ' ' CYS . . . . . 0.506 ' SG ' ' N ' ' A' ' 66' ' ' HIS . 2.6 t -94.28 161.54 14.21 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.851 179.944 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 66' ' ' HIS . . . . . 0.506 ' N ' ' SG ' ' A' ' 65' ' ' CYS . 7.8 p80 . . . . . 0 C--N 1.329 -0.295 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.802 179.93 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.231 0.131 0 CA-C-O 120.811 0.339 . . . . 0.0 111.094 . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 2' ' ' ARG . . . . . 0.515 ' NE ' ' OD2' ' A' ' 55' ' ' ASP . 30.3 ptt180 -153.24 164.35 38.24 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.866 -179.908 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 3' ' ' ASP . . . . . 0.581 ' OD1' HG23 ' A' ' 51' ' ' ILE . 1.6 m-20 -100.26 139.69 35.57 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.902 179.943 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 4' ' ' ALA . . . . . 0.588 ' HA ' ' CZ3' ' A' ' 49' ' ' TRP . . . -174.88 177.64 1.97 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.149 179.961 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 5' ' ' TYR . . . . . 0.419 ' CE2' ' HE3' ' A' ' 49' ' ' TRP . 13.8 m-85 -84.63 132.03 34.53 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.918 -179.87 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 6' ' ' ILE . . . . . 0.41 HG23 ' HB2' ' A' ' 14' ' ' TYR . 7.0 tt -72.04 136.03 26.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.124 -0.489 . . . . 0.0 111.135 179.9 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 7' ' ' ALA . . . . . 0.734 ' HB2' ' C ' ' A' ' 59' ' ' ILE . . . -101.51 152.65 20.52 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.189 -0.46 . . . . 0.0 111.102 179.828 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 8' ' ' LYS . . . . . 0.57 ' HD2' ' CE2' ' A' ' 14' ' ' TYR . 0.0 OUTLIER -118.0 172.32 4.23 Favored Pre-proline 0 C--N 1.328 -0.344 0 CA-C-O 121.606 0.717 . . . . 0.0 110.883 179.968 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 9' ' ' PRO . . . . . 0.547 ' HD2' ' CB ' ' A' ' 8' ' ' LYS . 53.9 Cg_endo -69.77 104.65 1.35 Allowed 'Trans proline' 0 C--O 1.231 0.163 0 C-N-CA 122.712 2.274 . . . . 0.0 112.327 179.86 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 10' ' ' HIS . . . . . 0.497 ' HA ' ' HA ' ' A' ' 9' ' ' PRO . 4.3 m-70 -131.91 120.14 22.12 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.89 -0.149 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 11' ' ' ASN . . . . . 0.552 ' N ' ' O ' ' A' ' 8' ' ' LYS . 41.5 t30 73.9 28.88 1.49 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.876 -179.903 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 12' ' ' CYS . . . . . 0.412 ' CB ' ' HG3' ' A' ' 8' ' ' LYS . 1.7 m -97.7 168.09 10.55 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.866 179.939 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 13' ' ' VAL . . . . . 0.78 HG12 ' HG2' ' A' ' 60' ' ' ARG . 0.9 OUTLIER -98.67 142.81 14.14 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.178 179.918 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 14' ' ' TYR . . . . . 0.57 ' CE2' ' HD2' ' A' ' 8' ' ' LYS . 11.2 m-85 -94.51 95.39 8.79 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.916 -179.886 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 4.1 pt-20 -65.01 135.41 55.59 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.878 -179.983 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -105.26 132.19 51.78 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.924 -179.943 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 17' ' ' TYR . . . . . 0.422 ' O ' ' HD3' ' A' ' 19' ' ' PRO . 0.2 OUTLIER -104.85 -38.64 6.58 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.945 -179.881 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 12.0 t-20 -106.22 84.38 1.35 Allowed Pre-proline 0 C--N 1.329 -0.3 0 CA-C-O 121.605 0.717 . . . . 0.0 110.893 179.997 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 19' ' ' PRO . . . . . 0.422 ' HD3' ' O ' ' A' ' 17' ' ' TYR . 53.7 Cg_endo -69.72 -27.39 26.7 Favored 'Trans proline' 0 C--N 1.341 0.164 0 C-N-CA 122.688 2.259 . . . . 0.0 112.322 179.93 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 19.1 mmtt -94.77 24.06 4.99 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.873 179.949 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -134.02 -174.59 13.57 Favored Glycine 0 N--CA 1.452 -0.276 0 C-N-CA 120.732 -0.747 . . . . 0.0 112.474 179.92 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 93.3 p -94.72 27.4 3.08 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.863 0.363 . . . . 0.0 110.797 -179.706 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 5.4 t80 -63.97 -68.2 0.37 Allowed 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.879 -179.852 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 24' ' ' CYS . . . . . 0.404 ' SG ' ' O ' ' A' ' 37' ' ' TYR . 47.3 t -64.89 -35.15 80.23 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.143 -0.481 . . . . 0.0 110.894 179.979 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 25' ' ' ASN . . . . . 0.83 ' O ' HG23 ' A' ' 29' ' ' THR . 3.4 t30 -58.03 -62.41 1.84 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.869 -179.967 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 89.2 m-20 -54.7 -50.49 68.18 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.847 179.944 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 27' ' ' LEU . . . . . 0.726 ' O ' HD12 ' A' ' 27' ' ' LEU . 1.5 tp -59.4 -38.02 79.5 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.884 -179.981 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 28' ' ' CYS . . . . . 0.461 ' SG ' ' SG ' ' A' ' 48' ' ' CYS . 1.9 m -65.15 -55.63 17.55 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.89 179.937 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 29' ' ' THR . . . . . 0.83 HG23 ' O ' ' A' ' 25' ' ' ASN . 1.1 p -64.07 -32.88 74.6 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.099 -179.918 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 32.6 mt-10 -55.66 -21.61 18.91 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.262 -0.427 . . . . 0.0 110.863 179.995 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 5.7 m120 -104.1 22.47 14.62 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.876 -179.94 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 32' ' ' GLY . . . . . 0.518 ' O ' ' CD ' ' A' ' 54' ' ' PRO . . . 83.23 69.31 1.39 Allowed Glycine 0 N--CA 1.451 -0.359 0 C-N-CA 120.772 -0.728 . . . . 0.0 112.515 179.97 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 33' ' ' ALA . . . . . 1.031 ' HB2' ' CD1' ' A' ' 53' ' ' LEU . . . -150.11 158.26 43.97 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.779 0.323 . . . . 0.0 111.098 -179.98 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 34' ' ' GLU . . . . . 0.5 ' HB2' ' CB ' ' A' ' 52' ' ' GLN . 0.9 OUTLIER -73.85 -40.47 63.26 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.877 -179.902 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 66.2 m -163.57 -176.61 4.77 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.822 -179.785 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -175.19 158.48 26.07 Favored Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.72 -0.753 . . . . 0.0 112.461 -179.938 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 37' ' ' TYR . . . . . 0.483 ' C ' ' CD2' ' A' ' 37' ' ' TYR . 0.0 OUTLIER -162.45 171.87 16.43 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.955 0.407 . . . . 0.0 110.908 -179.823 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 38' ' ' CYS . . . . . . . . . . . . . 42.1 t -74.94 127.45 33.24 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.858 -179.976 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 39' ' ' GLN . . . . . 0.519 ' OE1' ' N ' ' A' ' 41' ' ' LEU . 0.0 OUTLIER -105.33 119.46 39.14 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.898 -179.95 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 40' ' ' ILE . . . . . 0.53 ' N ' HD13 ' A' ' 40' ' ' ILE . 1.1 mm -88.41 -41.05 13.95 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 116.187 -0.461 . . . . 0.0 111.119 -179.989 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 41' ' ' LEU . . . . . 0.519 ' N ' ' OE1' ' A' ' 39' ' ' GLN . 3.4 mm? -75.32 47.88 0.4 Allowed 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.898 179.923 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -96.57 136.5 12.83 Favored Glycine 0 N--CA 1.451 -0.352 0 C-N-CA 120.762 -0.733 . . . . 0.0 112.519 179.89 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 33.4 mttm -53.93 -25.16 19.05 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 120.782 0.325 . . . . 0.0 110.874 -179.961 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 0.6 OUTLIER -112.28 24.01 13.03 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.889 -179.94 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 94.12 -134.57 12.11 Favored Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 120.722 -0.752 . . . . 0.0 112.51 179.997 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 27.6 m-80 -90.65 112.52 24.28 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-O 120.835 0.35 . . . . 0.0 110.907 -179.881 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -132.59 143.1 49.46 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.1 179.881 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 48' ' ' CYS . . . . . 0.461 ' SG ' ' SG ' ' A' ' 28' ' ' CYS . 51.3 t -65.03 107.49 1.53 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.231 -0.441 . . . . 0.0 110.855 -179.918 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 49' ' ' TRP . . . . . 0.588 ' CZ3' ' HA ' ' A' ' 4' ' ' ALA . 22.5 t-105 -94.9 119.57 33.67 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.929 179.997 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 50' ' ' CYS . . . . . 0.435 ' HB2' HD22 ' A' ' 53' ' ' LEU . 34.5 m -96.87 141.76 29.67 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.866 -179.961 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 51' ' ' ILE . . . . . 0.581 HG23 ' OD1' ' A' ' 3' ' ' ASP . 4.0 mp -105.17 135.99 40.9 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.14 179.936 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 52' ' ' GLN . . . . . 0.5 ' CB ' ' HB2' ' A' ' 34' ' ' GLU . 4.3 mm-40 66.99 33.68 5.63 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.944 179.992 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 53' ' ' LEU . . . . . 1.031 ' CD1' ' HB2' ' A' ' 33' ' ' ALA . 12.5 tp -86.16 132.28 43.95 Favored Pre-proline 0 C--N 1.328 -0.334 0 CA-C-O 121.578 0.704 . . . . 0.0 110.966 -180.0 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 54' ' ' PRO . . . . . 0.521 ' HG2' HG23 ' A' ' 57' ' ' VAL . 54.4 Cg_endo -69.65 150.8 69.38 Favored 'Trans proline' 0 C--O 1.231 0.156 0 C-N-CA 122.694 2.263 . . . . 0.0 112.367 179.861 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 55' ' ' ASP . . . . . 0.515 ' OD2' ' NE ' ' A' ' 2' ' ' ARG . 84.6 m-20 -65.42 -5.89 8.84 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.85 179.924 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 99.1 m-20 -74.71 -25.83 59.4 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.9 -179.971 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 57' ' ' VAL . . . . . 0.521 HG23 ' HG2' ' A' ' 54' ' ' PRO . 1.4 t -84.81 137.19 38.28 Favored Pre-proline 0 C--N 1.33 -0.275 0 CA-C-O 121.581 0.705 . . . . 0.0 111.156 179.895 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 58' ' ' PRO . . . . . 0.516 ' HD2' HG12 ' A' ' 57' ' ' VAL . 54.5 Cg_endo -69.71 126.55 13.47 Favored 'Trans proline' 0 C--O 1.231 0.152 0 C-N-CA 122.674 2.249 . . . . 0.0 112.348 179.905 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 59' ' ' ILE . . . . . 0.734 ' C ' ' HB2' ' A' ' 7' ' ' ALA . 4.8 pt -107.03 164.32 4.75 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.165 179.872 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 60' ' ' ARG . . . . . 0.78 ' HG2' HG12 ' A' ' 13' ' ' VAL . 20.4 tpt180 -75.17 119.59 19.52 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.868 179.982 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 61' ' ' ILE . . . . . 0.489 ' CG1' ' OD1' ' A' ' 11' ' ' ASN . 0.3 OUTLIER -122.51 160.84 46.64 Favored Pre-proline 0 C--N 1.329 -0.311 0 CA-C-O 121.632 0.729 . . . . 0.0 111.12 179.941 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.75 68.99 1.67 Allowed 'Trans proline' 0 C--N 1.342 0.194 0 C-N-CA 122.667 2.244 . . . . 0.0 112.372 179.904 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -144.22 -175.11 17.06 Favored Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.735 -0.745 . . . . 0.0 112.497 179.978 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 26.4 mtmt -84.98 134.88 34.22 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.787 0.327 . . . . 0.0 110.897 -179.976 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 65' ' ' CYS . . . . . 0.445 ' O ' ' C ' ' A' ' 66' ' ' HIS . 47.3 t -95.09 163.99 13.07 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.889 179.934 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 66' ' ' HIS . . . . . 0.483 ' CD2' ' O ' ' A' ' 9' ' ' PRO . 0.0 OUTLIER . . . . . 0 C--N 1.329 -0.293 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.852 179.991 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 1' ' ' ALA . . . . . 0.466 ' HB1' ' O ' ' A' ' 53' ' ' LEU . . . . . . . . 0 C--O 1.231 0.116 0 CA-C-O 120.83 0.347 . . . . 0.0 111.088 . . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 2' ' ' ARG . . . . . 0.589 HH22 HG21 ' A' ' 59' ' ' ILE . 6.3 ptt85 -154.6 159.36 40.81 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.852 -179.94 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 4.7 m-20 -92.62 132.81 36.56 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.878 179.949 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 4' ' ' ALA . . . . . 0.591 ' HA ' ' CZ3' ' A' ' 49' ' ' TRP . . . -175.16 -178.7 1.22 Allowed 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.085 179.988 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 5' ' ' TYR . . . . . 0.498 ' CD1' ' HB3' ' A' ' 47' ' ' ALA . 32.9 m-85 -84.36 131.63 34.68 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.917 -179.862 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 6' ' ' ILE . . . . . 0.534 HG23 ' HD1' ' A' ' 14' ' ' TYR . 3.7 tt -74.26 132.98 32.51 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-N 116.119 -0.491 . . . . 0.0 111.111 179.92 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 7' ' ' ALA . . . . . 0.788 ' HB2' ' C ' ' A' ' 59' ' ' ILE . . . -86.14 155.11 20.9 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.114 179.807 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 8' ' ' LYS . . . . . 0.551 ' HB2' ' CZ ' ' A' ' 14' ' ' TYR . 0.0 OUTLIER -133.54 167.19 24.17 Favored Pre-proline 0 C--N 1.329 -0.312 0 CA-C-O 121.566 0.698 . . . . 0.0 110.905 179.933 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 9' ' ' PRO . . . . . 0.484 ' HA ' ' HA ' ' A' ' 10' ' ' HIS . 53.7 Cg_endo -69.73 105.61 1.51 Allowed 'Trans proline' 0 C--O 1.231 0.154 0 C-N-CA 122.656 2.237 . . . . 0.0 112.363 179.902 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 10' ' ' HIS . . . . . 0.484 ' HA ' ' HA ' ' A' ' 9' ' ' PRO . 6.4 m-70 -131.35 128.94 40.72 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.92 -0.072 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 11' ' ' ASN . . . . . 0.486 ' OD1' ' CG1' ' A' ' 61' ' ' ILE . 3.6 t30 60.23 34.4 20.97 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.836 -179.916 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 12' ' ' CYS . . . . . 0.478 ' HB2' ' CD ' ' A' ' 8' ' ' LYS . 1.6 m -114.53 153.15 30.55 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.884 179.963 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 13' ' ' VAL . . . . . 0.553 HG12 ' CD ' ' A' ' 60' ' ' ARG . 0.9 OUTLIER -84.53 152.38 3.72 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.141 -0.481 . . . . 0.0 111.121 179.947 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 14' ' ' TYR . . . . . 0.551 ' CZ ' ' HB2' ' A' ' 8' ' ' LYS . 9.1 m-85 -94.8 89.56 5.73 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.123 -0.489 . . . . 0.0 110.902 -179.917 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 5.0 tp10 -64.93 136.47 56.86 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.812 -179.947 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 6.6 p -84.46 159.57 20.74 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.114 -0.493 . . . . 0.0 110.906 -179.974 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -96.72 -32.83 11.96 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.923 -179.894 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 18' ' ' ASN . . . . . 0.603 ' CG ' ' HD2' ' A' ' 19' ' ' PRO . 1.8 t-20 -154.41 146.86 17.52 Favored Pre-proline 0 C--N 1.329 -0.284 0 CA-C-O 121.624 0.726 . . . . 0.0 110.862 -179.969 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 19' ' ' PRO . . . . . 0.603 ' HD2' ' CG ' ' A' ' 18' ' ' ASN . 53.8 Cg_endo -69.75 -32.85 17.8 Favored 'Trans proline' 0 C--O 1.232 0.191 0 C-N-CA 122.738 2.292 . . . . 0.0 112.353 179.922 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 20.5 mmtt -94.55 24.56 4.5 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.871 179.892 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -114.63 132.37 10.39 Favored Glycine 0 N--CA 1.452 -0.267 0 C-N-CA 120.758 -0.734 . . . . 0.0 112.458 179.919 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 4.9 m -83.56 24.71 0.83 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.874 0.369 . . . . 0.0 110.838 -179.724 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 7.2 t80 -64.27 -43.15 95.72 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.933 -179.864 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 24' ' ' CYS . . . . . 0.405 ' SG ' ' O ' ' A' ' 37' ' ' TYR . 43.2 t -67.69 -42.75 81.58 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.899 179.971 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 25' ' ' ASN . . . . . 0.869 ' O ' HG23 ' A' ' 29' ' ' THR . 0.8 OUTLIER -55.1 -56.33 21.07 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.926 179.995 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 55.2 m-20 -55.3 -52.22 64.16 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.895 179.897 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 27' ' ' LEU . . . . . 0.705 ' O ' HD12 ' A' ' 27' ' ' LEU . 1.7 tp -58.24 -38.88 77.74 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.915 -179.962 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 28' ' ' CYS . . . . . 0.565 ' C ' ' HB3' ' A' ' 33' ' ' ALA . 11.0 m -62.12 -51.27 68.58 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.919 179.895 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 29' ' ' THR . . . . . 0.869 HG23 ' O ' ' A' ' 25' ' ' ASN . 1.1 p -62.99 -24.75 68.06 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.129 -0.487 . . . . 0.0 111.172 -179.964 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 19.5 tp10 -59.2 -22.82 61.63 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.864 -179.966 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 31' ' ' ASN . . . . . 0.625 ' O ' HG21 ' A' ' 57' ' ' VAL . 6.1 m120 -103.7 22.02 15.15 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.9 -179.956 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 83.29 19.96 61.46 Favored Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.755 -0.736 . . . . 0.0 112.456 -179.995 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 33' ' ' ALA . . . . . 0.779 ' HB2' HD13 ' A' ' 53' ' ' LEU . . . -85.16 147.7 26.48 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.776 0.322 . . . . 0.0 111.099 179.936 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 34' ' ' GLU . . . . . 0.493 ' HB2' ' CB ' ' A' ' 52' ' ' GLN . 5.8 tp10 -74.72 -31.37 61.82 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.911 -179.933 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 1.9 m -162.27 177.62 9.44 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.873 -179.829 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 36' ' ' GLY . . . . . 0.458 ' CA ' ' HA ' ' A' ' 25' ' ' ASN . . . -174.23 154.71 19.89 Favored Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 120.68 -0.772 . . . . 0.0 112.423 -179.924 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 37' ' ' TYR . . . . . 0.405 ' O ' ' SG ' ' A' ' 24' ' ' CYS . 48.8 p90 -165.35 166.37 18.68 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.964 0.411 . . . . 0.0 110.897 -179.819 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 38' ' ' CYS . . . . . . . . . . . . . 13.2 t -74.81 120.81 20.86 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.869 -179.985 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 39' ' ' GLN . . . . . 0.5 ' NE2' ' CD2' ' A' ' 49' ' ' TRP . 0.0 OUTLIER -104.06 127.29 51.62 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.899 -179.974 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 40' ' ' ILE . . . . . 0.511 ' N ' HD13 ' A' ' 40' ' ' ILE . 0.7 OUTLIER -95.53 -31.1 4.1 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.095 179.97 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 2.0 tt -77.28 47.08 0.54 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.934 179.919 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -101.77 138.87 14.13 Favored Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.711 -0.757 . . . . 0.0 112.485 179.881 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 1.8 mtmm -57.37 -24.65 56.57 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.768 0.318 . . . . 0.0 110.881 -179.944 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 1.1 m-85 -111.08 23.43 14.12 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.931 -179.946 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 93.22 -137.63 13.72 Favored Glycine 0 N--CA 1.451 -0.344 0 C-N-CA 120.719 -0.753 . . . . 0.0 112.498 179.992 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 46' ' ' ASN . . . . . 0.438 ' OD1' HG23 ' A' ' 40' ' ' ILE . 57.3 m-80 -86.45 117.76 25.45 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.85 0.357 . . . . 0.0 110.863 -179.894 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 47' ' ' ALA . . . . . 0.498 ' HB3' ' CD1' ' A' ' 5' ' ' TYR . . . -135.75 147.27 48.36 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.098 179.864 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 24.1 t -66.67 108.19 2.39 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.842 -179.957 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 49' ' ' TRP . . . . . 0.591 ' CZ3' ' HA ' ' A' ' 4' ' ' ALA . 53.6 t-105 -94.39 112.62 24.41 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.907 179.957 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 50' ' ' CYS . . . . . . . . . . . . . 34.8 m -95.12 142.41 27.6 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.913 179.969 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 51' ' ' ILE . . . . . 0.406 ' O ' ' HB2' ' A' ' 52' ' ' GLN . 3.8 mm -106.62 133.81 50.08 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.109 179.94 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 52' ' ' GLN . . . . . 0.493 ' CB ' ' HB2' ' A' ' 34' ' ' GLU . 3.4 mm-40 64.77 45.36 3.39 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.88 179.925 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 53' ' ' LEU . . . . . 0.779 HD13 ' HB2' ' A' ' 33' ' ' ALA . 14.6 tp -85.67 134.79 39.09 Favored Pre-proline 0 C--N 1.329 -0.307 0 CA-C-O 121.548 0.689 . . . . 0.0 110.942 -179.997 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 54' ' ' PRO . . . . . 0.847 ' HG2' HG23 ' A' ' 57' ' ' VAL . 53.9 Cg_endo -69.7 146.5 60.73 Favored 'Trans proline' 0 C--O 1.231 0.144 0 C-N-CA 122.668 2.245 . . . . 0.0 112.385 179.864 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 3.4 m-20 -65.18 -5.58 7.19 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.848 179.958 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 10.9 m120 -79.26 -26.39 42.4 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.921 -179.953 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 57' ' ' VAL . . . . . 0.847 HG23 ' HG2' ' A' ' 54' ' ' PRO . 21.3 t -88.85 136.7 30.48 Favored Pre-proline 0 C--N 1.33 -0.265 0 CA-C-O 121.571 0.701 . . . . 0.0 111.164 179.861 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 58' ' ' PRO . . . . . 0.471 ' HD2' HG13 ' A' ' 57' ' ' VAL . 53.6 Cg_endo -69.76 143.26 50.26 Favored 'Trans proline' 0 C--N 1.341 0.181 0 C-N-CA 122.71 2.273 . . . . 0.0 112.345 179.974 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 59' ' ' ILE . . . . . 0.788 ' C ' ' HB2' ' A' ' 7' ' ' ALA . 5.2 pt -117.03 168.9 7.95 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-N 116.255 -0.43 . . . . 0.0 111.156 179.895 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 60' ' ' ARG . . . . . 0.553 ' CD ' HG12 ' A' ' 13' ' ' VAL . 13.7 tpt180 -75.22 121.52 22.26 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.841 179.957 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 61' ' ' ILE . . . . . 0.653 HD13 ' N ' ' A' ' 61' ' ' ILE . 0.0 OUTLIER -110.26 160.46 28.25 Favored Pre-proline 0 C--N 1.329 -0.299 0 CA-C-O 121.589 0.709 . . . . 0.0 111.157 179.952 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -69.76 64.89 1.8 Allowed 'Trans proline' 0 C--N 1.341 0.16 0 C-N-CA 122.693 2.262 . . . . 0.0 112.381 179.84 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -142.56 -174.15 14.85 Favored Glycine 0 N--CA 1.451 -0.344 0 C-N-CA 120.739 -0.743 . . . . 0.0 112.476 180.0 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -85.16 151.23 24.26 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 120.797 0.332 . . . . 0.0 110.956 179.968 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 65' ' ' CYS . . . . . 0.601 ' SG ' ' CD2' ' A' ' 66' ' ' HIS . 1.2 t -95.13 160.92 14.33 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.885 179.953 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 66' ' ' HIS . . . . . 0.601 ' CD2' ' SG ' ' A' ' 65' ' ' CYS . 1.0 OUTLIER . . . . . 0 C--N 1.329 -0.31 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.857 179.981 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 1' ' ' ALA . . . . . 0.812 ' HB3' ' C ' ' A' ' 52' ' ' GLN . . . . . . . . 0 C--O 1.231 0.123 0 CA-C-O 120.759 0.314 . . . . 0.0 111.09 . . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 2' ' ' ARG . . . . . 0.528 ' NH1' HD13 ' A' ' 59' ' ' ILE . 3.3 ptm180 -90.71 -175.52 4.42 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.85 -179.922 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -145.55 121.43 10.62 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.892 179.979 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 4' ' ' ALA . . . . . 0.588 ' HA ' ' CZ3' ' A' ' 49' ' ' TRP . . . -173.89 -172.24 0.72 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.082 179.984 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 5' ' ' TYR . . . . . 0.546 ' CE1' ' HB2' ' A' ' 49' ' ' TRP . 66.9 m-85 -84.23 137.68 33.35 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.92 -179.883 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 6' ' ' ILE . . . . . 0.449 HG23 ' HD1' ' A' ' 14' ' ' TYR . 6.9 tt -75.39 143.84 12.77 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.074 -0.512 . . . . 0.0 111.12 179.924 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -84.6 165.1 18.26 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.2 -0.454 . . . . 0.0 111.113 179.792 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 8' ' ' LYS . . . . . 0.578 ' HB2' ' CE2' ' A' ' 14' ' ' TYR . 0.1 OUTLIER -145.41 165.57 21.06 Favored Pre-proline 0 C--N 1.329 -0.318 0 CA-C-O 121.565 0.698 . . . . 0.0 110.903 -179.973 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 9' ' ' PRO . . . . . 0.483 ' HA ' ' HA ' ' A' ' 10' ' ' HIS . 53.7 Cg_endo -69.78 105.77 1.55 Allowed 'Trans proline' 0 C--N 1.341 0.175 0 C-N-CA 122.691 2.26 . . . . 0.0 112.34 179.909 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 10' ' ' HIS . . . . . 0.483 ' HA ' ' HA ' ' A' ' 9' ' ' PRO . 8.1 m-70 -132.61 122.5 24.81 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.887 -0.127 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 11' ' ' ASN . . . . . 0.479 ' OD1' HD11 ' A' ' 61' ' ' ILE . 3.2 t30 71.73 20.68 4.54 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.893 -179.902 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 12' ' ' CYS . . . . . 0.448 ' HB2' ' HG2' ' A' ' 8' ' ' LYS . 1.5 m -109.57 168.64 9.25 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.892 -179.999 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 13' ' ' VAL . . . . . 0.767 HG12 ' HG2' ' A' ' 60' ' ' ARG . 0.9 OUTLIER -90.8 156.08 3.04 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.135 179.939 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 14' ' ' TYR . . . . . 0.578 ' CE2' ' HB2' ' A' ' 8' ' ' LYS . 4.1 m-85 -94.26 87.0 5.09 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.929 -179.921 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 30.6 tt0 -64.59 120.67 12.81 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.853 -179.986 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 16' ' ' CYS . . . . . 1.147 ' SG ' ' SG ' ' A' ' 24' ' ' CYS . 0.7 OUTLIER -104.45 171.56 7.27 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.158 -0.473 . . . . 0.0 110.894 -179.963 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 17' ' ' TYR . . . . . 0.446 ' O ' ' HD3' ' A' ' 19' ' ' PRO . 67.4 t80 -125.7 -23.79 3.96 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.899 -179.833 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 10.4 t-20 -105.64 85.0 1.32 Allowed Pre-proline 0 C--N 1.329 -0.286 0 CA-C-O 121.626 0.726 . . . . 0.0 110.89 -179.997 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 19' ' ' PRO . . . . . 0.446 ' HD3' ' O ' ' A' ' 17' ' ' TYR . 53.5 Cg_endo -69.88 -24.89 28.6 Favored 'Trans proline' 0 C--N 1.341 0.17 0 C-N-CA 122.636 2.224 . . . . 0.0 112.317 179.983 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 28.6 mmtm -94.4 -24.59 17.29 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.85 179.931 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -80.21 -174.7 47.78 Favored Glycine 0 N--CA 1.452 -0.287 0 C-N-CA 120.737 -0.744 . . . . 0.0 112.496 179.927 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 26.1 m -95.62 25.72 4.38 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.855 0.36 . . . . 0.0 110.814 -179.718 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 1.1 t80 -59.58 -66.88 0.44 Allowed 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.938 -179.894 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 24' ' ' CYS . . . . . 1.147 ' SG ' ' SG ' ' A' ' 16' ' ' CYS . 19.7 m -67.0 -37.39 84.12 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.141 -0.482 . . . . 0.0 110.913 179.953 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 25' ' ' ASN . . . . . 0.783 ' O ' HG23 ' A' ' 29' ' ' THR . 2.5 t30 -57.34 -58.92 6.13 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.114 -0.493 . . . . 0.0 110.891 -179.968 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 12.4 m-20 -56.22 -53.34 58.3 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.9 179.9 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 27' ' ' LEU . . . . . 0.66 ' O ' HD12 ' A' ' 27' ' ' LEU . 1.8 tp -58.99 -35.5 73.32 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.956 -179.962 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 28' ' ' CYS . . . . . 0.471 ' O ' ' HB3' ' A' ' 33' ' ' ALA . 1.7 m -64.36 -58.83 5.37 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.879 179.874 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 29' ' ' THR . . . . . 0.783 HG23 ' O ' ' A' ' 25' ' ' ASN . 1.1 p -62.7 -28.39 69.91 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.124 -0.489 . . . . 0.0 111.143 -179.92 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 41.3 tt0 -55.17 -20.56 10.69 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.866 -179.999 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 31' ' ' ASN . . . . . 0.671 ' O ' HG21 ' A' ' 57' ' ' VAL . 6.6 m120 -102.51 22.36 13.65 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.878 -179.94 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 95.35 -12.58 67.83 Favored Glycine 0 N--CA 1.452 -0.265 0 C-N-CA 120.766 -0.73 . . . . 0.0 112.497 179.977 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 33' ' ' ALA . . . . . 0.941 ' HB2' HD13 ' A' ' 53' ' ' LEU . . . -62.03 162.23 9.6 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.744 0.306 . . . . 0.0 111.131 179.959 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 34' ' ' GLU . . . . . 0.482 ' HB2' ' CB ' ' A' ' 52' ' ' GLN . 11.5 tp10 -90.33 -29.72 17.91 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.9 -179.91 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 15.6 m -162.41 179.62 7.68 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.838 -179.799 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -167.97 161.03 34.79 Favored Glycine 0 N--CA 1.452 -0.28 0 C-N-CA 120.721 -0.752 . . . . 0.0 112.47 -179.991 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 37' ' ' TYR . . . . . 0.619 ' CE2' ' CD1' ' A' ' 49' ' ' TRP . 3.3 p90 -162.44 151.86 15.71 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 120.953 0.406 . . . . 0.0 110.939 -179.828 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 38' ' ' CYS . . . . . 0.4 ' CB ' ' HA ' ' A' ' 19' ' ' PRO . 2.0 t -80.32 119.45 23.06 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.88 -179.969 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 39' ' ' GLN . . . . . 0.487 ' OE1' ' N ' ' A' ' 42' ' ' GLY . 1.4 tm0? -105.21 108.59 20.19 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.896 -179.943 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 40' ' ' ILE . . . . . 0.984 ' O ' HD12 ' A' ' 40' ' ' ILE . 0.1 OUTLIER -81.84 -35.79 13.76 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.153 179.983 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 41' ' ' LEU . . . . . 0.439 ' N ' HG13 ' A' ' 40' ' ' ILE . 3.4 mt -78.93 48.01 0.8 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.903 179.913 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 42' ' ' GLY . . . . . 0.487 ' N ' ' OE1' ' A' ' 39' ' ' GLN . . . -98.66 -179.71 32.01 Favored Glycine 0 N--CA 1.451 -0.303 0 C-N-CA 120.734 -0.746 . . . . 0.0 112.45 179.926 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 43' ' ' LYS . . . . . 0.56 ' HG2' ' CD1' ' A' ' 44' ' ' TYR . 0.3 OUTLIER -83.05 -26.83 30.76 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.787 0.327 . . . . 0.0 110.885 -179.983 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 44' ' ' TYR . . . . . 0.56 ' CD1' ' HG2' ' A' ' 43' ' ' LYS . 1.0 OUTLIER -114.31 24.45 11.92 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.907 -179.968 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 94.42 -133.96 11.81 Favored Glycine 0 N--CA 1.451 -0.342 0 C-N-CA 120.731 -0.747 . . . . 0.0 112.463 179.933 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 3.0 m120 -92.55 109.39 20.79 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 120.843 0.354 . . . . 0.0 110.893 -179.941 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -125.61 140.39 52.77 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.08 179.855 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 3.1 m -66.25 111.27 3.38 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.904 -179.96 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 49' ' ' TRP . . . . . 0.619 ' CD1' ' CE2' ' A' ' 37' ' ' TYR . 45.0 t-105 -94.78 115.13 27.12 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.931 180.0 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 50' ' ' CYS . . . . . . . . . . . . . 33.4 m -97.66 142.72 29.1 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.899 179.994 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 51' ' ' ILE . . . . . 0.495 HD11 ' CD2' ' A' ' 37' ' ' TYR . 4.0 mp -110.97 137.62 42.65 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.14 179.895 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 52' ' ' GLN . . . . . 0.812 ' C ' ' HB3' ' A' ' 1' ' ' ALA . 11.1 mm100 65.02 41.92 4.42 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.914 179.922 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 53' ' ' LEU . . . . . 0.941 HD13 ' HB2' ' A' ' 33' ' ' ALA . 15.7 tp -85.57 136.16 37.53 Favored Pre-proline 0 C--N 1.328 -0.327 0 CA-C-O 121.568 0.699 . . . . 0.0 110.969 179.961 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 54' ' ' PRO . . . . . 0.875 ' HG2' HG23 ' A' ' 57' ' ' VAL . 53.4 Cg_endo -69.8 147.68 63.12 Favored 'Trans proline' 0 C--N 1.341 0.174 0 C-N-CA 122.701 2.267 . . . . 0.0 112.299 179.93 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 74.3 m-20 -65.03 -5.3 6.01 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.858 179.899 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 17.7 m-20 -79.64 -30.28 41.28 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.87 -179.899 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 57' ' ' VAL . . . . . 0.875 HG23 ' HG2' ' A' ' 54' ' ' PRO . 15.5 t -86.55 136.36 35.13 Favored Pre-proline 0 C--N 1.329 -0.307 0 CA-C-O 121.617 0.722 . . . . 0.0 111.134 179.928 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 58' ' ' PRO . . . . . 0.465 ' HD2' ' CG1' ' A' ' 57' ' ' VAL . 54.4 Cg_endo -69.75 141.77 46.15 Favored 'Trans proline' 0 C--O 1.231 0.167 0 C-N-CA 122.681 2.254 . . . . 0.0 112.391 179.939 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 59' ' ' ILE . . . . . 0.528 HD13 ' NH1' ' A' ' 2' ' ' ARG . 5.0 pt -118.61 157.65 20.07 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.104 179.967 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 60' ' ' ARG . . . . . 0.767 ' HG2' HG12 ' A' ' 13' ' ' VAL . 9.3 tpt180 -68.72 117.39 10.37 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.925 179.933 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 61' ' ' ILE . . . . . 0.479 HD11 ' OD1' ' A' ' 11' ' ' ASN . 1.3 pp -123.21 160.66 49.01 Favored Pre-proline 0 C--N 1.329 -0.308 0 CA-C-O 121.669 0.747 . . . . 0.0 111.118 179.983 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.75 73.39 1.37 Allowed 'Trans proline' 0 C--N 1.342 0.194 0 C-N-CA 122.66 2.24 . . . . 0.0 112.362 179.901 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -135.2 -175.38 13.82 Favored Glycine 0 N--CA 1.451 -0.344 0 C-N-CA 120.705 -0.76 . . . . 0.0 112.479 179.985 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -84.88 115.35 22.72 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.855 0.359 . . . . 0.0 110.897 -179.97 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 65' ' ' CYS . . . . . 0.487 ' O ' ' CG ' ' A' ' 66' ' ' HIS . 8.4 t -94.46 159.66 15.0 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.894 179.977 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 66' ' ' HIS . . . . . 0.487 ' CG ' ' O ' ' A' ' 65' ' ' CYS . 43.3 p-80 . . . . . 0 C--N 1.329 -0.318 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.87 179.949 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.232 0.155 0 CA-C-O 120.803 0.335 . . . . 0.0 111.07 . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 16.1 ptt180 -152.55 171.43 18.14 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.871 -179.885 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 15.5 m-20 -99.63 130.49 45.87 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.868 179.961 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 4' ' ' ALA . . . . . 0.585 ' HA ' ' CZ3' ' A' ' 49' ' ' TRP . . . -174.94 -178.98 1.31 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.107 179.966 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 19.6 m-85 -84.6 135.33 34.24 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.896 -179.833 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 6' ' ' ILE . . . . . 0.456 HG12 ' CD1' ' A' ' 14' ' ' TYR . 3.1 tt -72.31 133.16 32.33 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.104 -0.498 . . . . 0.0 111.138 179.927 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 7' ' ' ALA . . . . . 0.855 ' HB2' ' C ' ' A' ' 59' ' ' ILE . . . -92.46 143.09 26.71 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.209 -0.45 . . . . 0.0 111.102 179.815 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 8' ' ' LYS . . . . . 0.538 ' HB2' ' CZ ' ' A' ' 14' ' ' TYR . 0.0 OUTLIER -115.09 167.29 10.09 Favored Pre-proline 0 C--N 1.329 -0.316 0 CA-C-O 121.533 0.682 . . . . 0.0 110.907 179.98 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 9' ' ' PRO . . . . . 0.487 ' HA ' ' HA ' ' A' ' 10' ' ' HIS . 54.0 Cg_endo -69.74 103.89 1.23 Allowed 'Trans proline' 0 C--O 1.232 0.202 0 C-N-CA 122.641 2.227 . . . . 0.0 112.359 179.905 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 10' ' ' HIS . . . . . 0.487 ' HA ' ' HA ' ' A' ' 9' ' ' PRO . 4.3 m80 -129.62 130.12 45.21 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.865 -0.053 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 11' ' ' ASN . . . . . 0.501 ' N ' ' O ' ' A' ' 8' ' ' LYS . 54.6 t-20 58.83 59.74 2.74 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.929 -179.914 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 12' ' ' CYS . . . . . 0.493 ' HB2' ' CD ' ' A' ' 8' ' ' LYS . 1.7 m -139.51 156.76 46.72 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.908 -179.982 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 13' ' ' VAL . . . . . 0.432 ' CG1' ' HE ' ' A' ' 60' ' ' ARG . 2.4 m -84.69 147.74 5.38 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.138 179.886 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 14' ' ' TYR . . . . . 0.538 ' CZ ' ' HB2' ' A' ' 8' ' ' LYS . 11.1 m-85 -94.67 101.01 12.84 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.909 -179.923 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 18.1 pt-20 -64.56 125.25 24.11 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.073 -0.512 . . . . 0.0 110.893 -180.0 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -101.99 135.35 43.71 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.86 -179.912 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 9.5 t80 -115.14 24.86 11.33 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.916 -179.902 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 10.8 t-20 -153.07 74.07 6.92 Favored Pre-proline 0 C--N 1.329 -0.309 0 CA-C-O 121.624 0.726 . . . . 0.0 110.849 -179.998 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.76 -19.89 35.54 Favored 'Trans proline' 0 C--O 1.232 0.18 0 C-N-CA 122.714 2.276 . . . . 0.0 112.317 179.903 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 56.8 mttm -94.16 -24.27 17.6 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.915 179.917 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -93.93 -176.99 39.51 Favored Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.702 -0.761 . . . . 0.0 112.468 179.925 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 52.6 p -95.49 25.83 4.25 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.906 0.384 . . . . 0.0 110.853 -179.721 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 23' ' ' TYR . . . . . 0.419 ' CD2' ' C ' ' A' ' 23' ' ' TYR . 1.1 t80 -55.0 -69.46 0.13 Allowed 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.91 -179.885 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 50.4 t -56.99 -36.61 70.56 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.103 -0.498 . . . . 0.0 110.905 179.966 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -57.87 -55.09 39.43 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.9 -179.946 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 47.7 m-20 -57.88 -52.71 64.35 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.174 -0.467 . . . . 0.0 110.794 179.958 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 27' ' ' LEU . . . . . 0.683 ' O ' HD12 ' A' ' 27' ' ' LEU . 1.7 tp -59.54 -37.4 78.3 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.965 -179.945 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 1.3 m -65.25 -54.53 27.97 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.874 179.884 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 29' ' ' THR . . . . . 0.617 HG22 ' O ' ' A' ' 33' ' ' ALA . 13.2 p -62.73 -29.15 70.46 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.139 -179.951 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 7.4 tp10 -54.69 -19.17 5.65 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.903 -179.981 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 31' ' ' ASN . . . . . 0.675 ' O ' HG21 ' A' ' 57' ' ' VAL . 2.3 m-80 -101.64 21.41 14.44 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.913 -179.946 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 95.5 -12.73 67.5 Favored Glycine 0 N--CA 1.452 -0.268 0 C-N-CA 120.682 -0.771 . . . . 0.0 112.463 -179.992 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 33' ' ' ALA . . . . . 0.91 ' HB2' HD13 ' A' ' 53' ' ' LEU . . . -61.75 153.91 27.1 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.729 0.3 . . . . 0.0 111.11 179.994 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 34' ' ' GLU . . . . . 0.514 ' OE1' ' NE2' ' A' ' 52' ' ' GLN . 67.0 mt-10 -85.6 -24.79 27.01 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.929 -179.959 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 12.4 m -161.99 177.88 9.37 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.841 -179.799 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -175.44 158.39 25.65 Favored Glycine 0 N--CA 1.452 -0.263 0 C-N-CA 120.722 -0.751 . . . . 0.0 112.448 -179.973 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 32.6 p90 -164.83 166.86 19.35 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.91 0.386 . . . . 0.0 110.904 -179.831 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 38' ' ' CYS . . . . . . . . . . . . . 4.1 t -75.33 124.3 26.87 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.11 -0.496 . . . . 0.0 110.857 179.996 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 2.4 tt0 -105.19 118.18 35.89 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.9 -179.978 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 0.9 OUTLIER -88.3 -29.32 5.38 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.102 179.974 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 14.0 mt -82.58 38.91 0.58 Allowed 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.924 179.935 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -87.91 139.14 15.59 Favored Glycine 0 N--CA 1.45 -0.367 0 C-N-CA 120.762 -0.732 . . . . 0.0 112.479 179.92 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 39.1 mttp -53.79 -25.09 17.54 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.856 0.36 . . . . 0.0 110.904 -179.953 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 0.4 OUTLIER -113.85 24.41 12.11 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.945 179.992 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 94.3 -137.58 13.59 Favored Glycine 0 N--CA 1.452 -0.288 0 C-N-CA 120.736 -0.745 . . . . 0.0 112.445 179.962 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 37.5 m-80 -85.69 111.53 20.19 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.826 0.346 . . . . 0.0 110.907 -179.848 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -130.62 145.51 51.92 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.109 179.91 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 14.6 t -65.44 110.29 2.61 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.899 -179.985 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 49' ' ' TRP . . . . . 0.585 ' CZ3' ' HA ' ' A' ' 4' ' ' ALA . 41.6 t-105 -94.97 127.33 40.94 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.949 179.971 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 50' ' ' CYS . . . . . . . . . . . . . 29.9 m -108.41 141.02 40.88 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.841 -179.953 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 51' ' ' ILE . . . . . 0.665 HG22 ' HG2' ' A' ' 52' ' ' GLN . 4.0 mm -108.06 130.99 59.64 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.126 179.917 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 52' ' ' GLN . . . . . 0.665 ' HG2' HG22 ' A' ' 51' ' ' ILE . 6.9 mm100 67.72 43.08 1.87 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.921 179.955 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 53' ' ' LEU . . . . . 0.91 HD13 ' HB2' ' A' ' 33' ' ' ALA . 15.1 tp -85.6 135.53 38.19 Favored Pre-proline 0 C--N 1.328 -0.339 0 CA-C-O 121.582 0.706 . . . . 0.0 110.949 -179.955 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 54' ' ' PRO . . . . . 0.802 ' HG2' HG23 ' A' ' 57' ' ' VAL . 53.6 Cg_endo -69.81 145.68 57.6 Favored 'Trans proline' 0 C--N 1.341 0.179 0 C-N-CA 122.697 2.265 . . . . 0.0 112.31 179.914 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -61.4 -9.1 4.79 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.867 179.936 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 67.6 m-20 -74.85 -24.84 58.65 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.872 -179.867 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 57' ' ' VAL . . . . . 0.802 HG23 ' HG2' ' A' ' 54' ' ' PRO . 11.1 t -90.31 136.29 28.7 Favored Pre-proline 0 C--N 1.329 -0.305 0 CA-C-O 121.622 0.725 . . . . 0.0 111.12 179.883 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 58' ' ' PRO . . . . . 0.467 ' HD2' ' CG1' ' A' ' 57' ' ' VAL . 53.8 Cg_endo -69.77 146.59 60.57 Favored 'Trans proline' 0 C--O 1.232 0.181 0 C-N-CA 122.68 2.253 . . . . 0.0 112.37 179.924 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 59' ' ' ILE . . . . . 0.855 ' C ' ' HB2' ' A' ' 7' ' ' ALA . 10.2 pt -123.89 159.98 28.37 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.116 179.964 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 60' ' ' ARG . . . . . 0.446 ' HD3' ' C ' ' A' ' 60' ' ' ARG . 2.9 tpp180 -64.66 111.19 2.64 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.885 179.924 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 61' ' ' ILE . . . . . 0.483 HG13 ' ND2' ' A' ' 11' ' ' ASN . 0.6 OUTLIER -110.48 161.74 23.39 Favored Pre-proline 0 C--N 1.329 -0.3 0 CA-C-O 121.625 0.726 . . . . 0.0 111.154 179.933 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -69.79 69.75 1.64 Allowed 'Trans proline' 0 C--N 1.342 0.199 0 C-N-CA 122.703 2.269 . . . . 0.0 112.342 179.851 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -144.95 -171.94 15.06 Favored Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.752 -0.737 . . . . 0.0 112.514 179.955 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 9.2 ptpt -85.47 131.23 34.41 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.836 0.35 . . . . 0.0 110.883 -179.964 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 65' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -91.06 140.58 29.7 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.872 179.953 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 66' ' ' HIS . . . . . 0.496 ' CG ' ' O ' ' A' ' 66' ' ' HIS . 26.9 p80 . . . . . 0 C--N 1.33 -0.279 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.824 179.95 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 1' ' ' ALA . . . . . 0.619 ' HB1' ' O ' ' A' ' 53' ' ' LEU . . . . . . . . 0 C--O 1.231 0.127 0 CA-C-O 120.8 0.333 . . . . 0.0 111.113 . . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 2' ' ' ARG . . . . . 0.441 ' NH1' ' O ' ' A' ' 53' ' ' LEU . 0.0 OUTLIER -136.8 157.04 47.67 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.894 -179.897 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 3' ' ' ASP . . . . . 0.724 ' OD2' HG23 ' A' ' 51' ' ' ILE . 3.0 m-20 -92.34 133.9 35.42 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.898 179.976 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 4' ' ' ALA . . . . . 0.588 ' HA ' ' CZ3' ' A' ' 49' ' ' TRP . . . -173.94 -179.24 1.68 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.101 179.926 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 5' ' ' TYR . . . . . 0.438 ' CD1' ' HB3' ' A' ' 47' ' ' ALA . 21.6 m-85 -84.99 136.41 33.6 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.948 -179.852 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 6' ' ' ILE . . . . . 0.592 HG23 ' HD2' ' A' ' 14' ' ' TYR . 3.5 tt -75.34 135.63 26.75 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-N 116.115 -0.493 . . . . 0.0 111.176 179.901 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 7' ' ' ALA . . . . . 0.513 ' HB2' ' C ' ' A' ' 59' ' ' ILE . . . -85.56 150.98 24.28 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.096 179.849 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 8' ' ' LYS . . . . . 0.554 ' HB2' ' CZ ' ' A' ' 14' ' ' TYR . 0.0 OUTLIER -133.12 166.9 25.88 Favored Pre-proline 0 C--N 1.329 -0.285 0 CA-C-O 121.54 0.686 . . . . 0.0 110.903 179.994 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 9' ' ' PRO . . . . . 0.426 ' HA ' ' HA ' ' A' ' 10' ' ' HIS . 53.6 Cg_endo -69.79 105.53 1.51 Allowed 'Trans proline' 0 C--O 1.232 0.192 0 C-N-CA 122.646 2.231 . . . . 0.0 112.361 179.875 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 10' ' ' HIS . . . . . 0.426 ' HA ' ' HA ' ' A' ' 9' ' ' PRO . 4.1 m-70 -131.28 128.97 40.91 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.872 -0.061 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 11' ' ' ASN . . . . . 0.615 ' OD1' HD11 ' A' ' 61' ' ' ILE . 3.6 t30 59.14 44.52 15.78 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.865 -179.957 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 12' ' ' CYS . . . . . 0.468 ' HB2' ' CE ' ' A' ' 8' ' ' LYS . 1.4 m -129.93 157.56 41.96 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.873 179.978 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 13' ' ' VAL . . . . . 0.532 ' HB ' ' HB1' ' A' ' 47' ' ' ALA . 1.3 m -85.91 155.39 3.42 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.131 -0.486 . . . . 0.0 111.15 179.912 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 14' ' ' TYR . . . . . 0.592 ' HD2' HG23 ' A' ' 6' ' ' ILE . 9.5 m-85 -94.45 94.87 8.49 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.939 -179.94 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 1.8 pm0 -64.6 133.98 53.38 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.869 -179.978 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 1.8 p -84.74 159.92 20.39 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.873 -179.96 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 8.4 t80 -95.47 -32.51 12.85 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.899 -179.865 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 18' ' ' ASN . . . . . 0.605 ' CG ' ' HD2' ' A' ' 19' ' ' PRO . 1.8 t-20 -154.7 147.0 17.46 Favored Pre-proline 0 C--N 1.329 -0.286 0 CA-C-O 121.604 0.716 . . . . 0.0 110.87 179.971 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 19' ' ' PRO . . . . . 0.605 ' HD2' ' CG ' ' A' ' 18' ' ' ASN . 54.1 Cg_endo -69.73 -31.45 20.62 Favored 'Trans proline' 0 C--O 1.231 0.166 0 C-N-CA 122.714 2.276 . . . . 0.0 112.348 179.918 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 2.0 mmmm -94.48 24.57 4.45 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.874 179.934 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -114.75 132.85 10.67 Favored Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.732 -0.747 . . . . 0.0 112.495 179.907 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 67.4 m -83.67 24.87 0.82 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.874 0.369 . . . . 0.0 110.819 -179.712 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 23' ' ' TYR . . . . . 0.42 ' O ' ' CD1' ' A' ' 23' ' ' TYR . 2.6 t80 -64.54 -41.24 96.48 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.134 -0.484 . . . . 0.0 110.916 -179.902 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 24' ' ' CYS . . . . . 0.409 ' SG ' ' O ' ' A' ' 37' ' ' TYR . 47.8 t -69.4 -43.12 74.09 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.866 -179.993 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 25' ' ' ASN . . . . . 0.858 ' O ' HG23 ' A' ' 29' ' ' THR . 1.9 t30 -55.12 -56.39 20.44 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.855 -179.992 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 9.5 m-20 -56.13 -52.3 64.84 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.893 179.939 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 27' ' ' LEU . . . . . 0.663 ' O ' HD12 ' A' ' 27' ' ' LEU . 1.9 tp -58.29 -37.13 74.4 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.872 -179.967 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 28' ' ' CYS . . . . . 0.587 ' C ' ' HB3' ' A' ' 33' ' ' ALA . 10.9 m -63.65 -51.31 65.71 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.231 -0.441 . . . . 0.0 110.874 179.901 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 29' ' ' THR . . . . . 0.858 HG23 ' O ' ' A' ' 25' ' ' ASN . 1.1 p -63.31 -24.54 67.9 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.145 -179.947 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 14.0 tp10 -59.68 -23.17 62.88 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.912 179.966 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 31' ' ' ASN . . . . . 0.581 ' O ' HG21 ' A' ' 57' ' ' VAL . 6.8 m120 -103.93 22.3 14.82 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.88 -179.95 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 82.78 19.68 62.99 Favored Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.699 -0.762 . . . . 0.0 112.506 179.966 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 33' ' ' ALA . . . . . 0.77 ' HB2' HD13 ' A' ' 53' ' ' LEU . . . -84.92 149.31 25.74 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.775 0.321 . . . . 0.0 111.047 -179.988 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 34' ' ' GLU . . . . . 0.481 ' HB2' ' CB ' ' A' ' 52' ' ' GLN . 5.7 tp10 -74.84 -34.7 62.34 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.907 -179.947 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 2.4 m -161.77 178.15 9.24 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.868 -179.8 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -169.12 159.77 32.91 Favored Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.735 -0.745 . . . . 0.0 112.49 -179.982 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 37' ' ' TYR . . . . . 0.635 ' CE1' HD11 ' A' ' 51' ' ' ILE . 3.9 p90 -163.84 160.55 22.41 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 120.957 0.408 . . . . 0.0 110.875 -179.778 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 38' ' ' CYS . . . . . . . . . . . . . 2.4 t -74.43 113.02 11.18 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.853 179.974 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 39' ' ' GLN . . . . . 0.503 ' OE1' ' N ' ' A' ' 41' ' ' LEU . 0.0 OUTLIER -90.3 122.99 33.7 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.889 179.994 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 40' ' ' ILE . . . . . 0.509 HD13 ' OD1' ' A' ' 46' ' ' ASN . 2.5 mm -92.81 -51.42 11.34 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.138 179.94 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 41' ' ' LEU . . . . . 0.539 HD23 ' H ' ' A' ' 41' ' ' LEU . 0.1 OUTLIER -75.17 57.93 0.88 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.121 -0.491 . . . . 0.0 110.976 179.887 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -99.93 144.14 16.77 Favored Glycine 0 N--CA 1.451 -0.358 0 C-N-CA 120.747 -0.74 . . . . 0.0 112.465 179.954 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 55.8 tttp -53.91 -26.14 23.64 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.785 0.326 . . . . 0.0 110.92 179.997 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 0.9 OUTLIER -115.25 23.83 12.14 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.926 -179.988 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 93.65 -132.66 11.31 Favored Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.791 -0.719 . . . . 0.0 112.48 179.946 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 46' ' ' ASN . . . . . 0.509 ' OD1' HD13 ' A' ' 40' ' ' ILE . 0.9 OUTLIER -90.69 117.32 29.25 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.786 0.327 . . . . 0.0 110.922 -179.908 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 47' ' ' ALA . . . . . 0.532 ' HB1' ' HB ' ' A' ' 13' ' ' VAL . . . -140.72 146.16 37.41 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.086 179.91 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 48' ' ' CYS . . . . . 0.451 ' N ' ' O ' ' A' ' 14' ' ' TYR . 40.1 t -67.39 109.33 3.12 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.891 -179.957 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 49' ' ' TRP . . . . . 0.588 ' CZ3' ' HA ' ' A' ' 4' ' ' ALA . 36.9 t-105 -94.66 114.22 26.13 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.917 -179.997 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 50' ' ' CYS . . . . . . . . . . . . . 42.6 m -94.96 142.43 27.49 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.888 -179.962 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 51' ' ' ILE . . . . . 0.724 HG23 ' OD2' ' A' ' 3' ' ' ASP . 3.7 mp -105.92 133.85 49.15 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.187 -0.46 . . . . 0.0 111.143 179.953 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 52' ' ' GLN . . . . . 0.481 ' CB ' ' HB2' ' A' ' 34' ' ' GLU . 9.3 mm-40 64.49 45.42 3.68 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.906 179.952 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 53' ' ' LEU . . . . . 0.77 HD13 ' HB2' ' A' ' 33' ' ' ALA . 15.3 tp -85.37 134.0 41.31 Favored Pre-proline 0 C--N 1.329 -0.305 0 CA-C-O 121.592 0.711 . . . . 0.0 110.928 -179.999 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 54' ' ' PRO . . . . . 0.841 ' HG2' HG23 ' A' ' 57' ' ' VAL . 53.9 Cg_endo -69.74 147.14 62.33 Favored 'Trans proline' 0 C--O 1.231 0.165 0 C-N-CA 122.662 2.241 . . . . 0.0 112.377 179.87 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 2.4 m-20 -63.88 -6.44 5.97 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.842 179.947 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 9.0 m120 -77.92 -24.94 48.12 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.914 -179.94 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 57' ' ' VAL . . . . . 0.841 HG23 ' HG2' ' A' ' 54' ' ' PRO . 12.3 t -91.14 136.39 27.32 Favored Pre-proline 0 C--N 1.33 -0.251 0 CA-C-O 121.601 0.715 . . . . 0.0 111.115 179.922 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 58' ' ' PRO . . . . . 0.46 ' HD2' ' CG1' ' A' ' 57' ' ' VAL . 54.0 Cg_endo -69.76 136.4 32.89 Favored 'Trans proline' 0 C--O 1.231 0.17 0 C-N-CA 122.724 2.283 . . . . 0.0 112.351 179.953 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 59' ' ' ILE . . . . . 0.513 ' C ' ' HB2' ' A' ' 7' ' ' ALA . 13.9 pt -116.23 164.15 12.82 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.276 -0.42 . . . . 0.0 111.162 179.922 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 60' ' ' ARG . . . . . 0.444 ' C ' ' CD ' ' A' ' 60' ' ' ARG . 0.3 OUTLIER -65.62 106.42 1.46 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.848 179.983 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 61' ' ' ILE . . . . . 0.615 HD11 ' OD1' ' A' ' 11' ' ' ASN . 1.3 pt -94.87 160.64 30.7 Favored Pre-proline 0 C--N 1.329 -0.315 0 CA-C-O 121.606 0.717 . . . . 0.0 111.171 179.912 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -69.71 66.11 1.75 Allowed 'Trans proline' 0 C--N 1.341 0.159 0 C-N-CA 122.755 2.303 . . . . 0.0 112.352 179.866 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -144.78 -173.86 16.49 Favored Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 120.765 -0.731 . . . . 0.0 112.499 179.973 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 11.4 ttmm -85.1 147.17 26.78 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 120.786 0.327 . . . . 0.0 110.902 -179.944 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 65' ' ' CYS . . . . . 0.484 ' SG ' ' N ' ' A' ' 66' ' ' HIS . 0.8 OUTLIER -94.04 159.53 15.12 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.909 179.947 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 66' ' ' HIS . . . . . 0.484 ' N ' ' SG ' ' A' ' 65' ' ' CYS . 42.0 p-80 . . . . . 0 C--N 1.329 -0.296 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.881 179.958 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 1' ' ' ALA . . . . . 0.564 ' HB1' ' O ' ' A' ' 53' ' ' LEU . . . . . . . . 0 C--O 1.231 0.12 0 CA-C-O 120.759 0.314 . . . . 0.0 111.099 . . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -152.99 150.08 28.85 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.229 -0.442 . . . . 0.0 110.897 -179.904 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 2.7 m-20 -89.02 132.36 34.78 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.859 179.967 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 4' ' ' ALA . . . . . 0.613 ' HA ' ' CZ3' ' A' ' 49' ' ' TRP . . . -174.93 -179.27 1.37 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.11 179.918 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 5' ' ' TYR . . . . . 0.405 ' CE2' ' HE3' ' A' ' 49' ' ' TRP . 12.5 m-85 -84.46 131.49 34.65 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.941 -179.861 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 6' ' ' ILE . . . . . 0.558 HG23 ' HD2' ' A' ' 14' ' ' TYR . 4.9 tt -75.04 146.24 9.77 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.123 179.949 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -84.76 164.05 18.76 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.095 179.839 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 8' ' ' LYS . . . . . 0.549 ' HB2' ' CZ ' ' A' ' 14' ' ' TYR . 0.5 OUTLIER -145.18 168.88 10.93 Favored Pre-proline 0 C--N 1.329 -0.323 0 CA-C-O 121.633 0.73 . . . . 0.0 110.861 179.975 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 9' ' ' PRO . . . . . 0.51 ' HA ' ' HA ' ' A' ' 10' ' ' HIS . 53.0 Cg_endo -69.8 104.94 1.4 Allowed 'Trans proline' 0 C--N 1.342 0.186 0 C-N-CA 122.682 2.255 . . . . 0.0 112.312 179.925 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 10' ' ' HIS . . . . . 0.51 ' HA ' ' HA ' ' A' ' 9' ' ' PRO . 5.5 m-70 -131.87 123.12 26.85 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.838 -0.071 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 11' ' ' ASN . . . . . 0.512 ' N ' ' O ' ' A' ' 8' ' ' LYS . 5.8 t30 69.59 21.42 6.69 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.899 -179.934 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 12' ' ' CYS . . . . . 0.414 ' HB2' ' HG2' ' A' ' 8' ' ' LYS . 1.5 m -108.25 172.01 7.08 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.884 179.975 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 13' ' ' VAL . . . . . 0.576 HG12 ' HG2' ' A' ' 60' ' ' ARG . 0.9 OUTLIER -92.85 155.6 3.11 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.109 179.958 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 14' ' ' TYR . . . . . 0.558 ' HD2' HG23 ' A' ' 6' ' ' ILE . 6.9 m-85 -93.82 95.7 9.29 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.878 -179.855 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 16.2 pt-20 -64.84 137.05 57.54 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.907 179.994 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 15.1 p -84.41 158.41 21.09 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.885 -179.923 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 24.2 t80 -95.57 -33.05 12.54 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.918 -179.866 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 18' ' ' ASN . . . . . 0.599 ' CG ' ' HD2' ' A' ' 19' ' ' PRO . 1.9 t-20 -155.15 147.0 17.15 Favored Pre-proline 0 C--N 1.328 -0.333 0 CA-C-O 121.637 0.732 . . . . 0.0 110.894 179.97 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 19' ' ' PRO . . . . . 0.599 ' HD2' ' CG ' ' A' ' 18' ' ' ASN . 53.4 Cg_endo -69.75 -33.96 15.56 Favored 'Trans proline' 0 C--N 1.342 0.188 0 C-N-CA 122.669 2.246 . . . . 0.0 112.343 179.935 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 3.7 mmmp? -94.61 24.56 4.53 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.87 179.907 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -115.83 135.59 12.3 Favored Glycine 0 N--CA 1.452 -0.281 0 C-N-CA 120.74 -0.743 . . . . 0.0 112.465 179.962 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 83.9 p -83.52 24.86 0.8 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.872 0.368 . . . . 0.0 110.835 -179.719 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 0.4 OUTLIER -60.67 -51.77 67.96 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.909 -179.874 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 24' ' ' CYS . . . . . 0.401 ' SG ' ' O ' ' A' ' 37' ' ' TYR . 42.7 t -62.23 -41.01 98.03 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.853 -179.978 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 25' ' ' ASN . . . . . 0.852 ' O ' HG23 ' A' ' 29' ' ' THR . 0.3 OUTLIER -54.41 -58.43 7.46 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.871 -179.966 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -54.92 -53.83 50.51 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.856 179.945 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 27' ' ' LEU . . . . . 0.699 ' O ' HD12 ' A' ' 27' ' ' LEU . 1.8 tp -56.75 -37.58 71.23 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.89 -179.922 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 28' ' ' CYS . . . . . 0.512 ' C ' ' HB3' ' A' ' 33' ' ' ALA . 4.9 m -63.73 -51.96 62.62 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.897 179.89 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 29' ' ' THR . . . . . 0.852 HG23 ' O ' ' A' ' 25' ' ' ASN . 1.1 p -62.43 -24.77 67.6 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.128 -0.487 . . . . 0.0 111.197 -179.993 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 5.2 tm-20 -58.81 -22.47 58.6 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.892 -180.0 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 31' ' ' ASN . . . . . 0.564 ' O ' HG21 ' A' ' 57' ' ' VAL . 1.8 m-80 -103.4 21.94 15.08 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.92 -179.956 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 83.46 19.23 62.55 Favored Glycine 0 N--CA 1.451 -0.366 0 C-N-CA 120.769 -0.729 . . . . 0.0 112.479 179.99 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 33' ' ' ALA . . . . . 0.831 ' HB2' ' CD1' ' A' ' 53' ' ' LEU . . . -85.24 148.65 25.97 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.801 0.334 . . . . 0.0 111.072 179.973 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 34' ' ' GLU . . . . . 0.489 ' HB2' ' CB ' ' A' ' 52' ' ' GLN . 5.7 tp10 -74.69 -31.27 61.84 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.837 -179.894 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 2.9 m -162.65 178.61 8.38 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.889 -179.774 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 36' ' ' GLY . . . . . 0.48 ' CA ' ' HA ' ' A' ' 25' ' ' ASN . . . -174.85 153.62 16.34 Favored Glycine 0 N--CA 1.451 -0.354 0 C-N-CA 120.72 -0.752 . . . . 0.0 112.465 -179.98 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 37' ' ' TYR . . . . . 0.401 ' O ' ' SG ' ' A' ' 24' ' ' CYS . 45.4 p90 -164.36 167.67 19.48 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.936 0.398 . . . . 0.0 110.876 -179.746 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 38' ' ' CYS . . . . . . . . . . . . . 27.0 t -75.11 120.15 20.24 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.845 179.993 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 39' ' ' GLN . . . . . 0.403 ' O ' ' HA ' ' A' ' 46' ' ' ASN . 0.6 OUTLIER -105.5 130.28 53.6 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.95 179.99 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 40' ' ' ILE . . . . . 0.753 ' H ' HD12 ' A' ' 40' ' ' ILE . 1.3 mp -95.35 -33.76 5.0 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-N 116.25 -0.432 . . . . 0.0 111.149 179.966 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 41' ' ' LEU . . . . . 0.457 HD22 ' HA ' ' A' ' 41' ' ' LEU . 0.4 OUTLIER -75.56 48.96 0.47 Allowed 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.918 179.89 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -101.98 139.3 14.35 Favored Glycine 0 N--CA 1.452 -0.298 0 C-N-CA 120.783 -0.722 . . . . 0.0 112.493 179.88 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 38.7 tttp -54.12 -24.97 19.72 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.794 0.33 . . . . 0.0 110.862 -179.966 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 44' ' ' TYR . . . . . 0.44 ' CE1' ' HG3' ' A' ' 60' ' ' ARG . 0.5 OUTLIER -112.65 23.93 13.0 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.922 -179.929 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 93.8 -129.96 10.11 Favored Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 120.711 -0.757 . . . . 0.0 112.439 179.974 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 46' ' ' ASN . . . . . 0.403 ' HA ' ' O ' ' A' ' 39' ' ' GLN . 68.6 m-80 -93.19 119.09 31.99 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.872 0.368 . . . . 0.0 110.875 -179.873 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -139.34 150.49 45.42 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.154 -0.476 . . . . 0.0 111.107 179.849 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 48' ' ' CYS . . . . . 0.447 ' SG ' ' SG ' ' A' ' 28' ' ' CYS . 41.5 t -65.99 109.55 2.59 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.851 -179.926 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 49' ' ' TRP . . . . . 0.613 ' CZ3' ' HA ' ' A' ' 4' ' ' ALA . 38.8 t-105 -95.21 115.17 27.07 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.9 -179.995 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 50' ' ' CYS . . . . . . . . . . . . . 39.9 m -95.79 142.47 28.02 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.834 -179.962 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 51' ' ' ILE . . . . . 0.412 ' O ' ' HB2' ' A' ' 52' ' ' GLN . 3.6 mm -107.52 133.16 53.12 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.145 179.871 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 52' ' ' GLN . . . . . 0.489 ' CB ' ' HB2' ' A' ' 34' ' ' GLU . 12.1 mm-40 64.95 42.8 4.1 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.922 179.958 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 53' ' ' LEU . . . . . 0.831 ' CD1' ' HB2' ' A' ' 33' ' ' ALA . 16.3 tp -85.5 136.77 36.98 Favored Pre-proline 0 C--N 1.329 -0.324 0 CA-C-O 121.611 0.72 . . . . 0.0 110.932 -179.996 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 54' ' ' PRO . . . . . 0.847 ' HG2' HG23 ' A' ' 57' ' ' VAL . 54.3 Cg_endo -69.74 146.07 59.23 Favored 'Trans proline' 0 C--N 1.342 0.194 0 C-N-CA 122.667 2.245 . . . . 0.0 112.394 179.823 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -65.23 -5.16 6.29 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.901 179.928 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 15.4 m-20 -78.35 -28.6 47.19 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.906 -179.947 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 57' ' ' VAL . . . . . 0.847 HG23 ' HG2' ' A' ' 54' ' ' PRO . 14.6 t -86.5 136.4 35.18 Favored Pre-proline 0 C--N 1.329 -0.294 0 CA-C-O 121.641 0.734 . . . . 0.0 111.121 179.917 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 58' ' ' PRO . . . . . 0.464 ' HD2' ' CG1' ' A' ' 57' ' ' VAL . 53.1 Cg_endo -69.77 145.36 56.88 Favored 'Trans proline' 0 C--N 1.342 0.19 0 C-N-CA 122.699 2.266 . . . . 0.0 112.322 179.966 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 41.7 pt -122.66 166.93 16.82 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.161 179.922 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 60' ' ' ARG . . . . . 0.576 ' HG2' HG12 ' A' ' 13' ' ' VAL . 6.0 tpt180 -65.83 128.31 35.49 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.848 -179.998 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 61' ' ' ILE . . . . . 0.474 ' N ' ' HD2' ' A' ' 60' ' ' ARG . 1.8 pt -138.32 155.41 74.03 Favored Pre-proline 0 C--N 1.329 -0.313 0 CA-C-O 121.65 0.738 . . . . 0.0 111.161 179.941 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.76 75.11 1.24 Allowed 'Trans proline' 0 C--N 1.342 0.204 0 C-N-CA 122.673 2.249 . . . . 0.0 112.345 179.876 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -141.1 -177.44 16.34 Favored Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 120.751 -0.738 . . . . 0.0 112.466 179.987 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 7.6 mtpm? -75.18 111.41 10.4 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.811 0.338 . . . . 0.0 110.884 -179.989 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 65' ' ' CYS . . . . . 0.604 ' SG ' ' CD2' ' A' ' 66' ' ' HIS . 1.6 t -94.84 163.28 13.41 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.913 179.897 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 66' ' ' HIS . . . . . 0.604 ' CD2' ' SG ' ' A' ' 65' ' ' CYS . 0.8 OUTLIER . . . . . 0 C--N 1.33 -0.281 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.836 179.952 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.231 0.085 0 CA-C-O 120.798 0.332 . . . . 0.0 111.072 . . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 2' ' ' ARG . . . . . 0.455 ' CZ ' ' OD2' ' A' ' 55' ' ' ASP . 5.5 ptt-85 -149.65 177.52 9.69 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.912 -179.905 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 3' ' ' ASP . . . . . 0.582 ' OD2' HG23 ' A' ' 51' ' ' ILE . 4.0 m-20 -107.66 140.15 41.12 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.898 179.935 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 4' ' ' ALA . . . . . 0.587 ' HA ' ' CZ3' ' A' ' 49' ' ' TRP . . . -171.86 -176.85 1.81 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.094 -179.993 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 5' ' ' TYR . . . . . 0.438 ' OH ' ' NE2' ' A' ' 39' ' ' GLN . 29.0 m-85 -92.92 124.51 36.95 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.899 -179.834 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 6' ' ' ILE . . . . . 0.514 HG12 ' CD1' ' A' ' 14' ' ' TYR . 8.4 tt -75.24 135.38 27.33 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.128 -0.487 . . . . 0.0 111.141 179.899 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 7' ' ' ALA . . . . . 0.681 ' HB1' ' O ' ' A' ' 12' ' ' CYS . . . -135.2 140.88 45.66 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.124 179.775 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 8' ' ' LYS . . . . . 0.592 ' HB3' ' CE1' ' A' ' 14' ' ' TYR . 8.2 pttt -101.18 160.85 25.45 Favored Pre-proline 0 C--N 1.329 -0.322 0 CA-C-O 121.622 0.725 . . . . 0.0 110.861 179.958 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 9' ' ' PRO . . . . . 0.508 ' HA ' ' HA ' ' A' ' 10' ' ' HIS . 54.2 Cg_endo -69.74 144.65 54.79 Favored 'Trans proline' 0 C--N 1.342 0.198 0 C-N-CA 122.651 2.234 . . . . 0.0 112.388 179.883 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 10' ' ' HIS . . . . . 0.508 ' HA ' ' HA ' ' A' ' 9' ' ' PRO . 2.4 m-70 -101.86 98.87 9.05 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.833 -0.008 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 11' ' ' ASN . . . . . 0.449 ' OD1' ' NH1' ' A' ' 60' ' ' ARG . 35.5 t-20 65.95 73.84 0.37 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.874 -179.931 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 12' ' ' CYS . . . . . 0.681 ' O ' ' HB1' ' A' ' 7' ' ' ALA . 10.0 m -141.19 145.21 35.37 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.928 179.943 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 13' ' ' VAL . . . . . 0.582 HG12 ' NE ' ' A' ' 60' ' ' ARG . 0.8 OUTLIER -84.06 155.32 3.67 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.153 179.943 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 14' ' ' TYR . . . . . 0.592 ' CE1' ' HB3' ' A' ' 8' ' ' LYS . 6.8 m-85 -103.83 88.6 3.08 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.939 -179.912 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -63.82 136.4 57.38 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.09 -0.505 . . . . 0.0 110.915 179.995 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 11.7 p -84.68 130.3 34.72 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.887 -179.948 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 17' ' ' TYR . . . . . 0.426 ' O ' ' HD3' ' A' ' 19' ' ' PRO . 65.1 t80 -101.03 -37.06 8.78 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.907 -179.902 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 13.3 t-20 -106.2 85.25 1.59 Allowed Pre-proline 0 C--N 1.328 -0.332 0 CA-C-O 121.604 0.716 . . . . 0.0 110.889 179.998 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 19' ' ' PRO . . . . . 0.426 ' HD3' ' O ' ' A' ' 17' ' ' TYR . 53.9 Cg_endo -69.76 -27.7 26.17 Favored 'Trans proline' 0 C--N 1.342 0.198 0 C-N-CA 122.65 2.233 . . . . 0.0 112.344 179.935 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 9.7 mmtp -95.02 24.36 4.92 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.919 179.915 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -144.27 -179.91 21.08 Favored Glycine 0 N--CA 1.452 -0.28 0 C-N-CA 120.719 -0.753 . . . . 0.0 112.463 179.976 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 17.6 m -95.21 28.87 2.66 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.907 0.384 . . . . 0.0 110.848 -179.738 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 20.3 t80 -54.94 -58.93 5.61 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.905 -179.87 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 24' ' ' CYS . . . . . 0.459 ' SG ' ' C ' ' A' ' 37' ' ' TYR . 35.5 t -58.0 -32.87 68.33 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.89 -179.995 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 25' ' ' ASN . . . . . 0.845 ' O ' HG23 ' A' ' 29' ' ' THR . 1.5 t30 -65.0 -56.38 13.44 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.928 179.961 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 17.7 m-20 -54.47 -47.91 72.42 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.868 179.938 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 27' ' ' LEU . . . . . 0.74 ' O ' HD12 ' A' ' 27' ' ' LEU . 1.4 tp -63.86 -38.81 92.46 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.972 179.989 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 28' ' ' CYS . . . . . 0.665 ' SG ' ' SG ' ' A' ' 48' ' ' CYS . 7.7 m -65.09 -57.45 8.58 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.894 179.892 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 29' ' ' THR . . . . . 0.845 HG23 ' O ' ' A' ' 25' ' ' ASN . 1.3 p -63.93 -34.52 78.15 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.126 -0.488 . . . . 0.0 111.132 -179.944 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 48.1 tt0 -54.78 -22.14 13.31 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.882 -179.98 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 5.7 m120 -104.81 23.11 14.0 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.868 -179.959 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 32' ' ' GLY . . . . . 0.531 ' O ' ' CD ' ' A' ' 54' ' ' PRO . . . 84.53 69.15 1.38 Allowed Glycine 0 N--CA 1.451 -0.36 0 C-N-CA 120.766 -0.731 . . . . 0.0 112.511 179.984 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 33' ' ' ALA . . . . . 0.978 ' HB2' ' CD1' ' A' ' 53' ' ' LEU . . . -150.15 153.65 36.69 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.778 0.323 . . . . 0.0 111.096 -179.998 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 34' ' ' GLU . . . . . 0.506 ' HB2' ' CB ' ' A' ' 52' ' ' GLN . 19.4 tp10 -74.08 -34.6 64.07 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.863 -179.937 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 22.1 m -163.48 -179.89 6.81 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.876 -179.771 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 36' ' ' GLY . . . . . 0.422 ' O ' ' CA ' ' A' ' 25' ' ' ASN . . . -176.18 139.23 4.48 Favored Glycine 0 N--CA 1.452 -0.288 0 C-N-CA 120.709 -0.758 . . . . 0.0 112.45 179.955 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 37' ' ' TYR . . . . . 0.575 ' CE1' HD11 ' A' ' 51' ' ' ILE . 1.2 p90 -144.91 164.64 30.48 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-O 120.913 0.387 . . . . 0.0 110.947 -179.799 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 38' ' ' CYS . . . . . . . . . . . . . 39.0 t -74.91 129.43 37.64 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.844 179.998 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 39' ' ' GLN . . . . . 0.438 ' NE2' ' OH ' ' A' ' 5' ' ' TYR . 16.4 tt0 -105.64 125.02 50.51 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.914 179.997 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 40' ' ' ILE . . . . . 0.509 ' HA ' ' ND2' ' A' ' 46' ' ' ASN . 0.7 OUTLIER -95.32 -24.87 4.63 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.154 179.934 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 41' ' ' LEU . . . . . 0.531 ' N ' HD22 ' A' ' 41' ' ' LEU . 2.7 mm? -82.22 35.34 0.44 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.923 179.935 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -92.58 131.76 10.94 Favored Glycine 0 N--CA 1.45 -0.37 0 C-N-CA 120.749 -0.739 . . . . 0.0 112.485 179.924 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -52.01 -24.69 7.01 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.756 0.312 . . . . 0.0 110.871 -179.967 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 0.7 OUTLIER -99.65 23.91 8.94 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.962 -179.957 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 93.81 -84.77 1.05 Allowed Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.725 -0.75 . . . . 0.0 112.498 -179.996 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 46' ' ' ASN . . . . . 0.509 ' ND2' ' HA ' ' A' ' 40' ' ' ILE . 2.5 m120 -144.12 130.49 19.85 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.86 0.362 . . . . 0.0 110.91 -179.916 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -145.95 146.54 31.08 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.105 179.847 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 48' ' ' CYS . . . . . 0.665 ' SG ' ' SG ' ' A' ' 28' ' ' CYS . 50.7 t -65.46 113.8 4.39 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.925 -179.952 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 49' ' ' TRP . . . . . 0.587 ' CZ3' ' HA ' ' A' ' 4' ' ' ALA . 49.6 t-105 -94.98 113.44 25.15 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.929 -179.982 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 50' ' ' CYS . . . . . . . . . . . . . 20.2 m -95.42 139.78 31.23 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.898 -179.994 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 51' ' ' ILE . . . . . 0.582 HG23 ' OD2' ' A' ' 3' ' ' ASP . 4.7 mp -107.25 138.74 31.73 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.095 179.945 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 52' ' ' GLN . . . . . 0.506 ' CB ' ' HB2' ' A' ' 34' ' ' GLU . 2.1 mm-40 67.38 30.77 6.78 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.897 179.955 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 53' ' ' LEU . . . . . 0.978 ' CD1' ' HB2' ' A' ' 33' ' ' ALA . 11.5 tp -85.93 132.88 42.56 Favored Pre-proline 0 C--N 1.328 -0.36 0 CA-C-O 121.616 0.722 . . . . 0.0 110.907 -179.999 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 54' ' ' PRO . . . . . 0.531 ' CD ' ' O ' ' A' ' 32' ' ' GLY . 53.7 Cg_endo -69.73 150.93 69.03 Favored 'Trans proline' 0 C--O 1.232 0.175 0 C-N-CA 122.712 2.275 . . . . 0.0 112.318 179.886 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 55' ' ' ASP . . . . . 0.455 ' OD2' ' CZ ' ' A' ' 2' ' ' ARG . 16.1 m-20 -65.11 -5.82 7.55 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.877 179.911 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 45.1 m-80 -74.93 -24.56 58.51 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.884 -179.908 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 57' ' ' VAL . . . . . 0.491 HG12 ' HD2' ' A' ' 58' ' ' PRO . 1.2 t -84.22 136.63 40.44 Favored Pre-proline 0 C--N 1.329 -0.287 0 CA-C-O 121.685 0.755 . . . . 0.0 111.119 179.936 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 58' ' ' PRO . . . . . 0.491 ' HD2' HG12 ' A' ' 57' ' ' VAL . 53.8 Cg_endo -69.79 130.26 18.99 Favored 'Trans proline' 0 C--N 1.342 0.186 0 C-N-CA 122.668 2.245 . . . . 0.0 112.324 179.971 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 59' ' ' ILE . . . . . 0.842 ' O ' HD13 ' A' ' 61' ' ' ILE . 27.4 pt -107.89 171.31 2.33 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.101 179.938 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 60' ' ' ARG . . . . . 0.582 ' NE ' HG12 ' A' ' 13' ' ' VAL . 5.6 tpt180 -75.76 113.53 13.33 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.871 179.936 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 61' ' ' ILE . . . . . 0.842 HD13 ' O ' ' A' ' 59' ' ' ILE . 0.0 OUTLIER -108.67 160.51 26.96 Favored Pre-proline 0 C--N 1.329 -0.304 0 CA-C-O 121.6 0.714 . . . . 0.0 111.124 179.986 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.77 64.17 1.8 Allowed 'Trans proline' 0 N--CA 1.465 -0.174 0 C-N-CA 122.692 2.262 . . . . 0.0 112.342 179.911 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -138.98 -179.49 17.42 Favored Glycine 0 N--CA 1.451 -0.351 0 C-N-CA 120.744 -0.741 . . . . 0.0 112.451 -179.989 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 25.9 ttmt -85.39 145.61 27.39 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-O 120.778 0.323 . . . . 0.0 110.871 -179.923 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 65' ' ' CYS . . . . . 0.449 ' O ' ' C ' ' A' ' 66' ' ' HIS . 7.9 t -93.85 148.37 22.2 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.885 179.957 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 66' ' ' HIS . . . . . 0.449 ' C ' ' O ' ' A' ' 65' ' ' CYS . 0.1 OUTLIER . . . . . 0 C--N 1.329 -0.313 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.871 -179.996 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 1' ' ' ALA . . . . . 0.449 ' HB1' ' O ' ' A' ' 53' ' ' LEU . . . . . . . . 0 C--O 1.231 0.115 0 CA-C-O 120.793 0.33 . . . . 0.0 111.095 . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 2' ' ' ARG . . . . . 0.447 ' HD3' ' N ' ' A' ' 2' ' ' ARG . 0.0 OUTLIER -150.71 -177.28 5.89 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.898 -179.921 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 3' ' ' ASP . . . . . 0.552 ' CG ' HD13 ' A' ' 51' ' ' ILE . 9.5 m-20 -107.23 134.08 50.86 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.881 179.932 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -175.67 -174.66 0.7 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.165 -0.47 . . . . 0.0 111.138 179.999 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 5' ' ' TYR . . . . . 0.458 ' CE1' ' CZ3' ' A' ' 49' ' ' TRP . 2.0 m-85 -85.06 135.07 34.16 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.883 -179.835 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 6' ' ' ILE . . . . . 0.673 HG23 ' HD2' ' A' ' 14' ' ' TYR . 3.7 tt -75.93 134.08 29.85 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.111 -0.495 . . . . 0.0 111.185 179.868 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 7' ' ' ALA . . . . . 0.411 ' HB2' ' C ' ' A' ' 59' ' ' ILE . . . -85.78 152.01 23.37 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.211 -0.45 . . . . 0.0 111.096 179.873 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 8' ' ' LYS . . . . . 0.554 ' HB2' ' CZ ' ' A' ' 14' ' ' TYR . 0.0 OUTLIER -135.19 167.22 23.7 Favored Pre-proline 0 C--N 1.329 -0.306 0 CA-C-O 121.593 0.711 . . . . 0.0 110.864 179.963 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 9' ' ' PRO . . . . . 0.449 ' HA ' ' HA ' ' A' ' 10' ' ' HIS . 53.9 Cg_endo -69.73 105.93 1.57 Allowed 'Trans proline' 0 C--N 1.342 0.192 0 C-N-CA 122.703 2.269 . . . . 0.0 112.35 179.873 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 10' ' ' HIS . . . . . 0.449 ' HA ' ' HA ' ' A' ' 9' ' ' PRO . 11.3 m-70 -131.4 127.73 38.1 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.855 -0.067 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 11' ' ' ASN . . . . . 0.412 ' N ' ' O ' ' A' ' 8' ' ' LYS . 4.2 t30 61.36 26.62 16.39 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.889 -179.945 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 1.6 m -107.14 154.9 20.5 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.89 -179.998 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 13' ' ' VAL . . . . . 0.449 HG12 ' NE ' ' A' ' 60' ' ' ARG . 0.9 OUTLIER -84.83 154.44 3.57 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.169 179.923 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 14' ' ' TYR . . . . . 0.673 ' HD2' HG23 ' A' ' 6' ' ' ILE . 9.5 m-85 -94.75 89.75 5.82 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.944 -179.912 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 3.3 pt-20 -64.65 125.41 24.65 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.89 -179.965 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 1.1 p -101.55 134.38 44.75 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.864 -179.901 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 17' ' ' TYR . . . . . 0.436 ' O ' ' HD3' ' A' ' 19' ' ' PRO . 4.8 m-30 -99.49 -28.18 13.37 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.929 -179.926 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -106.44 82.94 1.06 Allowed Pre-proline 0 C--N 1.329 -0.303 0 CA-C-O 121.616 0.722 . . . . 0.0 110.885 -179.987 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 19' ' ' PRO . . . . . 0.436 ' HD3' ' O ' ' A' ' 17' ' ' TYR . 53.5 Cg_endo -69.76 -26.56 27.47 Favored 'Trans proline' 0 C--N 1.342 0.199 0 C-N-CA 122.632 2.221 . . . . 0.0 112.372 179.928 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 20' ' ' LYS . . . . . 0.478 ' HD3' ' N ' ' A' ' 20' ' ' LYS . 0.0 OUTLIER -94.18 24.54 4.31 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.849 179.943 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -136.28 -178.84 16.08 Favored Glycine 0 N--CA 1.452 -0.299 0 C-N-CA 120.763 -0.732 . . . . 0.0 112.497 179.923 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 2.0 p -94.2 28.76 2.38 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.871 0.367 . . . . 0.0 110.855 -179.737 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 0.9 OUTLIER -59.84 -66.67 0.48 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.909 -179.88 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 24' ' ' CYS . . . . . 0.484 ' SG ' ' N ' ' A' ' 49' ' ' TRP . 53.2 t -60.47 -38.3 83.78 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.89 179.986 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 25' ' ' ASN . . . . . 0.846 ' O ' HG23 ' A' ' 29' ' ' THR . 1.7 t30 -54.89 -57.05 13.19 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.903 -179.993 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -57.6 -51.37 69.78 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.863 179.95 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 27' ' ' LEU . . . . . 0.662 ' O ' HD12 ' A' ' 27' ' ' LEU . 2.2 tp -57.13 -38.8 74.01 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.908 -179.967 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 28' ' ' CYS . . . . . 0.576 ' C ' ' HB3' ' A' ' 33' ' ' ALA . 19.1 m -62.41 -50.6 70.87 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.899 179.905 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 29' ' ' THR . . . . . 0.846 HG23 ' O ' ' A' ' 25' ' ' ASN . 1.1 p -62.78 -25.02 68.02 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.14 -179.97 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 6.8 tp10 -58.96 -22.75 60.7 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.938 179.992 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 31' ' ' ASN . . . . . 0.494 ' O ' HG21 ' A' ' 57' ' ' VAL . 1.9 m-80 -103.66 22.6 14.11 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.103 -0.498 . . . . 0.0 110.902 -179.949 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 84.15 18.83 62.03 Favored Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 120.765 -0.731 . . . . 0.0 112.515 -179.988 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 33' ' ' ALA . . . . . 0.797 ' HB2' HD13 ' A' ' 53' ' ' LEU . . . -85.4 152.37 23.29 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.733 0.301 . . . . 0.0 111.122 179.931 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . 0.476 ' CB ' ' HB2' ' A' ' 52' ' ' GLN . 4.3 tt0 -78.66 -33.07 47.38 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.233 -0.439 . . . . 0.0 110.886 -179.93 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 1.7 m -162.77 -177.2 5.39 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.844 -179.772 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 36' ' ' GLY . . . . . 0.446 ' CA ' ' HA ' ' A' ' 25' ' ' ASN . . . -174.92 157.54 24.7 Favored Glycine 0 N--CA 1.452 -0.284 0 C-N-CA 120.759 -0.734 . . . . 0.0 112.489 -179.984 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 37' ' ' TYR . . . . . 0.581 ' CE2' ' CD1' ' A' ' 49' ' ' TRP . 5.0 p90 -157.64 159.63 37.2 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.863 0.363 . . . . 0.0 110.918 -179.823 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 38' ' ' CYS . . . . . 0.409 ' CB ' ' HA ' ' A' ' 19' ' ' PRO . 21.3 t -74.88 119.47 19.1 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.913 179.999 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 39' ' ' GLN . . . . . 0.408 ' OE1' ' HA2' ' A' ' 42' ' ' GLY . 0.0 OUTLIER -98.49 126.03 43.91 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.913 -179.983 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 40' ' ' ILE . . . . . 0.771 HD12 ' N ' ' A' ' 40' ' ' ILE . 1.2 mp -95.97 -35.98 6.2 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.102 179.972 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 4.2 mm? -75.66 53.01 0.69 Allowed 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.934 179.922 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . 0.408 ' HA2' ' OE1' ' A' ' 39' ' ' GLN . . . -105.72 138.91 14.53 Favored Glycine 0 N--CA 1.452 -0.296 0 C-N-CA 120.758 -0.734 . . . . 0.0 112.462 179.94 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -57.45 -27.6 62.6 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.83 0.348 . . . . 0.0 110.908 -179.962 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 0.6 OUTLIER -109.22 23.72 14.11 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.903 -179.959 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 93.37 -139.08 14.42 Favored Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.734 -0.745 . . . . 0.0 112.527 -179.978 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 46' ' ' ASN . . . . . 0.472 ' ND2' ' HA ' ' A' ' 40' ' ' ILE . 9.9 m120 -82.96 116.22 22.15 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.821 0.343 . . . . 0.0 110.894 -179.914 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -125.71 141.57 51.95 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.098 179.864 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 48' ' ' CYS . . . . . 0.475 ' HB3' ' CG2' ' A' ' 6' ' ' ILE . 19.5 t -65.47 114.92 5.2 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.883 -179.967 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 49' ' ' TRP . . . . . 0.581 ' CD1' ' CE2' ' A' ' 37' ' ' TYR . 61.7 t-105 -94.1 135.2 35.72 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.947 179.955 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 50' ' ' CYS . . . . . . . . . . . . . 42.1 m -122.1 142.04 50.78 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.851 -179.97 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 51' ' ' ILE . . . . . 0.552 HD13 ' CG ' ' A' ' 3' ' ' ASP . 14.4 mm -111.01 134.48 53.18 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.139 179.895 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 52' ' ' GLN . . . . . 0.476 ' HB2' ' CB ' ' A' ' 34' ' ' GLU . 3.2 mm-40 65.08 44.58 3.32 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.884 179.926 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 53' ' ' LEU . . . . . 0.797 HD13 ' HB2' ' A' ' 33' ' ' ALA . 14.5 tp -85.93 134.34 39.43 Favored Pre-proline 0 C--N 1.328 -0.35 0 CA-C-O 121.631 0.729 . . . . 0.0 110.945 179.955 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 54' ' ' PRO . . . . . 0.809 ' HG2' HG23 ' A' ' 57' ' ' VAL . 53.3 Cg_endo -69.74 145.42 57.22 Favored 'Trans proline' 0 C--N 1.342 0.184 0 C-N-CA 122.656 2.238 . . . . 0.0 112.323 179.898 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -62.58 -7.75 5.25 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.851 179.915 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 27.6 m120 -76.17 -25.31 55.11 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.913 -179.886 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 57' ' ' VAL . . . . . 0.809 HG23 ' HG2' ' A' ' 54' ' ' PRO . 10.7 t -92.17 136.24 26.06 Favored Pre-proline 0 C--N 1.33 -0.264 0 CA-C-O 121.634 0.73 . . . . 0.0 111.087 179.928 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 58' ' ' PRO . . . . . 0.466 ' HD2' ' CG1' ' A' ' 57' ' ' VAL . 53.9 Cg_endo -69.78 152.53 69.24 Favored 'Trans proline' 0 C--N 1.342 0.193 0 C-N-CA 122.644 2.229 . . . . 0.0 112.366 179.936 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 59' ' ' ILE . . . . . 0.411 ' C ' ' HB2' ' A' ' 7' ' ' ALA . 19.1 pt -125.3 166.3 21.29 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.169 179.91 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 60' ' ' ARG . . . . . 0.485 ' HD2' ' N ' ' A' ' 61' ' ' ILE . 6.7 tpt180 -65.95 116.17 6.81 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.891 179.935 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . 0.485 ' N ' ' HD2' ' A' ' 60' ' ' ARG . 1.0 OUTLIER -117.31 160.13 38.84 Favored Pre-proline 0 C--N 1.329 -0.31 0 CA-C-O 121.606 0.717 . . . . 0.0 111.096 -179.996 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.77 64.81 1.81 Allowed 'Trans proline' 0 C--N 1.342 0.2 0 C-N-CA 122.631 2.221 . . . . 0.0 112.384 179.853 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -136.03 -178.65 15.92 Favored Glycine 0 N--CA 1.451 -0.355 0 C-N-CA 120.719 -0.753 . . . . 0.0 112.474 -179.986 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 1.1 tppp? -85.22 140.29 30.99 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.817 0.341 . . . . 0.0 110.925 179.952 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 65' ' ' CYS . . . . . 0.497 ' SG ' ' N ' ' A' ' 66' ' ' HIS . 1.0 OUTLIER -94.55 160.88 14.44 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.872 179.963 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 66' ' ' HIS . . . . . 0.497 ' N ' ' SG ' ' A' ' 65' ' ' CYS . 7.3 p80 . . . . . 0 C--N 1.329 -0.298 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.824 -179.985 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 1' ' ' ALA . . . . . 0.489 ' HB1' ' O ' ' A' ' 53' ' ' LEU . . . . . . . . 0 C--O 1.231 0.131 0 CA-C-O 120.77 0.319 . . . . 0.0 111.095 . . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 18.0 ptt180 -147.27 161.19 41.46 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.89 -179.965 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 3' ' ' ASP . . . . . 0.685 ' OD2' HG23 ' A' ' 51' ' ' ILE . 2.9 m-20 -96.71 134.04 40.49 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.869 -179.988 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 4' ' ' ALA . . . . . 0.605 ' HA ' ' CZ3' ' A' ' 49' ' ' TRP . . . -174.83 -179.09 1.37 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.097 179.982 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 5' ' ' TYR . . . . . 0.412 ' CD2' ' HB3' ' A' ' 47' ' ' ALA . 16.0 m-85 -84.81 135.44 34.1 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.96 -179.857 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 6' ' ' ILE . . . . . 0.447 HG23 ' HD2' ' A' ' 14' ' ' TYR . 5.5 tt -75.42 137.09 23.6 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.108 -0.496 . . . . 0.0 111.148 179.936 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 7' ' ' ALA . . . . . 0.575 ' HB2' ' C ' ' A' ' 59' ' ' ILE . . . -91.41 158.47 16.5 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.103 179.816 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 8' ' ' LYS . . . . . 0.545 ' HB2' ' CZ ' ' A' ' 14' ' ' TYR . 0.0 OUTLIER -134.72 166.26 30.51 Favored Pre-proline 0 C--N 1.328 -0.327 0 CA-C-O 121.632 0.729 . . . . 0.0 110.87 -179.988 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 9' ' ' PRO . . . . . 0.477 ' HA ' ' HA ' ' A' ' 10' ' ' HIS . 53.7 Cg_endo -69.79 106.97 1.76 Allowed 'Trans proline' 0 C--N 1.342 0.231 0 C-N-CA 122.666 2.244 . . . . 0.0 112.345 179.891 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 10' ' ' HIS . . . . . 0.477 ' HA ' ' HA ' ' A' ' 9' ' ' PRO . 7.7 m-70 -132.08 125.12 30.6 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.865 -0.069 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 11' ' ' ASN . . . . . 0.442 ' OD1' HD11 ' A' ' 61' ' ' ILE . 2.3 t30 65.49 44.29 3.12 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.902 -179.896 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 1.6 m -128.81 155.47 45.13 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.873 -179.983 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 13' ' ' VAL . . . . . 0.421 ' CG1' ' NE ' ' A' ' 60' ' ' ARG . 2.7 m -86.5 153.53 3.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.115 179.958 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 14' ' ' TYR . . . . . 0.545 ' CZ ' ' HB2' ' A' ' 8' ' ' LYS . 9.1 m-85 -95.09 100.7 12.48 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.931 -179.942 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 4.9 tm-20 -64.54 137.1 57.66 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.099 -0.501 . . . . 0.0 110.85 -179.945 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 9.1 p -84.83 126.01 33.09 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.864 -179.942 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -100.63 -24.56 14.41 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.903 -179.88 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -134.54 85.15 37.99 Favored Pre-proline 0 C--N 1.329 -0.307 0 CA-C-O 121.555 0.693 . . . . 0.0 110.897 -179.989 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.76 -25.08 28.94 Favored 'Trans proline' 0 C--O 1.231 0.147 0 C-N-CA 122.689 2.259 . . . . 0.0 112.372 179.929 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -94.42 24.23 4.66 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.893 179.914 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -142.88 -174.61 15.33 Favored Glycine 0 N--CA 1.452 -0.279 0 C-N-CA 120.699 -0.763 . . . . 0.0 112.46 179.903 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 50.3 m -95.25 29.14 2.58 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.867 0.365 . . . . 0.0 110.871 -179.729 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 43.9 t80 -64.52 -71.61 0.17 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.921 -179.853 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 42.0 t -55.19 -39.9 70.12 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.824 -179.995 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 25' ' ' ASN . . . . . 0.807 ' O ' HG23 ' A' ' 29' ' ' THR . 1.3 t30 -57.1 -55.57 32.96 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.895 179.998 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 4.5 m-20 -54.68 -53.33 56.34 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.895 179.94 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 27' ' ' LEU . . . . . 0.639 ' O ' HD12 ' A' ' 27' ' ' LEU . 2.1 tp -60.08 -36.38 77.25 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.918 -179.976 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 28' ' ' CYS . . . . . 0.47 ' CB ' ' HA3' ' A' ' 36' ' ' GLY . 1.3 m -64.73 -60.72 2.78 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.868 179.89 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 29' ' ' THR . . . . . 0.807 HG23 ' O ' ' A' ' 25' ' ' ASN . 1.1 p -62.75 -27.09 69.04 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.165 -0.47 . . . . 0.0 111.126 -179.971 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 9.5 tp10 -54.75 -19.83 7.16 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.253 -0.43 . . . . 0.0 110.861 -179.981 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 31' ' ' ASN . . . . . 0.572 ' O ' HG21 ' A' ' 57' ' ' VAL . 1.8 m-80 -101.81 21.99 13.66 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.154 -0.476 . . . . 0.0 110.914 -179.96 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 95.81 -12.66 67.14 Favored Glycine 0 N--CA 1.451 -0.302 0 C-N-CA 120.773 -0.727 . . . . 0.0 112.489 179.996 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 33' ' ' ALA . . . . . 1.086 ' HB2' ' CD1' ' A' ' 53' ' ' LEU . . . -62.17 155.27 24.89 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 120.742 0.306 . . . . 0.0 111.094 179.989 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . 0.504 ' HB2' ' CB ' ' A' ' 52' ' ' GLN . 2.7 tt0 -80.88 -31.46 35.27 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.9 -179.939 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 35' ' ' SER . . . . . 0.417 ' HA ' HG22 ' A' ' 29' ' ' THR . 46.2 m -162.77 177.92 8.91 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.881 -179.771 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 36' ' ' GLY . . . . . 0.47 ' HA3' ' CB ' ' A' ' 28' ' ' CYS . . . -175.24 157.27 23.9 Favored Glycine 0 N--CA 1.452 -0.277 0 C-N-CA 120.8 -0.714 . . . . 0.0 112.501 -179.976 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 37' ' ' TYR . . . . . 0.491 ' CZ ' HD11 ' A' ' 51' ' ' ILE . 0.6 OUTLIER -165.27 173.55 11.13 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.942 0.401 . . . . 0.0 110.904 -179.811 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 38' ' ' CYS . . . . . . . . . . . . . 41.9 t -74.72 120.28 20.05 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.858 -179.98 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 39' ' ' GLN . . . . . 0.478 ' OE1' ' CE3' ' A' ' 49' ' ' TRP . 3.8 tt0 -104.64 125.26 50.58 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.91 179.99 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 40' ' ' ILE . . . . . 0.757 ' H ' HD12 ' A' ' 40' ' ' ILE . 1.3 mp -95.44 -25.25 4.53 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.159 179.942 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 41' ' ' LEU . . . . . 0.432 ' O ' HD23 ' A' ' 41' ' ' LEU . 1.0 OUTLIER -81.11 40.91 0.56 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.919 179.918 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -97.38 134.49 11.77 Favored Glycine 0 N--CA 1.452 -0.296 0 C-N-CA 120.752 -0.737 . . . . 0.0 112.474 179.907 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -54.14 -25.05 20.25 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.762 0.315 . . . . 0.0 110.861 -179.992 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 44' ' ' TYR . . . . . 0.488 ' CE1' ' CG ' ' A' ' 60' ' ' ARG . 0.6 OUTLIER -108.6 23.76 14.06 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.964 -179.964 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 93.42 -134.47 12.14 Favored Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.734 -0.746 . . . . 0.0 112.477 179.944 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 46' ' ' ASN . . . . . 0.488 ' ND2' ' HA ' ' A' ' 40' ' ' ILE . 27.8 m120 -91.51 118.82 30.92 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.844 0.354 . . . . 0.0 110.86 -179.884 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 47' ' ' ALA . . . . . 0.412 ' HB3' ' CD2' ' A' ' 5' ' ' TYR . . . -137.33 148.52 46.37 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.099 179.842 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 48' ' ' CYS . . . . . 0.422 ' SG ' ' SG ' ' A' ' 28' ' ' CYS . 11.9 t -65.91 108.76 2.27 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.917 -179.976 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 49' ' ' TRP . . . . . 0.605 ' CZ3' ' HA ' ' A' ' 4' ' ' ALA . 36.3 t-105 -94.67 122.75 37.59 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.913 179.995 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 50' ' ' CYS . . . . . . . . . . . . . 4.9 m -107.79 135.13 49.72 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.844 -179.947 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 51' ' ' ILE . . . . . 0.685 HG23 ' OD2' ' A' ' 3' ' ' ASP . 4.2 mp -100.07 138.8 23.26 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.137 179.911 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 52' ' ' GLN . . . . . 0.504 ' CB ' ' HB2' ' A' ' 34' ' ' GLU . 5.7 mm-40 65.38 42.0 4.04 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.929 179.939 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 53' ' ' LEU . . . . . 1.086 ' CD1' ' HB2' ' A' ' 33' ' ' ALA . 12.7 tp -85.28 132.79 44.08 Favored Pre-proline 0 C--N 1.329 -0.32 0 CA-C-O 121.628 0.728 . . . . 0.0 110.941 -179.987 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 54' ' ' PRO . . . . . 0.842 ' HG2' HG23 ' A' ' 57' ' ' VAL . 53.5 Cg_endo -69.78 145.63 57.61 Favored 'Trans proline' 0 C--N 1.342 0.214 0 C-N-CA 122.694 2.263 . . . . 0.0 112.336 179.91 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 40.5 m-20 -62.89 -7.75 5.75 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.855 179.915 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 2.5 m120 -76.51 -25.64 54.4 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.908 -179.908 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 57' ' ' VAL . . . . . 0.842 HG23 ' HG2' ' A' ' 54' ' ' PRO . 12.1 t -92.01 136.23 26.3 Favored Pre-proline 0 C--N 1.33 -0.265 0 CA-C-O 121.642 0.734 . . . . 0.0 111.112 179.926 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 58' ' ' PRO . . . . . 0.463 ' HD2' ' CG1' ' A' ' 57' ' ' VAL . 53.6 Cg_endo -69.77 145.68 57.79 Favored 'Trans proline' 0 C--N 1.342 0.196 0 C-N-CA 122.691 2.261 . . . . 0.0 112.331 179.93 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 59' ' ' ILE . . . . . 0.575 ' C ' ' HB2' ' A' ' 7' ' ' ALA . 14.7 pt -124.23 173.8 9.51 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.111 179.914 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 60' ' ' ARG . . . . . 0.488 ' CG ' ' CE1' ' A' ' 44' ' ' TYR . 0.6 OUTLIER -69.04 118.8 12.4 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.879 179.965 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . 0.442 HD11 ' OD1' ' A' ' 11' ' ' ASN . 1.3 pt -118.14 160.59 38.62 Favored Pre-proline 0 C--N 1.329 -0.307 0 CA-C-O 121.642 0.734 . . . . 0.0 111.082 -179.964 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.73 66.34 1.76 Allowed 'Trans proline' 0 C--N 1.342 0.191 0 C-N-CA 122.667 2.244 . . . . 0.0 112.314 179.897 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -141.61 179.41 19.72 Favored Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 120.761 -0.733 . . . . 0.0 112.517 179.934 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 6.0 mmmm -83.38 142.01 31.33 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.804 0.335 . . . . 0.0 110.898 -179.955 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 65' ' ' CYS . . . . . 0.585 ' O ' ' CD2' ' A' ' 66' ' ' HIS . 1.7 t -89.31 156.27 18.84 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.872 179.97 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 66' ' ' HIS . . . . . 0.585 ' CD2' ' O ' ' A' ' 65' ' ' CYS . 16.9 p80 . . . . . 0 C--N 1.329 -0.314 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.883 179.963 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 1' ' ' ALA . . . . . 0.444 ' HB1' ' O ' ' A' ' 53' ' ' LEU . . . . . . . . 0 C--O 1.231 0.124 0 CA-C-O 120.801 0.334 . . . . 0.0 111.079 . . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -135.37 162.28 33.05 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.865 -179.92 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 3' ' ' ASP . . . . . 0.928 ' OD2' HG23 ' A' ' 51' ' ' ILE . 1.8 m-20 -97.77 133.13 42.71 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.887 179.989 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 4' ' ' ALA . . . . . 0.612 ' HA ' ' CZ3' ' A' ' 49' ' ' TRP . . . -172.82 -177.95 1.76 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.103 179.937 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 5' ' ' TYR . . . . . 0.618 ' CE2' ' OE1' ' A' ' 39' ' ' GLN . 68.9 m-85 -84.36 136.66 33.79 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.24 -0.437 . . . . 0.0 110.904 -179.845 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 6' ' ' ILE . . . . . 0.413 HG23 ' HB2' ' A' ' 14' ' ' TYR . 5.0 tt -74.93 134.7 28.87 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 116.12 -0.491 . . . . 0.0 111.097 179.929 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 7' ' ' ALA . . . . . 0.599 ' HB2' ' C ' ' A' ' 59' ' ' ILE . . . -93.48 156.73 16.58 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.085 179.815 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 8' ' ' LYS . . . . . 0.552 ' HB2' ' CZ ' ' A' ' 14' ' ' TYR . 0.0 OUTLIER -140.2 168.01 16.21 Favored Pre-proline 0 C--N 1.329 -0.297 0 CA-C-O 121.521 0.677 . . . . 0.0 110.886 179.991 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 9' ' ' PRO . . . . . 0.493 ' HA ' ' HA ' ' A' ' 10' ' ' HIS . 53.6 Cg_endo -69.74 107.95 1.97 Allowed 'Trans proline' 0 C--O 1.232 0.206 0 C-N-CA 122.665 2.243 . . . . 0.0 112.332 179.904 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 10' ' ' HIS . . . . . 0.493 ' HA ' ' HA ' ' A' ' 9' ' ' PRO . 5.2 m-70 -131.65 128.59 39.38 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.255 -0.429 . . . . 0.0 110.834 -0.065 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 2.4 t30 58.74 35.92 24.61 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.893 -179.889 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 1.5 m -119.38 152.29 37.05 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.878 179.981 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 13' ' ' VAL . . . . . 0.572 HG12 ' CD ' ' A' ' 60' ' ' ARG . 0.9 OUTLIER -84.55 156.04 3.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.143 -0.481 . . . . 0.0 111.169 179.903 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 14' ' ' TYR . . . . . 0.552 ' CZ ' ' HB2' ' A' ' 8' ' ' LYS . 9.3 m-85 -94.89 100.86 12.66 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.908 -179.889 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 38.1 tt0 -64.92 133.63 52.24 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.079 -0.509 . . . . 0.0 110.892 -179.996 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 1.0 OUTLIER -85.14 133.54 34.2 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.879 -179.949 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 9.3 t80 -121.54 24.89 9.64 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.902 -179.91 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 18' ' ' ASN . . . . . 0.472 ' CB ' ' HB2' ' A' ' 23' ' ' TYR . 9.8 t-20 -154.38 80.26 4.76 Favored Pre-proline 0 C--N 1.329 -0.293 0 CA-C-O 121.647 0.736 . . . . 0.0 110.882 179.959 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -69.76 -23.98 30.19 Favored 'Trans proline' 0 C--N 1.341 0.182 0 C-N-CA 122.702 2.268 . . . . 0.0 112.385 179.922 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 21.4 mtpp -94.52 -24.42 17.28 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.858 179.938 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -102.89 175.98 24.51 Favored Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.763 -0.732 . . . . 0.0 112.46 179.994 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 10.0 p -95.35 26.09 4.02 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.915 0.388 . . . . 0.0 110.874 -179.757 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 23' ' ' TYR . . . . . 0.472 ' HB2' ' CB ' ' A' ' 18' ' ' ASN . 34.4 t80 -44.59 -46.86 10.24 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.953 -179.881 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 53.9 t -65.67 -46.15 80.17 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.073 -0.512 . . . . 0.0 110.884 179.994 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 25' ' ' ASN . . . . . 0.841 ' O ' HG23 ' A' ' 29' ' ' THR . 0.2 OUTLIER -54.68 -51.78 64.45 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.859 -179.965 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -55.22 -52.1 64.45 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.84 179.945 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 27' ' ' LEU . . . . . 0.666 ' O ' HD12 ' A' ' 27' ' ' LEU . 1.8 tp -59.88 -35.55 75.06 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.88 -179.928 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 28' ' ' CYS . . . . . 0.5 ' C ' ' HB3' ' A' ' 33' ' ' ALA . 2.5 m -64.91 -53.2 50.2 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.887 179.919 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 29' ' ' THR . . . . . 0.841 HG23 ' O ' ' A' ' 25' ' ' ASN . 1.1 p -62.63 -24.61 67.69 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.152 -0.476 . . . . 0.0 111.149 -179.981 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 5.6 mt-10 -59.45 -22.12 61.03 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.862 -179.982 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 31' ' ' ASN . . . . . 0.632 ' O ' HG21 ' A' ' 57' ' ' VAL . 3.6 m-80 -103.28 21.81 15.24 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.91 -179.968 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 83.34 18.83 63.6 Favored Glycine 0 N--CA 1.451 -0.332 0 C-N-CA 120.768 -0.729 . . . . 0.0 112.512 -179.999 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 33' ' ' ALA . . . . . 0.875 ' HB2' ' CD1' ' A' ' 53' ' ' LEU . . . -85.08 148.15 26.29 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.774 0.321 . . . . 0.0 111.099 179.954 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . 0.483 ' HB2' ' CB ' ' A' ' 52' ' ' GLN . 7.8 tt0 -74.7 -31.91 62.02 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.883 -179.943 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 53.9 m -162.1 177.13 9.99 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.813 -179.801 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -172.17 151.75 15.45 Favored Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.777 -0.725 . . . . 0.0 112.505 -179.983 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 37' ' ' TYR . . . . . 0.402 ' HE1' ' CD1' ' A' ' 49' ' ' TRP . 1.1 p90 -154.24 160.4 41.8 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 120.944 0.402 . . . . 0.0 110.897 -179.756 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 38' ' ' CYS . . . . . . . . . . . . . 6.1 t -77.23 119.2 20.57 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.856 179.986 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 39' ' ' GLN . . . . . 0.622 ' NE2' ' N ' ' A' ' 42' ' ' GLY . 0.7 OUTLIER -96.01 117.05 29.9 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.908 -179.986 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 40' ' ' ILE . . . . . 0.451 ' HA ' ' ND2' ' A' ' 46' ' ' ASN . 0.8 OUTLIER -96.58 -36.22 6.19 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.131 -0.486 . . . . 0.0 111.109 179.983 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 7.1 mt -84.52 55.88 3.59 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.911 179.895 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . 0.622 ' N ' ' NE2' ' A' ' 39' ' ' GLN . . . -105.27 -167.01 23.87 Favored Glycine 0 N--CA 1.451 -0.336 0 C-N-CA 120.759 -0.734 . . . . 0.0 112.438 179.939 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 43' ' ' LYS . . . . . 0.555 ' HD2' ' CE2' ' A' ' 44' ' ' TYR . 0.4 OUTLIER -101.52 -23.97 14.22 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.822 0.344 . . . . 0.0 110.968 179.982 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 44' ' ' TYR . . . . . 0.555 ' CE2' ' HD2' ' A' ' 43' ' ' LYS . 0.9 OUTLIER -113.21 23.41 13.33 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.938 -179.986 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 92.78 -130.52 10.36 Favored Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.708 -0.758 . . . . 0.0 112.469 179.942 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 46' ' ' ASN . . . . . 0.451 ' ND2' ' HA ' ' A' ' 40' ' ' ILE . 5.5 m120 -92.97 111.6 23.27 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.845 0.355 . . . . 0.0 110.855 -179.838 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 47' ' ' ALA . . . . . 0.409 ' O ' ' HB3' ' A' ' 39' ' ' GLN . . . -129.11 137.76 51.42 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.174 -0.467 . . . . 0.0 111.082 179.898 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 8.5 t -67.88 108.26 2.94 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.889 -179.987 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 49' ' ' TRP . . . . . 0.612 ' CZ3' ' HA ' ' A' ' 4' ' ' ALA . 17.8 t-105 -94.76 116.86 29.25 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.948 179.967 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 50' ' ' CYS . . . . . . . . . . . . . 39.7 m -95.83 143.34 27.14 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.892 -179.982 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 51' ' ' ILE . . . . . 0.928 HG23 ' OD2' ' A' ' 3' ' ' ASP . 3.4 mp -108.96 135.75 46.89 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.113 179.918 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 52' ' ' GLN . . . . . 0.483 ' CB ' ' HB2' ' A' ' 34' ' ' GLU . 22.6 mm-40 63.71 43.99 5.3 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.916 179.963 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 53' ' ' LEU . . . . . 0.875 ' CD1' ' HB2' ' A' ' 33' ' ' ALA . 15.5 tp -85.38 137.43 36.77 Favored Pre-proline 0 C--N 1.329 -0.323 0 CA-C-O 121.666 0.746 . . . . 0.0 110.884 -179.992 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 54' ' ' PRO . . . . . 0.83 ' HG2' HG23 ' A' ' 57' ' ' VAL . 54.0 Cg_endo -69.78 147.78 63.46 Favored 'Trans proline' 0 C--N 1.342 0.221 0 C-N-CA 122.664 2.242 . . . . 0.0 112.398 179.841 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 3.8 m-20 -65.02 -5.96 7.54 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.851 179.974 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 7.8 m120 -78.14 -25.53 47.4 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.954 -179.978 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 57' ' ' VAL . . . . . 0.83 HG23 ' HG2' ' A' ' 54' ' ' PRO . 11.4 t -90.77 136.31 27.96 Favored Pre-proline 0 C--N 1.329 -0.288 0 CA-C-O 121.615 0.722 . . . . 0.0 111.132 179.895 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 58' ' ' PRO . . . . . 0.462 ' HD2' ' CG1' ' A' ' 57' ' ' VAL . 53.8 Cg_endo -69.78 135.77 31.25 Favored 'Trans proline' 0 C--N 1.341 0.161 0 C-N-CA 122.608 2.205 . . . . 0.0 112.353 179.945 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 59' ' ' ILE . . . . . 0.599 ' C ' ' HB2' ' A' ' 7' ' ' ALA . 3.9 pt -109.79 154.31 11.31 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.119 179.959 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 60' ' ' ARG . . . . . 0.572 ' CD ' HG12 ' A' ' 13' ' ' VAL . 8.0 tpt180 -65.34 132.67 49.62 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.86 179.933 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . 0.438 ' N ' ' HD2' ' A' ' 60' ' ' ARG . 1.3 pt -125.76 160.63 55.36 Favored Pre-proline 0 C--N 1.329 -0.306 0 CA-C-O 121.589 0.709 . . . . 0.0 111.125 179.969 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -69.73 65.08 1.79 Allowed 'Trans proline' 0 C--N 1.341 0.14 0 C-N-CA 122.715 2.276 . . . . 0.0 112.333 179.877 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -136.03 -173.67 13.07 Favored Glycine 0 N--CA 1.451 -0.308 0 C-N-CA 120.732 -0.746 . . . . 0.0 112.474 179.994 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 33.6 pttt -84.74 143.13 29.35 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.802 0.334 . . . . 0.0 110.878 -179.989 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 65' ' ' CYS . . . . . 0.506 ' SG ' ' N ' ' A' ' 66' ' ' HIS . 2.6 t -94.28 161.54 14.21 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.851 179.944 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 66' ' ' HIS . . . . . 0.506 ' N ' ' SG ' ' A' ' 65' ' ' CYS . 7.8 p80 . . . . . 0 C--N 1.329 -0.295 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.802 179.93 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.231 0.131 0 CA-C-O 120.811 0.339 . . . . 0.0 111.094 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 2' ' ' ARG . . . . . 0.515 ' NE ' ' OD2' ' A' ' 55' ' ' ASP . 30.3 ptt180 -153.24 164.35 38.24 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.866 -179.908 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 3' ' ' ASP . . . . . 0.581 ' OD1' HG23 ' A' ' 51' ' ' ILE . 1.6 m-20 -100.26 139.69 35.57 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.902 179.943 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 4' ' ' ALA . . . . . 0.588 ' HA ' ' CZ3' ' A' ' 49' ' ' TRP . . . -174.88 177.64 1.97 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.149 179.961 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 5' ' ' TYR . . . . . 0.419 ' CE2' ' HE3' ' A' ' 49' ' ' TRP . 13.8 m-85 -84.63 132.03 34.53 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.918 -179.87 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 6' ' ' ILE . . . . . 0.41 HG23 ' HB2' ' A' ' 14' ' ' TYR . 7.0 tt -72.04 136.03 26.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.124 -0.489 . . . . 0.0 111.135 179.9 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 7' ' ' ALA . . . . . 0.734 ' HB2' ' C ' ' A' ' 59' ' ' ILE . . . -101.51 152.65 20.52 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.189 -0.46 . . . . 0.0 111.102 179.828 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 8' ' ' LYS . . . . . 0.57 ' HD2' ' CE2' ' A' ' 14' ' ' TYR . 0.0 OUTLIER -118.0 172.32 4.23 Favored Pre-proline 0 C--N 1.328 -0.344 0 CA-C-O 121.606 0.717 . . . . 0.0 110.883 179.968 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 9' ' ' PRO . . . . . 0.547 ' HD2' ' CB ' ' A' ' 8' ' ' LYS . 53.9 Cg_endo -69.77 104.65 1.35 Allowed 'Trans proline' 0 C--O 1.231 0.163 0 C-N-CA 122.712 2.274 . . . . 0.0 112.327 179.86 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 10' ' ' HIS . . . . . 0.497 ' HA ' ' HA ' ' A' ' 9' ' ' PRO . 4.3 m-70 -131.91 120.14 22.12 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.89 -0.149 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 11' ' ' ASN . . . . . 0.552 ' N ' ' O ' ' A' ' 8' ' ' LYS . 41.5 t30 73.9 28.88 1.49 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.876 -179.903 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 12' ' ' CYS . . . . . 0.412 ' CB ' ' HG3' ' A' ' 8' ' ' LYS . 1.7 m -97.7 168.09 10.55 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.866 179.939 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 13' ' ' VAL . . . . . 0.78 HG12 ' HG2' ' A' ' 60' ' ' ARG . 0.9 OUTLIER -98.67 142.81 14.14 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.178 179.918 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 14' ' ' TYR . . . . . 0.57 ' CE2' ' HD2' ' A' ' 8' ' ' LYS . 11.2 m-85 -94.51 95.39 8.79 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.916 -179.886 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 4.1 pt-20 -65.01 135.41 55.59 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.878 -179.983 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -105.26 132.19 51.78 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.924 -179.943 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 17' ' ' TYR . . . . . 0.422 ' O ' ' HD3' ' A' ' 19' ' ' PRO . 0.2 OUTLIER -104.85 -38.64 6.58 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.945 -179.881 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 12.0 t-20 -106.22 84.38 1.35 Allowed Pre-proline 0 C--N 1.329 -0.3 0 CA-C-O 121.605 0.717 . . . . 0.0 110.893 179.997 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 19' ' ' PRO . . . . . 0.422 ' HD3' ' O ' ' A' ' 17' ' ' TYR . 53.7 Cg_endo -69.72 -27.39 26.7 Favored 'Trans proline' 0 C--N 1.341 0.164 0 C-N-CA 122.688 2.259 . . . . 0.0 112.322 179.93 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 19.1 mmtt -94.77 24.06 4.99 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.873 179.949 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -134.02 -174.59 13.57 Favored Glycine 0 N--CA 1.452 -0.276 0 C-N-CA 120.732 -0.747 . . . . 0.0 112.474 179.92 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 93.3 p -94.72 27.4 3.08 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.863 0.363 . . . . 0.0 110.797 -179.706 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 5.4 t80 -63.97 -68.2 0.37 Allowed 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.879 -179.852 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 24' ' ' CYS . . . . . 0.404 ' SG ' ' O ' ' A' ' 37' ' ' TYR . 47.3 t -64.89 -35.15 80.23 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.143 -0.481 . . . . 0.0 110.894 179.979 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 25' ' ' ASN . . . . . 0.83 ' O ' HG23 ' A' ' 29' ' ' THR . 3.4 t30 -58.03 -62.41 1.84 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.869 -179.967 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 89.2 m-20 -54.7 -50.49 68.18 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.847 179.944 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 27' ' ' LEU . . . . . 0.726 ' O ' HD12 ' A' ' 27' ' ' LEU . 1.5 tp -59.4 -38.02 79.5 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.884 -179.981 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 28' ' ' CYS . . . . . 0.461 ' SG ' ' SG ' ' A' ' 48' ' ' CYS . 1.9 m -65.15 -55.63 17.55 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.89 179.937 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 29' ' ' THR . . . . . 0.83 HG23 ' O ' ' A' ' 25' ' ' ASN . 1.1 p -64.07 -32.88 74.6 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.099 -179.918 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 32.6 mt-10 -55.66 -21.61 18.91 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.262 -0.427 . . . . 0.0 110.863 179.995 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 31' ' ' ASN . . . . . 0.428 ' ND2' ' O ' ' A' ' 27' ' ' LEU . 1.8 m-80 -104.1 22.47 14.62 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.876 -179.94 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . 0.518 ' O ' ' CD ' ' A' ' 54' ' ' PRO . . . 83.23 69.31 1.39 Allowed Glycine 0 N--CA 1.451 -0.359 0 C-N-CA 120.772 -0.728 . . . . 0.0 112.515 179.97 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 33' ' ' ALA . . . . . 1.031 ' HB2' ' CD1' ' A' ' 53' ' ' LEU . . . -150.11 158.26 43.97 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.779 0.323 . . . . 0.0 111.098 -179.98 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . 0.5 ' HB2' ' CB ' ' A' ' 52' ' ' GLN . 0.9 OUTLIER -73.85 -40.47 63.26 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.877 -179.902 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 66.2 m -163.57 -176.61 4.77 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.822 -179.785 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -175.19 158.48 26.07 Favored Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.72 -0.753 . . . . 0.0 112.461 -179.938 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 37' ' ' TYR . . . . . 0.483 ' C ' ' CD2' ' A' ' 37' ' ' TYR . 0.0 OUTLIER -162.45 171.87 16.43 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.955 0.407 . . . . 0.0 110.908 -179.823 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 38' ' ' CYS . . . . . . . . . . . . . 42.1 t -74.94 127.45 33.24 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.858 -179.976 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 39' ' ' GLN . . . . . 0.519 ' OE1' ' N ' ' A' ' 41' ' ' LEU . 0.0 OUTLIER -105.33 119.46 39.14 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.898 -179.95 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 40' ' ' ILE . . . . . 0.609 HD12 HD21 ' A' ' 46' ' ' ASN . 1.1 mm -88.41 -41.05 13.95 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 116.187 -0.461 . . . . 0.0 111.119 -179.989 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 41' ' ' LEU . . . . . 0.519 ' N ' ' OE1' ' A' ' 39' ' ' GLN . 3.4 mm? -75.32 47.88 0.4 Allowed 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.898 179.923 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -96.57 136.5 12.83 Favored Glycine 0 N--CA 1.451 -0.352 0 C-N-CA 120.762 -0.733 . . . . 0.0 112.519 179.89 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 33.4 mttm -53.93 -25.16 19.05 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 120.782 0.325 . . . . 0.0 110.874 -179.961 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 0.6 OUTLIER -112.28 24.01 13.03 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.889 -179.94 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 94.12 -134.57 12.11 Favored Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 120.722 -0.752 . . . . 0.0 112.51 179.997 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 46' ' ' ASN . . . . . 0.609 HD21 HD12 ' A' ' 40' ' ' ILE . 8.3 m120 -90.65 112.52 24.28 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-O 120.835 0.35 . . . . 0.0 110.907 -179.881 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -132.59 143.1 49.46 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.1 179.881 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 48' ' ' CYS . . . . . 0.461 ' SG ' ' SG ' ' A' ' 28' ' ' CYS . 51.3 t -65.03 107.49 1.53 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.231 -0.441 . . . . 0.0 110.855 -179.918 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 49' ' ' TRP . . . . . 0.588 ' CZ3' ' HA ' ' A' ' 4' ' ' ALA . 22.5 t-105 -94.9 119.57 33.67 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.929 179.997 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 50' ' ' CYS . . . . . 0.435 ' HB2' HD22 ' A' ' 53' ' ' LEU . 34.5 m -96.87 141.76 29.67 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.866 -179.961 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 51' ' ' ILE . . . . . 0.581 HG23 ' OD1' ' A' ' 3' ' ' ASP . 4.0 mp -105.17 135.99 40.9 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.14 179.936 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 52' ' ' GLN . . . . . 0.5 ' CB ' ' HB2' ' A' ' 34' ' ' GLU . 4.3 mm-40 66.99 33.68 5.63 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.944 179.992 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 53' ' ' LEU . . . . . 1.031 ' CD1' ' HB2' ' A' ' 33' ' ' ALA . 12.5 tp -86.16 132.28 43.95 Favored Pre-proline 0 C--N 1.328 -0.334 0 CA-C-O 121.578 0.704 . . . . 0.0 110.966 -180.0 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 54' ' ' PRO . . . . . 0.521 ' HG2' HG23 ' A' ' 57' ' ' VAL . 54.4 Cg_endo -69.65 150.8 69.38 Favored 'Trans proline' 0 C--O 1.231 0.156 0 C-N-CA 122.694 2.263 . . . . 0.0 112.367 179.861 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 55' ' ' ASP . . . . . 0.515 ' OD2' ' NE ' ' A' ' 2' ' ' ARG . 84.6 m-20 -65.42 -5.89 8.84 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.85 179.924 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 99.1 m-20 -74.71 -25.83 59.4 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.9 -179.971 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 57' ' ' VAL . . . . . 0.521 HG23 ' HG2' ' A' ' 54' ' ' PRO . 1.4 t -84.81 137.19 38.28 Favored Pre-proline 0 C--N 1.33 -0.275 0 CA-C-O 121.581 0.705 . . . . 0.0 111.156 179.895 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 58' ' ' PRO . . . . . 0.516 ' HD2' HG12 ' A' ' 57' ' ' VAL . 54.5 Cg_endo -69.71 126.55 13.47 Favored 'Trans proline' 0 C--O 1.231 0.152 0 C-N-CA 122.674 2.249 . . . . 0.0 112.348 179.905 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 59' ' ' ILE . . . . . 0.734 ' C ' ' HB2' ' A' ' 7' ' ' ALA . 4.8 pt -107.03 164.32 4.75 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.165 179.872 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 60' ' ' ARG . . . . . 0.78 ' HG2' HG12 ' A' ' 13' ' ' VAL . 20.4 tpt180 -75.17 119.59 19.52 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.868 179.982 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . 0.489 ' CG1' ' OD1' ' A' ' 11' ' ' ASN . 0.3 OUTLIER -122.51 160.84 46.64 Favored Pre-proline 0 C--N 1.329 -0.311 0 CA-C-O 121.632 0.729 . . . . 0.0 111.12 179.941 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.75 68.99 1.67 Allowed 'Trans proline' 0 C--N 1.342 0.194 0 C-N-CA 122.667 2.244 . . . . 0.0 112.372 179.904 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -144.22 -175.11 17.06 Favored Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.735 -0.745 . . . . 0.0 112.497 179.978 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 26.4 mtmt -84.98 134.88 34.22 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.787 0.327 . . . . 0.0 110.897 -179.976 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 65' ' ' CYS . . . . . 0.472 ' SG ' ' CD2' ' A' ' 66' ' ' HIS . 47.3 t -95.09 163.99 13.07 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.889 179.934 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 66' ' ' HIS . . . . . 0.472 ' CD2' ' SG ' ' A' ' 65' ' ' CYS . 0.6 OUTLIER . . . . . 0 C--N 1.329 -0.293 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.852 179.991 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 1' ' ' ALA . . . . . 0.466 ' HB1' ' O ' ' A' ' 53' ' ' LEU . . . . . . . . 0 C--O 1.231 0.116 0 CA-C-O 120.83 0.347 . . . . 0.0 111.088 . . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 2' ' ' ARG . . . . . 0.589 HH22 HG21 ' A' ' 59' ' ' ILE . 6.3 ptt85 -154.6 159.36 40.81 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.852 -179.94 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 4.7 m-20 -92.62 132.81 36.56 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.878 179.949 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 4' ' ' ALA . . . . . 0.591 ' HA ' ' CZ3' ' A' ' 49' ' ' TRP . . . -175.16 -178.7 1.22 Allowed 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.085 179.988 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 5' ' ' TYR . . . . . 0.498 ' CD1' ' HB3' ' A' ' 47' ' ' ALA . 32.9 m-85 -84.36 131.63 34.68 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.917 -179.862 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 6' ' ' ILE . . . . . 0.534 HG23 ' HD1' ' A' ' 14' ' ' TYR . 3.7 tt -74.26 132.98 32.51 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-N 116.119 -0.491 . . . . 0.0 111.111 179.92 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 7' ' ' ALA . . . . . 0.788 ' HB2' ' C ' ' A' ' 59' ' ' ILE . . . -86.14 155.11 20.9 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.114 179.807 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 8' ' ' LYS . . . . . 0.551 ' HB2' ' CZ ' ' A' ' 14' ' ' TYR . 0.0 OUTLIER -133.54 167.19 24.17 Favored Pre-proline 0 C--N 1.329 -0.312 0 CA-C-O 121.566 0.698 . . . . 0.0 110.905 179.933 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 9' ' ' PRO . . . . . 0.484 ' HA ' ' HA ' ' A' ' 10' ' ' HIS . 53.7 Cg_endo -69.73 105.61 1.51 Allowed 'Trans proline' 0 C--O 1.231 0.154 0 C-N-CA 122.656 2.237 . . . . 0.0 112.363 179.902 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 10' ' ' HIS . . . . . 0.484 ' HA ' ' HA ' ' A' ' 9' ' ' PRO . 6.4 m-70 -131.35 128.94 40.72 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.92 -0.072 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 11' ' ' ASN . . . . . 0.486 ' OD1' ' CG1' ' A' ' 61' ' ' ILE . 3.6 t30 60.23 34.4 20.97 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.836 -179.916 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 12' ' ' CYS . . . . . 0.478 ' HB2' ' CD ' ' A' ' 8' ' ' LYS . 1.6 m -114.53 153.15 30.55 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.884 179.963 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 13' ' ' VAL . . . . . 0.553 HG12 ' CD ' ' A' ' 60' ' ' ARG . 0.9 OUTLIER -84.53 152.38 3.72 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.141 -0.481 . . . . 0.0 111.121 179.947 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 14' ' ' TYR . . . . . 0.551 ' CZ ' ' HB2' ' A' ' 8' ' ' LYS . 9.1 m-85 -94.8 89.56 5.73 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.123 -0.489 . . . . 0.0 110.902 -179.917 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 5.0 tp10 -64.93 136.47 56.86 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.812 -179.947 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 6.6 p -84.46 159.57 20.74 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.114 -0.493 . . . . 0.0 110.906 -179.974 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -96.72 -32.83 11.96 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.923 -179.894 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 18' ' ' ASN . . . . . 0.603 ' CG ' ' HD2' ' A' ' 19' ' ' PRO . 1.8 t-20 -154.41 146.86 17.52 Favored Pre-proline 0 C--N 1.329 -0.284 0 CA-C-O 121.624 0.726 . . . . 0.0 110.862 -179.969 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 19' ' ' PRO . . . . . 0.603 ' HD2' ' CG ' ' A' ' 18' ' ' ASN . 53.8 Cg_endo -69.75 -32.85 17.8 Favored 'Trans proline' 0 C--O 1.232 0.191 0 C-N-CA 122.738 2.292 . . . . 0.0 112.353 179.922 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 20.5 mmtt -94.55 24.56 4.5 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.871 179.892 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -114.63 132.37 10.39 Favored Glycine 0 N--CA 1.452 -0.267 0 C-N-CA 120.758 -0.734 . . . . 0.0 112.458 179.919 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 4.9 m -83.56 24.71 0.83 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.874 0.369 . . . . 0.0 110.838 -179.724 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 7.2 t80 -64.27 -43.15 95.72 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.933 -179.864 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 24' ' ' CYS . . . . . 0.405 ' SG ' ' O ' ' A' ' 37' ' ' TYR . 43.2 t -67.69 -42.75 81.58 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.899 179.971 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 25' ' ' ASN . . . . . 0.869 ' O ' HG23 ' A' ' 29' ' ' THR . 0.8 OUTLIER -55.1 -56.33 21.07 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.926 179.995 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 55.2 m-20 -55.3 -52.22 64.16 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.895 179.897 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 27' ' ' LEU . . . . . 0.705 ' O ' HD12 ' A' ' 27' ' ' LEU . 1.7 tp -58.24 -38.88 77.74 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.915 -179.962 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 28' ' ' CYS . . . . . 0.565 ' C ' ' HB3' ' A' ' 33' ' ' ALA . 11.0 m -62.12 -51.27 68.58 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.919 179.895 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 29' ' ' THR . . . . . 0.869 HG23 ' O ' ' A' ' 25' ' ' ASN . 1.1 p -62.99 -24.75 68.06 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.129 -0.487 . . . . 0.0 111.172 -179.964 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 19.5 tp10 -59.2 -22.82 61.63 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.864 -179.966 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 31' ' ' ASN . . . . . 0.625 ' O ' HG21 ' A' ' 57' ' ' VAL . 1.8 m-80 -103.7 22.02 15.15 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.9 -179.956 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 83.29 19.96 61.46 Favored Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.755 -0.736 . . . . 0.0 112.456 -179.995 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 33' ' ' ALA . . . . . 0.779 ' HB2' HD13 ' A' ' 53' ' ' LEU . . . -85.16 147.7 26.48 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.776 0.322 . . . . 0.0 111.099 179.936 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . 0.493 ' HB2' ' CB ' ' A' ' 52' ' ' GLN . 5.8 tp10 -74.72 -31.37 61.82 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.911 -179.933 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 1.9 m -162.27 177.62 9.44 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.873 -179.829 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 36' ' ' GLY . . . . . 0.458 ' CA ' ' HA ' ' A' ' 25' ' ' ASN . . . -174.23 154.71 19.89 Favored Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 120.68 -0.772 . . . . 0.0 112.423 -179.924 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 37' ' ' TYR . . . . . 0.405 ' O ' ' SG ' ' A' ' 24' ' ' CYS . 48.8 p90 -165.35 166.37 18.68 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.964 0.411 . . . . 0.0 110.897 -179.819 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 38' ' ' CYS . . . . . . . . . . . . . 13.2 t -74.81 120.81 20.86 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.869 -179.985 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 39' ' ' GLN . . . . . 0.5 ' NE2' ' CD2' ' A' ' 49' ' ' TRP . 0.0 OUTLIER -104.06 127.29 51.62 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.899 -179.974 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 40' ' ' ILE . . . . . 0.908 HG23 HD21 ' A' ' 46' ' ' ASN . 0.7 OUTLIER -95.53 -31.1 4.1 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.095 179.97 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 2.0 tt -77.28 47.08 0.54 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.934 179.919 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -101.77 138.87 14.13 Favored Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.711 -0.757 . . . . 0.0 112.485 179.881 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 1.8 mtmm -57.37 -24.65 56.57 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.768 0.318 . . . . 0.0 110.881 -179.944 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 1.1 m-85 -111.08 23.43 14.12 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.931 -179.946 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 93.22 -137.63 13.72 Favored Glycine 0 N--CA 1.451 -0.344 0 C-N-CA 120.719 -0.753 . . . . 0.0 112.498 179.992 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 46' ' ' ASN . . . . . 0.908 HD21 HG23 ' A' ' 40' ' ' ILE . 18.8 m120 -86.45 117.76 25.45 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.85 0.357 . . . . 0.0 110.863 -179.894 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 47' ' ' ALA . . . . . 0.498 ' HB3' ' CD1' ' A' ' 5' ' ' TYR . . . -135.75 147.27 48.36 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.098 179.864 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 24.1 t -66.67 108.19 2.39 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.842 -179.957 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 49' ' ' TRP . . . . . 0.591 ' CZ3' ' HA ' ' A' ' 4' ' ' ALA . 53.6 t-105 -94.39 112.62 24.41 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.907 179.957 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 50' ' ' CYS . . . . . . . . . . . . . 34.8 m -95.12 142.41 27.6 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.913 179.969 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 51' ' ' ILE . . . . . 0.406 ' O ' ' HB2' ' A' ' 52' ' ' GLN . 3.8 mm -106.62 133.81 50.08 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.109 179.94 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 52' ' ' GLN . . . . . 0.493 ' CB ' ' HB2' ' A' ' 34' ' ' GLU . 3.4 mm-40 64.77 45.36 3.39 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.88 179.925 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 53' ' ' LEU . . . . . 0.779 HD13 ' HB2' ' A' ' 33' ' ' ALA . 14.6 tp -85.67 134.79 39.09 Favored Pre-proline 0 C--N 1.329 -0.307 0 CA-C-O 121.548 0.689 . . . . 0.0 110.942 -179.997 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 54' ' ' PRO . . . . . 0.847 ' HG2' HG23 ' A' ' 57' ' ' VAL . 53.9 Cg_endo -69.7 146.5 60.73 Favored 'Trans proline' 0 C--O 1.231 0.144 0 C-N-CA 122.668 2.245 . . . . 0.0 112.385 179.864 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 3.4 m-20 -65.18 -5.58 7.19 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.848 179.958 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 10.9 m120 -79.26 -26.39 42.4 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.921 -179.953 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 57' ' ' VAL . . . . . 0.847 HG23 ' HG2' ' A' ' 54' ' ' PRO . 21.3 t -88.85 136.7 30.48 Favored Pre-proline 0 C--N 1.33 -0.265 0 CA-C-O 121.571 0.701 . . . . 0.0 111.164 179.861 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 58' ' ' PRO . . . . . 0.471 ' HD2' HG13 ' A' ' 57' ' ' VAL . 53.6 Cg_endo -69.76 143.26 50.26 Favored 'Trans proline' 0 C--N 1.341 0.181 0 C-N-CA 122.71 2.273 . . . . 0.0 112.345 179.974 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 59' ' ' ILE . . . . . 0.788 ' C ' ' HB2' ' A' ' 7' ' ' ALA . 5.2 pt -117.03 168.9 7.95 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-N 116.255 -0.43 . . . . 0.0 111.156 179.895 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 60' ' ' ARG . . . . . 0.553 ' CD ' HG12 ' A' ' 13' ' ' VAL . 13.7 tpt180 -75.22 121.52 22.26 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.841 179.957 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . 0.653 HD13 ' N ' ' A' ' 61' ' ' ILE . 0.0 OUTLIER -110.26 160.46 28.25 Favored Pre-proline 0 C--N 1.329 -0.299 0 CA-C-O 121.589 0.709 . . . . 0.0 111.157 179.952 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -69.76 64.89 1.8 Allowed 'Trans proline' 0 C--N 1.341 0.16 0 C-N-CA 122.693 2.262 . . . . 0.0 112.381 179.84 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -142.56 -174.15 14.85 Favored Glycine 0 N--CA 1.451 -0.344 0 C-N-CA 120.739 -0.743 . . . . 0.0 112.476 180.0 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -85.16 151.23 24.26 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 120.797 0.332 . . . . 0.0 110.956 179.968 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 65' ' ' CYS . . . . . 0.601 ' SG ' ' CD2' ' A' ' 66' ' ' HIS . 1.2 t -95.13 160.92 14.33 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.885 179.953 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 66' ' ' HIS . . . . . 0.601 ' CD2' ' SG ' ' A' ' 65' ' ' CYS . 1.0 OUTLIER . . . . . 0 C--N 1.329 -0.31 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.857 179.981 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 1' ' ' ALA . . . . . 0.812 ' HB3' ' C ' ' A' ' 52' ' ' GLN . . . . . . . . 0 C--O 1.231 0.123 0 CA-C-O 120.759 0.314 . . . . 0.0 111.09 . . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 2' ' ' ARG . . . . . 0.528 ' NH1' HD13 ' A' ' 59' ' ' ILE . 3.3 ptm180 -90.71 -175.52 4.42 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.85 -179.922 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -145.55 121.43 10.62 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.892 179.979 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 4' ' ' ALA . . . . . 0.588 ' HA ' ' CZ3' ' A' ' 49' ' ' TRP . . . -173.89 -172.24 0.72 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.082 179.984 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 5' ' ' TYR . . . . . 0.546 ' CE1' ' HB2' ' A' ' 49' ' ' TRP . 66.9 m-85 -84.23 137.68 33.35 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.92 -179.883 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 6' ' ' ILE . . . . . 0.449 HG23 ' HD1' ' A' ' 14' ' ' TYR . 6.9 tt -75.39 143.84 12.77 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.074 -0.512 . . . . 0.0 111.12 179.924 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -84.6 165.1 18.26 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.2 -0.454 . . . . 0.0 111.113 179.792 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 8' ' ' LYS . . . . . 0.578 ' HB2' ' CE2' ' A' ' 14' ' ' TYR . 0.1 OUTLIER -145.41 165.57 21.06 Favored Pre-proline 0 C--N 1.329 -0.318 0 CA-C-O 121.565 0.698 . . . . 0.0 110.903 -179.973 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 9' ' ' PRO . . . . . 0.483 ' HA ' ' HA ' ' A' ' 10' ' ' HIS . 53.7 Cg_endo -69.78 105.77 1.55 Allowed 'Trans proline' 0 C--N 1.341 0.175 0 C-N-CA 122.691 2.26 . . . . 0.0 112.34 179.909 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 10' ' ' HIS . . . . . 0.483 ' HA ' ' HA ' ' A' ' 9' ' ' PRO . 8.1 m-70 -132.61 122.5 24.81 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.887 -0.127 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 11' ' ' ASN . . . . . 0.479 ' OD1' HD11 ' A' ' 61' ' ' ILE . 3.2 t30 71.73 20.68 4.54 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.893 -179.902 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 12' ' ' CYS . . . . . 0.448 ' HB2' ' HG2' ' A' ' 8' ' ' LYS . 1.5 m -109.57 168.64 9.25 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.892 -179.999 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 13' ' ' VAL . . . . . 0.767 HG12 ' HG2' ' A' ' 60' ' ' ARG . 0.9 OUTLIER -90.8 156.08 3.04 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.135 179.939 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 14' ' ' TYR . . . . . 0.578 ' CE2' ' HB2' ' A' ' 8' ' ' LYS . 4.1 m-85 -94.26 87.0 5.09 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.929 -179.921 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 30.6 tt0 -64.59 120.67 12.81 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.853 -179.986 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 16' ' ' CYS . . . . . 1.147 ' SG ' ' SG ' ' A' ' 24' ' ' CYS . 0.7 OUTLIER -104.45 171.56 7.27 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.158 -0.473 . . . . 0.0 110.894 -179.963 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 17' ' ' TYR . . . . . 0.446 ' O ' ' HD3' ' A' ' 19' ' ' PRO . 67.4 t80 -125.7 -23.79 3.96 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.899 -179.833 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 10.4 t-20 -105.64 85.0 1.32 Allowed Pre-proline 0 C--N 1.329 -0.286 0 CA-C-O 121.626 0.726 . . . . 0.0 110.89 -179.997 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 19' ' ' PRO . . . . . 0.446 ' HD3' ' O ' ' A' ' 17' ' ' TYR . 53.5 Cg_endo -69.88 -24.89 28.6 Favored 'Trans proline' 0 C--N 1.341 0.17 0 C-N-CA 122.636 2.224 . . . . 0.0 112.317 179.983 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 28.6 mmtm -94.4 -24.59 17.29 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.85 179.931 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -80.21 -174.7 47.78 Favored Glycine 0 N--CA 1.452 -0.287 0 C-N-CA 120.737 -0.744 . . . . 0.0 112.496 179.927 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 26.1 m -95.62 25.72 4.38 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.855 0.36 . . . . 0.0 110.814 -179.718 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 1.1 t80 -59.58 -66.88 0.44 Allowed 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.938 -179.894 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 24' ' ' CYS . . . . . 1.147 ' SG ' ' SG ' ' A' ' 16' ' ' CYS . 19.7 m -67.0 -37.39 84.12 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.141 -0.482 . . . . 0.0 110.913 179.953 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 25' ' ' ASN . . . . . 0.783 ' O ' HG23 ' A' ' 29' ' ' THR . 2.5 t30 -57.34 -58.92 6.13 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.114 -0.493 . . . . 0.0 110.891 -179.968 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 12.4 m-20 -56.22 -53.34 58.3 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.9 179.9 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 27' ' ' LEU . . . . . 0.66 ' O ' HD12 ' A' ' 27' ' ' LEU . 1.8 tp -58.99 -35.5 73.32 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.956 -179.962 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 28' ' ' CYS . . . . . 0.471 ' O ' ' HB3' ' A' ' 33' ' ' ALA . 1.7 m -64.36 -58.83 5.37 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.879 179.874 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 29' ' ' THR . . . . . 0.783 HG23 ' O ' ' A' ' 25' ' ' ASN . 1.1 p -62.7 -28.39 69.91 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.124 -0.489 . . . . 0.0 111.143 -179.92 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 41.3 tt0 -55.17 -20.56 10.69 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.866 -179.999 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 31' ' ' ASN . . . . . 0.671 ' O ' HG21 ' A' ' 57' ' ' VAL . 2.0 m-80 -102.51 22.36 13.65 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.878 -179.94 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 95.35 -12.58 67.83 Favored Glycine 0 N--CA 1.452 -0.265 0 C-N-CA 120.766 -0.73 . . . . 0.0 112.497 179.977 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 33' ' ' ALA . . . . . 0.941 ' HB2' HD13 ' A' ' 53' ' ' LEU . . . -62.03 162.23 9.6 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.744 0.306 . . . . 0.0 111.131 179.959 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . 0.482 ' HB2' ' CB ' ' A' ' 52' ' ' GLN . 11.5 tp10 -90.33 -29.72 17.91 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.9 -179.91 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 15.6 m -162.41 179.62 7.68 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.838 -179.799 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -167.97 161.03 34.79 Favored Glycine 0 N--CA 1.452 -0.28 0 C-N-CA 120.721 -0.752 . . . . 0.0 112.47 -179.991 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 37' ' ' TYR . . . . . 0.619 ' CE2' ' CD1' ' A' ' 49' ' ' TRP . 3.3 p90 -162.44 151.86 15.71 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 120.953 0.406 . . . . 0.0 110.939 -179.828 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 38' ' ' CYS . . . . . 0.4 ' CB ' ' HA ' ' A' ' 19' ' ' PRO . 2.0 t -80.32 119.45 23.06 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.88 -179.969 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 39' ' ' GLN . . . . . 0.487 ' OE1' ' N ' ' A' ' 42' ' ' GLY . 1.4 tm0? -105.21 108.59 20.19 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.896 -179.943 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 40' ' ' ILE . . . . . 0.984 ' O ' HD12 ' A' ' 40' ' ' ILE . 0.1 OUTLIER -81.84 -35.79 13.76 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.153 179.983 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 41' ' ' LEU . . . . . 0.439 ' N ' HG13 ' A' ' 40' ' ' ILE . 3.4 mt -78.93 48.01 0.8 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.903 179.913 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . 0.487 ' N ' ' OE1' ' A' ' 39' ' ' GLN . . . -98.66 -179.71 32.01 Favored Glycine 0 N--CA 1.451 -0.303 0 C-N-CA 120.734 -0.746 . . . . 0.0 112.45 179.926 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 43' ' ' LYS . . . . . 0.56 ' HG2' ' CD1' ' A' ' 44' ' ' TYR . 0.3 OUTLIER -83.05 -26.83 30.76 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.787 0.327 . . . . 0.0 110.885 -179.983 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 44' ' ' TYR . . . . . 0.56 ' CD1' ' HG2' ' A' ' 43' ' ' LYS . 1.0 OUTLIER -114.31 24.45 11.92 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.907 -179.968 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 94.42 -133.96 11.81 Favored Glycine 0 N--CA 1.451 -0.342 0 C-N-CA 120.731 -0.747 . . . . 0.0 112.463 179.933 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 3.0 m120 -92.55 109.39 20.79 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 120.843 0.354 . . . . 0.0 110.893 -179.941 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -125.61 140.39 52.77 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.08 179.855 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 3.1 m -66.25 111.27 3.38 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.904 -179.96 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 49' ' ' TRP . . . . . 0.619 ' CD1' ' CE2' ' A' ' 37' ' ' TYR . 45.0 t-105 -94.78 115.13 27.12 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.931 180.0 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 50' ' ' CYS . . . . . . . . . . . . . 33.4 m -97.66 142.72 29.1 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.899 179.994 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 51' ' ' ILE . . . . . 0.495 HD11 ' CD2' ' A' ' 37' ' ' TYR . 4.0 mp -110.97 137.62 42.65 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.14 179.895 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 52' ' ' GLN . . . . . 0.812 ' C ' ' HB3' ' A' ' 1' ' ' ALA . 36.2 mm-40 65.02 41.92 4.42 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.914 179.922 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 53' ' ' LEU . . . . . 0.941 HD13 ' HB2' ' A' ' 33' ' ' ALA . 15.7 tp -85.57 136.16 37.53 Favored Pre-proline 0 C--N 1.328 -0.327 0 CA-C-O 121.568 0.699 . . . . 0.0 110.969 179.961 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 54' ' ' PRO . . . . . 0.875 ' HG2' HG23 ' A' ' 57' ' ' VAL . 53.4 Cg_endo -69.8 147.68 63.12 Favored 'Trans proline' 0 C--N 1.341 0.174 0 C-N-CA 122.701 2.267 . . . . 0.0 112.299 179.93 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 74.3 m-20 -65.03 -5.3 6.01 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.858 179.899 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 5.1 m120 -79.64 -30.28 41.28 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.87 -179.899 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 57' ' ' VAL . . . . . 0.875 HG23 ' HG2' ' A' ' 54' ' ' PRO . 15.5 t -86.55 136.36 35.13 Favored Pre-proline 0 C--N 1.329 -0.307 0 CA-C-O 121.617 0.722 . . . . 0.0 111.134 179.928 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 58' ' ' PRO . . . . . 0.465 ' HD2' ' CG1' ' A' ' 57' ' ' VAL . 54.4 Cg_endo -69.75 141.77 46.15 Favored 'Trans proline' 0 C--O 1.231 0.167 0 C-N-CA 122.681 2.254 . . . . 0.0 112.391 179.939 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 59' ' ' ILE . . . . . 0.528 HD13 ' NH1' ' A' ' 2' ' ' ARG . 5.0 pt -118.61 157.65 20.07 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.104 179.967 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 60' ' ' ARG . . . . . 0.767 ' HG2' HG12 ' A' ' 13' ' ' VAL . 9.3 tpt180 -68.72 117.39 10.37 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.925 179.933 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . 0.479 HD11 ' OD1' ' A' ' 11' ' ' ASN . 1.3 pp -123.21 160.66 49.01 Favored Pre-proline 0 C--N 1.329 -0.308 0 CA-C-O 121.669 0.747 . . . . 0.0 111.118 179.983 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.75 73.39 1.37 Allowed 'Trans proline' 0 C--N 1.342 0.194 0 C-N-CA 122.66 2.24 . . . . 0.0 112.362 179.901 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -135.2 -175.38 13.82 Favored Glycine 0 N--CA 1.451 -0.344 0 C-N-CA 120.705 -0.76 . . . . 0.0 112.479 179.985 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -84.88 115.35 22.72 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.855 0.359 . . . . 0.0 110.897 -179.97 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 65' ' ' CYS . . . . . 0.487 ' O ' ' CG ' ' A' ' 66' ' ' HIS . 8.4 t -94.46 159.66 15.0 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.894 179.977 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 66' ' ' HIS . . . . . 0.487 ' CG ' ' O ' ' A' ' 65' ' ' CYS . 28.8 p80 . . . . . 0 C--N 1.329 -0.318 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.87 179.949 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.232 0.155 0 CA-C-O 120.803 0.335 . . . . 0.0 111.07 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 16.1 ptt180 -152.55 171.43 18.14 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.871 -179.885 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 15.5 m-20 -99.63 130.49 45.87 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.868 179.961 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 4' ' ' ALA . . . . . 0.585 ' HA ' ' CZ3' ' A' ' 49' ' ' TRP . . . -174.94 -178.98 1.31 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.107 179.966 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 19.6 m-85 -84.6 135.33 34.24 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.896 -179.833 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 6' ' ' ILE . . . . . 0.456 HG12 ' CD1' ' A' ' 14' ' ' TYR . 3.1 tt -72.31 133.16 32.33 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.104 -0.498 . . . . 0.0 111.138 179.927 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 7' ' ' ALA . . . . . 0.855 ' HB2' ' C ' ' A' ' 59' ' ' ILE . . . -92.46 143.09 26.71 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.209 -0.45 . . . . 0.0 111.102 179.815 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 8' ' ' LYS . . . . . 0.538 ' HB2' ' CZ ' ' A' ' 14' ' ' TYR . 0.0 OUTLIER -115.09 167.29 10.09 Favored Pre-proline 0 C--N 1.329 -0.316 0 CA-C-O 121.533 0.682 . . . . 0.0 110.907 179.98 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 9' ' ' PRO . . . . . 0.487 ' HA ' ' HA ' ' A' ' 10' ' ' HIS . 54.0 Cg_endo -69.74 103.89 1.23 Allowed 'Trans proline' 0 C--O 1.232 0.202 0 C-N-CA 122.641 2.227 . . . . 0.0 112.359 179.905 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 10' ' ' HIS . . . . . 0.487 ' HA ' ' HA ' ' A' ' 9' ' ' PRO . 2.9 m-70 -129.62 130.12 45.21 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.865 -0.053 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 11' ' ' ASN . . . . . 0.501 ' N ' ' O ' ' A' ' 8' ' ' LYS . 54.6 t-20 58.83 59.74 2.74 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.929 -179.914 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 12' ' ' CYS . . . . . 0.493 ' HB2' ' CD ' ' A' ' 8' ' ' LYS . 1.7 m -139.51 156.76 46.72 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.908 -179.982 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 13' ' ' VAL . . . . . 0.432 ' CG1' ' HE ' ' A' ' 60' ' ' ARG . 2.4 m -84.69 147.74 5.38 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.138 179.886 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 14' ' ' TYR . . . . . 0.538 ' CZ ' ' HB2' ' A' ' 8' ' ' LYS . 11.1 m-85 -94.67 101.01 12.84 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.909 -179.923 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 18.1 pt-20 -64.56 125.25 24.11 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.073 -0.512 . . . . 0.0 110.893 -180.0 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -101.99 135.35 43.71 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.86 -179.912 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 9.5 t80 -115.14 24.86 11.33 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.916 -179.902 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 18' ' ' ASN . . . . . 0.458 ' ND2' ' H ' ' A' ' 21' ' ' GLY . 0.2 OUTLIER -153.07 74.07 6.92 Favored Pre-proline 0 C--N 1.329 -0.309 0 CA-C-O 121.624 0.726 . . . . 0.0 110.849 -179.998 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.76 -19.89 35.54 Favored 'Trans proline' 0 C--O 1.232 0.18 0 C-N-CA 122.714 2.276 . . . . 0.0 112.317 179.903 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 56.8 mttm -94.16 -24.27 17.6 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.915 179.917 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 21' ' ' GLY . . . . . 0.458 ' H ' ' ND2' ' A' ' 18' ' ' ASN . . . -93.93 -176.99 39.51 Favored Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.702 -0.761 . . . . 0.0 112.468 179.925 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 52.6 p -95.49 25.83 4.25 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.906 0.384 . . . . 0.0 110.853 -179.721 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 23' ' ' TYR . . . . . 0.419 ' CD2' ' C ' ' A' ' 23' ' ' TYR . 1.1 t80 -55.0 -69.46 0.13 Allowed 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.91 -179.885 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 50.4 t -56.99 -36.61 70.56 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.103 -0.498 . . . . 0.0 110.905 179.966 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -57.87 -55.09 39.43 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.9 -179.946 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 47.7 m-20 -57.88 -52.71 64.35 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.174 -0.467 . . . . 0.0 110.794 179.958 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 27' ' ' LEU . . . . . 0.683 ' O ' HD12 ' A' ' 27' ' ' LEU . 1.7 tp -59.54 -37.4 78.3 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.965 -179.945 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 1.3 m -65.25 -54.53 27.97 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.874 179.884 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 29' ' ' THR . . . . . 0.617 HG22 ' O ' ' A' ' 33' ' ' ALA . 13.2 p -62.73 -29.15 70.46 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.139 -179.951 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 7.4 tp10 -54.69 -19.17 5.65 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.903 -179.981 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 31' ' ' ASN . . . . . 0.675 ' O ' HG21 ' A' ' 57' ' ' VAL . 2.3 m-80 -101.64 21.41 14.44 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.913 -179.946 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 95.5 -12.73 67.5 Favored Glycine 0 N--CA 1.452 -0.268 0 C-N-CA 120.682 -0.771 . . . . 0.0 112.463 -179.992 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 33' ' ' ALA . . . . . 0.91 ' HB2' HD13 ' A' ' 53' ' ' LEU . . . -61.75 153.91 27.1 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.729 0.3 . . . . 0.0 111.11 179.994 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . 0.424 ' CD ' ' HB3' ' A' ' 52' ' ' GLN . 67.0 mt-10 -85.6 -24.79 27.01 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.929 -179.959 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 12.4 m -161.99 177.88 9.37 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.841 -179.799 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -175.44 158.39 25.65 Favored Glycine 0 N--CA 1.452 -0.263 0 C-N-CA 120.722 -0.751 . . . . 0.0 112.448 -179.973 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 32.6 p90 -164.83 166.86 19.35 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.91 0.386 . . . . 0.0 110.904 -179.831 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 38' ' ' CYS . . . . . . . . . . . . . 4.1 t -75.33 124.3 26.87 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.11 -0.496 . . . . 0.0 110.857 179.996 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 2.4 tt0 -105.19 118.18 35.89 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.9 -179.978 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 40' ' ' ILE . . . . . 0.463 ' HA ' ' ND2' ' A' ' 46' ' ' ASN . 0.9 OUTLIER -88.3 -29.32 5.38 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.102 179.974 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 14.0 mt -82.58 38.91 0.58 Allowed 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.924 179.935 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -87.91 139.14 15.59 Favored Glycine 0 N--CA 1.45 -0.367 0 C-N-CA 120.762 -0.732 . . . . 0.0 112.479 179.92 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 39.1 mttp -53.79 -25.09 17.54 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.856 0.36 . . . . 0.0 110.904 -179.953 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 0.4 OUTLIER -113.85 24.41 12.11 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.945 179.992 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 94.3 -137.58 13.59 Favored Glycine 0 N--CA 1.452 -0.288 0 C-N-CA 120.736 -0.745 . . . . 0.0 112.445 179.962 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 46' ' ' ASN . . . . . 0.463 ' ND2' ' HA ' ' A' ' 40' ' ' ILE . 11.0 m120 -85.69 111.53 20.19 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.826 0.346 . . . . 0.0 110.907 -179.848 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -130.62 145.51 51.92 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.109 179.91 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 14.6 t -65.44 110.29 2.61 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.899 -179.985 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 49' ' ' TRP . . . . . 0.585 ' CZ3' ' HA ' ' A' ' 4' ' ' ALA . 41.6 t-105 -94.97 127.33 40.94 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.949 179.971 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 50' ' ' CYS . . . . . . . . . . . . . 29.9 m -108.41 141.02 40.88 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.841 -179.953 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 51' ' ' ILE . . . . . 0.665 HG22 ' HG2' ' A' ' 52' ' ' GLN . 4.0 mm -108.06 130.99 59.64 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.126 179.917 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 52' ' ' GLN . . . . . 0.665 ' HG2' HG22 ' A' ' 51' ' ' ILE . 4.0 mm-40 67.72 43.08 1.87 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.921 179.955 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 53' ' ' LEU . . . . . 0.91 HD13 ' HB2' ' A' ' 33' ' ' ALA . 15.1 tp -85.6 135.53 38.19 Favored Pre-proline 0 C--N 1.328 -0.339 0 CA-C-O 121.582 0.706 . . . . 0.0 110.949 -179.955 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 54' ' ' PRO . . . . . 0.802 ' HG2' HG23 ' A' ' 57' ' ' VAL . 53.6 Cg_endo -69.81 145.68 57.6 Favored 'Trans proline' 0 C--N 1.341 0.179 0 C-N-CA 122.697 2.265 . . . . 0.0 112.31 179.914 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -61.4 -9.1 4.79 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.867 179.936 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 67.6 m-20 -74.85 -24.84 58.65 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.872 -179.867 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 57' ' ' VAL . . . . . 0.802 HG23 ' HG2' ' A' ' 54' ' ' PRO . 11.1 t -90.31 136.29 28.7 Favored Pre-proline 0 C--N 1.329 -0.305 0 CA-C-O 121.622 0.725 . . . . 0.0 111.12 179.883 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 58' ' ' PRO . . . . . 0.467 ' HD2' ' CG1' ' A' ' 57' ' ' VAL . 53.8 Cg_endo -69.77 146.59 60.57 Favored 'Trans proline' 0 C--O 1.232 0.181 0 C-N-CA 122.68 2.253 . . . . 0.0 112.37 179.924 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 59' ' ' ILE . . . . . 0.855 ' C ' ' HB2' ' A' ' 7' ' ' ALA . 10.2 pt -123.89 159.98 28.37 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.116 179.964 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 60' ' ' ARG . . . . . 0.446 ' HD3' ' C ' ' A' ' 60' ' ' ARG . 2.9 tpp180 -64.66 111.19 2.64 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.885 179.924 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . 0.483 HG13 ' ND2' ' A' ' 11' ' ' ASN . 0.6 OUTLIER -110.48 161.74 23.39 Favored Pre-proline 0 C--N 1.329 -0.3 0 CA-C-O 121.625 0.726 . . . . 0.0 111.154 179.933 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -69.79 69.75 1.64 Allowed 'Trans proline' 0 C--N 1.342 0.199 0 C-N-CA 122.703 2.269 . . . . 0.0 112.342 179.851 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -144.95 -171.94 15.06 Favored Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.752 -0.737 . . . . 0.0 112.514 179.955 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 9.2 ptpt -85.47 131.23 34.41 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.836 0.35 . . . . 0.0 110.883 -179.964 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 65' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -91.06 140.58 29.7 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.872 179.953 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 66' ' ' HIS . . . . . 0.496 ' CG ' ' O ' ' A' ' 66' ' ' HIS . 26.9 p80 . . . . . 0 C--N 1.33 -0.279 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.824 179.95 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 1' ' ' ALA . . . . . 0.619 ' HB1' ' O ' ' A' ' 53' ' ' LEU . . . . . . . . 0 C--O 1.231 0.127 0 CA-C-O 120.8 0.333 . . . . 0.0 111.113 . . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 2' ' ' ARG . . . . . 0.441 ' NH1' ' O ' ' A' ' 53' ' ' LEU . 0.0 OUTLIER -136.8 157.04 47.67 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.894 -179.897 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 3' ' ' ASP . . . . . 0.724 ' OD2' HG23 ' A' ' 51' ' ' ILE . 3.0 m-20 -92.34 133.9 35.42 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.898 179.976 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 4' ' ' ALA . . . . . 0.588 ' HA ' ' CZ3' ' A' ' 49' ' ' TRP . . . -173.94 -179.24 1.68 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.101 179.926 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 5' ' ' TYR . . . . . 0.438 ' CD1' ' HB3' ' A' ' 47' ' ' ALA . 21.6 m-85 -84.99 136.41 33.6 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.948 -179.852 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 6' ' ' ILE . . . . . 0.592 HG23 ' HD2' ' A' ' 14' ' ' TYR . 3.5 tt -75.34 135.63 26.75 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-N 116.115 -0.493 . . . . 0.0 111.176 179.901 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 7' ' ' ALA . . . . . 0.513 ' HB2' ' C ' ' A' ' 59' ' ' ILE . . . -85.56 150.98 24.28 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.096 179.849 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 8' ' ' LYS . . . . . 0.554 ' HB2' ' CZ ' ' A' ' 14' ' ' TYR . 0.0 OUTLIER -133.12 166.9 25.88 Favored Pre-proline 0 C--N 1.329 -0.285 0 CA-C-O 121.54 0.686 . . . . 0.0 110.903 179.994 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 9' ' ' PRO . . . . . 0.426 ' HA ' ' HA ' ' A' ' 10' ' ' HIS . 53.6 Cg_endo -69.79 105.53 1.51 Allowed 'Trans proline' 0 C--O 1.232 0.192 0 C-N-CA 122.646 2.231 . . . . 0.0 112.361 179.875 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 10' ' ' HIS . . . . . 0.426 ' HA ' ' HA ' ' A' ' 9' ' ' PRO . 4.1 m-70 -131.28 128.97 40.91 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.872 -0.061 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 11' ' ' ASN . . . . . 0.615 ' OD1' HD11 ' A' ' 61' ' ' ILE . 3.6 t30 59.14 44.52 15.78 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.865 -179.957 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 12' ' ' CYS . . . . . 0.468 ' HB2' ' CE ' ' A' ' 8' ' ' LYS . 1.4 m -129.93 157.56 41.96 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.873 179.978 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 13' ' ' VAL . . . . . 0.532 ' HB ' ' HB1' ' A' ' 47' ' ' ALA . 1.3 m -85.91 155.39 3.42 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.131 -0.486 . . . . 0.0 111.15 179.912 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 14' ' ' TYR . . . . . 0.592 ' HD2' HG23 ' A' ' 6' ' ' ILE . 9.5 m-85 -94.45 94.87 8.49 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.939 -179.94 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 1.8 pm0 -64.6 133.98 53.38 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.869 -179.978 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 1.8 p -84.74 159.92 20.39 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.873 -179.96 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 8.4 t80 -95.47 -32.51 12.85 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.899 -179.865 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 18' ' ' ASN . . . . . 0.605 ' CG ' ' HD2' ' A' ' 19' ' ' PRO . 1.8 t-20 -154.7 147.0 17.46 Favored Pre-proline 0 C--N 1.329 -0.286 0 CA-C-O 121.604 0.716 . . . . 0.0 110.87 179.971 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 19' ' ' PRO . . . . . 0.605 ' HD2' ' CG ' ' A' ' 18' ' ' ASN . 54.1 Cg_endo -69.73 -31.45 20.62 Favored 'Trans proline' 0 C--O 1.231 0.166 0 C-N-CA 122.714 2.276 . . . . 0.0 112.348 179.918 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 2.0 mmmm -94.48 24.57 4.45 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.874 179.934 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -114.75 132.85 10.67 Favored Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.732 -0.747 . . . . 0.0 112.495 179.907 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 67.4 m -83.67 24.87 0.82 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.874 0.369 . . . . 0.0 110.819 -179.712 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 23' ' ' TYR . . . . . 0.42 ' O ' ' CD1' ' A' ' 23' ' ' TYR . 2.6 t80 -64.54 -41.24 96.48 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.134 -0.484 . . . . 0.0 110.916 -179.902 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 24' ' ' CYS . . . . . 0.409 ' SG ' ' O ' ' A' ' 37' ' ' TYR . 47.8 t -69.4 -43.12 74.09 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.866 -179.993 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 25' ' ' ASN . . . . . 0.858 ' O ' HG23 ' A' ' 29' ' ' THR . 1.9 t30 -55.12 -56.39 20.44 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.855 -179.992 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 9.5 m-20 -56.13 -52.3 64.84 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.893 179.939 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 27' ' ' LEU . . . . . 0.663 ' O ' HD12 ' A' ' 27' ' ' LEU . 1.9 tp -58.29 -37.13 74.4 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.872 -179.967 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 28' ' ' CYS . . . . . 0.587 ' C ' ' HB3' ' A' ' 33' ' ' ALA . 10.9 m -63.65 -51.31 65.71 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.231 -0.441 . . . . 0.0 110.874 179.901 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 29' ' ' THR . . . . . 0.858 HG23 ' O ' ' A' ' 25' ' ' ASN . 1.1 p -63.31 -24.54 67.9 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.145 -179.947 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 14.0 tp10 -59.68 -23.17 62.88 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.912 179.966 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 31' ' ' ASN . . . . . 0.581 ' O ' HG21 ' A' ' 57' ' ' VAL . 2.0 m-80 -103.93 22.3 14.82 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.88 -179.95 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 82.78 19.68 62.99 Favored Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.699 -0.762 . . . . 0.0 112.506 179.966 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 33' ' ' ALA . . . . . 0.77 ' HB2' HD13 ' A' ' 53' ' ' LEU . . . -84.92 149.31 25.74 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.775 0.321 . . . . 0.0 111.047 -179.988 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . 0.481 ' HB2' ' CB ' ' A' ' 52' ' ' GLN . 5.7 tp10 -74.84 -34.7 62.34 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.907 -179.947 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 2.4 m -161.77 178.15 9.24 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.868 -179.8 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -169.12 159.77 32.91 Favored Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.735 -0.745 . . . . 0.0 112.49 -179.982 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 37' ' ' TYR . . . . . 0.635 ' CE1' HD11 ' A' ' 51' ' ' ILE . 3.9 p90 -163.84 160.55 22.41 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 120.957 0.408 . . . . 0.0 110.875 -179.778 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 38' ' ' CYS . . . . . . . . . . . . . 2.4 t -74.43 113.02 11.18 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.853 179.974 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 39' ' ' GLN . . . . . 0.503 ' OE1' ' N ' ' A' ' 41' ' ' LEU . 0.0 OUTLIER -90.3 122.99 33.7 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.889 179.994 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 40' ' ' ILE . . . . . 0.509 HD13 ' OD1' ' A' ' 46' ' ' ASN . 2.5 mm -92.81 -51.42 11.34 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.138 179.94 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 41' ' ' LEU . . . . . 0.539 HD23 ' H ' ' A' ' 41' ' ' LEU . 0.1 OUTLIER -75.17 57.93 0.88 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.121 -0.491 . . . . 0.0 110.976 179.887 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -99.93 144.14 16.77 Favored Glycine 0 N--CA 1.451 -0.358 0 C-N-CA 120.747 -0.74 . . . . 0.0 112.465 179.954 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 55.8 tttp -53.91 -26.14 23.64 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.785 0.326 . . . . 0.0 110.92 179.997 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 0.9 OUTLIER -115.25 23.83 12.14 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.926 -179.988 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 93.65 -132.66 11.31 Favored Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.791 -0.719 . . . . 0.0 112.48 179.946 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 46' ' ' ASN . . . . . 0.509 ' OD1' HD13 ' A' ' 40' ' ' ILE . 0.9 OUTLIER -90.69 117.32 29.25 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.786 0.327 . . . . 0.0 110.922 -179.908 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 47' ' ' ALA . . . . . 0.532 ' HB1' ' HB ' ' A' ' 13' ' ' VAL . . . -140.72 146.16 37.41 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.086 179.91 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 48' ' ' CYS . . . . . 0.451 ' N ' ' O ' ' A' ' 14' ' ' TYR . 40.1 t -67.39 109.33 3.12 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.891 -179.957 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 49' ' ' TRP . . . . . 0.588 ' CZ3' ' HA ' ' A' ' 4' ' ' ALA . 36.9 t-105 -94.66 114.22 26.13 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.917 -179.997 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 50' ' ' CYS . . . . . . . . . . . . . 42.6 m -94.96 142.43 27.49 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.888 -179.962 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 51' ' ' ILE . . . . . 0.724 HG23 ' OD2' ' A' ' 3' ' ' ASP . 3.7 mp -105.92 133.85 49.15 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.187 -0.46 . . . . 0.0 111.143 179.953 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 52' ' ' GLN . . . . . 0.481 ' CB ' ' HB2' ' A' ' 34' ' ' GLU . 9.3 mm-40 64.49 45.42 3.68 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.906 179.952 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 53' ' ' LEU . . . . . 0.77 HD13 ' HB2' ' A' ' 33' ' ' ALA . 15.3 tp -85.37 134.0 41.31 Favored Pre-proline 0 C--N 1.329 -0.305 0 CA-C-O 121.592 0.711 . . . . 0.0 110.928 -179.999 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 54' ' ' PRO . . . . . 0.841 ' HG2' HG23 ' A' ' 57' ' ' VAL . 53.9 Cg_endo -69.74 147.14 62.33 Favored 'Trans proline' 0 C--O 1.231 0.165 0 C-N-CA 122.662 2.241 . . . . 0.0 112.377 179.87 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 2.4 m-20 -63.88 -6.44 5.97 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.842 179.947 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 9.0 m120 -77.92 -24.94 48.12 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.914 -179.94 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 57' ' ' VAL . . . . . 0.841 HG23 ' HG2' ' A' ' 54' ' ' PRO . 12.3 t -91.14 136.39 27.32 Favored Pre-proline 0 C--N 1.33 -0.251 0 CA-C-O 121.601 0.715 . . . . 0.0 111.115 179.922 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 58' ' ' PRO . . . . . 0.46 ' HD2' ' CG1' ' A' ' 57' ' ' VAL . 54.0 Cg_endo -69.76 136.4 32.89 Favored 'Trans proline' 0 C--O 1.231 0.17 0 C-N-CA 122.724 2.283 . . . . 0.0 112.351 179.953 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 59' ' ' ILE . . . . . 0.513 ' C ' ' HB2' ' A' ' 7' ' ' ALA . 13.9 pt -116.23 164.15 12.82 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.276 -0.42 . . . . 0.0 111.162 179.922 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 60' ' ' ARG . . . . . 0.444 ' C ' ' CD ' ' A' ' 60' ' ' ARG . 0.3 OUTLIER -65.62 106.42 1.46 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.848 179.983 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . 0.615 HD11 ' OD1' ' A' ' 11' ' ' ASN . 1.3 pt -94.87 160.64 30.7 Favored Pre-proline 0 C--N 1.329 -0.315 0 CA-C-O 121.606 0.717 . . . . 0.0 111.171 179.912 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -69.71 66.11 1.75 Allowed 'Trans proline' 0 C--N 1.341 0.159 0 C-N-CA 122.755 2.303 . . . . 0.0 112.352 179.866 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -144.78 -173.86 16.49 Favored Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 120.765 -0.731 . . . . 0.0 112.499 179.973 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 11.4 ttmm -85.1 147.17 26.78 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 120.786 0.327 . . . . 0.0 110.902 -179.944 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 65' ' ' CYS . . . . . 0.561 ' O ' ' CD2' ' A' ' 66' ' ' HIS . 0.8 OUTLIER -94.04 159.53 15.12 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.909 179.947 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 66' ' ' HIS . . . . . 0.561 ' CD2' ' O ' ' A' ' 65' ' ' CYS . 11.5 p80 . . . . . 0 C--N 1.329 -0.296 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.881 179.958 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 1' ' ' ALA . . . . . 0.564 ' HB1' ' O ' ' A' ' 53' ' ' LEU . . . . . . . . 0 C--O 1.231 0.12 0 CA-C-O 120.759 0.314 . . . . 0.0 111.099 . . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -152.99 150.08 28.85 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.229 -0.442 . . . . 0.0 110.897 -179.904 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 2.7 m-20 -89.02 132.36 34.78 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.859 179.967 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 4' ' ' ALA . . . . . 0.613 ' HA ' ' CZ3' ' A' ' 49' ' ' TRP . . . -174.93 -179.27 1.37 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.11 179.918 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 5' ' ' TYR . . . . . 0.405 ' CE2' ' HE3' ' A' ' 49' ' ' TRP . 12.5 m-85 -84.46 131.49 34.65 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.941 -179.861 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 6' ' ' ILE . . . . . 0.558 HG23 ' HD2' ' A' ' 14' ' ' TYR . 4.9 tt -75.04 146.24 9.77 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.123 179.949 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -84.76 164.05 18.76 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.095 179.839 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 8' ' ' LYS . . . . . 0.549 ' HB2' ' CZ ' ' A' ' 14' ' ' TYR . 0.5 OUTLIER -145.18 168.88 10.93 Favored Pre-proline 0 C--N 1.329 -0.323 0 CA-C-O 121.633 0.73 . . . . 0.0 110.861 179.975 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 9' ' ' PRO . . . . . 0.51 ' HA ' ' HA ' ' A' ' 10' ' ' HIS . 53.0 Cg_endo -69.8 104.94 1.4 Allowed 'Trans proline' 0 C--N 1.342 0.186 0 C-N-CA 122.682 2.255 . . . . 0.0 112.312 179.925 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 10' ' ' HIS . . . . . 0.51 ' HA ' ' HA ' ' A' ' 9' ' ' PRO . 5.5 m-70 -131.87 123.12 26.85 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.838 -0.071 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 11' ' ' ASN . . . . . 0.512 ' N ' ' O ' ' A' ' 8' ' ' LYS . 5.8 t30 69.59 21.42 6.69 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.899 -179.934 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 12' ' ' CYS . . . . . 0.414 ' HB2' ' HG2' ' A' ' 8' ' ' LYS . 1.5 m -108.25 172.01 7.08 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.884 179.975 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 13' ' ' VAL . . . . . 0.576 HG12 ' HG2' ' A' ' 60' ' ' ARG . 0.9 OUTLIER -92.85 155.6 3.11 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.109 179.958 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 14' ' ' TYR . . . . . 0.558 ' HD2' HG23 ' A' ' 6' ' ' ILE . 6.9 m-85 -93.82 95.7 9.29 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.878 -179.855 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 16.2 pt-20 -64.84 137.05 57.54 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.907 179.994 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 15.1 p -84.41 158.41 21.09 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.885 -179.923 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 24.2 t80 -95.57 -33.05 12.54 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.918 -179.866 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 18' ' ' ASN . . . . . 0.599 ' CG ' ' HD2' ' A' ' 19' ' ' PRO . 1.9 t-20 -155.15 147.0 17.15 Favored Pre-proline 0 C--N 1.328 -0.333 0 CA-C-O 121.637 0.732 . . . . 0.0 110.894 179.97 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 19' ' ' PRO . . . . . 0.599 ' HD2' ' CG ' ' A' ' 18' ' ' ASN . 53.4 Cg_endo -69.75 -33.96 15.56 Favored 'Trans proline' 0 C--N 1.342 0.188 0 C-N-CA 122.669 2.246 . . . . 0.0 112.343 179.935 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 3.7 mmmp? -94.61 24.56 4.53 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.87 179.907 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -115.83 135.59 12.3 Favored Glycine 0 N--CA 1.452 -0.281 0 C-N-CA 120.74 -0.743 . . . . 0.0 112.465 179.962 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 83.9 p -83.52 24.86 0.8 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.872 0.368 . . . . 0.0 110.835 -179.719 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 0.4 OUTLIER -60.67 -51.77 67.96 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.909 -179.874 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 24' ' ' CYS . . . . . 0.401 ' SG ' ' O ' ' A' ' 37' ' ' TYR . 42.7 t -62.23 -41.01 98.03 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.853 -179.978 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 25' ' ' ASN . . . . . 0.852 ' O ' HG23 ' A' ' 29' ' ' THR . 0.3 OUTLIER -54.41 -58.43 7.46 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.871 -179.966 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -54.92 -53.83 50.51 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.856 179.945 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 27' ' ' LEU . . . . . 0.699 ' O ' HD12 ' A' ' 27' ' ' LEU . 1.8 tp -56.75 -37.58 71.23 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.89 -179.922 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 28' ' ' CYS . . . . . 0.512 ' C ' ' HB3' ' A' ' 33' ' ' ALA . 4.9 m -63.73 -51.96 62.62 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.897 179.89 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 29' ' ' THR . . . . . 0.852 HG23 ' O ' ' A' ' 25' ' ' ASN . 1.1 p -62.43 -24.77 67.6 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.128 -0.487 . . . . 0.0 111.197 -179.993 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 5.2 tm-20 -58.81 -22.47 58.6 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.892 -180.0 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 31' ' ' ASN . . . . . 0.564 ' O ' HG21 ' A' ' 57' ' ' VAL . 1.8 m-80 -103.4 21.94 15.08 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.92 -179.956 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 83.46 19.23 62.55 Favored Glycine 0 N--CA 1.451 -0.366 0 C-N-CA 120.769 -0.729 . . . . 0.0 112.479 179.99 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 33' ' ' ALA . . . . . 0.831 ' HB2' ' CD1' ' A' ' 53' ' ' LEU . . . -85.24 148.65 25.97 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.801 0.334 . . . . 0.0 111.072 179.973 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . 0.489 ' HB2' ' CB ' ' A' ' 52' ' ' GLN . 5.7 tp10 -74.69 -31.27 61.84 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.837 -179.894 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 2.9 m -162.65 178.61 8.38 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.889 -179.774 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 36' ' ' GLY . . . . . 0.48 ' CA ' ' HA ' ' A' ' 25' ' ' ASN . . . -174.85 153.62 16.34 Favored Glycine 0 N--CA 1.451 -0.354 0 C-N-CA 120.72 -0.752 . . . . 0.0 112.465 -179.98 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 37' ' ' TYR . . . . . 0.401 ' O ' ' SG ' ' A' ' 24' ' ' CYS . 45.4 p90 -164.36 167.67 19.48 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.936 0.398 . . . . 0.0 110.876 -179.746 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 38' ' ' CYS . . . . . . . . . . . . . 27.0 t -75.11 120.15 20.24 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.845 179.993 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 39' ' ' GLN . . . . . 0.403 ' O ' ' HA ' ' A' ' 46' ' ' ASN . 0.6 OUTLIER -105.5 130.28 53.6 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.95 179.99 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 40' ' ' ILE . . . . . 0.753 ' H ' HD12 ' A' ' 40' ' ' ILE . 1.3 mp -95.35 -33.76 5.0 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-N 116.25 -0.432 . . . . 0.0 111.149 179.966 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 41' ' ' LEU . . . . . 0.457 HD22 ' HA ' ' A' ' 41' ' ' LEU . 0.4 OUTLIER -75.56 48.96 0.47 Allowed 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.918 179.89 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -101.98 139.3 14.35 Favored Glycine 0 N--CA 1.452 -0.298 0 C-N-CA 120.783 -0.722 . . . . 0.0 112.493 179.88 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 38.7 tttp -54.12 -24.97 19.72 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.794 0.33 . . . . 0.0 110.862 -179.966 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 44' ' ' TYR . . . . . 0.44 ' CE1' ' HG3' ' A' ' 60' ' ' ARG . 0.5 OUTLIER -112.65 23.93 13.0 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.922 -179.929 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 93.8 -129.96 10.11 Favored Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 120.711 -0.757 . . . . 0.0 112.439 179.974 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 46' ' ' ASN . . . . . 0.488 ' ND2' ' HA ' ' A' ' 40' ' ' ILE . 28.3 m120 -93.19 119.09 31.99 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.872 0.368 . . . . 0.0 110.875 -179.873 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -139.34 150.49 45.42 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.154 -0.476 . . . . 0.0 111.107 179.849 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 48' ' ' CYS . . . . . 0.447 ' SG ' ' SG ' ' A' ' 28' ' ' CYS . 41.5 t -65.99 109.55 2.59 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.851 -179.926 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 49' ' ' TRP . . . . . 0.613 ' CZ3' ' HA ' ' A' ' 4' ' ' ALA . 38.8 t-105 -95.21 115.17 27.07 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.9 -179.995 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 50' ' ' CYS . . . . . . . . . . . . . 39.9 m -95.79 142.47 28.02 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.834 -179.962 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 51' ' ' ILE . . . . . 0.412 ' O ' ' HB2' ' A' ' 52' ' ' GLN . 3.6 mm -107.52 133.16 53.12 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.145 179.871 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 52' ' ' GLN . . . . . 0.489 ' CB ' ' HB2' ' A' ' 34' ' ' GLU . 12.1 mm-40 64.95 42.8 4.1 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.922 179.958 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 53' ' ' LEU . . . . . 0.831 ' CD1' ' HB2' ' A' ' 33' ' ' ALA . 16.3 tp -85.5 136.77 36.98 Favored Pre-proline 0 C--N 1.329 -0.324 0 CA-C-O 121.611 0.72 . . . . 0.0 110.932 -179.996 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 54' ' ' PRO . . . . . 0.847 ' HG2' HG23 ' A' ' 57' ' ' VAL . 54.3 Cg_endo -69.74 146.07 59.23 Favored 'Trans proline' 0 C--N 1.342 0.194 0 C-N-CA 122.667 2.245 . . . . 0.0 112.394 179.823 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -65.23 -5.16 6.29 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.901 179.928 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 15.4 m-20 -78.35 -28.6 47.19 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.906 -179.947 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 57' ' ' VAL . . . . . 0.847 HG23 ' HG2' ' A' ' 54' ' ' PRO . 14.6 t -86.5 136.4 35.18 Favored Pre-proline 0 C--N 1.329 -0.294 0 CA-C-O 121.641 0.734 . . . . 0.0 111.121 179.917 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 58' ' ' PRO . . . . . 0.464 ' HD2' ' CG1' ' A' ' 57' ' ' VAL . 53.1 Cg_endo -69.77 145.36 56.88 Favored 'Trans proline' 0 C--N 1.342 0.19 0 C-N-CA 122.699 2.266 . . . . 0.0 112.322 179.966 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 41.7 pt -122.66 166.93 16.82 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.161 179.922 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 60' ' ' ARG . . . . . 0.576 ' HG2' HG12 ' A' ' 13' ' ' VAL . 6.0 tpt180 -65.83 128.31 35.49 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.848 -179.998 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . 0.474 ' N ' ' HD2' ' A' ' 60' ' ' ARG . 1.8 pt -138.32 155.41 74.03 Favored Pre-proline 0 C--N 1.329 -0.313 0 CA-C-O 121.65 0.738 . . . . 0.0 111.161 179.941 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.76 75.11 1.24 Allowed 'Trans proline' 0 C--N 1.342 0.204 0 C-N-CA 122.673 2.249 . . . . 0.0 112.345 179.876 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -141.1 -177.44 16.34 Favored Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 120.751 -0.738 . . . . 0.0 112.466 179.987 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 7.6 mtpm? -75.18 111.41 10.4 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.811 0.338 . . . . 0.0 110.884 -179.989 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 65' ' ' CYS . . . . . 0.604 ' SG ' ' CD2' ' A' ' 66' ' ' HIS . 1.6 t -94.84 163.28 13.41 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.913 179.897 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 66' ' ' HIS . . . . . 0.604 ' CD2' ' SG ' ' A' ' 65' ' ' CYS . 0.8 OUTLIER . . . . . 0 C--N 1.33 -0.281 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.836 179.952 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.231 0.085 0 CA-C-O 120.798 0.332 . . . . 0.0 111.072 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 2' ' ' ARG . . . . . 0.455 ' CZ ' ' OD2' ' A' ' 55' ' ' ASP . 5.5 ptt-85 -149.65 177.52 9.69 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.912 -179.905 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 3' ' ' ASP . . . . . 0.582 ' OD2' HG23 ' A' ' 51' ' ' ILE . 4.0 m-20 -107.66 140.15 41.12 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.898 179.935 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 4' ' ' ALA . . . . . 0.587 ' HA ' ' CZ3' ' A' ' 49' ' ' TRP . . . -171.86 -176.85 1.81 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.094 -179.993 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 5' ' ' TYR . . . . . 0.438 ' OH ' ' NE2' ' A' ' 39' ' ' GLN . 29.0 m-85 -92.92 124.51 36.95 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.899 -179.834 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 6' ' ' ILE . . . . . 0.514 HG12 ' CD1' ' A' ' 14' ' ' TYR . 8.4 tt -75.24 135.38 27.33 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.128 -0.487 . . . . 0.0 111.141 179.899 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 7' ' ' ALA . . . . . 0.681 ' HB1' ' O ' ' A' ' 12' ' ' CYS . . . -135.2 140.88 45.66 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.124 179.775 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 8' ' ' LYS . . . . . 0.592 ' HB3' ' CE1' ' A' ' 14' ' ' TYR . 8.2 pttt -101.18 160.85 25.45 Favored Pre-proline 0 C--N 1.329 -0.322 0 CA-C-O 121.622 0.725 . . . . 0.0 110.861 179.958 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 9' ' ' PRO . . . . . 0.508 ' HA ' ' HA ' ' A' ' 10' ' ' HIS . 54.2 Cg_endo -69.74 144.65 54.79 Favored 'Trans proline' 0 C--N 1.342 0.198 0 C-N-CA 122.651 2.234 . . . . 0.0 112.388 179.883 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 10' ' ' HIS . . . . . 0.508 ' HA ' ' HA ' ' A' ' 9' ' ' PRO . 20.7 m170 -101.86 98.87 9.05 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.833 -0.008 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 11' ' ' ASN . . . . . 0.449 ' OD1' ' NH1' ' A' ' 60' ' ' ARG . 35.5 t-20 65.95 73.84 0.37 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.874 -179.931 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 12' ' ' CYS . . . . . 0.681 ' O ' ' HB1' ' A' ' 7' ' ' ALA . 10.0 m -141.19 145.21 35.37 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.928 179.943 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 13' ' ' VAL . . . . . 0.582 HG12 ' NE ' ' A' ' 60' ' ' ARG . 0.8 OUTLIER -84.06 155.32 3.67 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.153 179.943 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 14' ' ' TYR . . . . . 0.592 ' CE1' ' HB3' ' A' ' 8' ' ' LYS . 6.8 m-85 -103.83 88.6 3.08 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.939 -179.912 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -63.82 136.4 57.38 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.09 -0.505 . . . . 0.0 110.915 179.995 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 11.7 p -84.68 130.3 34.72 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.887 -179.948 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 17' ' ' TYR . . . . . 0.426 ' O ' ' HD3' ' A' ' 19' ' ' PRO . 65.1 t80 -101.03 -37.06 8.78 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.907 -179.902 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 13.3 t-20 -106.2 85.25 1.59 Allowed Pre-proline 0 C--N 1.328 -0.332 0 CA-C-O 121.604 0.716 . . . . 0.0 110.889 179.998 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 19' ' ' PRO . . . . . 0.426 ' HD3' ' O ' ' A' ' 17' ' ' TYR . 53.9 Cg_endo -69.76 -27.7 26.17 Favored 'Trans proline' 0 C--N 1.342 0.198 0 C-N-CA 122.65 2.233 . . . . 0.0 112.344 179.935 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 9.7 mmtp -95.02 24.36 4.92 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.919 179.915 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -144.27 -179.91 21.08 Favored Glycine 0 N--CA 1.452 -0.28 0 C-N-CA 120.719 -0.753 . . . . 0.0 112.463 179.976 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 17.6 m -95.21 28.87 2.66 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.907 0.384 . . . . 0.0 110.848 -179.738 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 20.3 t80 -54.94 -58.93 5.61 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.905 -179.87 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 24' ' ' CYS . . . . . 0.459 ' SG ' ' C ' ' A' ' 37' ' ' TYR . 35.5 t -58.0 -32.87 68.33 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.89 -179.995 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 25' ' ' ASN . . . . . 0.845 ' O ' HG23 ' A' ' 29' ' ' THR . 1.5 t30 -65.0 -56.38 13.44 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.928 179.961 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 17.7 m-20 -54.47 -47.91 72.42 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.868 179.938 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 27' ' ' LEU . . . . . 0.74 ' O ' HD12 ' A' ' 27' ' ' LEU . 1.4 tp -63.86 -38.81 92.46 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.972 179.989 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 28' ' ' CYS . . . . . 0.665 ' SG ' ' SG ' ' A' ' 48' ' ' CYS . 7.7 m -65.09 -57.45 8.58 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.894 179.892 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 29' ' ' THR . . . . . 0.845 HG23 ' O ' ' A' ' 25' ' ' ASN . 1.3 p -63.93 -34.52 78.15 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.126 -0.488 . . . . 0.0 111.132 -179.944 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 48.1 tt0 -54.78 -22.14 13.31 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.882 -179.98 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 31' ' ' ASN . . . . . 0.498 ' ND2' ' O ' ' A' ' 27' ' ' LEU . 1.8 m-80 -104.81 23.11 14.0 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.868 -179.959 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . 0.531 ' O ' ' CD ' ' A' ' 54' ' ' PRO . . . 84.53 69.15 1.38 Allowed Glycine 0 N--CA 1.451 -0.36 0 C-N-CA 120.766 -0.731 . . . . 0.0 112.511 179.984 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 33' ' ' ALA . . . . . 0.978 ' HB2' ' CD1' ' A' ' 53' ' ' LEU . . . -150.15 153.65 36.69 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.778 0.323 . . . . 0.0 111.096 -179.998 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . 0.506 ' HB2' ' CB ' ' A' ' 52' ' ' GLN . 19.4 tp10 -74.08 -34.6 64.07 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.863 -179.937 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 22.1 m -163.48 -179.89 6.81 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.876 -179.771 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 36' ' ' GLY . . . . . 0.422 ' O ' ' CA ' ' A' ' 25' ' ' ASN . . . -176.18 139.23 4.48 Favored Glycine 0 N--CA 1.452 -0.288 0 C-N-CA 120.709 -0.758 . . . . 0.0 112.45 179.955 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 37' ' ' TYR . . . . . 0.575 ' CE1' HD11 ' A' ' 51' ' ' ILE . 1.2 p90 -144.91 164.64 30.48 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-O 120.913 0.387 . . . . 0.0 110.947 -179.799 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 38' ' ' CYS . . . . . . . . . . . . . 39.0 t -74.91 129.43 37.64 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.844 179.998 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 39' ' ' GLN . . . . . 0.438 ' NE2' ' OH ' ' A' ' 5' ' ' TYR . 16.4 tt0 -105.64 125.02 50.51 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.914 179.997 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 40' ' ' ILE . . . . . 0.509 ' HA ' ' ND2' ' A' ' 46' ' ' ASN . 0.7 OUTLIER -95.32 -24.87 4.63 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.154 179.934 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 41' ' ' LEU . . . . . 0.531 ' N ' HD22 ' A' ' 41' ' ' LEU . 2.7 mm? -82.22 35.34 0.44 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.923 179.935 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -92.58 131.76 10.94 Favored Glycine 0 N--CA 1.45 -0.37 0 C-N-CA 120.749 -0.739 . . . . 0.0 112.485 179.924 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -52.01 -24.69 7.01 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.756 0.312 . . . . 0.0 110.871 -179.967 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 0.7 OUTLIER -99.65 23.91 8.94 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.962 -179.957 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 93.81 -84.77 1.05 Allowed Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.725 -0.75 . . . . 0.0 112.498 -179.996 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 46' ' ' ASN . . . . . 0.509 ' ND2' ' HA ' ' A' ' 40' ' ' ILE . 2.5 m120 -144.12 130.49 19.85 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.86 0.362 . . . . 0.0 110.91 -179.916 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -145.95 146.54 31.08 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.105 179.847 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 48' ' ' CYS . . . . . 0.665 ' SG ' ' SG ' ' A' ' 28' ' ' CYS . 50.7 t -65.46 113.8 4.39 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.925 -179.952 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 49' ' ' TRP . . . . . 0.587 ' CZ3' ' HA ' ' A' ' 4' ' ' ALA . 49.6 t-105 -94.98 113.44 25.15 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.929 -179.982 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 50' ' ' CYS . . . . . . . . . . . . . 20.2 m -95.42 139.78 31.23 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.898 -179.994 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 51' ' ' ILE . . . . . 0.582 HG23 ' OD2' ' A' ' 3' ' ' ASP . 4.7 mp -107.25 138.74 31.73 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.095 179.945 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 52' ' ' GLN . . . . . 0.506 ' CB ' ' HB2' ' A' ' 34' ' ' GLU . 2.1 mm-40 67.38 30.77 6.78 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.897 179.955 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 53' ' ' LEU . . . . . 0.978 ' CD1' ' HB2' ' A' ' 33' ' ' ALA . 11.5 tp -85.93 132.88 42.56 Favored Pre-proline 0 C--N 1.328 -0.36 0 CA-C-O 121.616 0.722 . . . . 0.0 110.907 -179.999 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 54' ' ' PRO . . . . . 0.531 ' CD ' ' O ' ' A' ' 32' ' ' GLY . 53.7 Cg_endo -69.73 150.93 69.03 Favored 'Trans proline' 0 C--O 1.232 0.175 0 C-N-CA 122.712 2.275 . . . . 0.0 112.318 179.886 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 55' ' ' ASP . . . . . 0.455 ' OD2' ' CZ ' ' A' ' 2' ' ' ARG . 16.1 m-20 -65.11 -5.82 7.55 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.877 179.911 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 45.1 m-80 -74.93 -24.56 58.51 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.884 -179.908 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 57' ' ' VAL . . . . . 0.491 HG12 ' HD2' ' A' ' 58' ' ' PRO . 1.2 t -84.22 136.63 40.44 Favored Pre-proline 0 C--N 1.329 -0.287 0 CA-C-O 121.685 0.755 . . . . 0.0 111.119 179.936 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 58' ' ' PRO . . . . . 0.491 ' HD2' HG12 ' A' ' 57' ' ' VAL . 53.8 Cg_endo -69.79 130.26 18.99 Favored 'Trans proline' 0 C--N 1.342 0.186 0 C-N-CA 122.668 2.245 . . . . 0.0 112.324 179.971 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 59' ' ' ILE . . . . . 0.842 ' O ' HD13 ' A' ' 61' ' ' ILE . 27.4 pt -107.89 171.31 2.33 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.101 179.938 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 60' ' ' ARG . . . . . 0.582 ' NE ' HG12 ' A' ' 13' ' ' VAL . 5.6 tpt180 -75.76 113.53 13.33 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.871 179.936 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . 0.842 HD13 ' O ' ' A' ' 59' ' ' ILE . 0.0 OUTLIER -108.67 160.51 26.96 Favored Pre-proline 0 C--N 1.329 -0.304 0 CA-C-O 121.6 0.714 . . . . 0.0 111.124 179.986 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.77 64.17 1.8 Allowed 'Trans proline' 0 N--CA 1.465 -0.174 0 C-N-CA 122.692 2.262 . . . . 0.0 112.342 179.911 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -138.98 -179.49 17.42 Favored Glycine 0 N--CA 1.451 -0.351 0 C-N-CA 120.744 -0.741 . . . . 0.0 112.451 -179.989 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 25.9 ttmt -85.39 145.61 27.39 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-O 120.778 0.323 . . . . 0.0 110.871 -179.923 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 65' ' ' CYS . . . . . 0.566 ' SG ' ' CD2' ' A' ' 66' ' ' HIS . 7.9 t -93.85 148.37 22.2 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.885 179.957 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 66' ' ' HIS . . . . . 0.566 ' CD2' ' SG ' ' A' ' 65' ' ' CYS . 1.2 p-80 . . . . . 0 C--N 1.329 -0.313 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.871 -179.996 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . 0.449 ' HB1' ' O ' ' A' ' 53' ' ' LEU . . . . . . . . 0 C--O 1.231 0.115 0 CA-C-O 120.793 0.33 . . . . 0.0 111.095 . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 2' ' ' ARG . . . . . 0.447 ' HD3' ' N ' ' A' ' 2' ' ' ARG . 0.0 OUTLIER -150.71 -177.28 5.89 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.898 -179.921 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 3' ' ' ASP . . . . . 0.552 ' CG ' HD13 ' A' ' 51' ' ' ILE . 9.5 m-20 -107.23 134.08 50.86 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.881 179.932 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -175.67 -174.66 0.7 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.165 -0.47 . . . . 0.0 111.138 179.999 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 5' ' ' TYR . . . . . 0.458 ' CE1' ' CZ3' ' A' ' 49' ' ' TRP . 2.0 m-85 -85.06 135.07 34.16 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.883 -179.835 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 6' ' ' ILE . . . . . 0.673 HG23 ' HD2' ' A' ' 14' ' ' TYR . 3.7 tt -75.93 134.08 29.85 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.111 -0.495 . . . . 0.0 111.185 179.868 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 7' ' ' ALA . . . . . 0.411 ' HB2' ' C ' ' A' ' 59' ' ' ILE . . . -85.78 152.01 23.37 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.211 -0.45 . . . . 0.0 111.096 179.873 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 8' ' ' LYS . . . . . 0.554 ' HB2' ' CZ ' ' A' ' 14' ' ' TYR . 0.0 OUTLIER -135.19 167.22 23.7 Favored Pre-proline 0 C--N 1.329 -0.306 0 CA-C-O 121.593 0.711 . . . . 0.0 110.864 179.963 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 9' ' ' PRO . . . . . 0.449 ' HA ' ' HA ' ' A' ' 10' ' ' HIS . 53.9 Cg_endo -69.73 105.93 1.57 Allowed 'Trans proline' 0 C--N 1.342 0.192 0 C-N-CA 122.703 2.269 . . . . 0.0 112.35 179.873 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 10' ' ' HIS . . . . . 0.449 ' HA ' ' HA ' ' A' ' 9' ' ' PRO . 11.3 m-70 -131.4 127.73 38.1 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.855 -0.067 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 11' ' ' ASN . . . . . 0.412 ' N ' ' O ' ' A' ' 8' ' ' LYS . 4.2 t30 61.36 26.62 16.39 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.889 -179.945 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 1.6 m -107.14 154.9 20.5 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.89 -179.998 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 13' ' ' VAL . . . . . 0.449 HG12 ' NE ' ' A' ' 60' ' ' ARG . 0.9 OUTLIER -84.83 154.44 3.57 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.169 179.923 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 14' ' ' TYR . . . . . 0.673 ' HD2' HG23 ' A' ' 6' ' ' ILE . 9.5 m-85 -94.75 89.75 5.82 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.944 -179.912 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 3.3 pt-20 -64.65 125.41 24.65 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.89 -179.965 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 1.1 p -101.55 134.38 44.75 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.864 -179.901 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 17' ' ' TYR . . . . . 0.436 ' O ' ' HD3' ' A' ' 19' ' ' PRO . 4.8 m-30 -99.49 -28.18 13.37 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.929 -179.926 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -106.44 82.94 1.06 Allowed Pre-proline 0 C--N 1.329 -0.303 0 CA-C-O 121.616 0.722 . . . . 0.0 110.885 -179.987 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 19' ' ' PRO . . . . . 0.436 ' HD3' ' O ' ' A' ' 17' ' ' TYR . 53.5 Cg_endo -69.76 -26.56 27.47 Favored 'Trans proline' 0 C--N 1.342 0.199 0 C-N-CA 122.632 2.221 . . . . 0.0 112.372 179.928 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 20' ' ' LYS . . . . . 0.478 ' HD3' ' N ' ' A' ' 20' ' ' LYS . 0.0 OUTLIER -94.18 24.54 4.31 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.849 179.943 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -136.28 -178.84 16.08 Favored Glycine 0 N--CA 1.452 -0.299 0 C-N-CA 120.763 -0.732 . . . . 0.0 112.497 179.923 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 2.0 p -94.2 28.76 2.38 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.871 0.367 . . . . 0.0 110.855 -179.737 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 0.9 OUTLIER -59.84 -66.67 0.48 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.909 -179.88 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 24' ' ' CYS . . . . . 0.484 ' SG ' ' N ' ' A' ' 49' ' ' TRP . 53.2 t -60.47 -38.3 83.78 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.89 179.986 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 25' ' ' ASN . . . . . 0.846 ' O ' HG23 ' A' ' 29' ' ' THR . 1.7 t30 -54.89 -57.05 13.19 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.903 -179.993 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -57.6 -51.37 69.78 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.863 179.95 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 27' ' ' LEU . . . . . 0.662 ' O ' HD12 ' A' ' 27' ' ' LEU . 2.2 tp -57.13 -38.8 74.01 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.908 -179.967 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 28' ' ' CYS . . . . . 0.576 ' C ' ' HB3' ' A' ' 33' ' ' ALA . 19.1 m -62.41 -50.6 70.87 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.899 179.905 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 29' ' ' THR . . . . . 0.846 HG23 ' O ' ' A' ' 25' ' ' ASN . 1.1 p -62.78 -25.02 68.02 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.14 -179.97 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 6.8 tp10 -58.96 -22.75 60.7 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.938 179.992 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 31' ' ' ASN . . . . . 0.494 ' O ' HG21 ' A' ' 57' ' ' VAL . 1.9 m-80 -103.66 22.6 14.11 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.103 -0.498 . . . . 0.0 110.902 -179.949 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 84.15 18.83 62.03 Favored Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 120.765 -0.731 . . . . 0.0 112.515 -179.988 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 33' ' ' ALA . . . . . 0.797 ' HB2' HD13 ' A' ' 53' ' ' LEU . . . -85.4 152.37 23.29 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.733 0.301 . . . . 0.0 111.122 179.931 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . 0.476 ' CB ' ' HB2' ' A' ' 52' ' ' GLN . 4.3 tt0 -78.66 -33.07 47.38 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.233 -0.439 . . . . 0.0 110.886 -179.93 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 1.7 m -162.77 -177.2 5.39 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.844 -179.772 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . 0.446 ' CA ' ' HA ' ' A' ' 25' ' ' ASN . . . -174.92 157.54 24.7 Favored Glycine 0 N--CA 1.452 -0.284 0 C-N-CA 120.759 -0.734 . . . . 0.0 112.489 -179.984 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 37' ' ' TYR . . . . . 0.581 ' CE2' ' CD1' ' A' ' 49' ' ' TRP . 5.0 p90 -157.64 159.63 37.2 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.863 0.363 . . . . 0.0 110.918 -179.823 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 38' ' ' CYS . . . . . 0.409 ' CB ' ' HA ' ' A' ' 19' ' ' PRO . 21.3 t -74.88 119.47 19.1 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.913 179.999 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 39' ' ' GLN . . . . . 0.408 ' OE1' ' HA2' ' A' ' 42' ' ' GLY . 0.0 OUTLIER -98.49 126.03 43.91 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.913 -179.983 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 40' ' ' ILE . . . . . 0.771 HD12 ' N ' ' A' ' 40' ' ' ILE . 1.2 mp -95.97 -35.98 6.2 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.102 179.972 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 4.2 mm? -75.66 53.01 0.69 Allowed 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.934 179.922 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . 0.408 ' HA2' ' OE1' ' A' ' 39' ' ' GLN . . . -105.72 138.91 14.53 Favored Glycine 0 N--CA 1.452 -0.296 0 C-N-CA 120.758 -0.734 . . . . 0.0 112.462 179.94 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -57.45 -27.6 62.6 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.83 0.348 . . . . 0.0 110.908 -179.962 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 0.6 OUTLIER -109.22 23.72 14.11 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.903 -179.959 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 93.37 -139.08 14.42 Favored Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.734 -0.745 . . . . 0.0 112.527 -179.978 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 46' ' ' ASN . . . . . 0.472 ' ND2' ' HA ' ' A' ' 40' ' ' ILE . 9.9 m120 -82.96 116.22 22.15 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.821 0.343 . . . . 0.0 110.894 -179.914 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -125.71 141.57 51.95 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.098 179.864 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 48' ' ' CYS . . . . . 0.475 ' HB3' ' CG2' ' A' ' 6' ' ' ILE . 19.5 t -65.47 114.92 5.2 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.883 -179.967 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 49' ' ' TRP . . . . . 0.581 ' CD1' ' CE2' ' A' ' 37' ' ' TYR . 61.7 t-105 -94.1 135.2 35.72 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.947 179.955 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 50' ' ' CYS . . . . . . . . . . . . . 42.1 m -122.1 142.04 50.78 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.851 -179.97 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 51' ' ' ILE . . . . . 0.552 HD13 ' CG ' ' A' ' 3' ' ' ASP . 14.4 mm -111.01 134.48 53.18 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.139 179.895 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 52' ' ' GLN . . . . . 0.476 ' HB2' ' CB ' ' A' ' 34' ' ' GLU . 3.2 mm-40 65.08 44.58 3.32 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.884 179.926 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 53' ' ' LEU . . . . . 0.797 HD13 ' HB2' ' A' ' 33' ' ' ALA . 14.5 tp -85.93 134.34 39.43 Favored Pre-proline 0 C--N 1.328 -0.35 0 CA-C-O 121.631 0.729 . . . . 0.0 110.945 179.955 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 54' ' ' PRO . . . . . 0.809 ' HG2' HG23 ' A' ' 57' ' ' VAL . 53.3 Cg_endo -69.74 145.42 57.22 Favored 'Trans proline' 0 C--N 1.342 0.184 0 C-N-CA 122.656 2.238 . . . . 0.0 112.323 179.898 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -62.58 -7.75 5.25 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.851 179.915 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 27.6 m120 -76.17 -25.31 55.11 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.913 -179.886 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 57' ' ' VAL . . . . . 0.809 HG23 ' HG2' ' A' ' 54' ' ' PRO . 10.7 t -92.17 136.24 26.06 Favored Pre-proline 0 C--N 1.33 -0.264 0 CA-C-O 121.634 0.73 . . . . 0.0 111.087 179.928 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 58' ' ' PRO . . . . . 0.466 ' HD2' ' CG1' ' A' ' 57' ' ' VAL . 53.9 Cg_endo -69.78 152.53 69.24 Favored 'Trans proline' 0 C--N 1.342 0.193 0 C-N-CA 122.644 2.229 . . . . 0.0 112.366 179.936 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 59' ' ' ILE . . . . . 0.411 ' C ' ' HB2' ' A' ' 7' ' ' ALA . 19.1 pt -125.3 166.3 21.29 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.169 179.91 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 60' ' ' ARG . . . . . 0.485 ' HD2' ' N ' ' A' ' 61' ' ' ILE . 6.7 tpt180 -65.95 116.17 6.81 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.891 179.935 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . 0.485 ' N ' ' HD2' ' A' ' 60' ' ' ARG . 1.0 OUTLIER -117.31 160.13 38.84 Favored Pre-proline 0 C--N 1.329 -0.31 0 CA-C-O 121.606 0.717 . . . . 0.0 111.096 -179.996 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.77 64.81 1.81 Allowed 'Trans proline' 0 C--N 1.342 0.2 0 C-N-CA 122.631 2.221 . . . . 0.0 112.384 179.853 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -136.03 -178.65 15.92 Favored Glycine 0 N--CA 1.451 -0.355 0 C-N-CA 120.719 -0.753 . . . . 0.0 112.474 -179.986 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 1.1 tppp? -85.22 140.29 30.99 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.817 0.341 . . . . 0.0 110.925 179.952 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 65' ' ' CYS . . . . . 0.497 ' SG ' ' N ' ' A' ' 66' ' ' HIS . 1.0 OUTLIER -94.55 160.88 14.44 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.872 179.963 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 66' ' ' HIS . . . . . 0.497 ' N ' ' SG ' ' A' ' 65' ' ' CYS . 7.3 p80 . . . . . 0 C--N 1.329 -0.298 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.824 -179.985 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . 0.489 ' HB1' ' O ' ' A' ' 53' ' ' LEU . . . . . . . . 0 C--O 1.231 0.131 0 CA-C-O 120.77 0.319 . . . . 0.0 111.095 . . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 18.0 ptt180 -147.27 161.19 41.46 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.89 -179.965 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 3' ' ' ASP . . . . . 0.685 ' OD2' HG23 ' A' ' 51' ' ' ILE . 2.9 m-20 -96.71 134.04 40.49 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.869 -179.988 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 4' ' ' ALA . . . . . 0.605 ' HA ' ' CZ3' ' A' ' 49' ' ' TRP . . . -174.83 -179.09 1.37 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.097 179.982 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 5' ' ' TYR . . . . . 0.412 ' CD2' ' HB3' ' A' ' 47' ' ' ALA . 16.0 m-85 -84.81 135.44 34.1 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.96 -179.857 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 6' ' ' ILE . . . . . 0.447 HG23 ' HD2' ' A' ' 14' ' ' TYR . 5.5 tt -75.42 137.09 23.6 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.108 -0.496 . . . . 0.0 111.148 179.936 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 7' ' ' ALA . . . . . 0.575 ' HB2' ' C ' ' A' ' 59' ' ' ILE . . . -91.41 158.47 16.5 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.103 179.816 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 8' ' ' LYS . . . . . 0.545 ' HB2' ' CZ ' ' A' ' 14' ' ' TYR . 0.0 OUTLIER -134.72 166.26 30.51 Favored Pre-proline 0 C--N 1.328 -0.327 0 CA-C-O 121.632 0.729 . . . . 0.0 110.87 -179.988 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 9' ' ' PRO . . . . . 0.477 ' HA ' ' HA ' ' A' ' 10' ' ' HIS . 53.7 Cg_endo -69.79 106.97 1.76 Allowed 'Trans proline' 0 C--N 1.342 0.231 0 C-N-CA 122.666 2.244 . . . . 0.0 112.345 179.891 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 10' ' ' HIS . . . . . 0.477 ' HA ' ' HA ' ' A' ' 9' ' ' PRO . 7.7 m-70 -132.08 125.12 30.6 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.865 -0.069 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 11' ' ' ASN . . . . . 0.442 ' OD1' HD11 ' A' ' 61' ' ' ILE . 2.3 t30 65.49 44.29 3.12 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.902 -179.896 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 1.6 m -128.81 155.47 45.13 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.873 -179.983 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 13' ' ' VAL . . . . . 0.421 ' CG1' ' NE ' ' A' ' 60' ' ' ARG . 2.7 m -86.5 153.53 3.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.115 179.958 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 14' ' ' TYR . . . . . 0.545 ' CZ ' ' HB2' ' A' ' 8' ' ' LYS . 9.1 m-85 -95.09 100.7 12.48 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.931 -179.942 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 4.9 tm-20 -64.54 137.1 57.66 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.099 -0.501 . . . . 0.0 110.85 -179.945 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 9.1 p -84.83 126.01 33.09 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.864 -179.942 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -100.63 -24.56 14.41 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.903 -179.88 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -134.54 85.15 37.99 Favored Pre-proline 0 C--N 1.329 -0.307 0 CA-C-O 121.555 0.693 . . . . 0.0 110.897 -179.989 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.76 -25.08 28.94 Favored 'Trans proline' 0 C--O 1.231 0.147 0 C-N-CA 122.689 2.259 . . . . 0.0 112.372 179.929 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -94.42 24.23 4.66 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.893 179.914 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -142.88 -174.61 15.33 Favored Glycine 0 N--CA 1.452 -0.279 0 C-N-CA 120.699 -0.763 . . . . 0.0 112.46 179.903 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 50.3 m -95.25 29.14 2.58 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.867 0.365 . . . . 0.0 110.871 -179.729 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 43.9 t80 -64.52 -71.61 0.17 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.921 -179.853 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 42.0 t -55.19 -39.9 70.12 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.824 -179.995 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 25' ' ' ASN . . . . . 0.807 ' O ' HG23 ' A' ' 29' ' ' THR . 1.3 t30 -57.1 -55.57 32.96 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.895 179.998 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 4.5 m-20 -54.68 -53.33 56.34 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.895 179.94 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 27' ' ' LEU . . . . . 0.639 ' O ' HD12 ' A' ' 27' ' ' LEU . 2.1 tp -60.08 -36.38 77.25 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.918 -179.976 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 28' ' ' CYS . . . . . 0.47 ' CB ' ' HA3' ' A' ' 36' ' ' GLY . 1.3 m -64.73 -60.72 2.78 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.868 179.89 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 29' ' ' THR . . . . . 0.807 HG23 ' O ' ' A' ' 25' ' ' ASN . 1.1 p -62.75 -27.09 69.04 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.165 -0.47 . . . . 0.0 111.126 -179.971 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 9.5 tp10 -54.75 -19.83 7.16 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.253 -0.43 . . . . 0.0 110.861 -179.981 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 31' ' ' ASN . . . . . 0.572 ' O ' HG21 ' A' ' 57' ' ' VAL . 1.8 m-80 -101.81 21.99 13.66 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.154 -0.476 . . . . 0.0 110.914 -179.96 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 95.81 -12.66 67.14 Favored Glycine 0 N--CA 1.451 -0.302 0 C-N-CA 120.773 -0.727 . . . . 0.0 112.489 179.996 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 33' ' ' ALA . . . . . 1.086 ' HB2' ' CD1' ' A' ' 53' ' ' LEU . . . -62.17 155.27 24.89 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 120.742 0.306 . . . . 0.0 111.094 179.989 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . 0.504 ' HB2' ' CB ' ' A' ' 52' ' ' GLN . 2.7 tt0 -80.88 -31.46 35.27 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.9 -179.939 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 35' ' ' SER . . . . . 0.417 ' HA ' HG22 ' A' ' 29' ' ' THR . 46.2 m -162.77 177.92 8.91 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.881 -179.771 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . 0.47 ' HA3' ' CB ' ' A' ' 28' ' ' CYS . . . -175.24 157.27 23.9 Favored Glycine 0 N--CA 1.452 -0.277 0 C-N-CA 120.8 -0.714 . . . . 0.0 112.501 -179.976 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 37' ' ' TYR . . . . . 0.491 ' CZ ' HD11 ' A' ' 51' ' ' ILE . 0.6 OUTLIER -165.27 173.55 11.13 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.942 0.401 . . . . 0.0 110.904 -179.811 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 38' ' ' CYS . . . . . . . . . . . . . 41.9 t -74.72 120.28 20.05 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.858 -179.98 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 39' ' ' GLN . . . . . 0.478 ' OE1' ' CE3' ' A' ' 49' ' ' TRP . 3.8 tt0 -104.64 125.26 50.58 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.91 179.99 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 40' ' ' ILE . . . . . 0.757 ' H ' HD12 ' A' ' 40' ' ' ILE . 1.3 mp -95.44 -25.25 4.53 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.159 179.942 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 41' ' ' LEU . . . . . 0.432 ' O ' HD23 ' A' ' 41' ' ' LEU . 1.0 OUTLIER -81.11 40.91 0.56 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.919 179.918 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -97.38 134.49 11.77 Favored Glycine 0 N--CA 1.452 -0.296 0 C-N-CA 120.752 -0.737 . . . . 0.0 112.474 179.907 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -54.14 -25.05 20.25 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.762 0.315 . . . . 0.0 110.861 -179.992 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 44' ' ' TYR . . . . . 0.488 ' CE1' ' CG ' ' A' ' 60' ' ' ARG . 0.6 OUTLIER -108.6 23.76 14.06 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.964 -179.964 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 93.42 -134.47 12.14 Favored Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.734 -0.746 . . . . 0.0 112.477 179.944 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 46' ' ' ASN . . . . . 0.488 ' ND2' ' HA ' ' A' ' 40' ' ' ILE . 27.8 m120 -91.51 118.82 30.92 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.844 0.354 . . . . 0.0 110.86 -179.884 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 47' ' ' ALA . . . . . 0.412 ' HB3' ' CD2' ' A' ' 5' ' ' TYR . . . -137.33 148.52 46.37 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.099 179.842 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 48' ' ' CYS . . . . . 0.422 ' SG ' ' SG ' ' A' ' 28' ' ' CYS . 11.9 t -65.91 108.76 2.27 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.917 -179.976 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 49' ' ' TRP . . . . . 0.605 ' CZ3' ' HA ' ' A' ' 4' ' ' ALA . 36.3 t-105 -94.67 122.75 37.59 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.913 179.995 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 50' ' ' CYS . . . . . . . . . . . . . 4.9 m -107.79 135.13 49.72 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.844 -179.947 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 51' ' ' ILE . . . . . 0.685 HG23 ' OD2' ' A' ' 3' ' ' ASP . 4.2 mp -100.07 138.8 23.26 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.137 179.911 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 52' ' ' GLN . . . . . 0.504 ' CB ' ' HB2' ' A' ' 34' ' ' GLU . 5.7 mm-40 65.38 42.0 4.04 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.929 179.939 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 53' ' ' LEU . . . . . 1.086 ' CD1' ' HB2' ' A' ' 33' ' ' ALA . 12.7 tp -85.28 132.79 44.08 Favored Pre-proline 0 C--N 1.329 -0.32 0 CA-C-O 121.628 0.728 . . . . 0.0 110.941 -179.987 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 54' ' ' PRO . . . . . 0.842 ' HG2' HG23 ' A' ' 57' ' ' VAL . 53.5 Cg_endo -69.78 145.63 57.61 Favored 'Trans proline' 0 C--N 1.342 0.214 0 C-N-CA 122.694 2.263 . . . . 0.0 112.336 179.91 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 40.5 m-20 -62.89 -7.75 5.75 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.855 179.915 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 2.5 m120 -76.51 -25.64 54.4 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.908 -179.908 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 57' ' ' VAL . . . . . 0.842 HG23 ' HG2' ' A' ' 54' ' ' PRO . 12.1 t -92.01 136.23 26.3 Favored Pre-proline 0 C--N 1.33 -0.265 0 CA-C-O 121.642 0.734 . . . . 0.0 111.112 179.926 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 58' ' ' PRO . . . . . 0.463 ' HD2' ' CG1' ' A' ' 57' ' ' VAL . 53.6 Cg_endo -69.77 145.68 57.79 Favored 'Trans proline' 0 C--N 1.342 0.196 0 C-N-CA 122.691 2.261 . . . . 0.0 112.331 179.93 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 59' ' ' ILE . . . . . 0.575 ' C ' ' HB2' ' A' ' 7' ' ' ALA . 14.7 pt -124.23 173.8 9.51 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.111 179.914 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 60' ' ' ARG . . . . . 0.488 ' CG ' ' CE1' ' A' ' 44' ' ' TYR . 0.6 OUTLIER -69.04 118.8 12.4 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.879 179.965 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . 0.442 HD11 ' OD1' ' A' ' 11' ' ' ASN . 1.3 pt -118.14 160.59 38.62 Favored Pre-proline 0 C--N 1.329 -0.307 0 CA-C-O 121.642 0.734 . . . . 0.0 111.082 -179.964 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.73 66.34 1.76 Allowed 'Trans proline' 0 C--N 1.342 0.191 0 C-N-CA 122.667 2.244 . . . . 0.0 112.314 179.897 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -141.61 179.41 19.72 Favored Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 120.761 -0.733 . . . . 0.0 112.517 179.934 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 6.0 mmmm -83.38 142.01 31.33 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.804 0.335 . . . . 0.0 110.898 -179.955 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 65' ' ' CYS . . . . . 0.585 ' O ' ' CD2' ' A' ' 66' ' ' HIS . 1.7 t -89.31 156.27 18.84 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.872 179.97 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 66' ' ' HIS . . . . . 0.585 ' CD2' ' O ' ' A' ' 65' ' ' CYS . 16.9 p80 . . . . . 0 C--N 1.329 -0.314 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.883 179.963 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . 0.444 ' HB1' ' O ' ' A' ' 53' ' ' LEU . . . . . . . . 0 C--O 1.231 0.124 0 CA-C-O 120.801 0.334 . . . . 0.0 111.079 . . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -135.37 162.28 33.05 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.865 -179.92 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 3' ' ' ASP . . . . . 0.928 ' OD2' HG23 ' A' ' 51' ' ' ILE . 1.8 m-20 -97.77 133.13 42.71 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.887 179.989 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 4' ' ' ALA . . . . . 0.612 ' HA ' ' CZ3' ' A' ' 49' ' ' TRP . . . -172.82 -177.95 1.76 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.103 179.937 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 5' ' ' TYR . . . . . 0.618 ' CE2' ' OE1' ' A' ' 39' ' ' GLN . 68.9 m-85 -84.36 136.66 33.79 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.24 -0.437 . . . . 0.0 110.904 -179.845 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 6' ' ' ILE . . . . . 0.413 HG23 ' HB2' ' A' ' 14' ' ' TYR . 5.0 tt -74.93 134.7 28.87 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 116.12 -0.491 . . . . 0.0 111.097 179.929 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 7' ' ' ALA . . . . . 0.599 ' HB2' ' C ' ' A' ' 59' ' ' ILE . . . -93.48 156.73 16.58 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.085 179.815 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 8' ' ' LYS . . . . . 0.552 ' HB2' ' CZ ' ' A' ' 14' ' ' TYR . 0.0 OUTLIER -140.2 168.01 16.21 Favored Pre-proline 0 C--N 1.329 -0.297 0 CA-C-O 121.521 0.677 . . . . 0.0 110.886 179.991 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 9' ' ' PRO . . . . . 0.493 ' HA ' ' HA ' ' A' ' 10' ' ' HIS . 53.6 Cg_endo -69.74 107.95 1.97 Allowed 'Trans proline' 0 C--O 1.232 0.206 0 C-N-CA 122.665 2.243 . . . . 0.0 112.332 179.904 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 10' ' ' HIS . . . . . 0.493 ' HA ' ' HA ' ' A' ' 9' ' ' PRO . 5.2 m-70 -131.65 128.59 39.38 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.255 -0.429 . . . . 0.0 110.834 -0.065 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 2.4 t30 58.74 35.92 24.61 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.893 -179.889 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 1.5 m -119.38 152.29 37.05 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.878 179.981 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 13' ' ' VAL . . . . . 0.572 HG12 ' CD ' ' A' ' 60' ' ' ARG . 0.9 OUTLIER -84.55 156.04 3.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.143 -0.481 . . . . 0.0 111.169 179.903 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 14' ' ' TYR . . . . . 0.552 ' CZ ' ' HB2' ' A' ' 8' ' ' LYS . 9.3 m-85 -94.89 100.86 12.66 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.908 -179.889 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 38.1 tt0 -64.92 133.63 52.24 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.079 -0.509 . . . . 0.0 110.892 -179.996 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 1.0 OUTLIER -85.14 133.54 34.2 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.879 -179.949 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 9.3 t80 -121.54 24.89 9.64 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.902 -179.91 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 18' ' ' ASN . . . . . 0.472 ' CB ' ' HB2' ' A' ' 23' ' ' TYR . 9.8 t-20 -154.38 80.26 4.76 Favored Pre-proline 0 C--N 1.329 -0.293 0 CA-C-O 121.647 0.736 . . . . 0.0 110.882 179.959 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -69.76 -23.98 30.19 Favored 'Trans proline' 0 C--N 1.341 0.182 0 C-N-CA 122.702 2.268 . . . . 0.0 112.385 179.922 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 21.4 mtpp -94.52 -24.42 17.28 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.858 179.938 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -102.89 175.98 24.51 Favored Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.763 -0.732 . . . . 0.0 112.46 179.994 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 10.0 p -95.35 26.09 4.02 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.915 0.388 . . . . 0.0 110.874 -179.757 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 23' ' ' TYR . . . . . 0.472 ' HB2' ' CB ' ' A' ' 18' ' ' ASN . 34.4 t80 -44.59 -46.86 10.24 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.953 -179.881 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 53.9 t -65.67 -46.15 80.17 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.073 -0.512 . . . . 0.0 110.884 179.994 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 25' ' ' ASN . . . . . 0.841 ' O ' HG23 ' A' ' 29' ' ' THR . 0.2 OUTLIER -54.68 -51.78 64.45 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.859 -179.965 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -55.22 -52.1 64.45 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.84 179.945 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 27' ' ' LEU . . . . . 0.666 ' O ' HD12 ' A' ' 27' ' ' LEU . 1.8 tp -59.88 -35.55 75.06 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.88 -179.928 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 28' ' ' CYS . . . . . 0.5 ' C ' ' HB3' ' A' ' 33' ' ' ALA . 2.5 m -64.91 -53.2 50.2 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.887 179.919 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 29' ' ' THR . . . . . 0.841 HG23 ' O ' ' A' ' 25' ' ' ASN . 1.1 p -62.63 -24.61 67.69 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.152 -0.476 . . . . 0.0 111.149 -179.981 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 5.6 mt-10 -59.45 -22.12 61.03 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.862 -179.982 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 31' ' ' ASN . . . . . 0.632 ' O ' HG21 ' A' ' 57' ' ' VAL . 3.6 m-80 -103.28 21.81 15.24 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.91 -179.968 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 83.34 18.83 63.6 Favored Glycine 0 N--CA 1.451 -0.332 0 C-N-CA 120.768 -0.729 . . . . 0.0 112.512 -179.999 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 33' ' ' ALA . . . . . 0.875 ' HB2' ' CD1' ' A' ' 53' ' ' LEU . . . -85.08 148.15 26.29 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.774 0.321 . . . . 0.0 111.099 179.954 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . 0.483 ' HB2' ' CB ' ' A' ' 52' ' ' GLN . 7.8 tt0 -74.7 -31.91 62.02 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.883 -179.943 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 53.9 m -162.1 177.13 9.99 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.813 -179.801 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -172.17 151.75 15.45 Favored Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.777 -0.725 . . . . 0.0 112.505 -179.983 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 37' ' ' TYR . . . . . 0.402 ' HE1' ' CD1' ' A' ' 49' ' ' TRP . 1.1 p90 -154.24 160.4 41.8 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 120.944 0.402 . . . . 0.0 110.897 -179.756 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 38' ' ' CYS . . . . . . . . . . . . . 6.1 t -77.23 119.2 20.57 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.856 179.986 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 39' ' ' GLN . . . . . 0.622 ' NE2' ' N ' ' A' ' 42' ' ' GLY . 0.7 OUTLIER -96.01 117.05 29.9 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.908 -179.986 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 40' ' ' ILE . . . . . 0.451 ' HA ' ' ND2' ' A' ' 46' ' ' ASN . 0.8 OUTLIER -96.58 -36.22 6.19 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.131 -0.486 . . . . 0.0 111.109 179.983 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 7.1 mt -84.52 55.88 3.59 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.911 179.895 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . 0.622 ' N ' ' NE2' ' A' ' 39' ' ' GLN . . . -105.27 -167.01 23.87 Favored Glycine 0 N--CA 1.451 -0.336 0 C-N-CA 120.759 -0.734 . . . . 0.0 112.438 179.939 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 43' ' ' LYS . . . . . 0.555 ' HD2' ' CE2' ' A' ' 44' ' ' TYR . 0.4 OUTLIER -101.52 -23.97 14.22 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.822 0.344 . . . . 0.0 110.968 179.982 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 44' ' ' TYR . . . . . 0.555 ' CE2' ' HD2' ' A' ' 43' ' ' LYS . 0.9 OUTLIER -113.21 23.41 13.33 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.938 -179.986 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 92.78 -130.52 10.36 Favored Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.708 -0.758 . . . . 0.0 112.469 179.942 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 46' ' ' ASN . . . . . 0.451 ' ND2' ' HA ' ' A' ' 40' ' ' ILE . 5.5 m120 -92.97 111.6 23.27 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.845 0.355 . . . . 0.0 110.855 -179.838 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 47' ' ' ALA . . . . . 0.409 ' O ' ' HB3' ' A' ' 39' ' ' GLN . . . -129.11 137.76 51.42 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.174 -0.467 . . . . 0.0 111.082 179.898 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 8.5 t -67.88 108.26 2.94 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.889 -179.987 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 49' ' ' TRP . . . . . 0.612 ' CZ3' ' HA ' ' A' ' 4' ' ' ALA . 17.8 t-105 -94.76 116.86 29.25 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.948 179.967 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 50' ' ' CYS . . . . . . . . . . . . . 39.7 m -95.83 143.34 27.14 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.892 -179.982 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 51' ' ' ILE . . . . . 0.928 HG23 ' OD2' ' A' ' 3' ' ' ASP . 3.4 mp -108.96 135.75 46.89 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.113 179.918 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 52' ' ' GLN . . . . . 0.483 ' CB ' ' HB2' ' A' ' 34' ' ' GLU . 22.6 mm-40 63.71 43.99 5.3 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.916 179.963 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 53' ' ' LEU . . . . . 0.875 ' CD1' ' HB2' ' A' ' 33' ' ' ALA . 15.5 tp -85.38 137.43 36.77 Favored Pre-proline 0 C--N 1.329 -0.323 0 CA-C-O 121.666 0.746 . . . . 0.0 110.884 -179.992 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 54' ' ' PRO . . . . . 0.83 ' HG2' HG23 ' A' ' 57' ' ' VAL . 54.0 Cg_endo -69.78 147.78 63.46 Favored 'Trans proline' 0 C--N 1.342 0.221 0 C-N-CA 122.664 2.242 . . . . 0.0 112.398 179.841 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 3.8 m-20 -65.02 -5.96 7.54 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.851 179.974 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 7.8 m120 -78.14 -25.53 47.4 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.954 -179.978 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 57' ' ' VAL . . . . . 0.83 HG23 ' HG2' ' A' ' 54' ' ' PRO . 11.4 t -90.77 136.31 27.96 Favored Pre-proline 0 C--N 1.329 -0.288 0 CA-C-O 121.615 0.722 . . . . 0.0 111.132 179.895 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 58' ' ' PRO . . . . . 0.462 ' HD2' ' CG1' ' A' ' 57' ' ' VAL . 53.8 Cg_endo -69.78 135.77 31.25 Favored 'Trans proline' 0 C--N 1.341 0.161 0 C-N-CA 122.608 2.205 . . . . 0.0 112.353 179.945 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 59' ' ' ILE . . . . . 0.599 ' C ' ' HB2' ' A' ' 7' ' ' ALA . 3.9 pt -109.79 154.31 11.31 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.119 179.959 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 60' ' ' ARG . . . . . 0.572 ' CD ' HG12 ' A' ' 13' ' ' VAL . 8.0 tpt180 -65.34 132.67 49.62 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.86 179.933 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . 0.438 ' N ' ' HD2' ' A' ' 60' ' ' ARG . 1.3 pt -125.76 160.63 55.36 Favored Pre-proline 0 C--N 1.329 -0.306 0 CA-C-O 121.589 0.709 . . . . 0.0 111.125 179.969 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -69.73 65.08 1.79 Allowed 'Trans proline' 0 C--N 1.341 0.14 0 C-N-CA 122.715 2.276 . . . . 0.0 112.333 179.877 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -136.03 -173.67 13.07 Favored Glycine 0 N--CA 1.451 -0.308 0 C-N-CA 120.732 -0.746 . . . . 0.0 112.474 179.994 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 33.6 pttt -84.74 143.13 29.35 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.802 0.334 . . . . 0.0 110.878 -179.989 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 65' ' ' CYS . . . . . 0.506 ' SG ' ' N ' ' A' ' 66' ' ' HIS . 2.6 t -94.28 161.54 14.21 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.851 179.944 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 66' ' ' HIS . . . . . 0.506 ' N ' ' SG ' ' A' ' 65' ' ' CYS . 7.8 p80 . . . . . 0 C--N 1.329 -0.295 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.802 179.93 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.231 0.131 0 CA-C-O 120.811 0.339 . . . . 0.0 111.094 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 2' ' ' ARG . . . . . 0.515 ' NE ' ' OD2' ' A' ' 55' ' ' ASP . 30.3 ptt180 -153.24 164.35 38.24 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.866 -179.908 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 3' ' ' ASP . . . . . 0.581 ' OD1' HG23 ' A' ' 51' ' ' ILE . 1.6 m-20 -100.26 139.69 35.57 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.902 179.943 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 4' ' ' ALA . . . . . 0.588 ' HA ' ' CZ3' ' A' ' 49' ' ' TRP . . . -174.88 177.64 1.97 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.149 179.961 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 5' ' ' TYR . . . . . 0.419 ' CE2' ' HE3' ' A' ' 49' ' ' TRP . 13.8 m-85 -84.63 132.03 34.53 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.918 -179.87 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 6' ' ' ILE . . . . . 0.41 HG23 ' HB2' ' A' ' 14' ' ' TYR . 7.0 tt -72.04 136.03 26.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.124 -0.489 . . . . 0.0 111.135 179.9 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 7' ' ' ALA . . . . . 0.734 ' HB2' ' C ' ' A' ' 59' ' ' ILE . . . -101.51 152.65 20.52 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.189 -0.46 . . . . 0.0 111.102 179.828 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 8' ' ' LYS . . . . . 0.57 ' HD2' ' CE2' ' A' ' 14' ' ' TYR . 0.0 OUTLIER -118.0 172.32 4.23 Favored Pre-proline 0 C--N 1.328 -0.344 0 CA-C-O 121.606 0.717 . . . . 0.0 110.883 179.968 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 9' ' ' PRO . . . . . 0.547 ' HD2' ' CB ' ' A' ' 8' ' ' LYS . 53.9 Cg_endo -69.77 104.65 1.35 Allowed 'Trans proline' 0 C--O 1.231 0.163 0 C-N-CA 122.712 2.274 . . . . 0.0 112.327 179.86 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 10' ' ' HIS . . . . . 0.497 ' HA ' ' HA ' ' A' ' 9' ' ' PRO . 4.3 m-70 -131.91 120.14 22.12 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.89 -0.149 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 11' ' ' ASN . . . . . 0.552 ' N ' ' O ' ' A' ' 8' ' ' LYS . 41.5 t30 73.9 28.88 1.49 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.876 -179.903 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 12' ' ' CYS . . . . . 0.412 ' CB ' ' HG3' ' A' ' 8' ' ' LYS . 1.7 m -97.7 168.09 10.55 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.866 179.939 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 13' ' ' VAL . . . . . 0.78 HG12 ' HG2' ' A' ' 60' ' ' ARG . 0.9 OUTLIER -98.67 142.81 14.14 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.178 179.918 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 14' ' ' TYR . . . . . 0.57 ' CE2' ' HD2' ' A' ' 8' ' ' LYS . 11.2 m-85 -94.51 95.39 8.79 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.916 -179.886 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 4.1 pt-20 -65.01 135.41 55.59 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.878 -179.983 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -105.26 132.19 51.78 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.924 -179.943 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 17' ' ' TYR . . . . . 0.422 ' O ' ' HD3' ' A' ' 19' ' ' PRO . 0.2 OUTLIER -104.85 -38.64 6.58 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.945 -179.881 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 12.0 t-20 -106.22 84.38 1.35 Allowed Pre-proline 0 C--N 1.329 -0.3 0 CA-C-O 121.605 0.717 . . . . 0.0 110.893 179.997 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 19' ' ' PRO . . . . . 0.422 ' HD3' ' O ' ' A' ' 17' ' ' TYR . 53.7 Cg_endo -69.72 -27.39 26.7 Favored 'Trans proline' 0 C--N 1.341 0.164 0 C-N-CA 122.688 2.259 . . . . 0.0 112.322 179.93 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 19.1 mmtt -94.77 24.06 4.99 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.873 179.949 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -134.02 -174.59 13.57 Favored Glycine 0 N--CA 1.452 -0.276 0 C-N-CA 120.732 -0.747 . . . . 0.0 112.474 179.92 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 93.3 p -94.72 27.4 3.08 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.863 0.363 . . . . 0.0 110.797 -179.706 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 5.4 t80 -63.97 -68.2 0.37 Allowed 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.879 -179.852 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 24' ' ' CYS . . . . . 0.404 ' SG ' ' O ' ' A' ' 37' ' ' TYR . 47.3 t -64.89 -35.15 80.23 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.143 -0.481 . . . . 0.0 110.894 179.979 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 25' ' ' ASN . . . . . 0.83 ' O ' HG23 ' A' ' 29' ' ' THR . 3.4 t30 -58.03 -62.41 1.84 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.869 -179.967 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 89.2 m-20 -54.7 -50.49 68.18 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.847 179.944 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 27' ' ' LEU . . . . . 0.726 ' O ' HD12 ' A' ' 27' ' ' LEU . 1.5 tp -59.4 -38.02 79.5 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.884 -179.981 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 28' ' ' CYS . . . . . 0.461 ' SG ' ' SG ' ' A' ' 48' ' ' CYS . 1.9 m -65.15 -55.63 17.55 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.89 179.937 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 29' ' ' THR . . . . . 0.83 HG23 ' O ' ' A' ' 25' ' ' ASN . 1.1 p -64.07 -32.88 74.6 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.099 -179.918 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 32.6 mt-10 -55.66 -21.61 18.91 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.262 -0.427 . . . . 0.0 110.863 179.995 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 31' ' ' ASN . . . . . 0.428 ' ND2' ' O ' ' A' ' 27' ' ' LEU . 1.8 m-80 -104.1 22.47 14.62 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.876 -179.94 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . 0.518 ' O ' ' CD ' ' A' ' 54' ' ' PRO . . . 83.23 69.31 1.39 Allowed Glycine 0 N--CA 1.451 -0.359 0 C-N-CA 120.772 -0.728 . . . . 0.0 112.515 179.97 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 33' ' ' ALA . . . . . 1.031 ' HB2' ' CD1' ' A' ' 53' ' ' LEU . . . -150.11 158.26 43.97 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.779 0.323 . . . . 0.0 111.098 -179.98 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . 0.5 ' HB2' ' CB ' ' A' ' 52' ' ' GLN . 0.9 OUTLIER -73.85 -40.47 63.26 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.877 -179.902 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 66.2 m -163.57 -176.61 4.77 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.822 -179.785 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -175.19 158.48 26.07 Favored Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.72 -0.753 . . . . 0.0 112.461 -179.938 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 37' ' ' TYR . . . . . 0.483 ' C ' ' CD2' ' A' ' 37' ' ' TYR . 0.0 OUTLIER -162.45 171.87 16.43 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.955 0.407 . . . . 0.0 110.908 -179.823 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 38' ' ' CYS . . . . . . . . . . . . . 42.1 t -74.94 127.45 33.24 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.858 -179.976 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 39' ' ' GLN . . . . . 0.519 ' OE1' ' N ' ' A' ' 41' ' ' LEU . 0.0 OUTLIER -105.33 119.46 39.14 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.898 -179.95 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 40' ' ' ILE . . . . . 0.609 HD12 HD21 ' A' ' 46' ' ' ASN . 1.1 mm -88.41 -41.05 13.95 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 116.187 -0.461 . . . . 0.0 111.119 -179.989 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 41' ' ' LEU . . . . . 0.519 ' N ' ' OE1' ' A' ' 39' ' ' GLN . 3.4 mm? -75.32 47.88 0.4 Allowed 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.898 179.923 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -96.57 136.5 12.83 Favored Glycine 0 N--CA 1.451 -0.352 0 C-N-CA 120.762 -0.733 . . . . 0.0 112.519 179.89 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 33.4 mttm -53.93 -25.16 19.05 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 120.782 0.325 . . . . 0.0 110.874 -179.961 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 0.6 OUTLIER -112.28 24.01 13.03 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.889 -179.94 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 94.12 -134.57 12.11 Favored Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 120.722 -0.752 . . . . 0.0 112.51 179.997 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 46' ' ' ASN . . . . . 0.609 HD21 HD12 ' A' ' 40' ' ' ILE . 8.3 m120 -90.65 112.52 24.28 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-O 120.835 0.35 . . . . 0.0 110.907 -179.881 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -132.59 143.1 49.46 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.1 179.881 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 48' ' ' CYS . . . . . 0.461 ' SG ' ' SG ' ' A' ' 28' ' ' CYS . 51.3 t -65.03 107.49 1.53 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.231 -0.441 . . . . 0.0 110.855 -179.918 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 49' ' ' TRP . . . . . 0.588 ' CZ3' ' HA ' ' A' ' 4' ' ' ALA . 22.5 t-105 -94.9 119.57 33.67 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.929 179.997 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 50' ' ' CYS . . . . . 0.435 ' HB2' HD22 ' A' ' 53' ' ' LEU . 34.5 m -96.87 141.76 29.67 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.866 -179.961 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 51' ' ' ILE . . . . . 0.581 HG23 ' OD1' ' A' ' 3' ' ' ASP . 4.0 mp -105.17 135.99 40.9 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.14 179.936 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 52' ' ' GLN . . . . . 0.5 ' CB ' ' HB2' ' A' ' 34' ' ' GLU . 4.3 mm-40 66.99 33.68 5.63 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.944 179.992 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 53' ' ' LEU . . . . . 1.031 ' CD1' ' HB2' ' A' ' 33' ' ' ALA . 12.5 tp -86.16 132.28 43.95 Favored Pre-proline 0 C--N 1.328 -0.334 0 CA-C-O 121.578 0.704 . . . . 0.0 110.966 -180.0 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 54' ' ' PRO . . . . . 0.521 ' HG2' HG23 ' A' ' 57' ' ' VAL . 54.4 Cg_endo -69.65 150.8 69.38 Favored 'Trans proline' 0 C--O 1.231 0.156 0 C-N-CA 122.694 2.263 . . . . 0.0 112.367 179.861 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 55' ' ' ASP . . . . . 0.515 ' OD2' ' NE ' ' A' ' 2' ' ' ARG . 84.6 m-20 -65.42 -5.89 8.84 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.85 179.924 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 99.1 m-20 -74.71 -25.83 59.4 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.9 -179.971 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 57' ' ' VAL . . . . . 0.521 HG23 ' HG2' ' A' ' 54' ' ' PRO . 1.4 t -84.81 137.19 38.28 Favored Pre-proline 0 C--N 1.33 -0.275 0 CA-C-O 121.581 0.705 . . . . 0.0 111.156 179.895 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 58' ' ' PRO . . . . . 0.516 ' HD2' HG12 ' A' ' 57' ' ' VAL . 54.5 Cg_endo -69.71 126.55 13.47 Favored 'Trans proline' 0 C--O 1.231 0.152 0 C-N-CA 122.674 2.249 . . . . 0.0 112.348 179.905 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 59' ' ' ILE . . . . . 0.734 ' C ' ' HB2' ' A' ' 7' ' ' ALA . 4.8 pt -107.03 164.32 4.75 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.165 179.872 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 60' ' ' ARG . . . . . 0.78 ' HG2' HG12 ' A' ' 13' ' ' VAL . 20.4 tpt180 -75.17 119.59 19.52 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.868 179.982 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . 0.489 ' CG1' ' OD1' ' A' ' 11' ' ' ASN . 0.3 OUTLIER -122.51 160.84 46.64 Favored Pre-proline 0 C--N 1.329 -0.311 0 CA-C-O 121.632 0.729 . . . . 0.0 111.12 179.941 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.75 68.99 1.67 Allowed 'Trans proline' 0 C--N 1.342 0.194 0 C-N-CA 122.667 2.244 . . . . 0.0 112.372 179.904 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -144.22 -175.11 17.06 Favored Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.735 -0.745 . . . . 0.0 112.497 179.978 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 26.4 mtmt -84.98 134.88 34.22 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.787 0.327 . . . . 0.0 110.897 -179.976 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 65' ' ' CYS . . . . . 0.472 ' SG ' ' CD2' ' A' ' 66' ' ' HIS . 47.3 t -95.09 163.99 13.07 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.889 179.934 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 66' ' ' HIS . . . . . 0.472 ' CD2' ' SG ' ' A' ' 65' ' ' CYS . 0.6 OUTLIER . . . . . 0 C--N 1.329 -0.293 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.852 179.991 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . 0.466 ' HB1' ' O ' ' A' ' 53' ' ' LEU . . . . . . . . 0 C--O 1.231 0.116 0 CA-C-O 120.83 0.347 . . . . 0.0 111.088 . . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 2' ' ' ARG . . . . . 0.589 HH22 HG21 ' A' ' 59' ' ' ILE . 6.3 ptt85 -154.6 159.36 40.81 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.852 -179.94 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 4.7 m-20 -92.62 132.81 36.56 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.878 179.949 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 4' ' ' ALA . . . . . 0.591 ' HA ' ' CZ3' ' A' ' 49' ' ' TRP . . . -175.16 -178.7 1.22 Allowed 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.085 179.988 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 5' ' ' TYR . . . . . 0.498 ' CD1' ' HB3' ' A' ' 47' ' ' ALA . 32.9 m-85 -84.36 131.63 34.68 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.917 -179.862 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 6' ' ' ILE . . . . . 0.534 HG23 ' HD1' ' A' ' 14' ' ' TYR . 3.7 tt -74.26 132.98 32.51 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-N 116.119 -0.491 . . . . 0.0 111.111 179.92 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 7' ' ' ALA . . . . . 0.788 ' HB2' ' C ' ' A' ' 59' ' ' ILE . . . -86.14 155.11 20.9 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.114 179.807 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 8' ' ' LYS . . . . . 0.551 ' HB2' ' CZ ' ' A' ' 14' ' ' TYR . 0.0 OUTLIER -133.54 167.19 24.17 Favored Pre-proline 0 C--N 1.329 -0.312 0 CA-C-O 121.566 0.698 . . . . 0.0 110.905 179.933 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 9' ' ' PRO . . . . . 0.484 ' HA ' ' HA ' ' A' ' 10' ' ' HIS . 53.7 Cg_endo -69.73 105.61 1.51 Allowed 'Trans proline' 0 C--O 1.231 0.154 0 C-N-CA 122.656 2.237 . . . . 0.0 112.363 179.902 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 10' ' ' HIS . . . . . 0.484 ' HA ' ' HA ' ' A' ' 9' ' ' PRO . 6.4 m-70 -131.35 128.94 40.72 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.92 -0.072 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 11' ' ' ASN . . . . . 0.486 ' OD1' ' CG1' ' A' ' 61' ' ' ILE . 3.6 t30 60.23 34.4 20.97 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.836 -179.916 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 12' ' ' CYS . . . . . 0.478 ' HB2' ' CD ' ' A' ' 8' ' ' LYS . 1.6 m -114.53 153.15 30.55 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.884 179.963 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 13' ' ' VAL . . . . . 0.553 HG12 ' CD ' ' A' ' 60' ' ' ARG . 0.9 OUTLIER -84.53 152.38 3.72 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.141 -0.481 . . . . 0.0 111.121 179.947 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 14' ' ' TYR . . . . . 0.551 ' CZ ' ' HB2' ' A' ' 8' ' ' LYS . 9.1 m-85 -94.8 89.56 5.73 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.123 -0.489 . . . . 0.0 110.902 -179.917 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 5.0 tp10 -64.93 136.47 56.86 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.812 -179.947 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 6.6 p -84.46 159.57 20.74 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.114 -0.493 . . . . 0.0 110.906 -179.974 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -96.72 -32.83 11.96 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.923 -179.894 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 18' ' ' ASN . . . . . 0.603 ' CG ' ' HD2' ' A' ' 19' ' ' PRO . 1.8 t-20 -154.41 146.86 17.52 Favored Pre-proline 0 C--N 1.329 -0.284 0 CA-C-O 121.624 0.726 . . . . 0.0 110.862 -179.969 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 19' ' ' PRO . . . . . 0.603 ' HD2' ' CG ' ' A' ' 18' ' ' ASN . 53.8 Cg_endo -69.75 -32.85 17.8 Favored 'Trans proline' 0 C--O 1.232 0.191 0 C-N-CA 122.738 2.292 . . . . 0.0 112.353 179.922 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 20.5 mmtt -94.55 24.56 4.5 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.871 179.892 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -114.63 132.37 10.39 Favored Glycine 0 N--CA 1.452 -0.267 0 C-N-CA 120.758 -0.734 . . . . 0.0 112.458 179.919 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 4.9 m -83.56 24.71 0.83 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.874 0.369 . . . . 0.0 110.838 -179.724 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 7.2 t80 -64.27 -43.15 95.72 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.933 -179.864 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 24' ' ' CYS . . . . . 0.405 ' SG ' ' O ' ' A' ' 37' ' ' TYR . 43.2 t -67.69 -42.75 81.58 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.899 179.971 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 25' ' ' ASN . . . . . 0.869 ' O ' HG23 ' A' ' 29' ' ' THR . 0.8 OUTLIER -55.1 -56.33 21.07 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.926 179.995 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 55.2 m-20 -55.3 -52.22 64.16 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.895 179.897 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 27' ' ' LEU . . . . . 0.705 ' O ' HD12 ' A' ' 27' ' ' LEU . 1.7 tp -58.24 -38.88 77.74 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.915 -179.962 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 28' ' ' CYS . . . . . 0.565 ' C ' ' HB3' ' A' ' 33' ' ' ALA . 11.0 m -62.12 -51.27 68.58 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.919 179.895 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 29' ' ' THR . . . . . 0.869 HG23 ' O ' ' A' ' 25' ' ' ASN . 1.1 p -62.99 -24.75 68.06 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.129 -0.487 . . . . 0.0 111.172 -179.964 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 19.5 tp10 -59.2 -22.82 61.63 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.864 -179.966 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 31' ' ' ASN . . . . . 0.625 ' O ' HG21 ' A' ' 57' ' ' VAL . 1.8 m-80 -103.7 22.02 15.15 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.9 -179.956 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 83.29 19.96 61.46 Favored Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.755 -0.736 . . . . 0.0 112.456 -179.995 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 33' ' ' ALA . . . . . 0.779 ' HB2' HD13 ' A' ' 53' ' ' LEU . . . -85.16 147.7 26.48 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.776 0.322 . . . . 0.0 111.099 179.936 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . 0.493 ' HB2' ' CB ' ' A' ' 52' ' ' GLN . 5.8 tp10 -74.72 -31.37 61.82 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.911 -179.933 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 1.9 m -162.27 177.62 9.44 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.873 -179.829 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . 0.458 ' CA ' ' HA ' ' A' ' 25' ' ' ASN . . . -174.23 154.71 19.89 Favored Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 120.68 -0.772 . . . . 0.0 112.423 -179.924 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 37' ' ' TYR . . . . . 0.405 ' O ' ' SG ' ' A' ' 24' ' ' CYS . 48.8 p90 -165.35 166.37 18.68 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.964 0.411 . . . . 0.0 110.897 -179.819 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 38' ' ' CYS . . . . . . . . . . . . . 13.2 t -74.81 120.81 20.86 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.869 -179.985 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 39' ' ' GLN . . . . . 0.5 ' NE2' ' CD2' ' A' ' 49' ' ' TRP . 0.0 OUTLIER -104.06 127.29 51.62 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.899 -179.974 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 40' ' ' ILE . . . . . 0.908 HG23 HD21 ' A' ' 46' ' ' ASN . 0.7 OUTLIER -95.53 -31.1 4.1 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.095 179.97 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 2.0 tt -77.28 47.08 0.54 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.934 179.919 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -101.77 138.87 14.13 Favored Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.711 -0.757 . . . . 0.0 112.485 179.881 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 1.8 mtmm -57.37 -24.65 56.57 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.768 0.318 . . . . 0.0 110.881 -179.944 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 1.1 m-85 -111.08 23.43 14.12 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.931 -179.946 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 93.22 -137.63 13.72 Favored Glycine 0 N--CA 1.451 -0.344 0 C-N-CA 120.719 -0.753 . . . . 0.0 112.498 179.992 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 46' ' ' ASN . . . . . 0.908 HD21 HG23 ' A' ' 40' ' ' ILE . 18.8 m120 -86.45 117.76 25.45 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.85 0.357 . . . . 0.0 110.863 -179.894 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 47' ' ' ALA . . . . . 0.498 ' HB3' ' CD1' ' A' ' 5' ' ' TYR . . . -135.75 147.27 48.36 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.098 179.864 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 24.1 t -66.67 108.19 2.39 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.842 -179.957 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 49' ' ' TRP . . . . . 0.591 ' CZ3' ' HA ' ' A' ' 4' ' ' ALA . 53.6 t-105 -94.39 112.62 24.41 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.907 179.957 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 50' ' ' CYS . . . . . . . . . . . . . 34.8 m -95.12 142.41 27.6 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.913 179.969 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 51' ' ' ILE . . . . . 0.406 ' O ' ' HB2' ' A' ' 52' ' ' GLN . 3.8 mm -106.62 133.81 50.08 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.109 179.94 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 52' ' ' GLN . . . . . 0.493 ' CB ' ' HB2' ' A' ' 34' ' ' GLU . 3.4 mm-40 64.77 45.36 3.39 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.88 179.925 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 53' ' ' LEU . . . . . 0.779 HD13 ' HB2' ' A' ' 33' ' ' ALA . 14.6 tp -85.67 134.79 39.09 Favored Pre-proline 0 C--N 1.329 -0.307 0 CA-C-O 121.548 0.689 . . . . 0.0 110.942 -179.997 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 54' ' ' PRO . . . . . 0.847 ' HG2' HG23 ' A' ' 57' ' ' VAL . 53.9 Cg_endo -69.7 146.5 60.73 Favored 'Trans proline' 0 C--O 1.231 0.144 0 C-N-CA 122.668 2.245 . . . . 0.0 112.385 179.864 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 3.4 m-20 -65.18 -5.58 7.19 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.848 179.958 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 10.9 m120 -79.26 -26.39 42.4 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.921 -179.953 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 57' ' ' VAL . . . . . 0.847 HG23 ' HG2' ' A' ' 54' ' ' PRO . 21.3 t -88.85 136.7 30.48 Favored Pre-proline 0 C--N 1.33 -0.265 0 CA-C-O 121.571 0.701 . . . . 0.0 111.164 179.861 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 58' ' ' PRO . . . . . 0.471 ' HD2' HG13 ' A' ' 57' ' ' VAL . 53.6 Cg_endo -69.76 143.26 50.26 Favored 'Trans proline' 0 C--N 1.341 0.181 0 C-N-CA 122.71 2.273 . . . . 0.0 112.345 179.974 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 59' ' ' ILE . . . . . 0.788 ' C ' ' HB2' ' A' ' 7' ' ' ALA . 5.2 pt -117.03 168.9 7.95 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-N 116.255 -0.43 . . . . 0.0 111.156 179.895 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 60' ' ' ARG . . . . . 0.553 ' CD ' HG12 ' A' ' 13' ' ' VAL . 13.7 tpt180 -75.22 121.52 22.26 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.841 179.957 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . 0.653 HD13 ' N ' ' A' ' 61' ' ' ILE . 0.0 OUTLIER -110.26 160.46 28.25 Favored Pre-proline 0 C--N 1.329 -0.299 0 CA-C-O 121.589 0.709 . . . . 0.0 111.157 179.952 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -69.76 64.89 1.8 Allowed 'Trans proline' 0 C--N 1.341 0.16 0 C-N-CA 122.693 2.262 . . . . 0.0 112.381 179.84 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -142.56 -174.15 14.85 Favored Glycine 0 N--CA 1.451 -0.344 0 C-N-CA 120.739 -0.743 . . . . 0.0 112.476 180.0 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -85.16 151.23 24.26 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 120.797 0.332 . . . . 0.0 110.956 179.968 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 65' ' ' CYS . . . . . 0.601 ' SG ' ' CD2' ' A' ' 66' ' ' HIS . 1.2 t -95.13 160.92 14.33 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.885 179.953 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 66' ' ' HIS . . . . . 0.601 ' CD2' ' SG ' ' A' ' 65' ' ' CYS . 1.0 OUTLIER . . . . . 0 C--N 1.329 -0.31 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.857 179.981 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . 0.812 ' HB3' ' C ' ' A' ' 52' ' ' GLN . . . . . . . . 0 C--O 1.231 0.123 0 CA-C-O 120.759 0.314 . . . . 0.0 111.09 . . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 2' ' ' ARG . . . . . 0.528 ' NH1' HD13 ' A' ' 59' ' ' ILE . 3.3 ptm180 -90.71 -175.52 4.42 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.85 -179.922 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -145.55 121.43 10.62 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.892 179.979 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 4' ' ' ALA . . . . . 0.588 ' HA ' ' CZ3' ' A' ' 49' ' ' TRP . . . -173.89 -172.24 0.72 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.082 179.984 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 5' ' ' TYR . . . . . 0.546 ' CE1' ' HB2' ' A' ' 49' ' ' TRP . 66.9 m-85 -84.23 137.68 33.35 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.92 -179.883 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 6' ' ' ILE . . . . . 0.449 HG23 ' HD1' ' A' ' 14' ' ' TYR . 6.9 tt -75.39 143.84 12.77 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.074 -0.512 . . . . 0.0 111.12 179.924 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -84.6 165.1 18.26 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.2 -0.454 . . . . 0.0 111.113 179.792 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 8' ' ' LYS . . . . . 0.578 ' HB2' ' CE2' ' A' ' 14' ' ' TYR . 0.1 OUTLIER -145.41 165.57 21.06 Favored Pre-proline 0 C--N 1.329 -0.318 0 CA-C-O 121.565 0.698 . . . . 0.0 110.903 -179.973 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 9' ' ' PRO . . . . . 0.483 ' HA ' ' HA ' ' A' ' 10' ' ' HIS . 53.7 Cg_endo -69.78 105.77 1.55 Allowed 'Trans proline' 0 C--N 1.341 0.175 0 C-N-CA 122.691 2.26 . . . . 0.0 112.34 179.909 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 10' ' ' HIS . . . . . 0.483 ' HA ' ' HA ' ' A' ' 9' ' ' PRO . 8.1 m-70 -132.61 122.5 24.81 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.887 -0.127 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 11' ' ' ASN . . . . . 0.479 ' OD1' HD11 ' A' ' 61' ' ' ILE . 3.2 t30 71.73 20.68 4.54 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.893 -179.902 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 12' ' ' CYS . . . . . 0.448 ' HB2' ' HG2' ' A' ' 8' ' ' LYS . 1.5 m -109.57 168.64 9.25 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.892 -179.999 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 13' ' ' VAL . . . . . 0.767 HG12 ' HG2' ' A' ' 60' ' ' ARG . 0.9 OUTLIER -90.8 156.08 3.04 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.135 179.939 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 14' ' ' TYR . . . . . 0.578 ' CE2' ' HB2' ' A' ' 8' ' ' LYS . 4.1 m-85 -94.26 87.0 5.09 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.929 -179.921 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 30.6 tt0 -64.59 120.67 12.81 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.853 -179.986 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 16' ' ' CYS . . . . . 1.147 ' SG ' ' SG ' ' A' ' 24' ' ' CYS . 0.7 OUTLIER -104.45 171.56 7.27 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.158 -0.473 . . . . 0.0 110.894 -179.963 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 17' ' ' TYR . . . . . 0.446 ' O ' ' HD3' ' A' ' 19' ' ' PRO . 67.4 t80 -125.7 -23.79 3.96 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.899 -179.833 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 10.4 t-20 -105.64 85.0 1.32 Allowed Pre-proline 0 C--N 1.329 -0.286 0 CA-C-O 121.626 0.726 . . . . 0.0 110.89 -179.997 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 19' ' ' PRO . . . . . 0.446 ' HD3' ' O ' ' A' ' 17' ' ' TYR . 53.5 Cg_endo -69.88 -24.89 28.6 Favored 'Trans proline' 0 C--N 1.341 0.17 0 C-N-CA 122.636 2.224 . . . . 0.0 112.317 179.983 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 28.6 mmtm -94.4 -24.59 17.29 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.85 179.931 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -80.21 -174.7 47.78 Favored Glycine 0 N--CA 1.452 -0.287 0 C-N-CA 120.737 -0.744 . . . . 0.0 112.496 179.927 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 26.1 m -95.62 25.72 4.38 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.855 0.36 . . . . 0.0 110.814 -179.718 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 1.1 t80 -59.58 -66.88 0.44 Allowed 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.938 -179.894 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 24' ' ' CYS . . . . . 1.147 ' SG ' ' SG ' ' A' ' 16' ' ' CYS . 19.7 m -67.0 -37.39 84.12 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.141 -0.482 . . . . 0.0 110.913 179.953 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 25' ' ' ASN . . . . . 0.783 ' O ' HG23 ' A' ' 29' ' ' THR . 2.5 t30 -57.34 -58.92 6.13 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.114 -0.493 . . . . 0.0 110.891 -179.968 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 12.4 m-20 -56.22 -53.34 58.3 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.9 179.9 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 27' ' ' LEU . . . . . 0.66 ' O ' HD12 ' A' ' 27' ' ' LEU . 1.8 tp -58.99 -35.5 73.32 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.956 -179.962 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 28' ' ' CYS . . . . . 0.471 ' O ' ' HB3' ' A' ' 33' ' ' ALA . 1.7 m -64.36 -58.83 5.37 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.879 179.874 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 29' ' ' THR . . . . . 0.783 HG23 ' O ' ' A' ' 25' ' ' ASN . 1.1 p -62.7 -28.39 69.91 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.124 -0.489 . . . . 0.0 111.143 -179.92 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 41.3 tt0 -55.17 -20.56 10.69 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.866 -179.999 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 31' ' ' ASN . . . . . 0.671 ' O ' HG21 ' A' ' 57' ' ' VAL . 2.0 m-80 -102.51 22.36 13.65 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.878 -179.94 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 95.35 -12.58 67.83 Favored Glycine 0 N--CA 1.452 -0.265 0 C-N-CA 120.766 -0.73 . . . . 0.0 112.497 179.977 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 33' ' ' ALA . . . . . 0.941 ' HB2' HD13 ' A' ' 53' ' ' LEU . . . -62.03 162.23 9.6 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.744 0.306 . . . . 0.0 111.131 179.959 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . 0.482 ' HB2' ' CB ' ' A' ' 52' ' ' GLN . 11.5 tp10 -90.33 -29.72 17.91 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.9 -179.91 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 15.6 m -162.41 179.62 7.68 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.838 -179.799 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -167.97 161.03 34.79 Favored Glycine 0 N--CA 1.452 -0.28 0 C-N-CA 120.721 -0.752 . . . . 0.0 112.47 -179.991 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 37' ' ' TYR . . . . . 0.619 ' CE2' ' CD1' ' A' ' 49' ' ' TRP . 3.3 p90 -162.44 151.86 15.71 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 120.953 0.406 . . . . 0.0 110.939 -179.828 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 38' ' ' CYS . . . . . 0.4 ' CB ' ' HA ' ' A' ' 19' ' ' PRO . 2.0 t -80.32 119.45 23.06 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.88 -179.969 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 39' ' ' GLN . . . . . 0.487 ' OE1' ' N ' ' A' ' 42' ' ' GLY . 1.4 tm0? -105.21 108.59 20.19 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.896 -179.943 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 40' ' ' ILE . . . . . 0.984 ' O ' HD12 ' A' ' 40' ' ' ILE . 0.1 OUTLIER -81.84 -35.79 13.76 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.153 179.983 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 41' ' ' LEU . . . . . 0.439 ' N ' HG13 ' A' ' 40' ' ' ILE . 3.4 mt -78.93 48.01 0.8 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.903 179.913 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . 0.487 ' N ' ' OE1' ' A' ' 39' ' ' GLN . . . -98.66 -179.71 32.01 Favored Glycine 0 N--CA 1.451 -0.303 0 C-N-CA 120.734 -0.746 . . . . 0.0 112.45 179.926 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 43' ' ' LYS . . . . . 0.56 ' HG2' ' CD1' ' A' ' 44' ' ' TYR . 0.3 OUTLIER -83.05 -26.83 30.76 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.787 0.327 . . . . 0.0 110.885 -179.983 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 44' ' ' TYR . . . . . 0.56 ' CD1' ' HG2' ' A' ' 43' ' ' LYS . 1.0 OUTLIER -114.31 24.45 11.92 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.907 -179.968 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 94.42 -133.96 11.81 Favored Glycine 0 N--CA 1.451 -0.342 0 C-N-CA 120.731 -0.747 . . . . 0.0 112.463 179.933 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 3.0 m120 -92.55 109.39 20.79 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 120.843 0.354 . . . . 0.0 110.893 -179.941 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -125.61 140.39 52.77 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.08 179.855 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 3.1 m -66.25 111.27 3.38 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.904 -179.96 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 49' ' ' TRP . . . . . 0.619 ' CD1' ' CE2' ' A' ' 37' ' ' TYR . 45.0 t-105 -94.78 115.13 27.12 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.931 180.0 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 50' ' ' CYS . . . . . . . . . . . . . 33.4 m -97.66 142.72 29.1 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.899 179.994 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 51' ' ' ILE . . . . . 0.495 HD11 ' CD2' ' A' ' 37' ' ' TYR . 4.0 mp -110.97 137.62 42.65 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.14 179.895 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 52' ' ' GLN . . . . . 0.812 ' C ' ' HB3' ' A' ' 1' ' ' ALA . 36.2 mm-40 65.02 41.92 4.42 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.914 179.922 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 53' ' ' LEU . . . . . 0.941 HD13 ' HB2' ' A' ' 33' ' ' ALA . 15.7 tp -85.57 136.16 37.53 Favored Pre-proline 0 C--N 1.328 -0.327 0 CA-C-O 121.568 0.699 . . . . 0.0 110.969 179.961 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 54' ' ' PRO . . . . . 0.875 ' HG2' HG23 ' A' ' 57' ' ' VAL . 53.4 Cg_endo -69.8 147.68 63.12 Favored 'Trans proline' 0 C--N 1.341 0.174 0 C-N-CA 122.701 2.267 . . . . 0.0 112.299 179.93 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 74.3 m-20 -65.03 -5.3 6.01 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.858 179.899 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 5.1 m120 -79.64 -30.28 41.28 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.87 -179.899 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 57' ' ' VAL . . . . . 0.875 HG23 ' HG2' ' A' ' 54' ' ' PRO . 15.5 t -86.55 136.36 35.13 Favored Pre-proline 0 C--N 1.329 -0.307 0 CA-C-O 121.617 0.722 . . . . 0.0 111.134 179.928 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 58' ' ' PRO . . . . . 0.465 ' HD2' ' CG1' ' A' ' 57' ' ' VAL . 54.4 Cg_endo -69.75 141.77 46.15 Favored 'Trans proline' 0 C--O 1.231 0.167 0 C-N-CA 122.681 2.254 . . . . 0.0 112.391 179.939 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 59' ' ' ILE . . . . . 0.528 HD13 ' NH1' ' A' ' 2' ' ' ARG . 5.0 pt -118.61 157.65 20.07 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.104 179.967 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 60' ' ' ARG . . . . . 0.767 ' HG2' HG12 ' A' ' 13' ' ' VAL . 9.3 tpt180 -68.72 117.39 10.37 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.925 179.933 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . 0.479 HD11 ' OD1' ' A' ' 11' ' ' ASN . 1.3 pp -123.21 160.66 49.01 Favored Pre-proline 0 C--N 1.329 -0.308 0 CA-C-O 121.669 0.747 . . . . 0.0 111.118 179.983 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.75 73.39 1.37 Allowed 'Trans proline' 0 C--N 1.342 0.194 0 C-N-CA 122.66 2.24 . . . . 0.0 112.362 179.901 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -135.2 -175.38 13.82 Favored Glycine 0 N--CA 1.451 -0.344 0 C-N-CA 120.705 -0.76 . . . . 0.0 112.479 179.985 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -84.88 115.35 22.72 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.855 0.359 . . . . 0.0 110.897 -179.97 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 65' ' ' CYS . . . . . 0.487 ' O ' ' CG ' ' A' ' 66' ' ' HIS . 8.4 t -94.46 159.66 15.0 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.894 179.977 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 66' ' ' HIS . . . . . 0.487 ' CG ' ' O ' ' A' ' 65' ' ' CYS . 28.8 p80 . . . . . 0 C--N 1.329 -0.318 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.87 179.949 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.232 0.155 0 CA-C-O 120.803 0.335 . . . . 0.0 111.07 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 16.1 ptt180 -152.55 171.43 18.14 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.871 -179.885 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 15.5 m-20 -99.63 130.49 45.87 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.868 179.961 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 4' ' ' ALA . . . . . 0.585 ' HA ' ' CZ3' ' A' ' 49' ' ' TRP . . . -174.94 -178.98 1.31 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.107 179.966 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 19.6 m-85 -84.6 135.33 34.24 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.896 -179.833 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 6' ' ' ILE . . . . . 0.456 HG12 ' CD1' ' A' ' 14' ' ' TYR . 3.1 tt -72.31 133.16 32.33 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.104 -0.498 . . . . 0.0 111.138 179.927 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 7' ' ' ALA . . . . . 0.855 ' HB2' ' C ' ' A' ' 59' ' ' ILE . . . -92.46 143.09 26.71 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.209 -0.45 . . . . 0.0 111.102 179.815 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 8' ' ' LYS . . . . . 0.538 ' HB2' ' CZ ' ' A' ' 14' ' ' TYR . 0.0 OUTLIER -115.09 167.29 10.09 Favored Pre-proline 0 C--N 1.329 -0.316 0 CA-C-O 121.533 0.682 . . . . 0.0 110.907 179.98 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 9' ' ' PRO . . . . . 0.487 ' HA ' ' HA ' ' A' ' 10' ' ' HIS . 54.0 Cg_endo -69.74 103.89 1.23 Allowed 'Trans proline' 0 C--O 1.232 0.202 0 C-N-CA 122.641 2.227 . . . . 0.0 112.359 179.905 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 10' ' ' HIS . . . . . 0.487 ' HA ' ' HA ' ' A' ' 9' ' ' PRO . 2.9 m-70 -129.62 130.12 45.21 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.865 -0.053 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 11' ' ' ASN . . . . . 0.501 ' N ' ' O ' ' A' ' 8' ' ' LYS . 54.6 t-20 58.83 59.74 2.74 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.929 -179.914 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 12' ' ' CYS . . . . . 0.493 ' HB2' ' CD ' ' A' ' 8' ' ' LYS . 1.7 m -139.51 156.76 46.72 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.908 -179.982 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 13' ' ' VAL . . . . . 0.432 ' CG1' ' HE ' ' A' ' 60' ' ' ARG . 2.4 m -84.69 147.74 5.38 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.138 179.886 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 14' ' ' TYR . . . . . 0.538 ' CZ ' ' HB2' ' A' ' 8' ' ' LYS . 11.1 m-85 -94.67 101.01 12.84 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.909 -179.923 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 18.1 pt-20 -64.56 125.25 24.11 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.073 -0.512 . . . . 0.0 110.893 -180.0 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -101.99 135.35 43.71 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.86 -179.912 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 9.5 t80 -115.14 24.86 11.33 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.916 -179.902 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 18' ' ' ASN . . . . . 0.458 ' ND2' ' H ' ' A' ' 21' ' ' GLY . 0.2 OUTLIER -153.07 74.07 6.92 Favored Pre-proline 0 C--N 1.329 -0.309 0 CA-C-O 121.624 0.726 . . . . 0.0 110.849 -179.998 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.76 -19.89 35.54 Favored 'Trans proline' 0 C--O 1.232 0.18 0 C-N-CA 122.714 2.276 . . . . 0.0 112.317 179.903 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 56.8 mttm -94.16 -24.27 17.6 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.915 179.917 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 21' ' ' GLY . . . . . 0.458 ' H ' ' ND2' ' A' ' 18' ' ' ASN . . . -93.93 -176.99 39.51 Favored Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.702 -0.761 . . . . 0.0 112.468 179.925 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 52.6 p -95.49 25.83 4.25 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.906 0.384 . . . . 0.0 110.853 -179.721 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 23' ' ' TYR . . . . . 0.419 ' CD2' ' C ' ' A' ' 23' ' ' TYR . 1.1 t80 -55.0 -69.46 0.13 Allowed 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.91 -179.885 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 50.4 t -56.99 -36.61 70.56 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.103 -0.498 . . . . 0.0 110.905 179.966 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -57.87 -55.09 39.43 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.9 -179.946 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 47.7 m-20 -57.88 -52.71 64.35 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.174 -0.467 . . . . 0.0 110.794 179.958 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 27' ' ' LEU . . . . . 0.683 ' O ' HD12 ' A' ' 27' ' ' LEU . 1.7 tp -59.54 -37.4 78.3 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.965 -179.945 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 1.3 m -65.25 -54.53 27.97 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.874 179.884 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 29' ' ' THR . . . . . 0.617 HG22 ' O ' ' A' ' 33' ' ' ALA . 13.2 p -62.73 -29.15 70.46 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.139 -179.951 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 7.4 tp10 -54.69 -19.17 5.65 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.903 -179.981 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 31' ' ' ASN . . . . . 0.675 ' O ' HG21 ' A' ' 57' ' ' VAL . 2.3 m-80 -101.64 21.41 14.44 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.913 -179.946 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 95.5 -12.73 67.5 Favored Glycine 0 N--CA 1.452 -0.268 0 C-N-CA 120.682 -0.771 . . . . 0.0 112.463 -179.992 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 33' ' ' ALA . . . . . 0.91 ' HB2' HD13 ' A' ' 53' ' ' LEU . . . -61.75 153.91 27.1 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.729 0.3 . . . . 0.0 111.11 179.994 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . 0.424 ' CD ' ' HB3' ' A' ' 52' ' ' GLN . 67.0 mt-10 -85.6 -24.79 27.01 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.929 -179.959 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 12.4 m -161.99 177.88 9.37 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.841 -179.799 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -175.44 158.39 25.65 Favored Glycine 0 N--CA 1.452 -0.263 0 C-N-CA 120.722 -0.751 . . . . 0.0 112.448 -179.973 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 32.6 p90 -164.83 166.86 19.35 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.91 0.386 . . . . 0.0 110.904 -179.831 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 38' ' ' CYS . . . . . . . . . . . . . 4.1 t -75.33 124.3 26.87 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.11 -0.496 . . . . 0.0 110.857 179.996 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 2.4 tt0 -105.19 118.18 35.89 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.9 -179.978 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 40' ' ' ILE . . . . . 0.463 ' HA ' ' ND2' ' A' ' 46' ' ' ASN . 0.9 OUTLIER -88.3 -29.32 5.38 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.102 179.974 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 14.0 mt -82.58 38.91 0.58 Allowed 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.924 179.935 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -87.91 139.14 15.59 Favored Glycine 0 N--CA 1.45 -0.367 0 C-N-CA 120.762 -0.732 . . . . 0.0 112.479 179.92 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 39.1 mttp -53.79 -25.09 17.54 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.856 0.36 . . . . 0.0 110.904 -179.953 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 0.4 OUTLIER -113.85 24.41 12.11 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.945 179.992 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 94.3 -137.58 13.59 Favored Glycine 0 N--CA 1.452 -0.288 0 C-N-CA 120.736 -0.745 . . . . 0.0 112.445 179.962 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 46' ' ' ASN . . . . . 0.463 ' ND2' ' HA ' ' A' ' 40' ' ' ILE . 11.0 m120 -85.69 111.53 20.19 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.826 0.346 . . . . 0.0 110.907 -179.848 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -130.62 145.51 51.92 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.109 179.91 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 14.6 t -65.44 110.29 2.61 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.899 -179.985 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 49' ' ' TRP . . . . . 0.585 ' CZ3' ' HA ' ' A' ' 4' ' ' ALA . 41.6 t-105 -94.97 127.33 40.94 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.949 179.971 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 50' ' ' CYS . . . . . . . . . . . . . 29.9 m -108.41 141.02 40.88 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.841 -179.953 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 51' ' ' ILE . . . . . 0.665 HG22 ' HG2' ' A' ' 52' ' ' GLN . 4.0 mm -108.06 130.99 59.64 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.126 179.917 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 52' ' ' GLN . . . . . 0.665 ' HG2' HG22 ' A' ' 51' ' ' ILE . 4.0 mm-40 67.72 43.08 1.87 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.921 179.955 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 53' ' ' LEU . . . . . 0.91 HD13 ' HB2' ' A' ' 33' ' ' ALA . 15.1 tp -85.6 135.53 38.19 Favored Pre-proline 0 C--N 1.328 -0.339 0 CA-C-O 121.582 0.706 . . . . 0.0 110.949 -179.955 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 54' ' ' PRO . . . . . 0.802 ' HG2' HG23 ' A' ' 57' ' ' VAL . 53.6 Cg_endo -69.81 145.68 57.6 Favored 'Trans proline' 0 C--N 1.341 0.179 0 C-N-CA 122.697 2.265 . . . . 0.0 112.31 179.914 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -61.4 -9.1 4.79 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.867 179.936 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 67.6 m-20 -74.85 -24.84 58.65 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.872 -179.867 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 57' ' ' VAL . . . . . 0.802 HG23 ' HG2' ' A' ' 54' ' ' PRO . 11.1 t -90.31 136.29 28.7 Favored Pre-proline 0 C--N 1.329 -0.305 0 CA-C-O 121.622 0.725 . . . . 0.0 111.12 179.883 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 58' ' ' PRO . . . . . 0.467 ' HD2' ' CG1' ' A' ' 57' ' ' VAL . 53.8 Cg_endo -69.77 146.59 60.57 Favored 'Trans proline' 0 C--O 1.232 0.181 0 C-N-CA 122.68 2.253 . . . . 0.0 112.37 179.924 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 59' ' ' ILE . . . . . 0.855 ' C ' ' HB2' ' A' ' 7' ' ' ALA . 10.2 pt -123.89 159.98 28.37 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.116 179.964 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 60' ' ' ARG . . . . . 0.446 ' HD3' ' C ' ' A' ' 60' ' ' ARG . 2.9 tpp180 -64.66 111.19 2.64 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.885 179.924 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . 0.483 HG13 ' ND2' ' A' ' 11' ' ' ASN . 0.6 OUTLIER -110.48 161.74 23.39 Favored Pre-proline 0 C--N 1.329 -0.3 0 CA-C-O 121.625 0.726 . . . . 0.0 111.154 179.933 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -69.79 69.75 1.64 Allowed 'Trans proline' 0 C--N 1.342 0.199 0 C-N-CA 122.703 2.269 . . . . 0.0 112.342 179.851 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -144.95 -171.94 15.06 Favored Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.752 -0.737 . . . . 0.0 112.514 179.955 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 9.2 ptpt -85.47 131.23 34.41 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.836 0.35 . . . . 0.0 110.883 -179.964 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 65' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -91.06 140.58 29.7 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.872 179.953 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 66' ' ' HIS . . . . . 0.496 ' CG ' ' O ' ' A' ' 66' ' ' HIS . 26.9 p80 . . . . . 0 C--N 1.33 -0.279 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.824 179.95 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . 0.619 ' HB1' ' O ' ' A' ' 53' ' ' LEU . . . . . . . . 0 C--O 1.231 0.127 0 CA-C-O 120.8 0.333 . . . . 0.0 111.113 . . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 2' ' ' ARG . . . . . 0.441 ' NH1' ' O ' ' A' ' 53' ' ' LEU . 0.0 OUTLIER -136.8 157.04 47.67 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.894 -179.897 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 3' ' ' ASP . . . . . 0.724 ' OD2' HG23 ' A' ' 51' ' ' ILE . 3.0 m-20 -92.34 133.9 35.42 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.898 179.976 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 4' ' ' ALA . . . . . 0.588 ' HA ' ' CZ3' ' A' ' 49' ' ' TRP . . . -173.94 -179.24 1.68 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.101 179.926 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 5' ' ' TYR . . . . . 0.438 ' CD1' ' HB3' ' A' ' 47' ' ' ALA . 21.6 m-85 -84.99 136.41 33.6 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.948 -179.852 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 6' ' ' ILE . . . . . 0.592 HG23 ' HD2' ' A' ' 14' ' ' TYR . 3.5 tt -75.34 135.63 26.75 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-N 116.115 -0.493 . . . . 0.0 111.176 179.901 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 7' ' ' ALA . . . . . 0.513 ' HB2' ' C ' ' A' ' 59' ' ' ILE . . . -85.56 150.98 24.28 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.096 179.849 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 8' ' ' LYS . . . . . 0.554 ' HB2' ' CZ ' ' A' ' 14' ' ' TYR . 0.0 OUTLIER -133.12 166.9 25.88 Favored Pre-proline 0 C--N 1.329 -0.285 0 CA-C-O 121.54 0.686 . . . . 0.0 110.903 179.994 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 9' ' ' PRO . . . . . 0.426 ' HA ' ' HA ' ' A' ' 10' ' ' HIS . 53.6 Cg_endo -69.79 105.53 1.51 Allowed 'Trans proline' 0 C--O 1.232 0.192 0 C-N-CA 122.646 2.231 . . . . 0.0 112.361 179.875 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 10' ' ' HIS . . . . . 0.426 ' HA ' ' HA ' ' A' ' 9' ' ' PRO . 4.1 m-70 -131.28 128.97 40.91 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.872 -0.061 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 11' ' ' ASN . . . . . 0.615 ' OD1' HD11 ' A' ' 61' ' ' ILE . 3.6 t30 59.14 44.52 15.78 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.865 -179.957 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 12' ' ' CYS . . . . . 0.468 ' HB2' ' CE ' ' A' ' 8' ' ' LYS . 1.4 m -129.93 157.56 41.96 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.873 179.978 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 13' ' ' VAL . . . . . 0.532 ' HB ' ' HB1' ' A' ' 47' ' ' ALA . 1.3 m -85.91 155.39 3.42 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.131 -0.486 . . . . 0.0 111.15 179.912 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 14' ' ' TYR . . . . . 0.592 ' HD2' HG23 ' A' ' 6' ' ' ILE . 9.5 m-85 -94.45 94.87 8.49 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.939 -179.94 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 1.8 pm0 -64.6 133.98 53.38 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.869 -179.978 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 1.8 p -84.74 159.92 20.39 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.873 -179.96 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 8.4 t80 -95.47 -32.51 12.85 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.899 -179.865 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 18' ' ' ASN . . . . . 0.605 ' CG ' ' HD2' ' A' ' 19' ' ' PRO . 1.8 t-20 -154.7 147.0 17.46 Favored Pre-proline 0 C--N 1.329 -0.286 0 CA-C-O 121.604 0.716 . . . . 0.0 110.87 179.971 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 19' ' ' PRO . . . . . 0.605 ' HD2' ' CG ' ' A' ' 18' ' ' ASN . 54.1 Cg_endo -69.73 -31.45 20.62 Favored 'Trans proline' 0 C--O 1.231 0.166 0 C-N-CA 122.714 2.276 . . . . 0.0 112.348 179.918 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 2.0 mmmm -94.48 24.57 4.45 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.874 179.934 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -114.75 132.85 10.67 Favored Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.732 -0.747 . . . . 0.0 112.495 179.907 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 67.4 m -83.67 24.87 0.82 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.874 0.369 . . . . 0.0 110.819 -179.712 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 23' ' ' TYR . . . . . 0.42 ' O ' ' CD1' ' A' ' 23' ' ' TYR . 2.6 t80 -64.54 -41.24 96.48 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.134 -0.484 . . . . 0.0 110.916 -179.902 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 24' ' ' CYS . . . . . 0.409 ' SG ' ' O ' ' A' ' 37' ' ' TYR . 47.8 t -69.4 -43.12 74.09 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.866 -179.993 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 25' ' ' ASN . . . . . 0.858 ' O ' HG23 ' A' ' 29' ' ' THR . 1.9 t30 -55.12 -56.39 20.44 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.855 -179.992 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 9.5 m-20 -56.13 -52.3 64.84 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.893 179.939 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 27' ' ' LEU . . . . . 0.663 ' O ' HD12 ' A' ' 27' ' ' LEU . 1.9 tp -58.29 -37.13 74.4 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.872 -179.967 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 28' ' ' CYS . . . . . 0.587 ' C ' ' HB3' ' A' ' 33' ' ' ALA . 10.9 m -63.65 -51.31 65.71 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.231 -0.441 . . . . 0.0 110.874 179.901 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 29' ' ' THR . . . . . 0.858 HG23 ' O ' ' A' ' 25' ' ' ASN . 1.1 p -63.31 -24.54 67.9 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.145 -179.947 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 14.0 tp10 -59.68 -23.17 62.88 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.912 179.966 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 31' ' ' ASN . . . . . 0.581 ' O ' HG21 ' A' ' 57' ' ' VAL . 2.0 m-80 -103.93 22.3 14.82 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.88 -179.95 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 82.78 19.68 62.99 Favored Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.699 -0.762 . . . . 0.0 112.506 179.966 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 33' ' ' ALA . . . . . 0.77 ' HB2' HD13 ' A' ' 53' ' ' LEU . . . -84.92 149.31 25.74 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.775 0.321 . . . . 0.0 111.047 -179.988 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . 0.481 ' HB2' ' CB ' ' A' ' 52' ' ' GLN . 5.7 tp10 -74.84 -34.7 62.34 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.907 -179.947 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 2.4 m -161.77 178.15 9.24 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.868 -179.8 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -169.12 159.77 32.91 Favored Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.735 -0.745 . . . . 0.0 112.49 -179.982 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 37' ' ' TYR . . . . . 0.635 ' CE1' HD11 ' A' ' 51' ' ' ILE . 3.9 p90 -163.84 160.55 22.41 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 120.957 0.408 . . . . 0.0 110.875 -179.778 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 38' ' ' CYS . . . . . . . . . . . . . 2.4 t -74.43 113.02 11.18 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.853 179.974 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 39' ' ' GLN . . . . . 0.503 ' OE1' ' N ' ' A' ' 41' ' ' LEU . 0.0 OUTLIER -90.3 122.99 33.7 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.889 179.994 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 40' ' ' ILE . . . . . 0.509 HD13 ' OD1' ' A' ' 46' ' ' ASN . 2.5 mm -92.81 -51.42 11.34 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.138 179.94 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 41' ' ' LEU . . . . . 0.539 HD23 ' H ' ' A' ' 41' ' ' LEU . 0.1 OUTLIER -75.17 57.93 0.88 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.121 -0.491 . . . . 0.0 110.976 179.887 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -99.93 144.14 16.77 Favored Glycine 0 N--CA 1.451 -0.358 0 C-N-CA 120.747 -0.74 . . . . 0.0 112.465 179.954 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 55.8 tttp -53.91 -26.14 23.64 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.785 0.326 . . . . 0.0 110.92 179.997 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 0.9 OUTLIER -115.25 23.83 12.14 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.926 -179.988 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 93.65 -132.66 11.31 Favored Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.791 -0.719 . . . . 0.0 112.48 179.946 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 46' ' ' ASN . . . . . 0.509 ' OD1' HD13 ' A' ' 40' ' ' ILE . 0.9 OUTLIER -90.69 117.32 29.25 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.786 0.327 . . . . 0.0 110.922 -179.908 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 47' ' ' ALA . . . . . 0.532 ' HB1' ' HB ' ' A' ' 13' ' ' VAL . . . -140.72 146.16 37.41 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.086 179.91 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 48' ' ' CYS . . . . . 0.451 ' N ' ' O ' ' A' ' 14' ' ' TYR . 40.1 t -67.39 109.33 3.12 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.891 -179.957 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 49' ' ' TRP . . . . . 0.588 ' CZ3' ' HA ' ' A' ' 4' ' ' ALA . 36.9 t-105 -94.66 114.22 26.13 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.917 -179.997 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 50' ' ' CYS . . . . . . . . . . . . . 42.6 m -94.96 142.43 27.49 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.888 -179.962 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 51' ' ' ILE . . . . . 0.724 HG23 ' OD2' ' A' ' 3' ' ' ASP . 3.7 mp -105.92 133.85 49.15 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.187 -0.46 . . . . 0.0 111.143 179.953 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 52' ' ' GLN . . . . . 0.481 ' CB ' ' HB2' ' A' ' 34' ' ' GLU . 9.3 mm-40 64.49 45.42 3.68 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.906 179.952 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 53' ' ' LEU . . . . . 0.77 HD13 ' HB2' ' A' ' 33' ' ' ALA . 15.3 tp -85.37 134.0 41.31 Favored Pre-proline 0 C--N 1.329 -0.305 0 CA-C-O 121.592 0.711 . . . . 0.0 110.928 -179.999 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 54' ' ' PRO . . . . . 0.841 ' HG2' HG23 ' A' ' 57' ' ' VAL . 53.9 Cg_endo -69.74 147.14 62.33 Favored 'Trans proline' 0 C--O 1.231 0.165 0 C-N-CA 122.662 2.241 . . . . 0.0 112.377 179.87 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 2.4 m-20 -63.88 -6.44 5.97 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.842 179.947 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 9.0 m120 -77.92 -24.94 48.12 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.914 -179.94 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 57' ' ' VAL . . . . . 0.841 HG23 ' HG2' ' A' ' 54' ' ' PRO . 12.3 t -91.14 136.39 27.32 Favored Pre-proline 0 C--N 1.33 -0.251 0 CA-C-O 121.601 0.715 . . . . 0.0 111.115 179.922 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 58' ' ' PRO . . . . . 0.46 ' HD2' ' CG1' ' A' ' 57' ' ' VAL . 54.0 Cg_endo -69.76 136.4 32.89 Favored 'Trans proline' 0 C--O 1.231 0.17 0 C-N-CA 122.724 2.283 . . . . 0.0 112.351 179.953 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 59' ' ' ILE . . . . . 0.513 ' C ' ' HB2' ' A' ' 7' ' ' ALA . 13.9 pt -116.23 164.15 12.82 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.276 -0.42 . . . . 0.0 111.162 179.922 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 60' ' ' ARG . . . . . 0.444 ' C ' ' CD ' ' A' ' 60' ' ' ARG . 0.3 OUTLIER -65.62 106.42 1.46 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.848 179.983 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . 0.615 HD11 ' OD1' ' A' ' 11' ' ' ASN . 1.3 pt -94.87 160.64 30.7 Favored Pre-proline 0 C--N 1.329 -0.315 0 CA-C-O 121.606 0.717 . . . . 0.0 111.171 179.912 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -69.71 66.11 1.75 Allowed 'Trans proline' 0 C--N 1.341 0.159 0 C-N-CA 122.755 2.303 . . . . 0.0 112.352 179.866 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -144.78 -173.86 16.49 Favored Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 120.765 -0.731 . . . . 0.0 112.499 179.973 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 11.4 ttmm -85.1 147.17 26.78 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 120.786 0.327 . . . . 0.0 110.902 -179.944 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 65' ' ' CYS . . . . . 0.561 ' O ' ' CD2' ' A' ' 66' ' ' HIS . 0.8 OUTLIER -94.04 159.53 15.12 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.909 179.947 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 66' ' ' HIS . . . . . 0.561 ' CD2' ' O ' ' A' ' 65' ' ' CYS . 11.5 p80 . . . . . 0 C--N 1.329 -0.296 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.881 179.958 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . 0.564 ' HB1' ' O ' ' A' ' 53' ' ' LEU . . . . . . . . 0 C--O 1.231 0.12 0 CA-C-O 120.759 0.314 . . . . 0.0 111.099 . . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -152.99 150.08 28.85 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.229 -0.442 . . . . 0.0 110.897 -179.904 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 2.7 m-20 -89.02 132.36 34.78 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.859 179.967 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 4' ' ' ALA . . . . . 0.613 ' HA ' ' CZ3' ' A' ' 49' ' ' TRP . . . -174.93 -179.27 1.37 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.11 179.918 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 5' ' ' TYR . . . . . 0.405 ' CE2' ' HE3' ' A' ' 49' ' ' TRP . 12.5 m-85 -84.46 131.49 34.65 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.941 -179.861 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 6' ' ' ILE . . . . . 0.558 HG23 ' HD2' ' A' ' 14' ' ' TYR . 4.9 tt -75.04 146.24 9.77 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.123 179.949 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -84.76 164.05 18.76 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.095 179.839 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 8' ' ' LYS . . . . . 0.549 ' HB2' ' CZ ' ' A' ' 14' ' ' TYR . 0.5 OUTLIER -145.18 168.88 10.93 Favored Pre-proline 0 C--N 1.329 -0.323 0 CA-C-O 121.633 0.73 . . . . 0.0 110.861 179.975 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 9' ' ' PRO . . . . . 0.51 ' HA ' ' HA ' ' A' ' 10' ' ' HIS . 53.0 Cg_endo -69.8 104.94 1.4 Allowed 'Trans proline' 0 C--N 1.342 0.186 0 C-N-CA 122.682 2.255 . . . . 0.0 112.312 179.925 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 10' ' ' HIS . . . . . 0.51 ' HA ' ' HA ' ' A' ' 9' ' ' PRO . 5.5 m-70 -131.87 123.12 26.85 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.838 -0.071 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 11' ' ' ASN . . . . . 0.512 ' N ' ' O ' ' A' ' 8' ' ' LYS . 5.8 t30 69.59 21.42 6.69 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.899 -179.934 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 12' ' ' CYS . . . . . 0.414 ' HB2' ' HG2' ' A' ' 8' ' ' LYS . 1.5 m -108.25 172.01 7.08 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.884 179.975 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 13' ' ' VAL . . . . . 0.576 HG12 ' HG2' ' A' ' 60' ' ' ARG . 0.9 OUTLIER -92.85 155.6 3.11 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.109 179.958 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 14' ' ' TYR . . . . . 0.558 ' HD2' HG23 ' A' ' 6' ' ' ILE . 6.9 m-85 -93.82 95.7 9.29 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.878 -179.855 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 16.2 pt-20 -64.84 137.05 57.54 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.907 179.994 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 15.1 p -84.41 158.41 21.09 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.885 -179.923 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 24.2 t80 -95.57 -33.05 12.54 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.918 -179.866 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 18' ' ' ASN . . . . . 0.599 ' CG ' ' HD2' ' A' ' 19' ' ' PRO . 1.9 t-20 -155.15 147.0 17.15 Favored Pre-proline 0 C--N 1.328 -0.333 0 CA-C-O 121.637 0.732 . . . . 0.0 110.894 179.97 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 19' ' ' PRO . . . . . 0.599 ' HD2' ' CG ' ' A' ' 18' ' ' ASN . 53.4 Cg_endo -69.75 -33.96 15.56 Favored 'Trans proline' 0 C--N 1.342 0.188 0 C-N-CA 122.669 2.246 . . . . 0.0 112.343 179.935 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 3.7 mmmp? -94.61 24.56 4.53 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.87 179.907 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -115.83 135.59 12.3 Favored Glycine 0 N--CA 1.452 -0.281 0 C-N-CA 120.74 -0.743 . . . . 0.0 112.465 179.962 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 83.9 p -83.52 24.86 0.8 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.872 0.368 . . . . 0.0 110.835 -179.719 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 0.4 OUTLIER -60.67 -51.77 67.96 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.909 -179.874 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 24' ' ' CYS . . . . . 0.401 ' SG ' ' O ' ' A' ' 37' ' ' TYR . 42.7 t -62.23 -41.01 98.03 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.853 -179.978 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 25' ' ' ASN . . . . . 0.852 ' O ' HG23 ' A' ' 29' ' ' THR . 0.3 OUTLIER -54.41 -58.43 7.46 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.871 -179.966 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -54.92 -53.83 50.51 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.856 179.945 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 27' ' ' LEU . . . . . 0.699 ' O ' HD12 ' A' ' 27' ' ' LEU . 1.8 tp -56.75 -37.58 71.23 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.89 -179.922 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 28' ' ' CYS . . . . . 0.512 ' C ' ' HB3' ' A' ' 33' ' ' ALA . 4.9 m -63.73 -51.96 62.62 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.897 179.89 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 29' ' ' THR . . . . . 0.852 HG23 ' O ' ' A' ' 25' ' ' ASN . 1.1 p -62.43 -24.77 67.6 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.128 -0.487 . . . . 0.0 111.197 -179.993 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 5.2 tm-20 -58.81 -22.47 58.6 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.892 -180.0 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 31' ' ' ASN . . . . . 0.564 ' O ' HG21 ' A' ' 57' ' ' VAL . 1.8 m-80 -103.4 21.94 15.08 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.92 -179.956 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 83.46 19.23 62.55 Favored Glycine 0 N--CA 1.451 -0.366 0 C-N-CA 120.769 -0.729 . . . . 0.0 112.479 179.99 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 33' ' ' ALA . . . . . 0.831 ' HB2' ' CD1' ' A' ' 53' ' ' LEU . . . -85.24 148.65 25.97 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.801 0.334 . . . . 0.0 111.072 179.973 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . 0.489 ' HB2' ' CB ' ' A' ' 52' ' ' GLN . 5.7 tp10 -74.69 -31.27 61.84 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.837 -179.894 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 2.9 m -162.65 178.61 8.38 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.889 -179.774 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . 0.48 ' CA ' ' HA ' ' A' ' 25' ' ' ASN . . . -174.85 153.62 16.34 Favored Glycine 0 N--CA 1.451 -0.354 0 C-N-CA 120.72 -0.752 . . . . 0.0 112.465 -179.98 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 37' ' ' TYR . . . . . 0.401 ' O ' ' SG ' ' A' ' 24' ' ' CYS . 45.4 p90 -164.36 167.67 19.48 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.936 0.398 . . . . 0.0 110.876 -179.746 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 38' ' ' CYS . . . . . . . . . . . . . 27.0 t -75.11 120.15 20.24 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.845 179.993 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 39' ' ' GLN . . . . . 0.403 ' O ' ' HA ' ' A' ' 46' ' ' ASN . 0.6 OUTLIER -105.5 130.28 53.6 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.95 179.99 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 40' ' ' ILE . . . . . 0.753 ' H ' HD12 ' A' ' 40' ' ' ILE . 1.3 mp -95.35 -33.76 5.0 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-N 116.25 -0.432 . . . . 0.0 111.149 179.966 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 41' ' ' LEU . . . . . 0.457 HD22 ' HA ' ' A' ' 41' ' ' LEU . 0.4 OUTLIER -75.56 48.96 0.47 Allowed 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.918 179.89 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -101.98 139.3 14.35 Favored Glycine 0 N--CA 1.452 -0.298 0 C-N-CA 120.783 -0.722 . . . . 0.0 112.493 179.88 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 38.7 tttp -54.12 -24.97 19.72 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.794 0.33 . . . . 0.0 110.862 -179.966 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 44' ' ' TYR . . . . . 0.44 ' CE1' ' HG3' ' A' ' 60' ' ' ARG . 0.5 OUTLIER -112.65 23.93 13.0 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.922 -179.929 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 93.8 -129.96 10.11 Favored Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 120.711 -0.757 . . . . 0.0 112.439 179.974 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 46' ' ' ASN . . . . . 0.488 ' ND2' ' HA ' ' A' ' 40' ' ' ILE . 28.3 m120 -93.19 119.09 31.99 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.872 0.368 . . . . 0.0 110.875 -179.873 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -139.34 150.49 45.42 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.154 -0.476 . . . . 0.0 111.107 179.849 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 48' ' ' CYS . . . . . 0.447 ' SG ' ' SG ' ' A' ' 28' ' ' CYS . 41.5 t -65.99 109.55 2.59 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.851 -179.926 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 49' ' ' TRP . . . . . 0.613 ' CZ3' ' HA ' ' A' ' 4' ' ' ALA . 38.8 t-105 -95.21 115.17 27.07 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.9 -179.995 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 50' ' ' CYS . . . . . . . . . . . . . 39.9 m -95.79 142.47 28.02 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.834 -179.962 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 51' ' ' ILE . . . . . 0.412 ' O ' ' HB2' ' A' ' 52' ' ' GLN . 3.6 mm -107.52 133.16 53.12 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.145 179.871 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 52' ' ' GLN . . . . . 0.489 ' CB ' ' HB2' ' A' ' 34' ' ' GLU . 12.1 mm-40 64.95 42.8 4.1 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.922 179.958 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 53' ' ' LEU . . . . . 0.831 ' CD1' ' HB2' ' A' ' 33' ' ' ALA . 16.3 tp -85.5 136.77 36.98 Favored Pre-proline 0 C--N 1.329 -0.324 0 CA-C-O 121.611 0.72 . . . . 0.0 110.932 -179.996 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 54' ' ' PRO . . . . . 0.847 ' HG2' HG23 ' A' ' 57' ' ' VAL . 54.3 Cg_endo -69.74 146.07 59.23 Favored 'Trans proline' 0 C--N 1.342 0.194 0 C-N-CA 122.667 2.245 . . . . 0.0 112.394 179.823 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -65.23 -5.16 6.29 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.901 179.928 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 15.4 m-20 -78.35 -28.6 47.19 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.906 -179.947 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 57' ' ' VAL . . . . . 0.847 HG23 ' HG2' ' A' ' 54' ' ' PRO . 14.6 t -86.5 136.4 35.18 Favored Pre-proline 0 C--N 1.329 -0.294 0 CA-C-O 121.641 0.734 . . . . 0.0 111.121 179.917 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 58' ' ' PRO . . . . . 0.464 ' HD2' ' CG1' ' A' ' 57' ' ' VAL . 53.1 Cg_endo -69.77 145.36 56.88 Favored 'Trans proline' 0 C--N 1.342 0.19 0 C-N-CA 122.699 2.266 . . . . 0.0 112.322 179.966 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 41.7 pt -122.66 166.93 16.82 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.161 179.922 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 60' ' ' ARG . . . . . 0.576 ' HG2' HG12 ' A' ' 13' ' ' VAL . 6.0 tpt180 -65.83 128.31 35.49 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.848 -179.998 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . 0.474 ' N ' ' HD2' ' A' ' 60' ' ' ARG . 1.8 pt -138.32 155.41 74.03 Favored Pre-proline 0 C--N 1.329 -0.313 0 CA-C-O 121.65 0.738 . . . . 0.0 111.161 179.941 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.76 75.11 1.24 Allowed 'Trans proline' 0 C--N 1.342 0.204 0 C-N-CA 122.673 2.249 . . . . 0.0 112.345 179.876 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -141.1 -177.44 16.34 Favored Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 120.751 -0.738 . . . . 0.0 112.466 179.987 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 7.6 mtpm? -75.18 111.41 10.4 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.811 0.338 . . . . 0.0 110.884 -179.989 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 65' ' ' CYS . . . . . 0.604 ' SG ' ' CD2' ' A' ' 66' ' ' HIS . 1.6 t -94.84 163.28 13.41 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.913 179.897 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 66' ' ' HIS . . . . . 0.604 ' CD2' ' SG ' ' A' ' 65' ' ' CYS . 0.8 OUTLIER . . . . . 0 C--N 1.33 -0.281 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.836 179.952 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.231 0.085 0 CA-C-O 120.798 0.332 . . . . 0.0 111.072 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 2' ' ' ARG . . . . . 0.455 ' CZ ' ' OD2' ' A' ' 55' ' ' ASP . 5.5 ptt-85 -149.65 177.52 9.69 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.912 -179.905 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 3' ' ' ASP . . . . . 0.582 ' OD2' HG23 ' A' ' 51' ' ' ILE . 4.0 m-20 -107.66 140.15 41.12 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.898 179.935 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 4' ' ' ALA . . . . . 0.587 ' HA ' ' CZ3' ' A' ' 49' ' ' TRP . . . -171.86 -176.85 1.81 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.094 -179.993 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 5' ' ' TYR . . . . . 0.438 ' OH ' ' NE2' ' A' ' 39' ' ' GLN . 29.0 m-85 -92.92 124.51 36.95 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.899 -179.834 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 6' ' ' ILE . . . . . 0.514 HG12 ' CD1' ' A' ' 14' ' ' TYR . 8.4 tt -75.24 135.38 27.33 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.128 -0.487 . . . . 0.0 111.141 179.899 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 7' ' ' ALA . . . . . 0.681 ' HB1' ' O ' ' A' ' 12' ' ' CYS . . . -135.2 140.88 45.66 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.124 179.775 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 8' ' ' LYS . . . . . 0.592 ' HB3' ' CE1' ' A' ' 14' ' ' TYR . 8.2 pttt -101.18 160.85 25.45 Favored Pre-proline 0 C--N 1.329 -0.322 0 CA-C-O 121.622 0.725 . . . . 0.0 110.861 179.958 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 9' ' ' PRO . . . . . 0.508 ' HA ' ' HA ' ' A' ' 10' ' ' HIS . 54.2 Cg_endo -69.74 144.65 54.79 Favored 'Trans proline' 0 C--N 1.342 0.198 0 C-N-CA 122.651 2.234 . . . . 0.0 112.388 179.883 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 10' ' ' HIS . . . . . 0.508 ' HA ' ' HA ' ' A' ' 9' ' ' PRO . 20.7 m170 -101.86 98.87 9.05 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.833 -0.008 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 11' ' ' ASN . . . . . 0.449 ' OD1' ' NH1' ' A' ' 60' ' ' ARG . 35.5 t-20 65.95 73.84 0.37 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.874 -179.931 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 12' ' ' CYS . . . . . 0.681 ' O ' ' HB1' ' A' ' 7' ' ' ALA . 10.0 m -141.19 145.21 35.37 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.928 179.943 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 13' ' ' VAL . . . . . 0.582 HG12 ' NE ' ' A' ' 60' ' ' ARG . 0.8 OUTLIER -84.06 155.32 3.67 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.153 179.943 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 14' ' ' TYR . . . . . 0.592 ' CE1' ' HB3' ' A' ' 8' ' ' LYS . 6.8 m-85 -103.83 88.6 3.08 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.939 -179.912 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -63.82 136.4 57.38 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.09 -0.505 . . . . 0.0 110.915 179.995 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 11.7 p -84.68 130.3 34.72 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.887 -179.948 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 17' ' ' TYR . . . . . 0.426 ' O ' ' HD3' ' A' ' 19' ' ' PRO . 65.1 t80 -101.03 -37.06 8.78 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.907 -179.902 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 13.3 t-20 -106.2 85.25 1.59 Allowed Pre-proline 0 C--N 1.328 -0.332 0 CA-C-O 121.604 0.716 . . . . 0.0 110.889 179.998 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 19' ' ' PRO . . . . . 0.426 ' HD3' ' O ' ' A' ' 17' ' ' TYR . 53.9 Cg_endo -69.76 -27.7 26.17 Favored 'Trans proline' 0 C--N 1.342 0.198 0 C-N-CA 122.65 2.233 . . . . 0.0 112.344 179.935 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 9.7 mmtp -95.02 24.36 4.92 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.919 179.915 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -144.27 -179.91 21.08 Favored Glycine 0 N--CA 1.452 -0.28 0 C-N-CA 120.719 -0.753 . . . . 0.0 112.463 179.976 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 17.6 m -95.21 28.87 2.66 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.907 0.384 . . . . 0.0 110.848 -179.738 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 20.3 t80 -54.94 -58.93 5.61 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.905 -179.87 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 24' ' ' CYS . . . . . 0.459 ' SG ' ' C ' ' A' ' 37' ' ' TYR . 35.5 t -58.0 -32.87 68.33 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.89 -179.995 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 25' ' ' ASN . . . . . 0.845 ' O ' HG23 ' A' ' 29' ' ' THR . 1.5 t30 -65.0 -56.38 13.44 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.928 179.961 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 17.7 m-20 -54.47 -47.91 72.42 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.868 179.938 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 27' ' ' LEU . . . . . 0.74 ' O ' HD12 ' A' ' 27' ' ' LEU . 1.4 tp -63.86 -38.81 92.46 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.972 179.989 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 28' ' ' CYS . . . . . 0.665 ' SG ' ' SG ' ' A' ' 48' ' ' CYS . 7.7 m -65.09 -57.45 8.58 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.894 179.892 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 29' ' ' THR . . . . . 0.845 HG23 ' O ' ' A' ' 25' ' ' ASN . 1.3 p -63.93 -34.52 78.15 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.126 -0.488 . . . . 0.0 111.132 -179.944 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 48.1 tt0 -54.78 -22.14 13.31 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.882 -179.98 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 31' ' ' ASN . . . . . 0.498 ' ND2' ' O ' ' A' ' 27' ' ' LEU . 1.8 m-80 -104.81 23.11 14.0 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.868 -179.959 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . 0.531 ' O ' ' CD ' ' A' ' 54' ' ' PRO . . . 84.53 69.15 1.38 Allowed Glycine 0 N--CA 1.451 -0.36 0 C-N-CA 120.766 -0.731 . . . . 0.0 112.511 179.984 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 33' ' ' ALA . . . . . 0.978 ' HB2' ' CD1' ' A' ' 53' ' ' LEU . . . -150.15 153.65 36.69 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.778 0.323 . . . . 0.0 111.096 -179.998 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . 0.506 ' HB2' ' CB ' ' A' ' 52' ' ' GLN . 19.4 tp10 -74.08 -34.6 64.07 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.863 -179.937 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 22.1 m -163.48 -179.89 6.81 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.876 -179.771 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . 0.422 ' O ' ' CA ' ' A' ' 25' ' ' ASN . . . -176.18 139.23 4.48 Favored Glycine 0 N--CA 1.452 -0.288 0 C-N-CA 120.709 -0.758 . . . . 0.0 112.45 179.955 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 37' ' ' TYR . . . . . 0.575 ' CE1' HD11 ' A' ' 51' ' ' ILE . 1.2 p90 -144.91 164.64 30.48 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-O 120.913 0.387 . . . . 0.0 110.947 -179.799 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 38' ' ' CYS . . . . . . . . . . . . . 39.0 t -74.91 129.43 37.64 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.844 179.998 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 39' ' ' GLN . . . . . 0.438 ' NE2' ' OH ' ' A' ' 5' ' ' TYR . 16.4 tt0 -105.64 125.02 50.51 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.914 179.997 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 40' ' ' ILE . . . . . 0.509 ' HA ' ' ND2' ' A' ' 46' ' ' ASN . 0.7 OUTLIER -95.32 -24.87 4.63 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.154 179.934 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 41' ' ' LEU . . . . . 0.531 ' N ' HD22 ' A' ' 41' ' ' LEU . 2.7 mm? -82.22 35.34 0.44 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.923 179.935 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -92.58 131.76 10.94 Favored Glycine 0 N--CA 1.45 -0.37 0 C-N-CA 120.749 -0.739 . . . . 0.0 112.485 179.924 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -52.01 -24.69 7.01 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.756 0.312 . . . . 0.0 110.871 -179.967 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 0.7 OUTLIER -99.65 23.91 8.94 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.962 -179.957 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 93.81 -84.77 1.05 Allowed Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.725 -0.75 . . . . 0.0 112.498 -179.996 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 46' ' ' ASN . . . . . 0.509 ' ND2' ' HA ' ' A' ' 40' ' ' ILE . 2.5 m120 -144.12 130.49 19.85 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.86 0.362 . . . . 0.0 110.91 -179.916 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -145.95 146.54 31.08 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.105 179.847 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 48' ' ' CYS . . . . . 0.665 ' SG ' ' SG ' ' A' ' 28' ' ' CYS . 50.7 t -65.46 113.8 4.39 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.925 -179.952 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 49' ' ' TRP . . . . . 0.587 ' CZ3' ' HA ' ' A' ' 4' ' ' ALA . 49.6 t-105 -94.98 113.44 25.15 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.929 -179.982 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 50' ' ' CYS . . . . . . . . . . . . . 20.2 m -95.42 139.78 31.23 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.898 -179.994 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 51' ' ' ILE . . . . . 0.582 HG23 ' OD2' ' A' ' 3' ' ' ASP . 4.7 mp -107.25 138.74 31.73 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.095 179.945 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 52' ' ' GLN . . . . . 0.506 ' CB ' ' HB2' ' A' ' 34' ' ' GLU . 2.1 mm-40 67.38 30.77 6.78 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.897 179.955 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 53' ' ' LEU . . . . . 0.978 ' CD1' ' HB2' ' A' ' 33' ' ' ALA . 11.5 tp -85.93 132.88 42.56 Favored Pre-proline 0 C--N 1.328 -0.36 0 CA-C-O 121.616 0.722 . . . . 0.0 110.907 -179.999 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 54' ' ' PRO . . . . . 0.531 ' CD ' ' O ' ' A' ' 32' ' ' GLY . 53.7 Cg_endo -69.73 150.93 69.03 Favored 'Trans proline' 0 C--O 1.232 0.175 0 C-N-CA 122.712 2.275 . . . . 0.0 112.318 179.886 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 55' ' ' ASP . . . . . 0.455 ' OD2' ' CZ ' ' A' ' 2' ' ' ARG . 16.1 m-20 -65.11 -5.82 7.55 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.877 179.911 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 45.1 m-80 -74.93 -24.56 58.51 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.884 -179.908 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 57' ' ' VAL . . . . . 0.491 HG12 ' HD2' ' A' ' 58' ' ' PRO . 1.2 t -84.22 136.63 40.44 Favored Pre-proline 0 C--N 1.329 -0.287 0 CA-C-O 121.685 0.755 . . . . 0.0 111.119 179.936 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 58' ' ' PRO . . . . . 0.491 ' HD2' HG12 ' A' ' 57' ' ' VAL . 53.8 Cg_endo -69.79 130.26 18.99 Favored 'Trans proline' 0 C--N 1.342 0.186 0 C-N-CA 122.668 2.245 . . . . 0.0 112.324 179.971 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 59' ' ' ILE . . . . . 0.842 ' O ' HD13 ' A' ' 61' ' ' ILE . 27.4 pt -107.89 171.31 2.33 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.101 179.938 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 60' ' ' ARG . . . . . 0.582 ' NE ' HG12 ' A' ' 13' ' ' VAL . 5.6 tpt180 -75.76 113.53 13.33 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.871 179.936 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . 0.842 HD13 ' O ' ' A' ' 59' ' ' ILE . 0.0 OUTLIER -108.67 160.51 26.96 Favored Pre-proline 0 C--N 1.329 -0.304 0 CA-C-O 121.6 0.714 . . . . 0.0 111.124 179.986 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.77 64.17 1.8 Allowed 'Trans proline' 0 N--CA 1.465 -0.174 0 C-N-CA 122.692 2.262 . . . . 0.0 112.342 179.911 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -138.98 -179.49 17.42 Favored Glycine 0 N--CA 1.451 -0.351 0 C-N-CA 120.744 -0.741 . . . . 0.0 112.451 -179.989 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 25.9 ttmt -85.39 145.61 27.39 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-O 120.778 0.323 . . . . 0.0 110.871 -179.923 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 65' ' ' CYS . . . . . 0.566 ' SG ' ' CD2' ' A' ' 66' ' ' HIS . 7.9 t -93.85 148.37 22.2 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.885 179.957 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 66' ' ' HIS . . . . . 0.566 ' CD2' ' SG ' ' A' ' 65' ' ' CYS . 1.2 p-80 . . . . . 0 C--N 1.329 -0.313 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.871 -179.996 . . . . . . . . 1 1 . 1 stop_ save_